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Abstract
Cardiovascular disease (CVD) is a major cause premature death. Considerable efforts 
have been made to identify CVD risk factors, including dietary micronutrients. 
However there are no data on the relationship between micronutrients and CVD in 
Saudi Arabia despite the high prevalence of cardiovascular disease in the Middle East. 
Dietary intake was assessed by questionnaire in Saudis with established CVD (n=130) 
and age-matched controls (n=130). Demographic factors, lipid profile, serum trace 
elements, inflammatory markers and markers of antioxidant status were measured in 
each subject. There was a high prevalence of coronary risk factors among cases and 
controls, however, type 2 diabetes mellitus (p<0.0001), a positive smoking habit 
(p<0.0001) and hypertension (p<0.05) were more prevalent among CVD patients. 
They also had a higher intake of energy, total fat, cholesterol, selenium, zinc, copper 
and vitamin A (p<0.05 for all). Serum selenium, urinary copper (p<0.001) and urinary 
zinc (p<0.05) concentrations were lower among CVD patients.
Controls (n=303) were stratified by age, race, and socioeconomic (SE) class to 
investigate the association between nutritional factors and the risk and prevalence of 
coronary disease. Dietary energy and absolute carbohydrate intake fell with age and 
increased with SE class (p<0.05). The youngest group had the highest dietary intake 
of energy, fat, cholesterol (p<0.05), the highest % energy provided by SEA (p<0.001), 
and the lowest % energy as PUFA (p<0.05) compared to the other age groups. The 
intake of fiber also rose with age, and was significantly higher in the older group 
(p<0.05). Higher % energy as fat, dietary PUFA and PUFA/SFA ratio among subjects 
of low SE class than those of middle SE class (p<0.05). Mean cholesterol and SFA 
intake was higher among subjects of Arabian descent than those of Mediterranean
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background (p<0.05). Subjects of Mediterranean background had higher PUFA/SFA 
ratio than Asians and those of Arabian descent (p<0.05).
Among the controls without CVD (n=140), stratified by age; serum caeruloplasmin 
was positively associated with age and Framingham Risk Score whilst soluble 
intercellular adhesion molecule-1 (sICAM-1) was negatively associated with HDL-C 
among diabetic subjects.
New Zealand White rabbits were fed with copper, zinc, both, or neither, and allocated 
to a cholesterol or normal chow diet for 12 weeks (n=8 per group). The cholesterol- 
fed animals were matched for integrated serum cholesterol levels. Dietary 
supplementation with either zinc, copper, or both was associated with reduced 
atherosclerotic lesion formation (p<0.05). Plasma concentrations of lipid peroxides 
were significantly higher in the cholesterol-fed rabbits compared with the chow fed 
animals (P<0.001) and these were reduced significantly by dietary copper or zinc 
supplementation (p<0.001).
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Chapter 1
Introduction and Background
1. Introduction
Advances in molecular biology have led to an improved understanding of the 
mechanisms of atherogenesis and may lead to an improvement in the treatment and 
prevention of vascular diseases. Drugs such as statins, anti-hypertensives and anti­
diabetic treatment have improved outcomes in primary and secondary prevention. But 
despite a general improvement of health across the world, cardiovascular disease 
(CVD) remains a global problem, and coronary heart disease (CHD) is anticipated to 
be a continuing problem, both for the developed and developing countries. CVD 
accounts for almost 25% of deaths globally (Murray and Lopez, 1997). CVD, which 
includes CHD, stroke, and peripheral vascular disease (PVD), is the clinical 
expression of advanced atherosclerosis (Levy, 1981). CHD encompasses angina 
pectoris, myocardial infarction (MI), and sudden cardiac death (SCD). There have 
been changes over the last thirty years in the geographical distribution of the 
incidence of CVD with a significant decline in the industrialized countries and a rise 
in the developing countries (WHO, 1993). In developed countries, CVD, particularly, 
CHD and stroke are the leading causes of mortality, being responsible for 40-50% of 
deaths (Manton,1988). However, the knowledge of the biological mechanism of the 
disease along with the emergence of new technologies and therapeutic interventions 
have led to a 60% decline in mortality from CHD and stroke in America 
(Lewis,2000). The consequences of atherosclerosis impose a heavy financial burden 
on both developed and developing countries and there is no treatment strategy, 
including lipid-lowering medications, that provides optimal amelioration of these 
complications (Zimmet et al,2001).
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1.1 Definition of atherosclerosis
Arteriosclerosis (arterial hardening) is characterized by the thickening of the artery 
wall and luminal narrowing. Arteriosclerosis is most prominently found in 
atherosclerosis. Atherosclerosis is a specific type of arteriosclerosis that affects large 
arteries, and is the underlying pathological condition in most cases of coronary heart 
disease, aortic aneurysm, peripheral vascular disease and stroke.
Acute coronary syndromes (ACS) includes MI, SCD, and unstable angina, are the 
main cause of morbidity and mortality globally (Fuster et al, 1992). Atherosclerosis, 
the underlying cause of ACS, is characterized by a focal, slow and progressive 
accumulation of cells, extracellular matrix (ECM) and lipids in the intima of medium­
sized and large arteries. Complications that precipitate acute manifestations of 
atherosclerosis often happen suddenly. Changes in the internal elastic lamina and 
intimai thickening start to appear in the coronary arteries soon after birth, but in most 
cases clinical complications do not occur until several decades later.
1.2 Pathogenesis and inflammation
Several theories have been proposed concerning the etiology of atherosclerosis. Ross 
and Glomset (1976) initially proposed that vascular smooth muscle cells (SMC) 
migrate from the tunica media of the arterial wall to the intima, and were considered 
as the origin of so called foam cells in the early stages of atherosclerotic changes. This 
was called into question since the discovery of the LDL pathway of Goldstein and 
Brown (1977). Goldstein and Brown (1979) have drawn attention to the role of 
modified LDL and macrophages in the initial stage of the process of atherogenesis. 
Steinberg and his colleagues (1989) have proposed that modification of oxidative 
LDL is the basis of their findings. They hypothesized that various modifications of 
LDL increase its atherogenisity. Since then, oxidatively modified LDL has received
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increasing attention in the field of atherosclerosis research. Afterwards, many 
researchers who worked on the problems of the relation between plasma lipid 
peroxides and atherosclerotic diseases claimed that the lipid peroxide content of the 
blood was higher in the patients with atherosclerotic diseases and suggested that 
lipoperoxides in the circulation were the cause of atherosclerosis (Kovacs et al., 1997).
1.2.1 Endothelial dysfunction 
The vascular endothelium usually provides anticoagulant, vasodilatory, and anti­
inflammatory functions to maintain vascular homeostasis. Endothelial dysfunction 
plays a key role in all stages of atherosclerosis and is characterized by deterioration of 
endothelial vasodilator function. Fatty streaks are the foci of macrophage-derived 
foam cells trapped beneath the endothelial cell lining of the artery. Continued 
recruitment of mononuclear cells and the attendant proliferation and migration of 
SMC result in fibrous plaques (Shanahan and Weissberg,1998). Atherosclerotic 
plaques may develop a necrotic lipid core with increased numbers of macrophages 
and fewer SMC that predispose to plaque rupture (Libby, 1995). This leads to platelet 
activation, thrombosis, and embolism and results in ACS (Davies, 1996). Therefore, it 
is thrombosis superimposed on mature plaques that may be responsible for unstable 
angina, AMI, and SCD. As to that, plaque composition and thrombogenicity have 
emerged as being much more important than plaque size and stenosis severity 
(Libby,2001). Substantial evidence in basic and experimental science has illuminated 
the role of inflammation and the underlying cellular and molecular mechanisms that 
contribute to atherogenesis. Atherosclerosis is now believed to be an inflammatory 
process driven by inflammatory cells, in particular macrophages, in association with 
subendothelial deposition of lipids in the artery wall (Ross, 1999). Macrophage 
recruitment and activation occurs in response to chemotactic and proinflammatory
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molecules that help define and localize the infiammatory response at lesion sites. 
Continuing entry, survival, and replication of monocytes depend on the local 
production of cytokines, which are upregulated by modified lipids (Rajahvashisth et 
al., 1990). Cytokines and growth factors, secreted by the activated inflammatory cells, 
attract SMC into the intima. The migration and proliferation of SMC are facilitated by 
loss of contractile proteins and expression of matrix metalloproteinases (MMP), 
growth factors and matrix proteins which also facilitate synthesis of the matrix 
component of the fibrous cap (Shanahan and Weissberg,1998).
1.2.2 Response to injury theory 
The presence of macrophages and activated lymphocytes in the atherosclerotic plaque 
has raised the concept of atherosclerosis as an infiammatory disorder (Ross, 1993). 
According to the “response to injury” hypothesis of atherosclerosis, endothelial 
dysfunction is the first step in atherosclerosis, illustrated in figure (1.1) (Ross, 1999). 
A number of factors may contribute to endothelial dysfunction, such as, hypertension, 
diabetes mellitus, free radicals caused by smoking, and increased LDL levels. 
Endothelial dysfunction results in increased adhesiveness of the endothelium to 
leukocytes and platelets and increased permeability. The injury also induces the 
endothelium to have procoagulant instead of anticoagulant properties and to form 
cytokines and growth factors. The ongoing infiammatory response stimulates 
migration and proliferation of SMC that become intermixed in the area of 
inflammation to form an intermediate lesion. This response is mediated by monocyte- 
derived macrophages and leads to the release of hydrolytic enzymes, cytokines, 
chemokines and growth factors that lead to focal necrosis and plaque rupture. The 
cycle of accumulation and formation of fibrous tissue leads to fibrous cap. At some
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point the artery can no longer dilate and the lesion may intrude into the lumen and 
alter blood flow, leading to clinical signs and symptoms of ischemia.
ndothelium
Intima
Media
Adventitia
4^ ' A ». ||
m
Figure 1.1: Response to injury hypothesis of atherosclerosis. (1) Chronic endothelial 
injury. (2) Endothelial dysfunction. (3) Smooth muscle cells emigration from media to 
intima. Macrophage activation. (4) Macrophages and smooth muscle cells engulf 
lipid. (5) Smooth muscle proliferation, collagen and other extracellular matrix 
deposition, extracellular lipid. Each of the stages of lesion formation is potentially 
reversible (modified from Ross, 1993).
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1.2.3 Inflammatory markers
Since the recognition that atherosclerosis is an inflammatory disease, attention has 
focused on the potential role of plasma markers of inflammation as risk predictors of 
cardiovascular events (Blake and Ridker,2001). Inflammatory responses contributing 
to the progression of atherosclerosis may either be local, manifested as the activation 
of cells within the plaque microenvironment itself, or systemic, evidenced by acute- 
phase protein production and circulating proinflammatory mediators (Ross, 1993). 
Locally produced inflammatory mediators include products of activated macrophages, 
such as TNF-a and IL-ip that are produced in response to ox-LDL. Systemic 
mediators include and IL-6, C-reactive protein (CRP), and serum amyloid A protein 
(SAA). Inflammatory mediators that influence the development of atherosclerotic 
lesions in animal models can either have proatherogenic or antiatherogenic 
characteristics (Table 1.1).
Inflammation begins with primary proinflammatory cytokine stimulation of secretion 
of chemoattractants such as monocyte chemoattractant protein-1 (MCP-1),
chemokines such as interleukins, growth factors, and cell surface adhesion molecules 
that bind monocyes. All of which may play a major role in atherogenesis and can be 
used as markers of inflammation (Liao, 1998). In the intimai space, monocytes and T 
lymphocytes modulate inflammatory response and form foam cells with intimai 
thickening, plaque formation, and vessel narrowing (Alexander, 1994). This also 
includes the secretion of MMPs, disruption of type I collagen, and plaque disruption. 
Moreover, primary proinflammatory cytokines stimulate the production of secondary 
proinflammatory cytokines such as IL-6, which in turn stimulates the production of 
acute phase proteins, CRP by the liver (Castell et al., 1989).
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Table 1.1: Serum inflammatory markers
Proinflammatory
cytokines
Adhesion molecules
Acute phase reactants
IL-1
TNF-a
IL-6
IL-8
MCP-1
INF-Y
P-selectin
E-selectin
S-selectin
ICAM-1
VC AM-1
CRP
Fibrinogen
SAA
CRP: C-reactive protein, INF-y: interferon-y, IL-1: interlukin-1, IL-6: interlukin-6, IL-8: 
interlukin-8, MCP-1: monocyte chemotactic protein-1, SAA: serum amyloid A protein, TNF- 
a: tumor necrosis factor- a
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CRP circulates and binds to damaged membranes and proteins, fixes compliment, and 
opsonizes the removal of the target by the endothelium. The sequence of 
inflammatory cascade is illustrated in figure (1.2).
The participation of oxidative stress and immune responses in the pathogenesis of 
atherosclerosis is well established (Berliner et al., 1995). Therefore, if atherosclerosis 
is viewed as an inflammatory condition, it is conceivable that acute-phase reactants 
will be elevated to an extent that is proportional to the magnitude of the lesion size. 
During inflammation, serum concentrations of the most sensitive acute-phase 
proteins, CRP and SAA, can rise up to 10,000 fold (Pepys and Baltz,1983). In recent 
years, these “acute phase reactants” have been studied as potential markers of more 
subtle and persistent systemic alterations that may be called “low-grade 
inflammation” (Danesh et al.,2000a). Low-grade inflammation is thereby manifested 
in patients with increased plasma levels of cell adhesion molecules, interleukins, 
oxidative stress, activation and translocation of NF-kB, and increased plasma levels of 
CRP. Many inflammatory markers have been proposed to be of both of indicative and 
prognostic values at different stages of atherosclerosis among other novel markers 
(Table 1.2).
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Figure 1.2: Sequence of inflammatory cascade. Proinflammatory risk factors, such as 
ox-LDL, cause local or systemic inflammation, which triggers the production of 
primary proinflammatory cytokines, such as interlukein-1 and tumor necrosis factor- 
a. Primary proinflammatory cytokines and ox-LDL activate the endothelium and the 
expression of adhesion molecules that are crucial to the recruitment of inflammatory 
cells from blood stream into the vessel wall. In addition, primary proinflammatory 
cytokines stimulate the production of chemoattractant cytokines, which may play a 
major role in atherogenesis and can be used as markers of inflammation. Moreover, 
primary proinflammatory cytokines stimulate the production of secondary 
proinflammatory cytokines, which in turn stimulates the production of acute phase 
proteins by the liver.
Some of the inflammatory markers are discussed in details below:
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Table 1.2: Novel markers for prediction of cardiovascular risk
M arker Example
Oxidative stress TEARS assay
Conjugated dienes
Ethane and pentane gases
Isoprostanes
Lipid-related parameters Lp(a)
PLA2
CETP
Apolipoprotein A1
Apolipoprotein B
Infection, serological Chlamydia pneumoniae
markers Helicobacter pylori
Cytomegalovirus
Herpes viruses
Inflammatory markers Acute-phase reactants
Adhesion molecules
Cytokines
Endothelial function Selectins
Adhesion molecules
Clotting factors Fibrinogen
PAI-1
t-PA
Factor VII
Factor VIII
VWF
Hyperuricemia
Elevated homocysteine Folate
Vitamin B12 metabolites
CETP: cholesterol ester transfer protein, ICAM-1: intracellular adhesion m olecule-1, Lp(a): lipoprotein 
(a), MDA: malondialdehyde, PAI-1: plasminogen activator inhibitor type 1, PLA 2 : phospholipase A 2 , 
TEARS: thiobarbituric acid reactive substances, t-PA: tissue plasminogen activator, VCAM-1: 
vascular cell adhesion m olecule-1, VWF: Von Willebrand factor.
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1.2.3.1 CRP
CRP, the classical acute-phase protein, is produced from liver in response to a wide 
range of stimuli, such as interlukin-6, a proinflammatory cytokine (Pepys and 
Baltz,1983). Increased levels of CRP predict future myocardial infarction 
independently of other cardiovascular risk factors (Ridker et al., 1997). It has also 
been suggested that measurement of CRP in addition to traditional risk factors may 
improve the ability to predict CVD (Ridker et al., 1998a). However there is not 
complete consensus (Levinson,2004).
1.2.3.2 Adhesion molecules
Adhesion of circulating leukocytes to the endothelial cell and subsequent 
transendothelial migration is suggested to be an important step in the initiation of 
atherosclerosis (Ross, 1993). In part, this process is mediated by cellular adhesion 
molecules, expressed on the endothelial membrane in response to several 
inflammatory cytokines, such as interlukin-1, tumor necrosis factor-a, and interferon- 
y (Adams and Shaw, 1994). Pathological studies have shown increased cellular 
adhesion molecules expression in several components of the atherosclerotic plaque 
(Poston et al., 1992).
1.2.3.3 SAA
Serum amyloid A proteins, major acute phase reactants, are produced in response to 
proinflammatory stimuli due to synergistic effects of IL-1 and IL-6 (Steel et al., 1993). 
Their concentrations can rise as much as 1000-fold during inflammation. They rapidly 
bind to HDL after their synthesis and play a role in modifying cholesterol transport 
during inflammatory conditions (Banka et al., 1995).
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1.2.3.4 Proinflammatory cytokines (IL-6, TNF- a)
Cytokines, which cause the de novo hepatic production of acute-phase reactants such 
as C-reactive protein (Pepys and Baltz,1983), have been shown to increase in acute 
coronary syndrome even in the absence of myocardial necrosis (Liuzzo et ah, 1994). 
Thus, both can be potential markers for predicting CVD.
1.3 Epidemiological evidence of inflammation in CVD 
Prospective epidemiological data have generally supported this view, demonstrating 
an association between several inflammatory markers and cardiovascular events in 
apparently healthy middle-aged men (Ridker et al., 1997), in women (Ridker et 
al.,2000), in higher-risk middle-aged men (Kullar et al., 1996), in the elderly with 
subclinical disease (Tracy et al., 1997), and in patients with atherosclerosis (Liuzzo et 
al., 1994) although the data have not been totally consistent (Danesh et al.,2000a). 
Acute coronary events have been attributed to plaque rupture, a condition that may be 
associated with a local inflammatory response within the artery wall (Ross, 1999). 
Because plaque rupture and thrombus formation are thought to be important causes of 
progression of atherosclerotic plaques, CRP may be a good predictor of progression 
of atherosclerosis. Hence it is also possible that serum inflammatory markers are 
predictors of clinical end-points in patients with established atherosclerosis (Wallen et 
al., 1999, Blankenberg et al.2003). However, the use of CRP as a risk marker is not 
universally accepted (Levinson,2004).
Prospective epidemiological studies have also shown a strong and consistent 
association between clinical manifestations of atherothrombotic disease and various 
hemostatic proteins that are also acute-phase reactants such as fibrinogen (Ernst and 
Koenig, 1997), plasminogen-activator inhibitor type-1 (Juhan-Vague et al., 1994), and 
Von Willebrand factor (Thompson et al., 1995).
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CRP measurement has many advantages in the detection and monitoring of acute- 
phase response in systemic inflammation in general and the relation to atheroma and 
its complications in particular. Inflammation is a dynamic event that can change in a 
rather short time, as is also the case with endothelial function. In this context, CRP 
directly increases the endothelial expression of monocyte chemoattractant protein-1 
(Pasceri et al.,2001) and adhesion molecules (Pasceri et al.,2000). The latter exist in a 
soluble form that can be measured in the circulation. Thus it can be suggested that 
CRP may have a direct proatherogenic role by disturbing endothelial function and 
promoting the formation of early atherosclerotic lesions. CRP levels might also be of 
additive value to the prediction power of coronary risk score prediction charts as well 
as being interrelated with other classical determinants of cardiovascular risk. 
Similarly, intercellular adhesion molecules could be used as a marker of subclinical 
atherosclerosis since the focal expression of adhesion molecules seems to be mediated 
in part by modified lipoproteins or their constituents (Caterina et al., 1994).
Several prospective studies have shown that elevated serum caeruloplasmin may be 
an independent coronary risk factor (Reunanen et al., 1992, Mantarri et al., 1994). 
Caeruloplasmin is the major copper-containing plasma protein, and is also an 
important antioxidant in the protection from oxidative stress as well as an acute-phase 
reactant that can be used to indicate systemic inflammation (Atanasiu et al., 1998). 
Given both properties, it is unclear whether elevated caeruloplasmin is an independent 
coronary risk factor or merely an indicator of chronic inflammation.
Risk prediction for CVD was developed to help clinicians in estimating a patient’s 
absolute risk for developing CVD. The earliest prediction equations were developed 
using data from the Framingham heart study and have been periodically updated 
(Wilson et al., 1998). Algorithms currently used to estimate coronary risk do not take
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inflammatory markers into account. Although Framingham risk scores have been 
shown to be positively related to serum high sensitivity (hs)-CRP levels (Albert et 
al.,2003) virtually all of the research on coronary risk assessment has been undertaken 
in Western Caucasian populations, and the relevance of this work to other populations 
has been questioned (Leaverton et al., 1987, Wilson et al., 1998).
1.4 Plasma lipoproteins 
Plasma lipoproteins exist in four major classes: chylomicrons, very low density 
lipoprotein (VLDL), low density lipoprotein (LDL), and high density lipoprotein 
(HDL). Three of the lipoproteins have been associated with risk of CAD: VLDL, and 
LDL are positively associated, and HDL is negatively associated. Chylomicron 
particles contain apolipoprotein B-48 as the structural protein formed exclusively in 
the intestine. VLDL particles are secreted continuously from the liver. They are 
characterized by their apolipoprotein B-lOO content. In the plasma, chylomicrons 
acquire different classes of apo A, apo E and apo C. Apo C II, is an activator of 
lipoprotein lipase (LPL) that stimulates the hydrolysis of triglycerides in 
chylomicrons resulting in the formation of chylomicron remnants particles. LDL 
contains mostly cholesterol and is mostly derived from VLDL plus a de novo 
production in the liver. LDL also contains apolipoprotein B-lOO and trace levels of 
apolipoprotein E. HDL is mostly synthesized in liver and intestine. Apolipoproteins 
A-1, A-11, and D constitute ~ 55% of the protein moiety of HDL molecules. 
However, intestinal HDL does not contain apolipoprotein C and E which are 
synthesized in liver and added to intestinal HDL (reviewed by Ginsberg, 1998).
1.4.1 Lipid metabolism 
In the exogenous lipid pathway, chylomicrons are secreted by the intestines after 
consuming dietary fat. As chylomicrons circulate, triglycerides in their core are
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degraded by LPL. The resultant chylomicron remnants are removed by the liver. 
During their lipolysis, chylomicron associated apolipoproteins are exchanged with 
HDL. The released cholesterol regulates the rate of de novo cholesterol synthesis in 
liver by decreasing the cell content of Hydroxy Methyl Glutaryl CoA reductase. In the 
endogenous lipid pathway, VLDL is secreted from liver, and in the circulation, 
triglycerides are removed by the action of LPL. Apolipoprotein E and C are 
transferred to HDL. At the same time cholesterol esters are transferred from HDL to 
VLDL, a reaction catalyzed by cholesterol ester transfer protein (CETP). When 
VLDL molecules contain equal amounts of cholesterol and triglycerides, they are 
called intermediate density lipoprotein (IDL). IDL has a short lifetime and 
subsequently converted to LDL by hepatic lipases. When LDL is formed, it is taken 
up by specific receptors located on cell surfaces (apo B/E receptors). After entering 
the cells, LDL molecules release their cholesterol content, which contributes to 
membrane formation and to steroid synthesis in adrenal cortex and gonads. 
Cholesterol taken up by receptors inhibits further uptake by reducing the synthesis of 
LDL receptors. The transfer of cholesterol from peripheral tissues to the liver involves 
HDL. Nascent HDL molecules bind to lecithin cholesterol acyltransferase (LCAT) to 
convert its surface phospholipids and free cholesterol into cholesteryl esters and 
lysolecithin (Mayes, 1996). Figure (1.3) provides an overview of lipid metabolism.
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Figure 1.3: Overview of lipid metabolism. The lipid transport can be divided into the 
exogenous pathway, which refers to the metabolism of intestinally derived 
lipoproteins, and the endogenous pathway, which refers to hepatic-derived 
lipoproteins. In the plasma lipid transport is regulated by specific apolipoproteins, 
lipoprotein receptors, lipolytic enzymes and transfer proteins. The liver has a central 
role in the regulation of lipoprotein metabolism. The following review focuses on 
LDL cholesterol metabolism. C: cholesterol, CE: cholesterol esters, CM: 
chylomicrons, CMR: chylomicron remnants, FFA: free fatty acids, HDL: high density 
lipoprotein, IDL: intermediate density lipoprotein, LCAT: lecithin cholesterol 
acyltransferase, LDL: low density lipoprotein, LP: lipoproteins, LPL: lipoprotein 
lipase, VLDL: very low density lipoprotein.
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1.4.2 Lipoproteins and atherogenesis
Epidemiological and clinical studies have provided overwhelming evidence that high 
plasma concentrations of total cholesterol and LDL are strong predictors of CHD 
(Castelli et ah,1986). They have also established that low levels of HDL are 
associated with increased risk (Genest and Cohn, 1995). The total cholesterol/HDL-C 
ratio has been proposed as an atherogenic index for better assessment of CHD risk 
(Castelli et al., 1986). Many investigators have attributed low HDL levels association 
with increased CAD risk to its role in “reverse cholesterol transport”, which is 
believed to remove cholesterol from developing lesions. Whether 
hypertriglyceridemia is an independent risk factor for CHD remains a matter of debate 
but it is increasingly accepted that the presence of hypertriglyceidemia increases the 
likelihood of finding related atherothrombotic metabolic abnormalities (Mussoni et 
al., 1992).
Several other lipoproteins are linked with the formation of lipid-rich plaques and 
thrombosis, these are further discussed below:
1.4.2.1 Small dense LDL 
Early work suggested that small dense LDL particles are part of a cluster of lipid 
abnormalities, collectively termed the atherogenic lipoprotein phenotype (Austin et 
al., 1990). Recent studies have shown that small dense forms of LDL are relatively 
rich in apolipoprotien B and are associated with greater CAD risk (Stampfer et 
al., 1996). Phenotype B subpopulation of LDL is usually accompanied by increased 
plasma triglycerides, decreased HDL-C, and decreased apoA-I concentrations, and 
with insulin resistance (Austin et al., 1990). The atherogenic lipoprotein phenotype is 
one of several associated metabolic disorders comprising the insulin resistance
40
syndrome (Reaven, 1994). The presence of these particles is strongly associated with 
premature risk of CVD (Stampfer et al., 1996).
1.4.2.2 Lipoprotein (a)
Lipoprotein (a) has structural similarities to LDL. The lipid composition of both 
lipoproteins is similar. The major protein component of both is apolipoprotein B-lOO 
but lipoprotein (a) also contains an additional glycosylated protein, apolipoprotein (a) 
(Utermann and Weber, 1983). Elements of the structure of apolipoprotein (a) are 
similar to plasminogen, thus it can interfere with hemolytic function and increase the 
time required for clot hemolysis by competing with the plasminogen receptor 
(McLean et al., 1987). Therefore, lipoprotein (a) may provide a link between 
atherothrombosis and atherosclerosis. Lipoprotein (a) levels have strong genetic links 
and are neither affected by lifestyle nor altered by medication (Scanu,1991). 
Prospective studies of CHD and blood concentration of lipoprotein (a) have yielded a 
clear association (Danesh et al.,2000b) yet, it is not clear whether this association is 
causal.
1.4.2.3 Oxidized-LDL
The oxidative modification of LDL appears to be an important process linking 
hyperlipidemia and the development of atherosclerosis. Various initiators of lipid 
peroxidation, such as metal ions and nitric oxide, can oxidize LDL (Berliner and 
Heinecke,1996). Substantial evidence indicates that ox-LDL plays a major role in the 
pathogenesis of atherosclerosis (Steinberg et al., 1989). Ox-LDL exhibits many 
atherogenic activities, including chemotaxis for T lymphocytes and macrophages, 
cytotoxicity towards endothelial cells, and induction of proinflammatory genes 
(Reaven and Witztum,1996). Oxidized lipoprotein particles and lipid peroxidation 
products have been detected in atherosclerotic lesions. As mentioned earlier the
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appearance of lipid laden foam cells is a characteristic event in the early stages of the 
development of atherosclerosis. Hypercholesterolemia is usually associated with an 
elevation of LDL, which is the ultimate source of cholesterol that accumulates in 
developing foam cells. An increment of LDL levels in lumen and/or shear stress lead 
to an increase in the adhesion of circulating monocytes and T cells to arterial 
endothelial cells and also to an entry of LDL and/or ox-LDL into the intima. Ox-LDL 
is also avidly taken up by macrophages via several types of receptors, greatly 
enhancing intracellular cholesterol accumulation and foam cell formation. LDL 
oxidation also affects gene regulation of vascular cells and promotes expression of a 
number of adhesion molecules (e.g. VCAM-1) and chemotactic proteins (e.g. MCP-1) 
by endothelial cells that may in turn contribute to lesion formation (Figure 1.4) 
(Steinberg and Witztum,1999).
1.5 Conventional risk factors 
Atherosclerosis is a multifactorial disease characterized by the unregulated 
accumulation of lipids in the vessel wall (Epstein, 1979). The hallmark of 
cardiovascular disease risk is the synergistic effect of more than one cardiovascular 
disease risk factor on overall cardiovascular disease risk (Russell et al., 1984). 
Although the etiology of risk factor clustering is unknown, both genetic and 
environmental factors have been implicated. Insulin resistance and hyperinsulinemia 
appear pivotal to risk factor clustering and contribute to the pathogenesis of coexistent 
hypertension, diabetes, dyslipidemia, and atherosclerosis (Reaven, 1994).
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Figure 1.4: Proposed role of LDL oxidation in the initiation of fatty streak lesions. (1) 
LDL crosses the endothelium. (2) Subintimal accumulation of LDL for a sufficiently 
long period leads to oxidative changes and the formation of minimally modified LDL 
and ox-LDL. (3) ox-LDL leads to changes in the expression of monocyte adhesion 
molecules (ICAM-1), monocyte chemoattractant protein (MCP-1), and macrophage 
colony stimulating factors (CSFs). (4) These factors promote the recruitment of 
monocytes. (5) Monocytes differentiate into macrophages. (6) Further oxidation leads 
to foam cells formation. (7) Cholesteryl esters enrichment of smooth muscle cells. (8) 
Increased lipid and cholesterol oxidation render LDL particles cytotoxic, leading to 
further endothelial injury and favoring further entry of LDL and circulating 
monocytes and thus a continuation of the disease process.
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Systematic studies on CVD epidemiology, such as Framingham heart study and the 
seven countries study were initiated over 50 years ago. Standardized information has 
been collected in the seven countries and the MONICA study (1988). The concept of 
risk factors has evolved only over the past 45 years or so, and new factors have been 
added. Research has identified the major risk factors. Accumulated evidence of 
causality through the classical risk factors has increased substantially since 1983 
(Kuulasmaa et al.,2000). The prevalence of the major CHD risk factors and their 
synergistic effect on the risk of developing CHD has been documented in several 
major prospective studies (Keys, 1970; Kannel et al., 1976; Shaper et al., 1985). 
However, CHD rarely has a single cause but is usually multifactorial in origin. 
Furthermore, risk factors interact in complex ways but often multiplicatively. The 
cause of atherosclerosis is uncertain, but several acquired and genetic factors have 
been identified that seem to determine an individual’s risk of developing the disease. 
The most important of these risk factors are summarized in table (1.3). Lesion 
progression depends on the genetic make-up, gender, and certain well-recognized risk 
factors as well as a number of non-traditional risk factors that are currently the subject 
of intense investigation. Extensive epidemiological studies have identified newly 
emerging factors such as homocysteine and C-reactive protein. Approximately 300 
cardiovascular risk factors have been reported in the literature. Although, many of 
them have been evaluated in epidemiological studies, most of them are not at present 
used routinely for patient screening (Pahor et al., 1999). However, such risk factors are 
associated with only about 50% of cases of CVD (Braunwald, 1997). Therefore, all the 
efforts to control them have led to a very modest decrease in the clinical 
manifestations and complications of the disease.
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Table 1.3: Categorization of classical cardiovascular risk factors
Category Examples Reference
Non-modifiable Advancing age Kannel and Gordon, 1987
Male sex Wenger, 1990
Ethnicity Keys et ah, 1984
Family history Marenberg et ah, 1994
Behavioural Physical inactivity Wannamethee et ah, 1998
Smoking Howard et ah, 1998
Heavy alcohol consumption Frankel et ah, 1993
Nutrition factors (high saturated fat) Keys, 1957
Physiological Hypertension Kannel, 1996
Diabetes mellitus and impaired 
glucose tolerance
Yudkin et ah, 1996
Hyperinsulinemia and insulin Reaven, 1994
resistance syndrome
Overweight and obesity Rimm et ah, 1995
Lipid Hypercholestrolemia Grundy, 1997
abnormalities
and Hypertriglyceridemia Mussoni et ah, 1992
dyslipidemias Small and dense LDL Austin et ah, 1990
Low HDL-C Genest and Cohn, 1995
HDL: high density lipoprotein, LDL: low density lipoprotein
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Classical risk factors can be generally categorized, as indicated in table (1.3), into 
non-modifiable risk factors (i.e. personal characteristics), modifiable risk factors like 
physiological risk factors, and lifestyle or behavioral risk factors.
1.5.1 Family history
The importance of family history of diabetes and/or coronary heart disease as a 
coronary risk factor has been established by a number of long-term follow-up studies 
(Marenberg et al., 1994).
1.5.2 Smoking
There is overwhelming evidence for an adverse effect of smoking on the risk of CVD 
(Howard et al., 1998). This adverse effect of smoking is related to the amount of 
tobacco smoked daily and the duration of smoking.
1.5.3 Diet
Diet is an important determinant of CVD risk. The effect of diet on the development 
of CVD is mediated through the influence of biological risk factors like plasma lipids 
or blood pressure (Appel et al., 1997, Clarke et al., 1997).
The association between regular alcohol intake and early atherogenesis was U-shaped. 
Protection offered by alcohol consumption may be explained by an increased intake 
of antioxidant phenols contained in alcoholic beverages (Frankel et al., 1993). Alcohol 
use increases plasma HDL-C level and this may partly explain the protective effect of 
light or moderate consumption of alcohol (Rehm et al., 1997). More aspects of diet 
will be discussed in greater details further below.
1.5.4 Physical inactivity
Sedentary lifestyle has been shown to be associated with an adverse effect on the risk 
of death from all causes and CVD (Wannamethee et ah, 1998). Regular exercise is 
usually associated with less body fat, higher HDL-C and lower LDL-C and
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triglycerides levels, greater insulin sensitivity, and lower blood glucose and blood 
pressure.
1.5.5 Obesity
Prospective epidemiological studies have shown a strong relation between body 
weight expressed in relation to height, usually in terms of body mass index, and the 
risk of cardiovascular mortality. Risk begins to increase at moderate levels of weight 
gain and overweight (Rimm et al., 1995). Furthermore, central adiposity, as assessed 
by waist-to-hip ratio, is more strongly associated with the risk of CVD than general 
adiposity and has an adverse effect on lipid levels, blood pressure, insulin resistance, 
and glucose tolerance (Reaven, 1994).
1.5.6 Blood pressure
The importance of elevated blood pressure as a risk factor for coronary heart diseases, 
heart failure, cerebrovascular diseases, and renal failure has been demonstrated in 
many epidemiological studies (Kannel, 1996). Nonetheless, hypertension is a 
multifactorial disorder. When hypertension coexists with overt diabetes, the risk of 
CVD including nephropathy is doubly increased.
1.5.7 Diabetes mellitus and insulin resistance
Both major types of diabetes mellitus, type I (insulin-dependent) diabetes and type II 
(non-insulin-dependent) diabetes are associated with a markedly increased risk of 
coronary heart disease, cerebrovascular disease, and peripheral vascular disease 
(Yudkin et al., 1996).
Hyperinsulinemia and insulin resistance have been shown to cluster with several 
cardiovascular risk factors, including elevated plasma triglycerides, low HDL-C, 
impaired glucose tolerance, elevated blood pressure and central type of obesity. This 
cluster is termed insulin resistance syndrome or metabolic syndrome (Reaven, 1994).
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1.5.8 Metabolic syndrome
Metabolic syndrome is a cluster of metabolic disturbances that strongly predisposes to 
the development and progression of atherosclerosis. Peripheral resistance to insulin 
seems to be the central feature of this syndrome, which is characterized by central 
obesity, hyperinsulinemia, and 1 or more of the following abnormalities: impaired 
glucose tolerance, dyslipidemia, hypertension, hyperuricemia, gout, and fatty liver 
(Reaven,1994).
1.5.9 Dyslipidemia
An atherogenic lipoprotein phenotype is characterized by 3 lipoprotein abnormalities: 
elevated VLDL, small LDL particles, and low HDL-C. These abnormalities occur 
frequently in patients with premature CHD and appear to be an atherogenic 
lipoprotein phenotype independent of elevated LDL-C (Grundy, 1997). Most patients 
with atherogenic dyslipidemia are insulin resistant (Grundy, 1998).
1.6 Development of experimental models 
A limitation of epidemiological studies lies in their focus on the available 
explanations such as thrombosis as plausible triggers of ischemic events. Thus 
experimental studies are necessary to understand the role of the single pathogenic 
component of atherosclerotic disease. A good animal model could be postulated as 
resulting in lesions similar in structure and composition to those found in humans, 
over a relatively short period of time, and with an immune system that is well 
characterized, easy to manipulate, and maintained preferably at a reasonable cost. 
Rabbits were the first to be used as models of atherosclerosis (reviewed by Fox, 1984). 
Ignatowski carried out the first purely nutritional investigation into experimental 
atherosclerosis in 1908 (reviewed by Kritchevsky, 1995). The discovery in 1912 that 
dietary cholesterol per se was atherogenic, turned attention to fat and cholesterol. It is
48
well known that atherosclerosis in rabbits particularly generalized fibrocalcific 
atherosclerosis resembles human atherosclerotic lesions (Watanabe 1980; Huang et 
al, 1993; Hong et al, 1997) and so rabbits are widely used as an animal model for 
vascular research in medicine (Simonsen et al, 1991; Finta et al, 1993; Hiromoto et 
al, 1996). In rabbits fed a cholesterol-rich diet, a similar pattern of plaque distribution 
to the disease distribution pattern in human aorta but dissimilar in some peripheral 
arteries is produced. In adult human arteries, lesions usually form upstream of branch 
points. Especially noteworthy, rabbits are easily handled, cheap, and their 
atherosclerotic plaques grow quickly when fed a cholesterol-rich diet. 
Atherosclerosis follows a distinctive topographical distribution in the intimai surface 
of each affected artery. Most of the established major risk factors for CHD are 
associated with the extent of both fatty streaks and raised lesions in the large muscular 
and elastic arteries of adults (Solberg and Strong, 1983). The fatty streak is the earliest 
macroscopically evident lesion of atherosclerosis in the rabbit model, and is similar to 
the type II lesions of human atherosclerosis. This lesion is predominantly composed 
of macrophage derived foam cells, which accumulate beneath an intact endothelial 
cell layer. Subsequent smooth muscle cell migration and proliferation appear to be 
key events in lesion progression, leading to the formation of the fibro-fatty plaque 
(Ross, 1993). In contrast to human atherosclerotic plaques, which usually take 
decades to develop, the development of atherosclerosis in this animal model can be 
easily evaluated at an earlier stage in a relatively short time period.
In this respect, the study of murine models of atherosclerosis has contributed much to 
the understanding of the role of inflammatory mediators. Several transgenic knockout 
mice have been developed to render the mice susceptible to the development of 
atherosclerosis (Plump et al, 1992, Zhang et al, 1992). Atherosclerosis has also been
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studied in larger animals mainly non-human primates and rabbits. Moreover, rabbits 
are useful alternative experimental animals to mice because some physiological 
manipulations can be more easily performed in rabbits than in mice, such as, the 
cannulation of certain blood vessels and the sufficient amounts of collected blood and 
tissue samples for biochemical analysis.
The availability of rabbit strains with genetic defects in the LDL receptors, the 
Watanabe heritable hyperlipidémie WHHL rabbit (Watanabe, 1980) for the study of 
familial hypercholesterolemia and a strain that overproduces LDL, St Thomas rabbits 
(Seddon et al., 1987), have made rabbits a unique model for the study of 
hypertriglyceridemia and combined hyperlipidemia. Diet induced 
hypercholesterolemia in New Zealand White NZW rabbits also results in an increase 
in the apoproteins B and E containing lipoproteins. Serum cholesterol and 
triglycerides levels can go up to a level similar to those in humans and thus resembles 
atherosclerosis in man (Goldstein et al, 1983). They can also develop complex 
advanced lesions that more closely resemble those found in humans (Daley et 
al., 1994).
1.7 Copper, zinc, and selenium metabolism
1.7.1 Copper
Copper is an essential nutritional element of fundamental importance in human 
biology (Linder 1991). It is required for normal cell metabolism and is present in all 
human cells and tissues. It is a component of a wide range of intra- and extracellular 
metalloenzymes that are involved in important metabolic processes, including 
antioxidant defense (reviewed by Ferns et al., 1997). Among these are enzymes that 
may be protective against atherosclerosis, including copper-zinc superoxide dismutase 
(Cu-Zn SOD), and endothelial nitric oxide synthase (eNOS). Cross-linking of arterial
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collagen and elastin requires lysyl oxidase, a copper enzyme. Arterial proteoglycan 
metabolism is disrupted by copper deficiency. Caeruloplasmin is the major copper- 
containing plasma protein. It is an acute phase reactant protein synthesized in the liver 
and present in human plasma. It may act as either an antioxidant or pro-oxidant 
depending on the prevailing conditions. Caeruloplasmin has ferrioxidase activity 
(catalyses Fe^  ^ to Fe^^) and may therefore be involved in iron metabolism (Fox et 
al., 1995).
1.7.2 Zinc
Zinc is an essential mineral necessary for maintenance of membrane structure and 
function (Bettger and O’Dell, 1981). Zinc has a crucial role in metabolism; it is an 
intrinsic part of more than 300 metallo-enzymes involved in the metabolism of 
carbohydrates, lipids, proteins and nucleic acids. There is evidence suggesting that 
zinc may act as an endogenous protective factor against atherosclerosis by inhibiting 
LDL oxidation by cells or transition metals (Wilkins and Leake, 1994, Disilvestro and 
Blosteinfiiji,1997). An antioxidant effect of zinc against cell-destabilizing agents, 
such as polyunsaturated fatty acids and inflammatory cytokines, has been 
hypothesized based on its membrane-stabilizing properties (Hennig et al., 1996).
1.7.3 Selenium
Selenium was identified as an essential trace element for humans in the 1970s. This 
has become increasingly obvious as new research has shown a hitherto unsuspected 
role for this element in areas important to human health (Rayman,2000). The 
synergism of selenium and vitamin E in preventing experimental deficiency 
syndromes was recognized as a complicating factor in establishing nutritional 
requirements for both nutrients (Levander,1982). Until recently, the only known
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metabolic role for selenium in the form of selenocysteine is part of the catalytic site of 
glutathione peroxidase (Mamiemi et al., 1998).
1.7.4 Studies on Copper, zinc, and selenium and atherosclerosis 
Some trace elements such as iron and copper are known to be able to generate free 
radicals, which are associated with genetic damage and tissue oxidation, and hence 
the mechanisms of free radical formation are increasingly being implicated in the 
aetiology of chronic degenerative diseases (Halliwell and Gutteridge,1989). The most 
important trace elements, which are thought to have a role in protection against free 
radicals, are copper, zinc and selenium. They are involved in both the inflammatory 
and immune systems. Infection activates these two systems both of which will be 
depressed by nutritional deficiencies.
1.7.4.1 Copper
Copper is a transition metal that has been shown to promote the oxidation of LDL in 
vitro (Steinbrecher et al., 1984). Thus, putative atherogenic effects of copper may be 
mediated by increased oxidation of LDL. Catalytically active copper has been 
reported to be present in atherosclerotic lesions (Lamb et al., 1995) and 
caeruloplasmin, the copper-containing protein in plasma, can also catalyze LDL 
oxidation as demonstrated by in vitro studies (Lamb and Leake, 1994). However, 
copper is also an essential micronutrient that affects several important biological 
processes including the elimination of potentially toxic molecules such as the 
superoxide radical (Ferns et al., 1997) and copper deficiency has been shown to be 
associated with hypertension, hypercholesterolemia, and diabetes mellitus in man 
(Klevay, 1975; Klevay,1980; Hassel et al., 1982). Hence it is possible that copper 
status influences cardiovascular risk by other mechanisms. It is therefore unclear 
whether these epidemiological data reflect a positive association between coronary
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heart disease and copper status per se, or whether raised serum copper levels are an 
indication of an underlying inflammatory process.
1.7.4.2 The copper/ zinc hypothesis of Klevay 
It was hypothesized by Klevay (1975) that CHD is predominately a disease of 
imbalance between zinc and copper metabolism. He demonstrated that 
hypercholesterolemia can be produced either by copper deprivation or by increasing 
the dietary zinc to copper ratio (Klevay, 1973). The hypothesis is based on the axioms 
that all people do not share equally the risk of the disease and that changes in serum 
cholesterol level, blood pressure, glucose tolerance, and electrocardiographic 
abnormalities are useful in coronary risk prediction. Furthermore, an inverse 
association between serum cholesterol and copper levels has been reported in humans, 
suggesting that copper depletion can result in increased risk of CVD (Klevay et 
al., 1984, He et al., 1992).
Thus, there is uncertainty whether copper has pro-atherogenic or anti-atherogenic 
properties. It has been claimed that in Western populations suboptimal copper status 
or marginal copper deficiency is an important but unnoticed risk factor for 
atherosclerosis (Klevay, 1980). Perturbations in copper and zinc metabolism have 
been implicated in the etiology of CVD, possibly through their effects on lipid 
metabolism (Kromhout et al., 1985). Several epidemiological studies support the 
possibility that increased serum copper concentrations and decreased or normal zinc 
concentration may increase the risk of CVD (Niskanen et al.,1987; Kok et al.,1988; 
Reunanen et al., 1996; Manthey et al., 1981; Mamiemi et al.,1988; Salonen et 
al., 1991(a); Iskra et al., 1993).
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1.7.4.3 Caeruloplasmin
Caeruloplasmin, an acute phase protein, and the major carrier of copper in plasma has 
been shown to predict CHD (Manttari et ah, 1994, Reunanen et ah, 1992). However, 
epidemiological evidence is difficult to interpret because measurements were made in 
patients with previous MI, which may have affected trace element levels. Changes in 
plasma copper and caeruloplasmin can be nonspecific secondary manifestations of 
inflammation accompanying atherosclerosis. A major difficulty in interpreting many 
of the studies relating it to atherosclerosis is the fact that plasma caeruloplasmin levels 
are often elevated in the presence of acute or chronic inflammatory disease 
(Singh, 1992). Moreover, copper may be related to CHD in other ways. LDL-C 
oxidation and free radical formation can be induced by excess copper (Lynch and 
Frei,1993) whereas marginal copper levels inhibit SOD (Paynter,1980).
1.7.4.4 Zinc
Zinc has been implicated in the aetiology of cardiovascular disease through its effect 
on serum lipids (Klevay, 1975). With respect to changes in serum zinc and copper 
level in various conditions, zinc was found to decrease during the acute phase 
response, being associated with an increase of serum copper (Reunanen et al., 1996). 
Experimental and clinical studies indicate that zinc deficiency may predispose to 
glucose intolerance, diabetes mellitus, insulin resistance, atherosclerosis and coronary 
artery disease (Kok et al.,1988, Singh et al., 1995 Uza et al., 1985). It has been known 
for some time that serum copper and caeruloplasmin concentrations are increased 
while serum zinc concentrations are decreased in many inflammatory conditions, 
being associated with increased hepatic storage, and decreased levels of serum 
albumin, its major binding protein (Cousins, 1985). However, no large 
epidemiological studies have examined the relationship between zinc deficiency and
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coronary artery disease. It is yet unclear whether altered zinc has any etiologic 
relevance for cardiovascular disease. At the moment controversy exists about the 
mechanism by which zinc could act in man to affect the atherogenic risk at an early 
stage. Experimental studies have shown that zinc protects against metabolic 
physiological derangements of the vascular endothelium and interferes with signaling 
pathways involved in apoptosis, whereas zinc deficiency causes an impairment of 
endothelial barrier function (Henning et al., 1999). The results of epidemiological 
studies are inconsistent, although most of them found lower levels of serum zinc in 
patients with differing manifestations of CVD than in apparently healthy controls 
(Singh et al., 1983; Uza et al., 1985; Oster et al., 1989). However, an intervention study 
conducted in men did not support the hypothesis that zinc supplementation may 
provide antioxidant protection by decreasing LDL-cholesterol oxidizability (Gatto and 
Samman,1995). Indeed a high intake of zinc has been reported to lower HDL- 
cholesterol (Black et al.,1988) and compromise antioxidant defenses through lowered 
superoxide dismutase activity (Abdallah and Samman,1993). These effects are 
probably the result of the well-known antagonistic effect of zinc on copper status.
1.7.4.5 Selenium
Epidemiological studies on selenium and CHD are inconclusive. Some reported 
increased MI risk in subjects with very low serum selenium levels (Salonen et 
al., 1982; Virtamo et al.,1985; Kok et al., 1989). Because of geographic variability of 
selenium content in soil and food, considerable variation in serum selenium levels 
exists. This relationship was not confirmed by others (Miettinen et al., 1983; Ringstad 
et al.,1987; Salvini et al.,1995). Hence there may be several explanations for the 
conflicting results of the reported epidemiological data. Low serum selenium may not 
be an independent cardiovascular disease risk factor. The confounding effects of other
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dietary constituents in foods rich in selenium or other lifestyle habits (e.g. alcohol 
consumption and smoking) cannot be excluded. Many of the negative studies were 
based on a relatively small number of patients and had a low power to detect any 
disease associations with risk factors (Huttunen,1997). Another possible explanation 
for the disparate results is a threshold in the effect of dietary selenium intake on risk. 
The results of the large epidemiological studies are consistent with the existence of a 
threshold effect as no association between coronary heart disease risk and serum 
selenium has been observed in populations with high serum selenium values (Salvini 
et al., 1995), whereas weak associations have been shown in several populations with 
lower mean values (Kardinnal et al., 1997). The threshold value for serum selenium 
was approximately 45 pg/L (0.5 pmol/L) in the Finnish population in whom the first 
studies were conducted (Salonen et al., 1982). Moreover, the antioxidant properties of 
selenium, as a part of GPx, may play an important protective role in the etiology of 
CHD and it is probably related to decreased platelets aggregability, decreased 
production of thromboxane A2, and increased production of prostacyclin. All of 
which may potentially be linked to CVD with low plasma selenium levels (Salonen et 
al.,1988).
1.8 Trace elements and CVD 
Hence possible associations between trace element status and cardiovascular disease 
may arise because of nutritional or metabolic imbalances that have a direct effect on 
the cells of the vascular system, or that act via effects on lipid metabolism, or 
lipoprotein oxidation. The latter process is mediated by an interaction between free 
radicals, released by activated leucocytes and other cells, and lipoproteins within the 
artery wall (Halliwell, 1996). Lipoprotein oxidation may be inhibited by antioxidants, 
such as vitamin E (Dieber-Rothender et al., 1992, Jialal and Grundy, 1992), or by
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enzymatic antioxidants, such as glutathione peroxidase (GPx) and Cu/Zn-superoxide 
dismutase (SOD). The activities of these enzymes depend on a sufficient supply of 
selenium, copper and zinc respectively (Hussein et al.,1997, Paynter,1980). In the 
absence of sufficient antioxidant protection, lipoproteins become oxidized within the 
artery wall, leading to the release of lipid peroxides, and the formation of 
malondialdehyde (MDA)-modified lipoproteins (Haberland et al.,1988).
1.9 Trace elements in diet 
Although diet may play an important role in the development of CVD, most of the 
published dietary studies have focused on the intake of macronutrients rather than 
micronutrients. Table (1.4) shows the distribution of the 3 trace elements in foodstuffs. 
Low copper intake rarely leads to copper deficiency due to its wide distribution among 
foodstuffs. More zinc is generally available from animal sources than plant sources. 
Other dietary nutrients, such as protein and iron, might affect zinc bioavailability by 
reducing zinc intestinal absorption. A close correlation between the concentrations of 
selenium in foodstuffs and the selenium content of the soil in which the food is grown 
has been found (Sun et al., 1985). Hence selenium deficient soils can lead to a lack of 
the element in the diet (Combs and Combs, 1986). Serum selenium levels have been 
widely used as an index of selenium status and in general there is a good association 
between serum selenium and the dietary intake levels (Levander,1982). The major 
sources of selenium in most diets are meats and cereal products. Wheat is grown 
locally in different regions of Saudi Arabia and most of wheat-based traditional dishes 
are of great preference among Saudis. Wide variations in the content of selenium in 
wheat sampled from different regions of Saudi Arabia has been reported, possibly 
reflecting variation in selenium content of soil (Al-Saleh and Al-Doush,1997). It has 
been proposed that low soil content of selenium in certain regions of Saudi Arabia may
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be associated with an increased risk of disorders linked to selenium deficiency (Al- 
Saleh,2000).
Table 1.4: Food sources of micronutrients vitamins and trace elements
Antioxidant Food sources
Copper Shellfish, crab meat, nuts, seeds, legumes, whole grains, liver and
viscera, fruit, vegetables, chocolate 
Zinc Oysters, meat, nuts, cereals, grains, legumes
Selenium Sea food, vegetables, wheat, organ meat
Vitamin E Vegetable oils (com, soybean, safflower), margarine, whole grain
cereals, wheat germ, nuts and seeds, green vegetables 
Vitamin A Provitamin A carotenoids: yellow and green vegetables
Retinyl esters and carotenoids: animal source (dairy products, fish, 
eggs, organ meat)
Vitamin C Citms fmit (strawberries, kiwi), papaya, green and red pepper,
tomatoes, potatoes, spinach, peas, lettuce 
p-carotene Yellow-orange fruit (cantaloupe, grapefmit), carrots, tomatoes,
apricot, sweet potatoes, yellow pumpkin, green leafy vegetables
_______________ (spinach), broccoli_________________ ___________ ____________
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1.9.1 Limitations of parameters used for trace elements assessment
Contradictory results in the literature may be due to the lack of consistency in the 
indicators used to measure trace elements status.
Plasma and/or serum have been used most frequently as an indicator of trace element 
status (Levander,1982, King, 1990, Milne, 1994). However, serum/ plasma levels may 
only be useful in accessing trace elements status in cases of severe deficiency or 
excess. It has been suggested that zinc leukocyte levels may be a better indicator of 
long-term zinc status (Patrick and Dervish, 1984). However, because of the difficulties 
in storage, transport and separation, and the requirement of large blood sample 
volumes, very few investigators have actually measured zinc leukocyte levels (Hocke 
et al., 1995). Erythrocytes have a slower turnover; hence, their trace element 
concentrations might reflect long-term mineral status. However, in subjects with high 
or low coronary risk, erythrocytes and plasma trace element concentrations were 
similar (Mahalingam et al., 1997). Because these tissues turn over slowly, however, 
the zinc levels do not reflect recent changes with respect to body zinc stores.
Urinary copper, zinc, and selenium have also been measured to provide a better 
indication of their overall balance since their excretion rate were shown to be 
decreased with the development of trace elements deficiency (Tumlund et al., 1990, 
Alaejos and Romero, 1993, Johnson et al., 1993). In general, trace elements are 
measured in 24hr urine samples, which are not reliably collectable. Thus, the use of 
trace elements / creatinine ratio in fasting urine samples as an indicator of dietary 
intake has been considered more appropriate (de Portela and Weisstaub, 2000). 
Assessment of nail and hair samples has been suggested as long-term markers in 
epidemiological studies (Hunter et al., 1990, Taylor, 1986). However, toenail specimen
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weight is a confounding variable, because lighter samples were found to yield lower 
concentration readings and hair selenium content can be unreliable since selenium is 
an ingredient of shampoos. The usefulness of hair analysis as an indicator of chronic 
copper toxicity is well documented, however, external contamination must be 
prevented.
The use of functional biochemical indices, caeruloplasmin as a copper-containing 
protein as well as the activity of intracellular antioxidant enzymatic systems; Cu/Zn- 
SOD, and the selenium-containing GPx, were measured to give an additional index of 
longer-term trace elements status (Reiser et al., 1985, Milne, 1994, Diplock,1993). 
Changes in circulating caeruloplasmin may be related to its ferroxidase activity and to 
endogenous response to an acute-phase reaction, thus it was suggested that 
caeruloplasmin is a good indicator of copper status during severe deficiency since >70- 
80% of plasma copper is associated with caeruloplasmin (Milne, 1994). The 
ferroxidase activity of caeruloplasmin catalyzes oxidation of ferrous ions into ferric 
ions and is thought to facilitate in vitro iron loading into iron transport and storage 
proteins, transferrin and ferritin (Fox et al., 1995). Alternatively, erythrocytes SOD was 
shown to be more sensitive to changes in copper status rather than to other factors not 
related to copper nutrient (Reiser et al., 1985). Similarly, it has been postulated that the 
plateau in GPx activity seen when blood selenium values rise above lOOpg/L 
(1.27pmol/L) represents physiological selenium repletion and that blood levels below 
this may be associated with suboptimal GPx activity (Rayman,1997).
1.10 Role of antioxidant vitamins 
It has been hypothesized that free radical reactions mediate the development of CHD 
and antioxidants may play a protective role (Halliwell, 1996). The antioxidants 
vitamin E, vitamin C and carotenoids have been implicated in preventing or slowing
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the atherosclerotic process by inhibiting LDL oxidation. Some vitamins and 
micronutrients are among non-enzymatic antioxidants. They are obtained directly 
from the diet, such as vitamin E, vitamin C and carotenoids, and act either directly or 
require micronutrients as integral components of protective enzymes (for example, 
selenium in glutathione peroxidase, and copper and zinc in superoxide dismutase). 
Many endogenously produced compounds, such as glutathione, uric acid, albumin, 
and caeruloplasmin also exhibit antioxidant functions and often act synergistically 
with antioxidants of dietary origin (Esterbauer et al., 1992).
1.10.1 Vitamin E
Vitamin E exists as at least 8 naturally occurring compounds, including a-, p-, y-, and 
5-tocopherols and a-, P-, y-, and 6-tocotrienol; from which a-tocopherol is the most 
active component and naturally occurs in 1 isomer. Dietary vitamin E is primarily 
found in foods high in PUFAs, which are susceptible to lipid peroxidation. It appears 
that the primary role of vitamin E is to act as an antioxidant, a-tocopherol is a chain- 
breaking antioxidant that traps peroxyl free radicals and is the principle lipid-soluble 
antioxidant in plasma and LDL (Jialal and Grundy, 1992). It may therefore act as the 
first line antioxidative defence molecule protecting LDL particles from oxidation 
(Marchioli, 1999). It may also work synergistically with vitamin C in enhancing 
immune function (de la Fuente et al., 1998). Vitamin E is necessary for the action of 
vitamin A and may protect against some of the adverse effects of excessive vitamin 
A. Vitamin E extenuates oxidation at the outer surface of the membrane and 
carotenoids and vitamin A protect in the interior of the membrane.
1.10.2 Carotenoids
Carotenoids are a group of over 600 highly colored plant compounds in nature. About 
40 are present in human diet and only 14 have been identified in blood and tissue. The
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carotenoids, p-carotene, a-carotene, lycopene, cryptoxanthin, and lutein are widely 
consumed in human diets. Carotenoids differ in their tissue localization and 
antioxidant properties with only some, predominantly P-carotene, with provitamin A 
activity. Lycopene seems to have a protective effect against certain cancers according 
to epidemiological studies (Giovannucci et al., 1995). Lutein from vegetables has been 
reported to be 5 times more available than P-carotene in a group of healthy adults 
(Van het Hof et al., 1999). The antioxidant actions of carotenoids are based on their 
singlet oxygen quenching and their ability to trap peroxyl radicals in inhibiting free 
radical chain reactions (Jialal et al.,1991).
1.10.3 Vitamin A
Vitamin A is the generic descriptor for a group of chemical compounds known as 
retinoids exhibiting qualitatively the biological activity of retinol. They include retinal 
and retinoic acid. Vitamin A is a fat-soluble substance found in ester form in animal 
and dairy products. Vitamin A has an antioxidant activity against the thiyl radical 
(Jialal et al., 1991).
1.10.4 Vitamin C
Vitamin C, ascorbic acid, is a water-soluble vitamin that inhibits LDL lipid 
peroxidation by directly scavenging aqueous radicals; singlet oxygen, superoxide, and 
hydroxyl radicals, or by reducing the chain-carrying a-tocopheroxyl radical (May et 
al.,1998). This implies that increased vitamin C plasma levels could spare vitamin E 
by improving redox cycling (Chan, 1993), thus augmenting defences in the lipid 
compartments of the body. Vitamin C can be then considered as the first defence line 
in water-soluble compartments (Marchioli, 1999).
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1.11 Antioxidant vitamins in diet
The antioxidant defence system includes both endogenously and exogenously 
(dietary) derived compounds. Diet is believed to be a major factor in the aetiology of 
CVD but there is considerable uncertainty about the relationship between specific 
dietary components and cardiovascular risk (Willett, 1998). Naturally occurring 
antioxidant vitamins include vitamin E, A, C, and p-carotene. They are lipophilic 
substances apart from ascorbic acid, which is hydrophilic. Fresh fruits and vegetables 
are important dietary sources of antioxidants (Table 1.4).
Lipophilic antioxidants are likely to be particularly important in directly preventing 
the oxidation of LDL, whereas water-soluble antioxidants, such as vitamin C may be 
involved in the regeneration of the lipophilic antioxidant vitamins such as vitamin E. 
In addition, other effects on CVD are proposed, such as the prevention of platelets 
aggregation and endothelial dysfunction (Freedman et al.,1996, Keaney et al.,1996).
1.11.1 Epidemiological studies on antioxidant vitamins 
Convincing evidence that antioxidants supplementation can prevent the progression of 
atherosclerosis has been provided by animal studies (Bocan et al.,1992; Parker et 
al.,1995). Epidemiological data have raised strong supportive arguments for an 
inverse relationship between intake of antioxidant vitamins as well as trace elements 
along with the risk of cardiovascular disease (Salonen et al.,1985; Kok et al.,1987).
The ability of antioxidant vitamins to inhibit the formation of modified LDL 
potentially slowing the rate of atherogenesis has been tested in primary (the ATBC 
study group, 1994; PPP study group,2001) and secondary intervention studies (CISSI 
prevention group, 1999; HOPE study group,2000; HPS study group,2002) using 
antioxidant vitamins and other antioxidant compounds such as probucol and BHT in 
animal and human studies (Walldius et al.,1994; Tardif et al.,1997; Freyschuss et
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al.,2001; Frank et al.,2003). However, because of the adverse effects of long-term use 
of probucol on lowering plasma HDL (Tardif et al.,1997), naturally occurring 
antioxidants, if efficacious, could represent a good alternative in cardiovascular 
patients.
Observational cohort studies (Table 1.5) have suggested that antioxidant intake in diet 
or as supplements (Rimm et al.,1993; Stampfer et al.,1993; Knekt et al.,1994) 
specifically vitamin E, can prevent coronary events. Similarly a few studies indicated 
an inverse association between dietary intake of carotenoids and risk of CVD, 
particularly among smokers (Kardinaal et al.,1993, Kritchevsky et al.,1998) while 
other studies found no significant relationship (Gaziano et al.,1995). However, not all 
published results have suggested the possible importance of supplemental levels of 
antioxidants (Kushi et al.,1996). None of the aforementioned analyses revealed a 
relationship between vitamin C intake and coronary risk, in contrast to the results 
from the second national health and nutrition examination survey (NHANES II) that 
showed reduced coronary risk with increased vitamin C intake (Enstrom et al.,1992). 
Only randomized trials monitoring specifically the intake of antioxidants and their 
bioavailability can address their preventive effects (Table 1.6). A number of 
randomized controlled clinical trials have explored the role of antioxidants on CVD 
and several are still ongoing (Manson et al.,1995, Hercberg et al,1999). In general, the 
results have failed to demonstrate any improvement of the prognosis in patients with 
CAD (the ATBC study group 1994; Hennekens et al., 1996a; Omenn et al.,1996; 
Stephens et al.,1996; GISSI Prevenzione investigators 1999; Yusuf et al.,2000). Yet it 
appears that p-carotene from fruits and vegetables and supplemental vitamin E are 
beneficial in the prevention of cardiovascular disease, whereas synthetic p-carotene 
should be avoided.
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1.11.2 Methodological limitations of epidemiological studies
Although the results of most of the observational studies suggest that vitamins are of 
some benefit, no causality link can be extrapolated. Observational studies have 
potentially serious methodological problems that limit their interpretation. First, 
lifestyle and dietary habits may differ according to trial location. Second, intake of 
drugs (e.g.) statins, might influence the vitamin's efficiency towards atherosclerosis. 
Moreover most of these associations might easily reflect confounding by associated 
substances present in fruits and vegetables. While most observational studies tended 
to statistically adjust for confounding factors that may co-affect the cardiovascular 
risk, such adjustments are difficult and not always adequate.
The discrepancies between the interventional studies may be explained by differences 
in the inclusion criteria, the population tested, the duration of trial, the number of 
vitamins tested, the antioxidant content of the basal diet of the sample population 
under investigation, and the dose composition of antioxidant supplements used, and 
whether the vitamins were administrated alone or in combination.
Hence, the pathophysiological importance of oxidative events in the development of 
CVD and the resulting therapeutic implications, remain unresolved.
1.12 Role of fatty acids 
Low rates of CVD in populations with high intake of fish, such as Alaskan natives 
have suggested that fish consumption may protect against atherosclerosis (Newman et 
al.,1993). There is considerable evidence that a diet enriched with (0-3 fatty acids 
protects against atherosclerosis (Mori and Beilin,2001). It has also been reported that 
diets rich in monounsaturated fatty acids are as effective as diets rich in 
polyunsaturated fatty acids in lowering LDL-C (Mensik and Katan,1989). Several 
mechanisms for their beneficial effects have been hypothesized including anti­
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adhesion, anti-arrhythmic, and lipoprotein altering effects (Connor,2000). Dietary 
fatty acids have also been shown to modulate lipoprotein concentrations (Keys et 
al.,1965, Mori and Beilin,2001), and immune and endothelial function (Yaqoob et 
al.,1998, Tsimikas et al.,1999). Fatty acids may also contribute to atherosclerosis by 
altering cellular functions (Hodgkin et al.,1991), which may be related to changes in 
cellular membrane fatty acid composition (Berlin et al.,1987). co-3 and co-6 fatty acids 
are essential PUFA, those of the œ-6 type have inflammatory effects while those of 
the 00-3 type have anti-inflammatory effects, and these 2 classes compete in the 
production of inflammatory lipid mediators, co-3 fatty acids reduce the production of 
inflammatory cytokines associated with several chronic diseases including 
atherosclerosis. Because the lipid composition of plasma and tissues is closely related 
to dietary fat intake (Reaven et al.,1993), exposure of endothelial cells to individual 
fatty acids can be directly influenced by the types of fatty acids in diet (Tsimikas et 
al.,1999). However, concerns still remain with respect to the potential for increased 
lipid peroxidation following long-chain polyunsaturated co-3 fatty acids, particularly 
eicosapentaenoic acid and docosahexaenoic acid (Nenseter and Drevon,1996).
1.13 Role of macro- and micronutrients in atherogenesis 
Nutrition has been shown to be strongly related to many behavioural risk factors, such 
as smoking and physical activity, as well as lifestyle related biological risk factors, 
such as blood pressure and BMI. Much of the scientific literature published in the past 
50 years has focused on the relationship between macronutrient intake, mainly fat and 
cholesterol, and coronary heart disease. This research has helped to inform the public 
and create a greater awareness of the connection between diet and health/disease. 
Over the last few years, a number of researchers have studied the relationship between 
the intake of various micronutrients and heart disease (Miller, 1996).
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It is noteworthy that the observed associations between antioxidant intake and disease 
risk could reflect the importance of other potentially important dietary factors, such as 
minerals, flavenoids, indoles, as well as carotenoids other than P-carotene, distributed 
similarly within food rich in antioxidants in such a way that vitamin intake may be a 
surrogate marker. In addition, diets rich in vitamins tend to be lower in saturated fat 
and cholesterol and higher in fibre.
Micronutrients, both organic (vitamins) and inorganic (trace elements) play a wide 
range role in metabolism, as coenzymes, cofactors or prosthetic groups of antioxidant 
cellular enzymes, such as superoxide dismutase or glutathione peroxidase. They are 
therefore necessary for effective utilization of the macronutrients (e.g. protein, 
carbohydrates, amino acids and fat). The antioxidant defences rely heavily on 
vitamins and minerals in the diet as well as essential amino acids required to 
synthesize glutathione. Because classical risk factors do not fully explain coronary 
heart disease incidence and mortality, the search for additional risk factors continues. 
An important avenue of research has been the roles of prooxidants and antioxidants in 
atherosclerosis (Table 1.7).
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Table 1.7: Antioxidant defenses in human plasma and LDL
Lipid-soluble vitamins
Vitamin E
B-carotene
Vitamin A
Enzymes
SOD
GSHPx
Catalase
Water-soluble molecules
Vitamin C 
Bilirubin 
Uric acid 
GSH
Transition metal-containing proteins
Caeruloplasmin
Transferrin
Albumin
GSH: glutathione, GPx: glutathione peroxidase, SOD: superoxide dismutase
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Most of these risk factors could be efficiently modified by preventive measures. 
Simple, accessible and cost-effective preventive therapies that decrease the incidence 
of cardiovascular diseases could greatly affect public health. Substantial interest has 
focused in the past few years on preventive strategies including the use of 
antioxidants, particularly naturally occurring antioxidant vitamins, such as vitamin E, 
vitamin C and P-carotene. Nevertheless, relating effects of dietary deficiencies to 
biochemical activity is a major goal in understanding and alleviating malnutrition. 
The development of biomarkers to measure oxidative stress means that more reliable 
and precise estimate of oxidative stress may be made (Halliwell,1999). There is a 
need to measure these biomarkers in micronutrient deficient populations and correlate 
them to micronutrient status and infections. It is expected that the assessment of these 
risk factors will help to identify specific mechanistic patterns that lead to 
cardiovascular events in our region and will be useful for better targeting preventive 
interventions along with supplementation recommendation.
1.14 Coronary risk scores 
Global risk assessment has become an accepted component of clinical guidelines and 
recommendations in CVD primary prevention. A valid estimate of the probability of a 
defined cardiovascular event over a period of 10 years in individuals free of clinical 
manifestations of CVD is necessary. Estimation of the actual risk resulting from 
combined risk factor levels is the first step for effective preventive approach. The 
Framingham study was the first epidemiological study that prospectively collected 
population based data on the association between risk factors and the occurence of 
fatal and non-fatal CVD (Anderson et al., 1991). Equations based on the Framingham 
heart study have been recommended by the joint British guidelines (British Cardiac
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Society et al., 1998) and the New Zealand guidelines (New Zealand guidelines group, 
1996). These equations use the individuals risk factors (age, sex, SBP or DBF, 
smoking habits, presence of DM and LVH, and TC and HDL-C) and are only applied 
to those aged 30-74 years. The validity of the Framingham equations in those with 
diabetes mellitus has been questioned, since relatively few diabetics patients were 
included in the Framingham cohort and also because the equations exclude serum TG 
concentrations which are considered to be an important risk factor in DM. There has 
been debate as to whether it is reasonable to extrapolate data collected from a white 
middle class population in Massachusetts to other parts of the world. Recent 
comparisons revealed reasonable agreement between Framingham predicted risk and 
observed risk in six US cohorts of white and black people, but not in those of 
Japanese, Hispanic, or native American ethnic origin (D’Agostino et al.,2001). 
However, despite being derived from a Northern American population the CHD risk 
equation has been shown to predict events in several other populations, for example in 
UK patients (Ramachandran et al.,2000).
An alternative risk prediction equation has been derived from the Northern European 
male population recruited to the Prospective Cardiovascular Munster study 
(PROCAM) (Assmasn et al.,2002). This study uses the same risk factors as the 
Framingham equation, but additionally includes TG concentration and family history 
of CHD. Due to the characteristics of the PROCAM population, the equation’s use is 
limited to men aged 40-65 years.
The usefulness of algorithms for CHD risk assessment and guidelines for lipid 
lowering drug therapy depend on their applicability in subjects with parameters within 
the range of validity of the algorithms. However, these scoring systems seem to 
overpredict risk in non-Caucasian populations, rendering independent validation
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difficult (Laurier et al., 1994, Wilson et al., 1998). Moreover, there are only a very 
limited number of epidemiological studies available that are large and long enough to 
allow CHD risk estimation (Pyrola and Wood, 1998). The absence of a “gold 
standard” for a CHD risk scoring system prevents us from determining which is 
correct and only provides evidence of agreement. Because of the obvious discrepancy 
between guidelines, it is difficult to recommend which guidelines to follow. Thus 
other novel parameters may provide additional information when in doubt about 
coronary risk assessment (Ridker and Libby, 1998, Danesh et al.,2000a). These tests 
may indicate whether early forms of atherosclerosis are present. However, the 
usefulness of these parameters is still under debate and it is unclear how their results 
should be incorporated into existing guidelines. The concept of basing management 
on coronary risk stratification albeit should be taking novel markers into 
consideration.
1.15 Assessment of dietary intake 
Dietary studies can give valuable information concerning the types of food consumed 
and nutrient intake. Analysing food consumption as dietary patterns offer an 
additional dimension to examining the relations between diet and disease risk. In 
contrast to the literature on diet and cancer risk, most studies of CVD have reported 
the associations of risk with nutrients rather than with foods. It is often very difficult 
to relate the biochemistry of a dietary deficiency with clinical symptoms that may 
arise because many vitamins and minerals have multiple roles in metabolism.
The lack of a valid indicator precludes a true estimate of micronutrients intake. 
Nutrient intakes are more accurately measured when two methods of dietary 
evaluation are employed to replicate and validate the reported nutrients intake 
(Willett, 1998). However, it is possible that mild to moderate deficiency as assessed by
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available indicators may be common in developing countries. Although there is no 
gold standard to use in validating FFQ estimates of intake, these instruments have 
been evaluated by correlating intake estimates with serum levels of specific nutrients 
(Block, 1989; Willett et al., 1983). Serum vitamin A, E and carotenoids levels do vary 
with intake (Willett et al., 1983) and therefore may be used as indicators of intake.
The estimation of the nutrient intake has two major limiting factors. One of them is 
that this estimation usually depends on the accurate cooperation of the subject. The 
second factor is the limitation of the food composition database (Horwath and 
Worsley,1990). Indeed, we must take into account that we are only evaluating intake 
but not the effects of absorption, energy expenditure. Despite these uncertainties, 
there is little doubt that a poor nutritional status can aggravate declining physiological 
and psychosocial conditions.
In light of the likely changes, it is not sensible to rely on the results of previous 
nutritional studies conducted in other societies. There is a need for current 
information to assess both the existing and future health needs, particularly with the 
changing society and altered food habits, nutritional problems and the demands of 
professional practices. With easier accessibility to food and services over the years 
and improved socio-economic conditions, a more Westernized lifestyle is being 
followed by the urban community, and this is reflected in their nutrient intake, 
particularly the relative contribution of energy-supplying nutrients.
1.15.1 Dietary assessment methods 
Ideally, dietary assessment methods used in chronic disease epidemiology need to be 
reliable, valid, inexpensive and easy to administer to large numbers of people who can 
then be ranked according to the food and/or nutrient of interest. However, members of 
different ethnic and socioeconomic groups from different geographic regions differ by
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the type of food eaten habitually, the methods of food preparation, and in the usual 
amount consumed. The difficulties may be especially great in a region such as the 
Western province of the kingdom of Saudi Arabia, in which a heterogeneous mixture 
of native Arabs and immigrants from different parts of the Islamic world constitute 
the population. Therefore, the primary requirement of a dietary assessment tool was to 
be able to accurately rank individuals by intake, rather than to make accurate 
estimates of absolute intake. The tool used to do this was a Food Frequency 
Questionnaire (FFQ).
Food Frequency Questionnaires 
FFQs have been widely used in studies on the relationship between food consumption 
and risk of chronic diseases, because such questionnaires allow an evaluation of these 
relationships at relatively low cost, within a short time frame and in a large population 
samples. They also avoid the difficulties associated with more precise estimates due 
to the between-day variation in food consumption, which for some nutrients such as 
B-carotene, can be considerable (Block, 1982). Moreover, since chronic diseases 
evolve over a long period of time the method of dietary assessment needs to be able to 
estimate long-term habitual dietary intake. FFQ are designed to assess long term or 
past food intake rather than short-term intake (Willet,1998). The information collected 
allows individuals to be ranked on the basis of levels of past nutrient intake (Block et 
al., 1986). However, due to the large variability of dietary patterns and food 
availability among populations, the food items included in the FFQ need to be 
carefully selected to reflect the usual food preferences of the population under study. 
Among the most commonly used questionnaires today are those developed by 
Willett’s and colleagues for the Nurse’s Health Study (Willet et al., 1985) and by 
Block’s and colleagues (Health Habits and History Questionnaire) in North America
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(Block et al., 1986). In these FFQs respondents are asked to indicate their frequency of 
consumption of various foods in terms of categories rather than the exact frequency 
with which they consumed the food. Although the reliability and validity of these 
FFQs has been tested, they have been used almost exclusively in Caucasian groups 
(Willet et al., 1985; Rimm et al., 1992) and few data exist on their validity in more 
diverse populations. Moreover, because the validity of any FFQ may be affected by 
educational or cultural factors that influence recall, the validity of the technique itself 
may vary between populations. Validity of the FFQ of the Block instrument has been 
documented for some nutrients within black population of urban women with or 
without inclusion of regional or ethnic-specific foods, suggesting that the Block 
instrument was reasonably robust to cultural differences (Coates et al., 1991). 
Although there is no gold standard to use in validating FFQ estimates of intake, these 
instruments have been evaluated by correlating intake estimates with serum levels of 
specific nutrients (Block, 1989; Willett et al., 1983). Serum vitamin E and A levels do 
vary with intake (Willett et al., 1983) and therefore may be used as surrogate 
indicators of intake. Numerous validations have been conducted, most of which show 
a reasonable ability of FFQ to rank respondent with respect to their intake of a 
particular nutrient (Block, 1982; Block et al., 1986).
24H r dietary recall
Other methods for dietary assessment are dietary recalls and food diaries of daily 
consumption. Daily consumption methods may provide more accurate estimates of 
absolute nutrient intake for recorded days. However, dietary recalls are often 
preferred because they are easier to perform and provide comparable estimates to 
more intensive methods, such as dietary records. Furthermore, it is generally assumed 
that errors associated with dietary recall are largely uncorrelated with errors
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associated with FFQ. Therefore, 24hr recalls were administered by interviewers, 
because diets vary across days of the week (Rimm et al., 1992). Participant interview 
were conducted to reflect the relative frequency of weekdays and weekend days. Only 
weekdays were included since meals at weekends maybe atypical. Therefore, those 
whose diet on the previous day was, in their opinion, not typical for them were 
excluded from the dietary survey.
Validation and reproducibility 
Validity and reproducibility of dietary instruments are of particular importance in 
studies that compare a diet-disease relationship between different groups. Validity 
refers to the degree to which the information that is recorded by the instrument for 
example FFQ corresponds with the subject’s usual intakes. In most studies on the 
validity of dietary assessments, the reference measurements have been based on more 
detailed dietary assessment methods, such as 24hr recalls (Lee-Han et al., 1989). 
Because different methods of dietary assessment may have correlated measurement 
errors, an alternative validation strategy may be to use biochemical measurements 
such as plasma concentrations of nutrients (Willet et al., 1985). The primary advantage 
of this form of validation is that it is based on independent measurements; therefore, 
the sources of error in the two methods should be uncorrelated. Although many 
biochemical markers do not qualify as tests of questionnaire validity because 
physiological mechanisms regulate their blood levels more than dietary intake, plasma 
fat-soluble vitamin levels are reported to vary with intake and consequently may be 
used as indicators of intake (Willet et al., 1983b).
1.16 Coronary artery diseases in Kingdom of Saudi Arabia 
Saudi Arabia is a country, which has gone through a significant improvement in social 
and economic status. This has been paralleled by a change in life style, with the
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adoption of more Western habits with respect to diet and tobacco consumption, 
accompanied by an increased consumption of processed food, which is known for its 
lower content of minerals especially trace elements and a reduction in physical 
activity. These factors have either led to or augmented other risk factors of 
cardiovascular disease and led to the current situation, where CVD is the leading 
cause of mortality (Alwan,1993, Alobaid et al., 1994). However the prevalence of 
CVD in Saudi Arabia is not known. Therefore epidemiological studies of the 
prevalence of CVD and its risk factors among Saudis of both sexes at the national 
level were initiated in different parts of Saudi Arabia in 1991. There is a regional 
population variation with respect to demographic, social, cultural and nutritional 
factors. The special characterization of each region of Saudi Arabia, may contribute to 
the regional differences in the prevalence of disease. The Western region is 
characterized by wide variation of socioeconomic status and the multi-racial make up 
due to its close proximity to the holy lands, Makkah and Al-Madinah. This has made 
it a focal point for pilgrim’s settlement after performing Hajj and Umraa over the 
years.
1.16.1 Hypercholesterolemia
Hypercholesterolemia has been recognized as a direct and independent risk factor for 
CVD. The prevalence of hypercholesterolemia (serum cholesterol level >5.2 mmol/L) 
among Saudi subjects has been reported to be 21% and 22% for male and female 
respectively (Al-Nuaim, 1997a), which is lower than the reported prevalence from 
developed countries, such as 40% of serum cholesterol level >6.2mmol/L in USA 
(Sempos et al., 1989), and higher than that reported by developing countries, such as 
8.5% of serum cholesterol level >6.5mmol/L in Turkey (Onat et al., 1992). In 
comparing prevalence from these data with those from other countries, several
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factors, such as the age difference between studied subjects, variability in cut-off 
levels beyond which the disease is diagnosed, and urban versus rural characteristics of 
the population, should be taken into consideration. In the same context, the low mean 
age of the Saudi population (60% of the population is under thirty years old) could 
account to some extent for the relatively low prevalence of hypercholesterolemia (Al- 
Nuaim, 1997a). However, this may increase in the future as the population advances in 
age and is exposed to contributing or precipitating environmental factors, such as poor 
nutritional habits, obesity and lack of regular exercise (Al-Nuaim et al., 1997b).
1.16.2 Diabetes mellitus
Diabetes mellitus is another classical risk factor for ischemic heart diseases. The 
overall prevalence of diabetes mellitus and impaired glucose tolerance among Saudi 
adults have been reported to be 17.3% and 1.3% respectively in males, being higher in 
the age group of thirty-five and above, especially in females (12.18% and 2.2% 
respectively) (El-Hazmi et al., 1996). These results place Saudi Arabia among the 
countries of the world that are high-prevalence regions (King and Rewers,1993).
1.16.3 Hypertension
Hypertension is a major risk factor for cardiovascular and cerebrovascular diseases. 
The prevalence of hypertension (>140/90 mmHg) among Saudis of both sexes aged 
18 years and older has been reported to be 20.4% for systolic blood pressure and 
25.9% for diastolic blood pressure (Al-Nozha et al.,1997). Reports from neighboring 
countries show similar alarming rates (Al-Mahroos et al.,2000). Similar prevalence 
rates in industrialized countries were reported, 24% in the USA (Burt et al., 1995) and 
21% in China (Chen et al., 1995).
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Hypertension and type 2 diabetes tend to occur together as part of the metabolic 
syndrome that includes insulin resistance, raised plasma triglycerides, and low HDL- 
C levels (Grundy, 1997).
1.16.4 Obesity
Obesity is widely recognized as a major risk factor for several chronic diseases in 
studies that have shown increased mortality from diabetes mellitus, coronary heart 
diseases, and cancer in obese subjects (Thompson et al., 1999). Overweight and 
obesity (defined as BMI 25-29.9 and BMI >30 respectively) are widely prevalent 
among males (42% and 30% respectively) and females (32% and 49% respectively) in 
Saudi Arabia (Alsaif et al.,2002). Similar prevalence rates of coronary risk factors 
were also reported in neighbouring countries in the Gulf region (Al-Isa,1995; Jackson 
et al.,2001). The prevalence of obesity in Western populations varies greatly, but a 
weighed estimate suggests prevalence between 15%-20% (Haffiier,2000).
1.16.5 Smoking
Cigarette smoking is one of the major health hazard etiologies covering a wide range 
of mortality and morbidity worldwide (Law et al., 1997). Smoking prevalence is 
increasing at alarming trend and was reported to be 35% in Saudi males in a recent 
community-based study (Siddiqui et al.,2001), albeit the actual prevalence rate is 
expected to be higher in a conservative community like ours
1.16.6 Dietary studies
The multiracial composition of many societies has led to an assimilation of ethnic 
foods into the mainstream diet. Although nutrient data on raw foods, which are mostly 
imported into Saudi Arabia and other Gulf Cooperation Council (GCC) countries are 
available (FAO,1982), these food items are usually consumed as cooked dishes that 
require different methods of preparation. Traditional methods of meal preparation
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may affect greatly the nutritive value of these foods since each country and every 
region in a country has its own typical diets and ways of combining them into meals. 
Unfortunately, there has been a paucity of studies examining the dietary intakes 
among Saudis and how these are related to cardiovascular risk factors among the 
different ethnic groups in the country (Abalkhail,1998; Hakim et al.,2003). One 
important reason for this is the lack of a suitable local dietary tool to assess the usual 
intake of individuals over a period of time. Moreover, methodologies developed in 
other populations are probably not suitable for use in Saudi Arabia because of the 
large variety of local foods consumed by the different ethnic groups that differ from 
those consumed elsewhere.
1.16.7 Trace elements and antioxidant vitamins 
Furthermore, the distribution of novel coronary risk factors within this Saudi 
community is unknown. These data are needed for establishing prevention strategies 
and for giving proper advice to the general population. A paucity of epidemiological 
studies have evaluated novel cardiovascular risk factors such as homocysteine in 
Saudi Arabia (Al-Nozha et al.,2002) and lipoprotein A in Kuwait (Alsaeid et 
al., 1999). However, few have investigated the possible role of antioxidant vitamins 
and trace element deficiency (Abahusain et al., 1999 ; Al-Senaidy,2000). Although in 
a population of subjects living in a rich country like Saudi Arabia, food availability 
and dietary habits might be considered as adequate; determination of serum vitamin 
homeostatic levels is of importance. These values give knowledge of reference levels 
and serve as possible functional parameters of adequate nutritional status to allow a 
better assessment of borderline vitamin deficiency at the public health level. Studies 
on zinc and copper status are limited (El-Yazigi et al., 1991, El-Yazigi et al., 1993). 
Selenium is another trace element that has been scarcely investigated in Saudi Arabia
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(El-Yazigi and Legayada, 1996). Moreover, the soil selenium content of any 
geographical region is reflected in locally produced foodstuffs, which in turn 
determine the regional nutritional selenium supply of animal and man. Wheat grain is 
one of the major sources of selenium in diet and is being preferred among Saudis. 
Unfortunately most of the widely consumed dishes may contain phytate, which may 
aggravate minerals deficiency in Saudis (Almana,2000). Recent studies have shown 
low selenium status in soil and subsequently in dietary intake levels (Al-Saleh and Al- 
Doush,1997, Al-Saleh,2000).
Apart from these few studies, no data on trace elements status in Saudi Arabia has 
been obtained. Moreover, no studies were performed on selenium, zinc, and copper 
deficiency in regard to their relation to atherosclerosis. The lack of systematic 
investigation of mineral and antioxidants status in different ethnic groups and the 
great demand for surveillance of these factors in such a developing community 
motivated us to investigate the relationship between dietary insufficiency of the above 
mentioned nutrients and cardiovascular diseases.
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1.17 Hypothesis
Our working hypothesis in designing our clinical and experimental studies was as 
follows:
1, There is a relationship between micronutrient status and the prevalence of 
coronary artery disease in the Saudi male population. Trace element and/or 
antioxidant vitamin insufficiency may cause a predisposition to coronary heart 
disease among Saudi male subjects.
2. Dietary zinc and copper may alter the rate of atherogenesis in an animal model 
of atherosclerosis, the cholesterol-fed rabbit.
1.18 General aims
1. To investigate the indices of trace elements status (copper, zinc and selenium) 
and antioxidant vitamins status (vitamin A and E) in Saudi males with 
established coronary atherosclerosis by comparing them with an age-matched 
population of subjects without CVD.
2. To assess the effects of zinc and copper singly and in combination on 
atherogenesis in the cholesterol-fed rabbit, including the composition of 
atherosclerotic lesions in this model.
1.19 Specific aims
1.19.1 Human study
1. To measure the antioxidants (vitamin A and E) in the serum and trace 
elements (zinc, copper, and selenium) in the urine and serum of a population 
of Saudi Arabian males with and without established coronary heart disease.
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2. To investigate whether the dietary intake of energy, macronutrients, fiber, and 
micronutrients differ among age tertiles, racial groups and socioeconomic 
classes in Saudi males controls.
3. To test the association of nutritional factors with coronary heart disease 
prevalence and their correlation with cardiovascular risk factors in age- 
matched Saudi males with established atherosclerosis.
4. To examine the relation of some of the inflammatory markers to coronary risk 
score in healthy Saudi male subjects without established coronary heart 
disease, to the individual classical risk factors, and their graded effect 
according to disease severity in angiographically-defined atherosclerotic 
patients.
1.20 Animal study
1. To assess the effects of cholesterol feeding and dietary supplementation with 
zinc and copper on biochemical measures of antioxidant status in the 
cholesterol fed and normally fed rabbits.
2. To assess the effects of supplements of zinc, copper, and a combination of 
zinc and copper on atherosclerotic lesions in the cholesterol-fed rabbit using 
histological techniques in cholesterol fed, and normally fed rabbits.
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Chapter 2
Materials and Methods
2.1 Demographic measurement
Demographic features including: age, height, weight, body mass index (BMI), systolic 
and diastolic blood pressure, physical activity, smoking status, history of 
hypercholesterolemia, diabetes, family history of heart diseases (the occurrence of 
myocardial infarction or cardiac death in a first-degree relative; parents, brother or 
son, or siblings, of the patient before the age of 55 years) were assessed for each 
subject. Height, weight, and blood pressure were measured according to standardized 
protocols by the medical staff.
2.1.1 Dyslipidaemia
Dyslipidaemia was defined as total cholesterol level > 5 .2  mmol/L, a LDL-C >3.36 
mmol/L, and/or a HDL-C< 1.04 mmol/L (the 3"^  ^ report of the NCEP expert panel 
2001). Total cholesterol/HDL-C ratio was used as an index of CVD risk (Anderson et 
al., 1990).
2.1.2 Hypertension
Blood pressure was measured by sphygmomanometer in a supine position after 
several minutes’ bed rest and recorded in mmHg. Hypertension was defined as a 
systolic blood pressure above 140 mm Hg, or diastolic blood pressure above 90 mm 
Hg respectively, or current use of antihypertensive medication (Hennekens et 
al., 1996b).
2.1.3 Diabetes mellitus
Diabetes was defined as a known history of diabetes mellitus, fasting blood glucose 
>7 mmol/L or treatment with insulin or oral hypoglycemic agents (The expert 
committee on the diagnosis and classification of Diabetes Mellitus, 1997).
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2.1.4 Metabolic syndrome
Metabolic syndrome was defined according to the WHO criteria (Alberti and 
Zimmet,1998) by the presence of insulin resistance, defined by the presence of type 2 
diabetes, plus any 2 risk factors of the following: hypertension as defined above, 
serum triglycerides >1.7mmol/L, serum HDL-C <0.9mmol/L, BMI>30 Kg/m^, 
microalbuminuria (urinary albumin excretion rate > 20pg/min or albumin to creatinine 
ratio > 20mg/gm).
2.1.5 Body mass index
Body weight was assessed by weighing the subject wearing indoor light clothing 
without shoes. Height was measured without shoes. Body mass index (BMI) was 
calculated as weight in Kg/ height^ in m ,^ and classified into normal; defined as 
BMI<25 kg/m^, overweight as BMI = 25-29.9 kg/m^, obese as BMI >30 kg/m^ 
(WHO,1997).
2.1.6 Smoking status
Smoking habit was categorized as non-smoker, former smoker, and current smoker. 
Current smokers were fiirther categorized into those who smoked < 20 cigarettes/day 
and those who smoked >20 cigarettes/day.
2.1.7 Physical activity level
The score for physical activity was self-assessed by the participant according to the 
number of episodes of exercise undertaken per week and subjects were categorized as 
being active (> 3 times / week) or inactive (< 3 times / week) according to the 
recommendations of the American Heart Association consensus statement on primary 
prevention of coronary diseases and from the USA Surgeon General’s report (US 
Department of Health and Human Services, 1996).
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2.1.8 Assessment of coronary risk
Framingham risk scores were derived from the National Cholesterol Education 
Program Expert Panel on Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults /Adult Treatment Panel III (NCEP/ATP III) algorithm (Wilson 
et al., 1998). The PROCAM score derived from the Northern European male 
population recruited to the Prospective Cardiovascular Munster (PROCAM) was 
calculated using the computerized algorithm (Assman,1993). Three levels of risk were 
defined for both scores accordingly: <10%, 10% to 20%, and >20%.
2.2 Subjects
2.2.1 Cases
Individuals with established CVD were identified by positive findings on angiography 
(n= 66), or by a past medical history of myocardial infarction or angina (n=64). They 
were recruited from The King Fahad Armed Forces Hospital, Jeddah, Kingdom of 
Saudi Arabia. Patients were classified according to the number of stenosed coronary 
arteries (defined as >50% occlusion of luminal diameter), or occluded vessels (1 to 3 
vessel disease) as previously described (Judkins, 1967). The severity of 
angiographically defined disease was scored from 0 in controls who were admitted to 
undergo angiography (i.e. no CVD) to 3 coronary vessels (stenosis >50% in 3 
vessels).
A diagnosis of a myocardial infarction was made in accordance with Joint European 
Society of Cardiology/American College of Cardiology Committee criteria (Alpert et 
al.,2000): chest pain with elevated cardiac enzymes (creatine kinase elevation twice 
above the upper normal limit within 24 hours after the onset of pain, aspartate 
aminotransferase, and lactate dehydrogenase), and characteristic ECG changes. None
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of the patients included in the study had suffered a heart attack within 6 months of 
recruitment into the study.
2.2.2 Controls
Age-matched individuals (n=130), who possessed CVD risk factors, but were without 
known coronary artery disease served as controls and were recruited from The King 
Abdulaziz University Hospital, Jeddah. Each case was matched with a control subject: 
whose age did not differ by more than 2 years. Controls were identified by a 
cardiologist in each hospital. Controls were usually referred for risk factor 
modification, principally hyperlipidemia, hypertension, and diabetes mellitus, but 
were free from overt coronary disease. The absence of CVD was confirmed by 
medical measurements performed routinely and they include ECG recording and 
blood cardiac enzymes. Drawing controls from the same population pool was 
considered to enhance the comparability of coronary risk estimation in cases and 
controls.
2.2.3 Exclusion criteria
Subjects with established renal or hepatic disease were excluded, as were those on 
treatment with antioxidants or supplement users. The local ethical committees of both 
hospitals approved the study.
2.2.4 Controls for the study of inflammatory markers
One hundred and forty subjects who were at risk of developing CVD, but were 
without known coronary artery disease were recruited from King Abdul Aziz 
University and the University Hospital, Jeddah. The subjects did not have symptoms 
of CHD on questioning and no personal history of ACS was documented in their 
medical files. They were aged between 16 and 87 years. Exclusion criteria included: 
established renal or hepatic disease, vascular diseases (i.e. peripheral vascular disease.
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cerebrovascular disease), or those on treatment with statins (HMG-CoA reductase 
inhibitor) or aspirin (or any other anticoagulant), or those using antioxidant vitamin 
supplements.
2.2.5 Controls for the dietary study 
Data were collected from 303 male subjects who had no evidence of established 
coronary disease and were aged 15-80 years. They were recruited randomly from 
students and staff members of King Abdulaziz University as well as blood donors and 
patients with minor conditions but with no evidence of CVD (e.g. orthopedic patients) 
from the King Abdulaziz University Hospital in Jeddah, Saudi Arabia. The ethical 
committee for studies on human subjects of the medical center in KAAU approved 
the study. Informed consent was obtained from all participants. They were stratified 
by age tertiles, by socioeconomic status, and by race.
2.3 Blood and urine samples 
Blood samples were collected after an overnight fast using disposable siliconized 
syringes and needles into trace element-free Vacutainer™ tubes (Beckton Dickinson, 
Rutherford). Tubes were centrifuged at 3000g- for 10 minutes. The plasma obtained 
was separated and frozen at -80°C until the time of analysis. The red blood cell 
suspensions were prepared from phosphate buffered saline (PBS) washed red blood 
cells after removal of plasma. The red cells were washed three times with PBS at 4°C. 
Cells were then re-suspended to their original volume with PBS. Erythrocyte 
hemolysates were obtained by adding 4 volumes of de-ionized distilled water to 1 
volume of red blood cell suspension. The lysate was frozen at -80°C until the time of 
analysis. Urine samples were collected in polyethylene containers and centrifuged at 
3000g for 10 minutes. The supernatant obtained was separated and frozen at -80°C 
until the time of analysis.
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2.4 Analytical methods
2.4.1 Estimation of glucose
Plasma glucose was estimated in fasting samples using a commercial kit obtained 
from a local agent (Crescent Diagnostics, KSA) based on an enzymatic method 
(Trinder, 1969). The oxidation of glucose was catalyzed by glucose oxidase. The 
resultant hydrogen peroxide was oxidatively coupled with 4-aminophenazone and 
phenol in the presence of peroxidase to yield a red quinoneimine dye, the absorbance 
of which at 546 nm was proportional to the concentration of glucose.
Alpha-d-glucose —  ^ Beta-d-glucose 
Beta-d-glucose + H2O + O2 ^^-gluconic acid + H2O2
H2O2 + 4-aminophenazone + phenol — Peroxidase  ^ quinoneimine +4 H2O 
Ten pi of distilled water, samples, in duplicate, and standard were added to 1ml of 
enzyme reagent. The reaction mixture were mixed and incubated for 10 minutes at 
room temperature (20-25 °C). The absorbance of samples and standard was measured 
against the reagent blank at 546nm within 60 minutes. Readings were carried out on 
NovaSpec II, spectrophotometer of adjustable wavelength, model 80-2088-71 
(Amersham Pharmacia biotech, Greece, Athens). Glucose was determined in mmol/L. 
This test was linear up to a glucose concentration of 22.2 mmol/L. Samples with 
higher values were diluted 1:2 with distilled water, reassayed and the values were 
multiplied by three. The within batch coefficient of variation was 3.5% and the 
between batch coefficient of variation was 4.9%.
2.4.2 Lipid profile
2.4.2.1 Estimation of cholesterol 
Total cholesterol was determined in fasting serum samples using a commercial kit 
depending on an enzymatic method (Allain et al., 1974). The kit was obtained fi*om a
93
local agent (Crescent Diagnostics, KSA). The method is based on hydrolysis of any 
cholesterol esters in serum by cholesterol esterase, then oxidation of total cholesterol 
in serum by cholesterol oxidase with the production of hydrogen peroxide. The latter 
reacts with phenol and 4-amino antipyrine in the presence of peroxidase to give 
quinoneimine and the change in absorption can be followed spectrophotometrically at 
546nm.
Cholesterol esters + H2O — choiesteroiEsterase  ^ Cholesterol + fatty acids
Cholesterol + O2 -> Cholesterol-3-one + H2O2
2 H2O2 + 4-amino antipyrine + phenol — Peroxidase  ^quinoneimine + 4 H2O 
lOpl of distilled water, samples, or standard in duplicate were added to 1ml of enzyme 
reagent. The reaction mixture was mixed and incubated for 10 minutes at room 
temperature (20-25 °C). The absorbance of samples and standard was measured 
against the reagent blank at 546nm within 60 minutes. Readings were carried out on 
NovaSpec II, spectrophotometer of adjustable wavelength, model 80-2088-71 
(Amersham Pharmacia biotech, Greece, Athens). Total cholesterol was determined in 
mmol/L. This method is linear up to a cholesterol concentration of 19.3 mmol/L. For 
samples with higher levels, dilution 1:3 with physiological saline (0.9% NaCl) was 
carried out and the result multiplied by four. Intra-assay and inter-assays precision 
were 4.7% and 7.1 % respectively.
2.4.2.2 Estimation of HDL-cholesterol 
HDL-cholesterol was determined in fasting serum samples using a commercial kit 
supplied by a local agent (Crescent Diagnostics, KSA). The method depended on 
precipitation of chylomicron, very low and low density lipoproteins (VLDL and LDL) 
using precipitating reagent, phosphotungstic acid and magnesium ions (Wamick et 
al., 1982). Two hundred pi of samples were added to 500pl of the precipitating
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reagent, mixed and allowed to stand for 10 minutes at room temperature (20-25 °C). 
After centrifugation for 10 minutes at 4000 rpm, cholesterol content of the HDL 
supernatant were estimated as described above for total cholesterol. The within batch 
coefficient of variation was 6.9% whereas the between batch coefficient of variation 
was 8.4%.
2.4.2.3 Calculation of LDL-cholesterol
LDL-cholesterol was calculated from the estimated value of total cholesterol, HDL- 
cholesterol and triglycerides using the Friedewald formula (Friedewald et al., 1972): 
LDL-C= total cholesterol - [triglycerides/2.2 + HDL-C]. LDL concentration cannot be 
calculated using this formula for TG values over 4mmol/L because the equation 
deviates from the values obtained by ultracentrifugation. However, no TG values 
above that limit were obtained.
2.4.2.4 Estimation of triglycerides
Triglycerides were estimated in fasting serum samples using a commercial kit that 
was obtained from a local agent (Crescent Diagnostics, KSA) and is based on an 
enzymatic method (Fossati and Prencipe,1982). The principle of the method depended 
on enzymatic estimation of glycerol produced from hydrolysis by the enzyme 
lipoprotein lipase. In the presence of glycerol kinase and ATP, glycerol was converted 
to glycerol-3-phosphate and ADP was formed, the former reacted with molecular 
oxygen in the presence of glycerol phosphate oxidase to produce dihydroxyacetone 
phosphate and hydrogen peroxide. The latter was then used to oxidize 4- 
aminoantipyrine in the presence of chlorophenol and the enzyme peroxidase, the 
change in color was followed spectrophotometrically at 546nm.
Triglycerides + H2O — > Glycerol + free fatty acids 
Glycerol + ATP > Glycerol-3-phosphate + ADP
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Glycerol-3-phosphate + Û2 —Giyceroi-s-phosphateoxidase  ^ H2O2 + dihydroxyacetone 
phosphate
2 H2O2 + 4-aminoantipyrine + chlorophenol — Peroxidase  ^ quinoneimine +4 H2O 
Ten pl of distilled water, samples, in duplicate, and standard were added to 1ml of 
enzyme reagent. The reaction mixture were mixed and incubated for 10 minutes at 
room temperature (20-25 °C). The absorbance of samples and standard was measured 
against the reagent blank at 546nm within 60 minutes. Readings were carried out on 
NovaSpec II, spectrophotometer of adjustable wavelength, model 80-2088-71 
(Amersham Pharmacia biotech, Greece, Athens). Triglycerides were determined in 
mmol/L. This test was linear up to a triglyceride concentration of 11.3 mmol/L. 
Samples with higher values were diluted 1:5 with physiological saline (0.9% NaCl), 
reassayed and the values were multiplied by six. The within batch coefficient of 
variation was 8.6% and the between batch coefficient of variation was 9.3%.
2.4.2.S Estimation of lipoprotein (a)
Plasma lipoprotein (a) levels were measured using an ELISA assay kit (Biopool, CA, 
USA) obtained through local agents. The method is based on the method described by 
Marcovina et al. (1995).
This test is a sandwich immunoassay, which utilizes both a monoclonal antibody and 
polyclonal antibodies, capable of binding specifically to the apolipoprotein (a) moiety 
of lipoprotein (a). The monoclonal antibody was coated in the wells of a microtiter 
plate and used to capture lipoprotein (a) from the sample during 1 hour incubation at 
room temperature. After washing the plate, a polyclonal anti-lipoprotein (a) 
horseradish peroxidase (HRP) conjugate was added to bind to other sites on the 
lipoprotein (a) molecule to form a sandwich. After 15 minutes the plate was washed a 
second time, and the lipoprotein (a)/ antibody sandwich on the plate wells was then
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detected using a substrate for HRP and a chromogen producing a colored solution. 
After 15 minutes the reaction was stopped with sulfuric acid. The color that develops 
is directly proportional to the concentration of lipoprotein (a) in the sample. The 
absorbance was measured at 492nm. Lipoprotein (a) concentration was quantitatively 
determined by comparison of the absorbance of the samples with a standard curve 
prepared with known concentrations of lipoprotein (a) provided with the kit.
Each sample was diluted 1:2601 with sample buffer in two steps. Twenty pi of sample 
was added to 1ml of sample buffer and mixed. Twenty pi of this solution was added 
to another 1ml of sample buffer and mixed. Samples that contained >60mg/dl were 
further diluted with sample buffer with an additional 1:2 dilution. Fifty pi of PBS- 
BDTA-Tween (PET) buffer was added to each well using a multi channel pipette and 
agitated for 1 minute. Twenty pi of six standards, one control, and diluted samples, in 
duplicate, were added into the wells. The plate was covered with a lid and incubated 
at room temperature (20-25 °C) for Ihour ± 2 minutes on an orbital shaker (Lab line 
instruments. Inc. Melrose park, ILL, USA) at 120 ± 5 rpm. Fifty pi of anti-lipoprotein 
(a)-HRP conjugate was added to each well using a multi channel pipette and the plate 
was incubated at room temperature (20-25 °C) for 15 ± 1 minutes on the orbital 
shaker at 120 ± 5 rpm. The plate was aspirated and washed 4-5 times with the PBS- 
EDTA-Tween 20 buffer using an automated washer (Laboratory equipment, USA). 
Then the plate was inverted and tapped forcefully on adsorbent pad to remove any 
excess wash solution. The color developing solution was prepared by mixing 200pl 
of o-phenylenodiamine dihydrochloride (OPD) solution with 200pl of hydrogen 
peroxide and 2ml of deionized distilled water. One hundred pi of color developing 
solution was added to each well using a multi channel pipette and the plate was 
incubated at room temperature (20-25 °C) for 15 ± 1 minute on an orbital shaker at
97
120 ± 5 rpm. Finally 50pl of stop solution (sulfuric acid) was added and agitated for 
5minutes on the shaker. The absorbance of the resultant solution was measured at 
492nm within 15 minutes using a plate reader (Molecular devices-VMAX, kinetic 
microplate reader, Sunnyvale, CA, USA). Lipoprotein (a) concentration was 
determined in mg/dl using the standard curve.
The detection limit was <0.8 mg/dl calculated as two standard deviations above the 
zero standard according to the supplier’s package insert. Intra-assay and inter-assays 
precision were 9.1% and 12.6% respectively.
Limitation o f  serum Lp(a) evaluation
Lipoprotein (a) is a complex lipoprotein consisting of a central core of LDL 
covalently linked by a single disulphide bond to a polypeptide chain of apolipoprotein 
(a) [apo (a)]. The structural gene for apo (a) is located on chromosome 6, with the 
gene for plasminogen being nearby. Apo (a) also exists in many isoforms of variable 
sizes. The size heterogeneity of Lp(a) and the inclusion of LDL and plasminogen-like 
sequences in its structure have caused major challenges to the design of 
immunoassays for its measurement. This was overcame by the use of a polyclonal 
detection antibody against apo B component of Lp(a) that is not sensitive to 
variability in size of apo (a) (Marcovina et al., 1995).
2.4.2.6 Estimation of oxidized-LDL 
Plasma oxidized-LDL levels were measured using a competitive ELISA kit 
(Mercodia, Uppsala, Sweden), which was obtained through a local agent. The 
principle of the assay is based on the method described by Holvoet et al. (1998). The 
assay used was a sandwich ELISA in which the wells of the microtiter plates were 
coated with a specific murine monoclonal antibody, mAb-4E6, directed against 
epitope in the lipoprotein B-lOO moiety of LDL.
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The method is based on a direct sandwich technique in which two monoclonal 
antibodies are directed against separate antigenic determinants on the oxidized 
apolipoprotein B molecule. During incubation oxidized-LDL in the sample is reacted 
with anti-oxidized-LDL antibodies bound to the wells. Non-reactive plasma 
components were removed by washing with the wash buffer, and a peroxidase 
conjugated anti-apolipoprotein B antibody recognizing oxidized-LDL is bound to the 
solid phase. After a second incubation and a simple washing step that removed 
unbound enzyme labeled antibody, the bound conjugate was detected by reaction with 
3,3’,5,5’-tetramethylbenzidine (TMB). The reaction was terminated by adding 
sulfuric acid to give a colorimetric endpoint that was read spectrophotometrically at 
450nm.
Each sample was diluted with the sample buffer provided in the kit in two steps to a 
final dilution of 6561 times. Twenty five pi of six standards, controls (high and low), 
and diluted samples, were added to the wells of a 96 well tray coated with the anti­
oxidized LDL antibody, in duplicate. One hundred pi of assay buffer was added to 
each well using a multi channel pipette. The plate was incubated on a shaker (Lab line 
instruments. Inc. Melrose park, ILL, USA) for 2 hours at room temperature (20-25 
°C). The plate was washed 6 times with an automated washer (Laboratory equipment, 
USA) using 350pl of washing solution provided with the assay kit. After the final 
wash, the plate was inverted and tapped firmly against absorbent paper. One hundred 
pi of conjugate solution was added to each well and the plate was incubated on a 
shaker for another hour at room temperature (20-25 °C). The washing step was 
repeated. Two hundred pi of peroxidase substrate was added. The plate was incubated 
for 15 minutes at room temperature (20-25 °C). Finally 50pl of stop solution (sulfuric 
acid) was added and the plate was placed on the shaker for 15 seconds to ensure
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mixing of substrate and stop solution. The absorbance was measured at 450nm within 
30 minutes using a plate reader (Molecular devices-VMAX, kinetic microplate reader, 
Sunnyvale, CA, USA). Oxidized-LDL concentration was determined in U/L using the 
standard curve. The detection limit was 1 mU/L calculated as three standard 
deviations above the zero standard according to the supplier’s package insert. Intra­
assay and inter-assays precision were 8.6% and 14.6% respectively.
Limitation o f  serum ox-LDL evaluation
Ox-LDL is a very complex particle and its measurement as a single epitope has the 
inherent problem of not recognizing this heterogeneity. The major shortcoming in 
quantifying circulating levels of ox-LDL is in the specificity of the antibodies used, 
particularly when heterogeneous complexes of lipids are analysed. This was 
overcome by the use of anti-oxLDL monoclonal antibody (mAb4E6) and anti-human 
apoprotein B antibody (Holvoet et al., 1998). The mAb4E6 is also capable of detecting 
minute concentrations of plasma ox-LDL containing a conformational epitope in the 
apolipoprotein B-lOO moiety of LDL that is generated as a consequence of 
substitution of lysine residues of apolipoprotein B-lOO with aldehydes. However, to 
some extent the mAb4E6 also detects circulating malondialdehyde LDL.
2.4.3 Inflammatory markers
2.4.3.1 Estimation of soluble Intercellular Adhesion Molecule-1 
Plasma soluble intercellular adhesion molecule-1 (sICAM-1) levels were measured 
using an ELISA assay kit (R&D systems, Minneapolis, USA) obtained through local 
agents.
This assay employs a quantitative sandwich technique in which a monoclonal 
antibody specific for human sICAM-1 has been pre-coated onto a microplate. 
Samples were pipetted into the wells and any sICAM-1 present was sandwiched by
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the immobilized antibody and the enzyme-linked monoclonal antibody specific for 
sICAM-1. Following a wash with washing solution to remove any unbound 
substances and/or antibody-enzyme reagent, a substrate solution was added to the 
wells and color developed in proportion to the amount of sICAM-1 bound. The color 
development was stopped and the absorbance measured. sICAM-1 concentration was 
determined in ng/ml from a standard curve.
All samples and controls were diluted 20 fold into sample diluent. One hundred pi of 
diluted conjugate was added to each well of a plate using a multi channel pipette. One 
hundred pi of six standards, one control, or samples, in duplicate, were added to their 
respective wells. The plate was covered with a plate sealer provided and incubated for
1.5 hours at room temperature (20-25 °C). The reaction volume was aspirated and 
washed 6 times with an automated washer (Laboratory equipment, USA) using 300pl 
of washing solution. After the final wash, the plate was inverted and tapped firmly 
against absorbent paper to remove any remaining wash buffer. One hundred pi of 
substrate was added to each well using a multi channel pipette. The plate was covered 
with a new plate sealer and incubated for 30 minutes at room temperature (20-25 °C). 
One hundred pi of stop acid solution was added to each well in the same order as the 
substrate using a multi channel pipette. The absorbance was measured at 450nm 
within 30 minutes using a plate reader (Molecular devices-VMAX, kinetic microplate 
reader, Sunnyvale, CA, USA). The absorbance was also measured at 620nm and 
subtracted firom readings at 450nm to correct for any optical imperfections in the 
plate. SICAM-1 concentration was determined in ng/ml using the standard curve. The 
detection limit of the assay a sICAM-1 concentration of approximately 0.35ng/ml 
determined by adding two standard deviations to the mean optical density value of 20 
zero standard replicates and calculating the corresponding concentration according to
101
the supplier’s package insert. Samples with sICAM-1 concentration >49.55ng/ml 
were further diluted with sample diluent. Intra-assay coefficient of variation was 3.9% 
and inter-assay coefficient of variation was 9.6%.
Limitation o f  serum sICAM-1 evaluation
With the use of the present method it is not possible to measure the expression of cell- 
adhesion molecules on endothelial cells in vivo, only shed molecules circulating in 
the blood are detected by ELISA technique.
2.4.3.2 Estimation of high sensitivity C-reactive protein 
Serum high sensitivity C-reactive protein levels were measured using an ELISA assay 
kit (DRG Diagnostics, Germany) obtained through local agent.
The assay system utilizes a unique monoclonal antibody directed against a distinct 
antigenic determinant on the CRP molecule. This mouse monoclonal anti-CRP 
antibody was used for solid phase immobilization on the microtiter wells. A goat anti­
human CRP antibody conjugated to horseradish peroxidase was used as the detection 
antibody. The samples were allowed to react simultaneously with the two antibodies, 
resulting in the CRP molecules being sandwiched between the solid phase and 
enzyme-linked antibodies. After the first incubation step, the wells were washed to 
remove unbound labeled antibodies. After removal of the unbound conjugate, the 
plate was incubated with a substrate solution containing tetramehylbenzidine (TMB) 
reagent. A blue color developed in proportion to the amount of immunocomplex 
bound to the wells. The color development was stopped with the addition of 
hydrochloric acid changing the color to yellow.
Serum and control samples were diluted 100 fold with the dilution buffer provided 
with the kit. Ten pi of six standards, controls, and samples, in duplicate, were added 
to the plate. One hundred pi of CRP enzyme conjugate reagent was added to each
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well using a multi channel pipette and thoroughly vortex mixed for 30 sec. The plate 
was incubated for 45 minutes at room temperature (20-25 °C) and then aspirated and 
washed five times with an automated washer (Laboratory equipment, USA) using the 
deionized distilled water. After the final wash, the plate was inverted and tapped 
firmly against absorbent paper. One hundred pi of conjugate was added to each well 
using a multi channel pipette and gently mixed for 5 sec. The plate was incubated for 
20 minutes at room temperature (20-25 °C). Finally lOOpl of stop solution (IN  HCL) 
was added to each well using a multi channel pipette and vortex mixed for 30sec. The 
absorbance was measured at 450nm within 15 minutes using a plate reader (Molecular 
devices-VMAX, kinetic microplate reader, Sunnyvale, CA, USA). The concentration 
of C-reactive protein was determined in mg/L from a standard curve. The detection 
limit of the assay was estimated as two standard deviations from the mean of a zero 
standard and was approximately 0.1 mg/L according to the supplier’s package insert. 
Samples with CRP concentrations over lOmg/L were further diluted 10 fold of the 
100 fold diluted solution (final dilution 1:1000). Intra-assay coefficient of variation 
was 7.9% and inter-assay coefficient of variation was 8.5%.
Limitation o f  serum CRP evaluation
CRP is an acute-phase reactant, which is a marker for underlying systemic 
inflammation. Elevated serum levels of CRP have been widely considered to be 
nonspecific but sensitive markers of the acute inflammatory response. When 
measured with a high sensitivity method, CRP levels also appear to predict coronary 
events in patients with CVD as well as apparently healthy subjects.
2.4.3.3 Estimation of caeruloplasmin 
Methods for quantitative estimation of caeruloplasmin in plasma have been based on 
its blue color, copper content, its diamine oxidase activity, or its immunological
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properties. The most commonly used methods are based on the oxidase activity of the 
protein. The enzymatic activity of caeruloplasmin was determined by using o- 
dianisidine dihydrochloride as a substrate (Schosinsky et al. 1974).
All chemicals were of at least analytical grade unless indicated otherwise and were 
obtained from (Sigma chemical, St. Louis, USA) through a local agent. Duplicate 
plasma samples each of a 50pl, were added to 0.75 ml of O.IM acetate buffer pH5.0 
and placed in a 30°C water bath (see appendix 1 for details on buffer preparation). 
The pre-incubated substrate at 30°C, 0.2 ml of 7.88M o-dianisidine dihydrochloride, 
was added into each tube. The reaction was terminated in the first tube after 5 min and 
after 15 min in the second tube with the addition of 2ml (9M) sulfuric acid. The 
absorbance of both solutions was measured at 540nm vs. deionized distilled water as a 
blank. The rate of oxidation was calculated as the change in optical density at 540 nm 
over 15 minutes. Readings were carried out on NovaSpec II, spectrophotometer of 
adjustable wavelength, model 80-2088-71 (Amersham Pharmacia Biotech, Greece, 
Athens). The difference in absorbance between the two tubes was calculated and the 
enzyme activity was estimated using the molar absorption coefficient of the oxidized 
substrate (9.6 ml/pmol/cm) and expressed as IU/1. The intra-assay and inter-assay 
coefficient of variations was 6.4% and 7.6% respectively.
Limitation o f  serum caeruloplasmin evaluation
One of the sources of errors when using o-dianisidine dihydrochloride as a substrate is 
due to its enzymatic oxidation. To prevent this, the tube in which the reaction was 
stopped after 5 min is used as a control. The difference between the control tube and 
the reaction tube will determine the enzymatic oxidation of o-dianisidine 
dihydrochloride. Additionally, this reaction is subjected to a lag phase due to the 
oxidation by caeruloplasmin of plasma ascorbic acid. Therefore, the timing of the
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reaction is deliberately delayed 5min after the substrate addition to plasma in the 
control tube.
2.4.4 Antioxidant enzymes activities
2.4.4.1 Sample preparation
Erythrocytes were washed three times in ten times their volume of cold saline (0.9% 
NaCl). The erythrocytes were then centrifuged at 10,000 x g for 15 minutes at 4°C. 
The cells were collected after removal of the supernatant; lysed in four times their 
volume of ice-cold deionized water and stored at -80°C until analysis.
Preparation of the tissue supernatant for subsequent SOD activity determination was 
according to the method of (Kuthan et al., 1986). Small frozen sections of aorta (5- 
15mg) or liver (0.5g) were rinsed in 50mM phosphate buffer saline, pH 7.4, 
containing 0.3M potassium bromide and 3% (v/v) proteases cocktail inhibitor (Sigma, 
Poole, Dorset, UK). Tissues were then homogenized in 4-8 volume (v/w) of 50mM 
Tris-HCL (pH 7.5, containing 5mM EDTA and ImM 2-mercaptoethanol), using a 
micro-homogenizer (Tissue Tearor, BioSpec products, INC. model 398. WI, USA). 
The homogenate was then sonicated for 5 minutes at full power in an Ultrawave 
sonicating water bath (Philip Harris Scientific, London, UK) and the supernatant 
following centrifugation at 10000 x g for 20 min at 4°C was retained. See appendix 
(1) for details of the buffers preparation.
Preparation of the aortic supernatant for subsequent GPx activity determination was 
according to the method of (Forstrom et al.,1978) and involved homogenizing small 
frozen sections of aorta (5-15mg) in 4-8 volume (v/w) of 50mM Tris-HCL (pH 7.5, 
5mM EDTA, and ImM DTT) per gram tissue using a micro-homogenizer (Tissue 
Tearor, BioSpec products, INC. model 398. WI, USA). The homogenate was then
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centrifuged at 10000 x g for 20 min at 4°C. See appendix (1) for details of the buffer 
preparation.
2.4.4.2 Estimation of erythrocyte haemoglobin
Haemoglobin content of the erythrocytes was estimated using a commercial kit 
(Crescent Diagnostics, KSA) based on the method of Drabkin (Von-Kompen and 
Zijlstra,1961). Haemoglobin was converted into cyanmethaemoglobin under the 
influence of potassium ferricyanide and potassium cyanide. Twenty pi of samples 
were added, in duplicate, to 5ml of Drabkin’s working solution and vortex mixed. 
Standard solution of cyanmethaemoglobin of known concentration according to 
international recommendations (15gm/dl) was supplied with the kit. The absorbance 
of samples and standard was measured against the reagent blank at 540nm within 60 
minutes. Readings were carried out using a plate reader (Molecular devices-VMAX, 
kinetic microplate reader, Sunnyvale, CA, USA). Haemoglobin concentration was 
estimated in gm/dl.
2.4.4.3 Estimation of tissue protein
Protein content of the animal tissue homogenates was measured by the method of 
Lowry (1951). All chemical were obtained from (Sigma Chemical, St. Louis, USA) 
through a local agent. The procedure involved protein reaction with cupric sulfate and 
tartrate in an alkaline solution, resulting in formation of tetradenate copper-protein 
complex. When the Folin-Ciocalteu reagent (phospho-molybdic-phosphotungstic 
reagent) was added, it is effectively reduced in proportion to chelated copper 
complex, thus producing blue colored complex. One hundred pi of standards and 
samples in duplicate were added to 1.0 ml of Lowry reagent (consisting of a freshly 
made mixture of 48 parts of solution A [2% Na2COs in O.IN NaOH] and 1 part of 
both of solution B [1% NaK tartarate.4H20] and solution C [0.5% CUSO4.5 H2O]),
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vortex mixed and incubated at room temperature (20-25 °C) for lOmin. One hundred 
pi of Folin-Ciocalteu reagent was added to each tube, vortex mixed, covered and 
incubated at room temperature for 30min. Readings at 600nm were carried out using a 
plate reader (Molecular devices-VMAX, kinetic microplate reader, Sunnyvale, CA, 
USA). Protein concentration was determined with reference to standards of bovine 
serum albumin (BSA) and estimated in pg/ml.
2.4.4.4 Estimation of glutathione peroxidase 
GPx activity was measured in erythrocytes lysates using a Randox kit (Randox 
Laboratories Ltd, Antrim, UK) obtained through local agent. The method is based on 
that of Paglia and Valentine (1967). GPx catalyzes the oxidation of glutathione by 
cumene hydroperoxide. In the presence of glutathione reductase (GR) and NADPH, 
the oxidized glutathione was converted to the reduced form with a concomitant 
oxidation of NADPH to NADP^. The decrease in absorbance at 340nm was measured.
2GSH + ROOH > ROH + GSSG + H2O
GSSG + NADPH + H^ —^  NADP^ + 2GSH 
Erythrocytes were diluted by adding 2ml of diluting agent to convert glutathione to 
the reduced form. Drabkin’s reagent was added subsequently to inhibit the other 
peroxidases present in human blood that may give falsely elevated results. Twenty pi 
of sample, controls, and reagent blank in duplicate, were added into the bottom of 
quartz spectrophotometer cuvettes. One ml of reagent and 40pl of cumene 
hydroperoxide were added and mixed well. Initial readings were taken after Imin and 
after each min for 3min using NovaSpec II, spectrophotometer of adjustable 
wavelength, model 80-2088-71 (Amersham Pharmacia biotech, Greece, Athens). The 
results were calculated as U/gm hemoglobin in whole blood or U/gm protein in tissue 
extracts. If the absorbance change per minute exceeded 0.1, samples were further
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diluted with diluting agent and the result multiplied by the dilution factor. Within 
batch imprecision was 3.1% whereas between-batch imprecision was 5.3%.
2.4.4.S Estimation of superoxide dismutase 
SOD activity was measured in erythrocyte lysates using the Randox kit (Randox 
Laboratories Ltd, Antrim, UK) obtained through local agent. EDTA whole blood 
samples were used and erythrocyte lysates were prepared as described above.
The method employs xanthine and xanthine oxidases (XOD) to generate superoxide 
radicals, which react with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium 
chloride (INT) to form a red formazan dye. SOD inhibits the absorption change of the 
INT in a degree proportional to the amount of the enzyme present. The SOD is then 
measured by the degree of inhibition of this reaction (Marklund 1976).
Xanthine —™  > Uric acid + O2 '
O2 ' + IN T  > formazan dye
OR
O2' + O2" + 2H+ > O2 + H2O2
A 25 fold dilution of lysate of the sample diluent was recommended for human 
sample to give a final dilution factor of 100. Fifty pi of six standards, controls, and 
samples, in duplicate, were added into the bottom of quartz spectrophotometer 
cuvettes. 1.7ml of mixed substrate was added to each cuvette, mixed well and 0.25ml 
of xanthine oxidase was added simultaneously and mixed well again. Initial readings 
were taken after 30sec and after 3min using NovaSpec II, spectrophotometer of 
adjustable wavelength, model 80-2088-71 (Amersham Pharmacia biotech, Greece, 
Athens). The change in absorbance was calculated using the following equation: (A2- 
A1)/3=AA of the standard or sample per minute. Sample diluent rate (standard 1 rate) 
is the rate of the uninhibited reaction (i.e. blank = 100%). All standards rates and
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diluted samples rates were converted into % of the sample diluent rate (or blank rate) 
and subtracted from 100% to give the inhibition %.
The inhibition % for all standards were plotted against log lo standards concentrations 
in SOD (U/ml). The inhibition % of samples were used against the standard curve to 
obtain units of SOD. The enzyme activity was calculated as U/gm hemoglobin in 
erythrocytes lysates or U/gm protein in tissue extracts. Samples should be diluted to 
give an inhibition between 30% and 60% of the sample diluent rate (i.e. the 
uninhibited reaction). Within batch imprecision was 5.7% whereas between-batch 
imprecision was 8.1%.
Limitation o f  the SOD assay
SOD exists intracellularly in 2 forms, Cu-Zn/SOD in the microsome fraction of the 
cells and Mn-SOD in the mitochondria. However, the assay used in this study is 
conducted at a pH of 10.2 that inactivates Mn-SOD, making the assay specific for 
Cu/Zn-SOD.
2.4.5 Lipid peroxides markers
Lipid hydroperoxides concentrations were determined by two methods. The Thio- 
Barbituric Acid Reactive Substances (TBARS) method has been criticized for its lack 
of specificity and accuracy. However, many of the difficulties encountered in its use 
are attributable to inappropriate modifications of the assay. The FOX assay was used 
as a second measure of peroxidation.
2.4.5.1 Thio-Barbituric Acid Reactive Substances method 
Aldehyde products of lipid peroxidation in plasma, aortic, and liver tissues in animal 
and in human serum were measured by the TBARS method (Ohkawa et al., 1979). 
Aortic tissues were homogenized in lOOmM phosphate-buffered saline (PBS) and the
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homogenates were used for determination of malondialdehyde (MDA) using TBARS 
method. See appendix (1) for details of the buffer preparation.
Duplicate plasma samples of 0.5ml were incubated with 0.25ml of 1% (w/v) 2- 
thiobarbituric acid in 50mM NaOH and 0.25ml of 30% (w/v) trichloroacetic acid in a 
boiling water bath for 15min to prevent lipid peroxidation. Twenty five pi of 0.88% of 
butylated hydroxytoluene in ethanol was added subsequently to the samples. The 
solutions were then cooled in ice for 5min and cold centrifuged at 3000 rpm for 
15min. The supernatant were removed and absorbance at 535nm was measured using 
NovaSpec II, spectrophotometer of adjustable wavelength, model 80-2088-71 
(Amersham Pharmacia biotech, Greece, Athens). The molar extinction coefficient, as 
determined from the standard samples, was 1.56x10^ M'^ cm '\ This was used to 
calculate the concentrations in samples. TBARS were expressed as pM of MDA 
equivalents. The within run coefficients of variation was 3.7% and between run 
coefficients of variation was 7.2%.
Limitation o f  the serum TBARS assay
The sensitivity of measuring TBARS has made this assay the method of choice for 
screening and monitoring lipid peroxidation, an index of oxidative stress. Although 
much controversy has appeared in the literature regarding the specificity of TBARS 
toward compounds other than MDA, it remains the most widely employed assay to 
determine lipid peroxidation. Biological samples contain a mixture of TBARS, 
including lipid hydroperoxides and aldehydes, which increase as a result of oxidative 
stress and eventually, result in an overestimation of the actual MDA levels.
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2.4.S.2 Ferrous Oxidation Xylenol orange assay 
The FOX assay is a more specific assay for lipid peroxides, and is used to detect low 
concentrations of lipid-soluble peroxides in the presence of large concentrations of 
nonperoxide lipids.
The method is based on ferrous ions oxidation by the peroxides into ferric ions. 
Antioxidant (butylated hydroxytoluene) is included in the reagent mixture to remove 
the alkyl radicals produced by this reaction. At acidic pH, the ferric ions complexed 
with xylenol orange dye to yield a blue purple product (Nourooz-Zadeh et al., 1995). 
ROOH + Fe^ "" ^  + RO + OH'
RO- + RH + Fe '^" ^  Fe^* + ROH + R 
R + B H T ^ R H
Fe^* + XO blue-purple complex 
All chemicals were of at least analytical grade unless indicated otherwise and were 
obtained from (Sigma chemical, St. Louis, USA) through a local agent. Glassware 
was cleaned in nitric acid followed by thorough rinsing and drying. Aqueous solutions 
were made up in deionized distilled water. Ninety pi of plasma was added in duplicate 
either to 10 pi of triphenylphosphine (TTP) or to 10 pi methanol (HPLC grade) and 
incubated at room temperature (20-25 °C) for 30 min. Followingly, 900 pi of FOX 
reagent (100 pM xylenol orange, 250 pM ammonium ferrious sulphate, 25mM 
sulfuric acid, and 4mM BHT in 90% (v/v) methanol) was added to each tube, vortex 
mixed, sealed with Teflon stoppers and incubated in the dark at room temperature 
(20-25 °C) for another 30min. Centrifugation at 12,000 x g for lOmin was carried out 
to get rid of any flocculated proteins. The absorbance was read subsequently at 560nm 
using NovaSpec II, spectrophotometer of adjustable wavelength, model 80-2088-71 
(Amersham Pharmacia biotech, Greece, Athens). The net absorbance for each sample
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was then calculated by subtracting the absorbance in the (-TPP) tube from the 
absorbance in the (+TPP) tube, which reflects the authentic hydroperoxides. Dilution 
factor was taken into account by dividing by 0.9. The molar extinction coefficient, as 
determined from the standard samples of H2O2, cumene hydroperoxide, and butyl 
hydroperoxide was (s = 4.3 x 10"^  M’^  cm'^). This was used to calculate the 
concentrations of lipid peroxides in samples, which were expressed as pM. The within 
run coefficients of variation was 4.1% whereas between run coefficients of variation 
was 7.3%.
2.4.6 Estimation of trace elements
2.4.6.1 Reagents and glassware
All reagents were at least of analytical grade. All acids were of Aristar grade and 
Spectrosol grade (BDH chemicals Ltd., Poole Dorset, England). All digestion tubes 
and any other glass or plastic ware used for trace elements determination were 
cleaned by soaking overnight in 10% (v/v) hydrochloric acid, followed by thorough 
rinsing with deionized distilled water (18 Mfl/cm^) and drying. All solutions were 
made with deionized distilled water. Deionized distilled water was obtained from an 
Elga reverse osmosis deionizer system.
2.4.6.2 Calibration and analytical characteristics
Atomic absorption mixed standard solutions (Sigma chemical, St. Louis, USA) of 
copper and zinc were prepared from a 1 gm/L (1000 ppm) stock solutions covering 
ranges from 0.05-1 mg/ml for external calibration. Alternatively urine samples were 
used to prepare a standard curve in the standard addition method. It is well known that 
aspiration rate differs between samples and aqueous standards due to the differences 
in viscosity. Therefore, all standard solutions were diluted with 10% (v/v) glycerol. A 
10% (v/v) glycerol solution was used as a blank solution as instructed by the
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manufacturer. A typical standard curve of copper and zinc estimation is illustrated in 
figure (2.1).
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Figure 2.1: Typical standard curve of copper and zinc estimation by flame atomic 
absorption spectrophotometer on a SOLAAR M5-flame (Thermo Electron, 
Cambridge, UK) equipped with an air-acetylene flame burner. Stock atomic 
absorption standard solutions of copper or zinc containing from 0-40 pmol/L were 
diluted with 10% (v/v) glycerol to obtain a standard curve. A 10% (v/v) glycerol 
solution was used as a blank solution as instructed by the manufacturer.
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The atomic absorption standard solution (Sigma chemical, St. Louis, USA) of 
selenium was prepared from a 1 g/L (1000 ppm) stock solution. A graphite furnace 
selenium calibration curve was prepared by further dilution of 100 pg/L of the 
corresponding standard to give concentrations ranged from 0 to 80 pg/L in a solution 
containing 0.5% NiNOs and 0.072M HNO3. A blank solution of deionized distilled 
water was treated the same. Working selenium standard solutions of the hydride 
generation technique were similarly constructed from 0  to 80 pg/ml and were 
prepared using a solution containing 1.5% (v/v) HCl. A blank reagent of deionized 
distilled water was also prepared with a 1.5% (v/v) HCl. A typical standard curve of 
selenium estimation using the graphite furnace and hydride generation methods are 
illustrated in figure (2.2) and (2.3).
114
y = 0.0021X + 0.0772
0.25 1
c 0.15
0.05
0 10 20 30 40 50 60 70 80
® Selenium 
 Linear (Selenium)
Concentration (ug/L)
Figure 2.2: A typical calibration curve of selenium measurement by the standard 
addition method using the graphite furnace prepared by further dilution of 100 pg/L 
of the corresponding standard to give concentrations ranged from 0 to 80 pg/L in a 
solution containing 0.5% NiNOs and 0.072M HNO3. A blank solution of deionized 
distilled water was treated the same.
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Figure 2.3: A typical working selenium standard solutions of the hydride generation 
technique constructed from 0 to 80 pg/ml and prepared using a solution containing 
1.5% HCl. A blank reagent of deionized distilled water was also prepared with a 1.5% 
HCl.
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2.4.6.3 Instrumentation
An atomic absorption spectrophotometer (SOLAAR M5) with dual AA 
spectrophotometer, double beam optics, equipped with a single slot burner head and 
deuterium lamp background correction was used to measure trace element levels 
(Thermo Electron, Cambridge, UK). A schematic representation of the main parts of 
the flame atomic absorption spectrophotometer is shown in figure (2.4). Copper and 
zinc concentrations were determined by the air/acetylene flame atomic absorption 
spectrophotometer. Serum selenium was measured using the GF95 graphite furnace 
with auto-sampler. Argon gas was used as the purging gas. Urine selenium was 
measured using the VP90 continuous flow vapor system. Copper, zinc, and selenium 
hollow cathode lamps (Thermo Electron, Cambridge, UK) were operated at 20mA for 
copper, at 15mA for zinc, and at for 11mA for selenium. Atomic absorption 
measurements were made at a wavelength of 324.8nm for copper, at 213.9nm for 
zinc, and at 196nm for selenium.
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Figure 2.4: The main components of the flame atomic spectrophotometer. Aqueous 
samples containing the analyte are aspirated into an air-acetylene flame causing 
evaporation of the solvent and vaporization of the free metal ions. Hollow cathode 
lamps operating in the UV-visible spectral region are used to cause electronic 
excitation of the metal ions, and the absorbance is measured with a spectrophotometer 
with photomultiplier detector.
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All analyses were performed in peak height mode to calculate absorbance values. All 
samples were analysed in duplicate. The plot of peak height versus concentration was 
linear and was used to determine the concentrations of the specimens.
The within batch coefficient of variation was 5.3% for serum copper, 9.4% for serum 
zinc, 8.1% for serum selenium, 9.8% for urine copper, 9.1% for urine zinc, and 9.2% 
for urine selenium whereas the between batch coefficient of variation was 11.5% for 
serum copper, 10.1% for serum zinc, 12.4% for serum selenium, 9.9% for urine 
copper, 10.5% for urine zinc, and 12.4% for urine selenium.
2.4.6.4 Sample preparation
2.4.6.4.1 Estimation of copper and zinc 
Serum samples were diluted 1 in 5 with deionized distilled water for the estimation of 
copper and zinc content (Agget,1991). The measurement of copper and zinc in 
undiluted urine was complicated by the interference of the urine matrix with the 
atomic absorption signal. Urine copper and zinc were measured by the method of 
standard addition. The urine samples were used to prepare a standard curve of 5 
points (Table 2.1), thus any matrix effect of the urine was similar for standards and 
tests. A calibration curve of peak height against the concentration of added standards 
was constructed in which the intercept with the y-axis was equal to the concentration 
in tube 1. The urinary output of trace elements was expressed in pmol/mmol of 
creatinine. A typical standard curve of copper and zinc estimation in urine samples 
using a standard addition method is illustrated in figure (2.5).
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Table 2.1: Standard  co n cen tra tio n s  o f  c o p p er  and z in c  in  standard  a d d itio n  m e th o d
Tube
No.
Urine
volume
(ml)
Standard 
volume (fil)
Added 
[Cu] or [Zn] 
(nmol/5ml)
Equivalent 
[Cu] or [Zn] 
(jimol/L)
1 5 0 0 0
2 5 10 1 0.2
3 5 30 3 0.6
4 5 70 7 1.4
5 5 150 15 3.0
0.14 y = 0.0333X + 0.0284
0.12
O U.1
0
1 0.08a
o 0.06 
<  0.04 y = 0.0234X + 0.0201
0.02
320 1 4
♦ Copper
♦ Zinc 
Linear (Copper)
 Linear (Zinc)
Concentrations (umol/L)
Figure 2.5: Typical standard curve of copper and zinc estimation by flame atomic 
absorption spectrophotometer in urine samples using a standard addition method.
1 1 9
Copper and zinc were also determined in animal tissue (Puchades et al., 1989). Tissue 
samples (0.5g) from liver, kidney, muscle, and (5-15mg) aorta were digested first 
using a Techator digestor (Perstop Analytical Ltd., Bristol, UK) according to the 
following steps. Briefly, tissue samples were dissolved in 7ml 3.5M nitric acid by 
heating to 150°C for 30 minutes in a Techator digestor (Perstop Analytical Ltd., 
Bristol, UK). When cool, 1ml of 11.6 M perichloric acid was added and all tubes 
heated to 150°C for 30 minutes, 200°C for 15 minutes and 250°C for 15 minutes and 
then allowed to cool. The volume was made up to 10ml with 1% nitric acid.
Limitation o f  copper and zinc evaluation
• Usually the measurement of urinary excretion of trace elements is carried out
in 24hr urine samples, which were not easily collectable in our study. Thus the
use of trace elements/creatinine ratio in urine was used in this study.
• At low dilutions, animal serum samples tended to clog the nebulizer of the
flame aspiration AAS. Therefore, the higher 6 -fold dilution was used and this 
was followed by centrifugation at 25,000 g  before analysis.
2.4.6.4.2 Estimation of creatinine 
Urine creatinine levels were measured by a Jaffe based reaction (Husdan and 
Rapoport, 1968) using a commercial kit (Crescent Diagnostics, KSA) obtained 
through a local agent. In the Jaffe reaction, creatinine reacts with alkaline picrate to 
produce a reddish-orange complex. Five hundred pi of samples and standards, in 
duplicate, were added to 500pl of working reagent (fresh mixing of equal volumes of 
picric acid and NaOH) and vortex mixed. Readings were carried out using a plate 
reader at 520nm after 20min (Molecular devices-VMAX, kinetic microplate reader, 
Sunnyvale, CA, USA). Urine creatinine was expressed in mmol/L. The assay was
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linear to 0.88 mmol/L. For values above that, samples were diluted 1:6 with normal 
saline, reassayed and the results were then multiplied by 7.
2.4.6.4.3 Estimation of serum selenium 
Serum selenium samples were introduced by an autosampler into a graphite furnace. 
The autosampler was programmed to deliver 20pl of solution to the graphite tube. 
Standard pyrolitically coated graphite tubes with platform were used. Adequate 
recovery of serum selenium was attained without sample digestion; only dilution with 
nickel as the matrix modifier was needed. Without the modifier selenium is lost 
before concomitants can be volatilized. Nickel was incorporated into the diluent as a 
thermostabilising agent to reduce loss of selenium during ashing. Triton-XlOO was 
added as a flow agent to assure consistent deposition of the sample in the platform 
and consistent solubilization of the sera.
The serum selenium concentrations were determined by the method of standard 
addition (Alflhan and Kumpulaien, 1982) using 3 different standard concentrations 
(Table 2.2). A calibration curve of peak heights was plotted against added standard 
concentrations. The absorbance of the first test cup (zero standard) intersected the y- 
axis and extrapolated to y = 0  to get the concentration value in the original sample. 
Serum samples were diluted (1:4) with 0.05% Triton-X 100 in 0.125% (v/v) nitric 
acid before introduction in the atomizer to minimize protein precipitation in the 
samples caused by the subsequent addition of the modifier (Nixon et al., 1999). After 
the introduction of standards or samples into a graphite tube, a matrix modifier ( 1% 
(w/v) NiN03.6H20 in 0.144M HNO3) was added (Table 2.3) and the measurement 
was performed using the heating program according to a temperature program in table 
(2.4). Extra steps were employed at the termination of the atomization furnace 
program to allow the graphite tube to cool slowly to 40°C and thus prevent spattering
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of the subsequent injection. Along with this modification, an extended dispensing rate 
was used to ensure that all the dispensed liquid would be slowly introduced to be 
contained within the platform cavity for subsequent temperature programming.
Table 2.2: Concentrations of selenium standards in standard addition method
Tube
No.
[Se] standard (pg/L) Standards 
volume (ml)
DDW 
volume (ml)
1 0 0 10
2 20 2 8
3 40 4 6
4 60 6 4
DDW; deionized distilled water
Table 2.3: Concentrations of selenium standards in graphite furnace method
Tube
No.
Standards 
volume (ml)
Diluent 
volume (ml)
Final [Se] 
standard 
(Pg/L)
1 5 5 0
2 5 5 10
3 5 5 20
4 5 5 30
Table 2.4: Graphite furnace temperature programming profile.
Phase Temperature
m
Ramp time 
(s)
Hold time 
(s)
Argon gas flow 
(ml/min)
Diying 1 70 9 10 200
Drying 2 130 9 20 200
Ashing 3 1100 50 20 200
Atomization 4 2400 0 4 Stop flow
Cleaning 5 2900 0 3 300
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2.4.6.4.4 Estimation of urine selenium
Many selenium compounds are volatile and can be lost during the decomposition 
process. Therefore, a gradual destruction with nitric, sulphuric, and perchloric acids to 
a final temperature of 310°C was found to be optimum for the subsequent 
determination of selenium with hydride generation (Weltz et al., 1987). Acid digestion 
of urine samples was carried out by using a Techator digestor (Perstop Analytical 
Ltd., Bristol, UK). The procedure consisted of placing 1ml of urine sample into an 
acid-washed digestion tube with 5ml HNO3 and heated in the heating block at a 
setting of 140°C during 10 minutes and held for 20 minutes. Urine pool samples and 
reagent blank were also taken through the same procedure. Digestion tubes were 
removed fi*om the block, cooled and 0 .2 ml of HCIO4 and 0.5 H2SO4 were added to 
each tube. The tubes were then replaced in heating block and reheated according to 
the following setting: at 150°C during 15 minutes and held for 30 minutes, at 200°C 
during 15 minutes and held for 15 minutes, then at 250°C during 10 minutes and held 
for 15 minutes, and finally at 310°C during 10 minutes and held for 25 minutes. Tubes 
were left to cool, then 5ml of 50% (v/v) HCl was added and reheated to 90°C over 10 
minutes and held for 20 minutes. Tubes were removed fi*om block and 5ml deionized 
distilled water was added and mixed well. This 10ml aliquot was then transferred to 
acid-washed plastic tubes and stored at -80°C until analysis.
An alkaline NaBH4 solution [(5% (w/v) of NaBH4 dissolved in 1% (w/v) NaOH ] was 
used as a reductant meeting a carrier stream of 1.5% (v/v) HCl in a T-junction and 
was injected by peristaltic pump into the hydride generator. The reduction of Se (VI) 
was carried out by HCl and the resulting gaseous Se (IV) hydride was transported by 
a stream of argon gas into the electrically heated cell at 900°C where the selenium 
atoms were formed and absorption of light occurred. The disappearance of free atoms
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in the absorption chamber of the atomizer (quartz tube) is caused by a change in the 
character of the surface as a result of disposition of interfering substances on the 
walls.
The major problem with the hydride generation technique arises from the presence of 
contaminants, which can produce interferences in the liquid phase, during the hydride 
transport to the atomizer and in the atomization step. The ideal method for the control 
of interferences would be the use of appropriate chemical modifications including the 
use of masking agents in the hydride generation step, which reduce interferences and 
maintain the analytical sensitivity of the technique. In general, the decreasing of 
sodium borohydride (NaBH4) concentration and the increasing of sample acidity are 
reported to improve the tolerance limits. In addition the continuous flow hydride 
generation apparatus is less prone to liquid phase interferences.
Limitation o f  selenium evaluation
• The hydride generation technique is a sensitive method and can handle all
sample types equally. However, large amounts of samples and acid pre­
digestion, to convert all selenium into inorganic form, are required.
• The graphite furnace technique does not require prior digestion of samples nor
large volumes of samples. However, high dilution of samples is not suitable 
since the sensitivity is barely adequate and the background correction at such a 
low wavelength of 196.0nm causes problems.
• The use of deuterium background correction was found to be suitable for use 
with serum and urine samples because Zeeman background correction is only 
necessary in case of analyzing blood samples. This is because iron, which is 
present at very high concentrations in erythrocytes, constitutes an interference
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that leads to overcompensating effects when deuterium background correction 
is used.
2.4.7 Estimation of antioxidant vitamins
2.4.7.1 Instrumentation
Serum vitamin A (measured as retinol) and E (measured as a-tocopherol) were 
determined separately using isocratic reverse phased high performance liquid 
chromatography with multi-wave length detection. Figure (2.6) shows a schematic 
presentation of the basic parts of the HPLC system.
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Figure 2.6: Schematic presentation of the basic parts of HPLC system. The 
components of the applied sample are separated by the continuous passage of the 
mobile phase through the column. The flow rate of the mobile phase is regulated by 
adjusting the operating pressure by the use of the peristaltic pump. As the resolved 
analytes emerge in the effluent from the column, detection of its presence is based on 
ultraviolet/visible light absorption or fluorescence spectroscopy by a detector. 
Chromatogram is recorded on the data system showing the peak signal of the analyte 
components. They can be then be identified by eomparison of their retention times 
and their ultraviolet/visible absorption with those of the internal standards.
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2.4.7.2 Conditions of measurement
The separation was carried out on a reverse phase stainless steel (50 x 4.6 mm) 
prodigy 5-pm 0DS2 eolumn (Phenomenex Ltd, Maeelesfield, Cheshire, UK), using 
methanol as the mobile phase and a flow rate of 1.40 ml/min. The column was 
preceded by a disposable ODS C l8  (4mm) guard eolumn (Phenomenex Ltd, 
Maeelesfield, Cheshire, UK). Peaks were deteeted at 294nm and 325nm for vitamin E 
and A respectively. Retention time for internal standard and a-toeopherol was 5.0, and
6.0 min respeetively and 3.3 min for vitamin A.
2.4.7.3 Reagents
All solvents were of HPLC grade and obtained from Fisher Scientific (Fairlawn, NJ, 
USA). All other reagents of analytical grade (Sigma, Poole, Dorset, UK). Vitamin A 
and E standard and quality control material were obtained from BioRad Laboratories 
Ltd, Hemel Hempstead, UK.
2.4.7.4 Sample preparation
Blood samples for vitamin A analysis were originally collected in vacutainer tubes 
wrapped with aluminum foil and serum samples were subsequently stored in amber 
polypropylene tubes after centrifugation to be stored at -80°C until time of analysis. A 
modification of the method of Bieri et al (1979) was used.
Two hundred pi of plasma samples were extracted by the addition of 200 pi of 
isopropyl alcohol containing 1 0  pg/ml of 8 -tocopherol as an internal standard and 
vortex mixed. Two hundred pi of aqueous ammonium sulphate (3.9mol/L) was added 
and again vortex mixed. After centrifugation at 1000 g for 5 min, 50 pi of the 
supernatant was ready to be injected into the column.
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2.4.7.S Analytical characteristics
Fifty pi of a-tocopherol and vitamin A controls, 50 pi of the working standard of 5- 
tocopherol, and 50 pi of samples in duplicates were injected into the column using 
methanol as the mobile phase. The different standards were injected separately in 
order to examine the peak shapes and retention times. Peaks were identified by 
comparing retention times with those of the corresponding standards. A representative 
chromatogram of the separation of both vitamins is shown in figure (2.7). Peaks 
numbering indicate 5-tocopherol, a-tocopherol, and vitamin A.
The within assay precisions were 4.6% for vitamin A and 3.2% for vitamin E, and 
between assay precisions were 6.2% for vitamin A and 4.2% for vitamin E.
Limit of detection (LOD) was determined by a sample with vitamin concentration of 
3-5 times the noise level measured 10 times and was approximately 0.14pmol/L for 
vitamin A and 1.6 pmol/L for vitamin E.
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Figure 2.7: Typical chromatogram showing peaks of a-tocopherol and the internal 
standard 5-tocopherol at 294nm and at 325 nm for retinol. Retention times are 
indicated above each peak.
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2.5 Quality control
Precision (reproducibility) was estimated by calculating the intra-assay variation and 
the inter-assay variation. Pool samples of serum, urine, and erythrocytes lysates were 
obtained from ten controls. Each pool was aliquoted into several tubes and frozen at - 
80 °C. Intra-assay variation was calculated by running a pool sample in ten replicates 
in the same run. Inter-assay variation was calculated by running the same sample with 
each assay in duplicate. Acceptable levels of intra-assay and inter-assay precision are 
10% and 20% respectively (O'Connell et al, 1993). In general within batch 
imprecision (CV) of all assays was below 10% whereas between-batch imprecision 
was below 2 0 %.
Accuracy (validation) of the methods was determined by the use of certified reference 
materials either supplied with kits or purchased separately (e.g. Seronorm'^^ serum 
trace elements. Level I, MI0181, Nycomed Pharma, Oslo, Norway for selenium). The 
reliability of methods was tested by the use of inter-laboratory quality control trial 
materials (e.g. Trace Elements External Quality Assessment Scheme TEQAS, 
University of Surrey, Guildford, UK for copper, zinc, and selenium). Good 
agreement with target concentrations was obtained for all controls. There was no 
significant difference between the obtained values and the target concentrations 
(p>0.05).
2.6 Development of the questionnaire
In addition to the FFQ, each subject completed a brief questionnaire about their 
demographic characteristics; biochemical parameters, and a list of drugs used by the 
patients were obtained from their medical notes. Questions were derived from 
previous studies and/or developed anew to reflect issues of interest. In consultation 
with various experts in nutritional epidemiology and social sciences, 58 questions
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were prepared which were pertinent to the medical history, socioeconomic status, 
physical activity level, smoking habits, and some of the common dietary habits. Such 
as, use of salt, canned food, way of cooking, and their likes and dislikes (see appendix 
3). Some of the questions were repeated or re-phrased in different sections of the 
questionnaire to test the subject’s consistency and reliability. Fifty eligible candidates 
were randomly selected to participate in the pilot study to produce the final version of 
the questionnaire.
To simplify dietary assessment without loss of validity and precision, a semi- 
quantitative FFQ was adapted for use in a Saudi male population (see appendix 3). 
The structure of the FFQ used in this study was developed using a data-based 
approach designed by Block et al., (1986). Likewise, initial pretest of the FFQ was 
carried out among 1 0  volunteer candidates who had helped in other dietary surveys to 
assess whether the list of food and/or dishes was complete and appropriate. 
Accordingly, six food items were added based on the relevance of their 
macronutrients and micronutrients content.
The subjects were asked to complete the developed questionnaire (interviewer- 
administrated) concerning their demographic characteristics, health history, lifestyle 
habits, and dietary habits and intakes (see appendix 3). Subjects were also questioned 
about symptoms of peripheral vascular disease, current use of prescription and 
nonprescription medications and supplements. Nine clinical factors were assessed: 
age, history of diabetes, history of hypertension, history of dyslipidaemia, and family 
history of diabetes and coronary heart disease. Socioeconomic status was classified 
into three categories: low, middle, and upper social classes based on an aggregate 
score of the educational attainment, occupation, and material conditions (Al- 
Dawood,2000). Subjects were classified ethnically according to the place of origin of
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their ancestors using the following categories; Arabian tribes, Africans, Caucasian 
Mid-Asians, Indian Asians, Far Eastern Asian, and Mediterranean.
2.7 Assessment of dietary intake
2.7.1 FFQ
An interviewer-administered FFQ, with closed questions with fixed categories was 
used. Criteria for grouping separate foods included similarity in nutrient content per 
usual serving, and importance of a particular food. The reporting of intake of food 
items was based on predefined portion sizes instead of actual amount eaten since it is 
assumed that the contribution of between-person variance to the total variance in 
portion size is much smaller than the within-person variance. Thus, the specification 
of a standard portion size by the investigator may not introduce a large error in the 
estimation of food and nutrient intake (Hunter et al., 1988).
The FFQ asked about frequency of intake of ninety-four food items and beverages in 
the past year. Foods and beverages were expressed in serving sizes (grams), 
household measures (cup, spoon) or natural units (slice of bread, apple). Food items 
were classified into eleven categories: grains (5 items), bread (5 items), fimits (11 
items), vegetables (19 items), legumes (4 items), nuts (4 items), meats, poultry and 
fish (12 items), dairy products (10 items), fat and oil (3 items), soft drinks ( 6  items), 
miscellaneous (12 items) and junk food (3 items) (see appendix 3). Subjects were 
asked to select either per day, per week, per month or almost never as a denominator 
and then to enter frequency of use. This was used to assess the dietary intake of 
energy as well as macronutrients (protein, carbohydrate, total fat, saturated fatty acids, 
monounsaturated fatty acids, polyunsaturated fatty acids, cholesterol, fiber) and 
micronutrients (copper, zinc, selenium, vitamin E, vitamin C, vitamin A, and 
carotenoids). The nutrient database used was based primarily on the UK food
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composition tables (Holland et a l, 1991) supplemented by the food composition tables 
for use in East Asia (1972) and the US handbook of food composition (Watt and 
Merrill, 1963) and all were used for computing the nutrients, while data on the 
nutrient composition of traditional local foods not included in the tables were derived 
from another local study (Abalkhail,1998). Analytic values were calculated using 
known recipes for other food items not listed in the food tables (Pellett and 
Shadarevian, 1970). The dietary intake of all nutrients for each individual was 
expressed in terms of % recommended nutrient intake (RNIs) for UK adults. As 
currently there are no published nutrient requirements for the Saudi population, the 
most recent version of UK dietary reference values (2003) and the most recent US 
recommended dietary intake (2 0 0 0 ) were used as a standard for the evaluation of the 
pattern of nutrient intake.
Limitations o f  FFQ
• FFQ like any other dietary assessment instrument are subjected to errors such 
as under- and over-reporting, misreporting data. This could be due to the 
tendency of subjects to conceal their true intake in case of obesity or dietary 
modification in CVD patients.
• FFQ are often restricted by estimating dietary intake in terms of given portion 
sizes and a fixed set of closely related foods.
• Thousands of food items cannot possibly be represented individually and 
consequently food items must be grouped. Food items that have similar 
nutrient contents are often grouped together into food categories.
• Limited ability to differentiate between cooked and raw vegetable which 
affects vitamins bioavailability.
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• FFQ might not be comparable across diverse racial/ethnic and socio-economic 
groups.
2.7.2 24hr dietary recall
Not all study participants were asked to provide dietary recalls because it is important 
for them to be amenable to cooperating and to be attentive to accurate reporting of 
their actual intake. Therefore, a subset sample of 263 participants (162 of which were 
controls and 10 1  were patients) were randomly selected and further interviewed to 
recall all food and drink consumed from first awakening the previous day and for the 
following 24hr (see appendix 3). Ideally, participants should be recruited from the 
study population specifically for a validation study. However, some of the subjects 
were also asked to participate due to the nature of study design and that dietary 
elements are of major concern in this study. The enquiry followed the meal sequence. 
Participants were also prompted for details of between-meal snacks. Quantities were 
estimated in household measures. The specific nutrient content of the reported portion 
size and estimated a nutrient intake for each day was calculated. No data were 
obtained for weekends because dietary habits on weekends typically differ from those 
on other weekdays.
Limitations o f  24hr dietary recall
• Unlike FFQ, 24hr dietary recall is an open-ended method that depends on 
short-term memory in recognizing and recalling of food. Thus cognitive 
challenge in reporting all food items consumed over the last 24hr is a potential 
problem in elderly subjects.
• The sequential administration of both methods raises concerns that completion 
of one method might have influenced responses to the other.
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• Both methods share some sources of error in common e.g. subject specific 
underreporting or over-reporting of data.
• The use of a single recall does not take into account within subject variations 
due to day-to-day fluctuation and seasonal variations.
2.7.3 Validation experiments
Since any FFQ may perform differently in diverse cultural and demographic groups, 
the use of a previously validated FFQ must be evaluated for use in a population that is 
different from that in which the FFQ was initially developed and validated. 
Correlations coefficients were measured to determine consistency and reliability of 
participants in answering questions within the questionnaire, Spearman’s for the 
yes/no questions and Cronbach’s alpha for questions with more than two answers to 
choose from. As mentioned earlier validity and reliability of dietary instruments are 
important in studies that compare a diet-disease relationship among different groups. 
Only the relative validity may really be estimated, as there is no gold standard for 
measuring “true” dietary intake. The estimated nutrient intakes obtained from the FFQ 
were compared with the results of a single 24hr dietary recall and with serum 
biomarkers of antioxidant vitamin intake. Due to limited funding, serum vitamins 
were only measured in blood samples drawn from the subjects participating in the 
case control study. The purpose of the comparison was to evaluate the accuracy of the 
FFQ against that of the 24hr recalls, and to quantify the extent to which the two 
dietary methods produce similar rankings of study participants according to the intake 
of individual nutrients (Block, 1982).
2.7.4 Reproducibility test
Reproducibility was assessed by a second administration of the FFQ to fifty control 
participants, selected randomly from the students of King Abdulaziz University, after
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an interval of approximate nine-months. Second administration of FFQ is subjected to 
respondents’ fatigue and increasing lack of interest, which might affect their reporting 
of intake. Thus the choice of young participants, as a highly motivated sample of the 
study population, was thought to be appropriate for testing the FFQ reproducibility.
2.8 Statistical analysis 
Statistical significance was assumed with a P value <0.05. All analyses were 
performed using SPSS (version 11) software.
2.8.1 Animal study
The results obtained were either expressed as mean ± standard error of mean for 
normally distributed parameters or as a median and range for non-normal distributed 
parameters. Statistical analyses were performed using Wilcoxon signed rank test for 
non-parametric data when comparing within the same group, or Mann Whitney U  test 
when the comparing is between two different groups for non-parametric data. A 
Kruskall-Wallis test was performed to compare mean values of repeated measures of 
non-normally distributed parameters. A Bonferroni correction was made for multiple 
comparisons.
2.8.2 Case-control study 
All data are presented as mean and standard error of mean for normally distributed 
parameters or as median and intra quartile range for non-normal distributed 
parameters. The check for normal distribution was carried out with Kolmogoroff- 
Simimoff test. Since most nutrient distributions were skewed toward higher values, 
natural logarithm and/or square root transformation was used for skewed nutrient 
values as well as other skewed biochemical and demographic variables to improve 
their distribution towards normality before statistical analysis and then back
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transformed to their natural units for presentation. A value of 0.001 was added to zero 
values to allow transformation of nutrients that were not consumed by all participants. 
Statistical analyses were performed using unpaired t-test and Mann Whitney-1/ test 
for comparison of parametric and non-parametric data respectively. A ^  test was used 
for comparison of categorical data. Levels of the trace elements were correlated with 
the classical risk factors using the Pearson’s or Spearman’s correlation coefficients. 
Conditional logistic regression analysis was used to determine the magnitude of 
associations between trace elements status or antioxidant vitamins status and 
atherosclerosis (Satten and Kupper,1993). The case-control specification was used as 
the dependent variable with a 0 value representing those with no CAD and a 1 value 
representing CAD patients. In the model, numeric variables were entered as 
continuous variables and categoric variables were coded. Variables that differed 
between CVD patients and their age-matched controls on univariate analysis, with p 
values <0.1, were included in the model. The Wald statistic was calculated to assess 
the significance of individual logistic regression coefficients for each independent 
variable. The Wald estimates give the importance of the contribution of each variable 
in the model. The higher the value, the more important it is.
2.8.3 Controls for the dietary study 
The distribution of the intake frequency for the dietary constituents was examined for 
the total sample stratified by age tertiles, by socioeconomic status, and by race. Each 
subgroup was then compared for demographic characteristics and nutrients intake 
using ANOVA test and Kruskal-Wallis tests for parametric and nonparametric 
variables respectively. If a significant difference was found, Bonferroni correction 
was made for multiple comparisons to determine differences between each pair of 
groups. A test was used for comparison of categorical data. Associations between
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characteristics were examined using Pearson and Spearman correlation coefficients 
when appropriate.
2.8.4 Controls for the assessment of coronary risk
ANOVA test for normally distributed parameters or Kruskall-Wallis test for non- 
normally distributed parameters were used to compare mean values of demographic 
and biochemical measures of between age tertiles. Concentrations of serum 
inflammatory markers were correlated with 1 0 -year risk of coronary disease using 
Framingham risk scores and PROCAM scores by Spearman’s correlation coefficients. 
Associations between traditional risk factors and individual inflammatory markers 
were also assessed using Pearson’s correlation coefficient. Stepwise multiple 
regression analysis was used to model the association between each inflammatory 
marker with all independent variables with p value up to 0 .1  to demonstrate their 
contribution to the inflammatory marker serum level.
2.8.5 Correction for serum cholesterol levels
Serum levels of the fat-soluble vitamins were corrected for cholesterol levels as 
suggested by Jordan et al. (1995). Associations between dietary intake of antioxidant 
vitamins and their serum levels were tested using Pearson and/or Spearman’s 
correlation coefficients when appropriate. Based on the results of the univariate tests, 
stepwise linear regression models were developed to evaluate the contribution of 
dietary intake levels of vitamins to predict their serum concentrations.
2.8.6 Dietary intake calculations
All food consumption data were converted to energy and nutrient intakes per day. 
FFQ data were analysed by a self-developed program using the Microsoft Excel 
spreadsheet application (Microsoft Corporation, Redmond, WA, USA) based on the 
UK food composition tables (Holland et al., 1991) and the food composition tables for
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use in East Asia (US Dept, of Health, 1972) and the US handbook of food 
composition (Watt and Merrill, 1963). Nutrient intake was evaluated using a formula 
that included frequency of consumption of each food item, standard serving sizes, and 
nutrients content in each food item. Nutrients were then summed across all foods to 
obtain the total nutrient intake for each individual. The percentage of total energy 
contributed by fat, protein, and carbohydrates was also calculated. Consumption of 
energy and nutrients were analyzed using Comp-Eat version 5.5 software in case of 
the 24hr recalls data, which is based on the UK food composition tables (Holland et 
al.,1991).
2.8.7 Adequacy of nutrient intakes 
Energy intakes from FFQ and 24hr recall methods were checked for underreporting 
by comparing the reported energy intake with the calculated energy requirements. 
They were also checked for extreme values. Values < 1300 kcal and > 3500 kcal were 
very few but considered implausible and were excluded from the study. Adequacy of 
macro- and micronutrient intakes was determined using age specific dietary reference 
intakes (DRI) or recommended daily allowance (RDA), as appropriate. The most 
recent version of the United Kingdom Dietary Recommended Values (DRVs) (2003) 
was used to standardize the pattern of nutrient intake except for vitamin E intake since 
there has not been an agreement on the optimal dose of vitamin E. Therefore it was 
taken from the most recent US recommended dietary intake (2000). The updated 
recommendations incorporated 3 types of values: the estimated average requirements 
(EAR), the recommended dietary allowance (RDA), and the tolerable upper intake 
level (UL). Collectively, these values are referred to as dietary reference intakes 
(DRI). EAR is the intake value that is estimated to meet the requirements of 50% of 
the population, thus it represents the mean estimates of nutrient intake. RDA is the
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dietary intake level that is sufficient to meet the requirements of nearly all individuals, 
thus it equals EAR + 2SD, and lower reference nutrient intake (LRNIs) values 
represent EAR -  2SD. UL represents the highest level of intake that is unlikely to 
have any adverse health effects in most individuals. Adequacy of macronutrient 
intake was represented by the proportion of individuals having mean intakes above 
the EAR value of each nutrient.
2.8.8 Energy adjustment
Adjustment of macronutrient intake for energy intake produces an estimate of dietary 
composition, rather than absolute intake. It provides an assessment of nutrient intake 
independent of body size and activity level as well as of energy intake itself. Energy 
adjustment was carried out by using a regression analysis of the log-transformed 
nutrient (dependent variable) against the log-transformed energy intake (independent 
variable). The residuals from the model were then added to the sample mean of that 
nutrient (i.e., the nutrient intake at mean caloric intake) (Willett and Stampfer,1986).
2.8.9 Validity testing
Relative validity of the FFQ compared to the 24hr recall method was assessed by 
calculating correlation coefficients between nutrient estimates of the FFQ and 24hr 
recalls. According to the distribution of energy and nutrients intake, Pearson’s, 
Spearman rank order, and intra-class correlation coefficients were calculated to test 
precision in ranking subjects by both dietary methods.
The ability of both methods to classify individuals similarly in categories of nutrient 
intake was evaluated by cross-classification. The distributions of nutrient intakes 
derived fi*om FFQ and 24hr recall methods were divided into quartiles to evaluate the 
effect of measurement error on the ranking of individuals. Cut-points were defined 
separately for both methods. The degree of classification was estimated by examining
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the proportion of control subjects classified by the FFQ that fell into the same, 
adjacent or opposite quartile of energy and macronutrients intake as that obtained 
from the 24hr recalls. Individuals were deemed classified correctly if they were 
categorized into the same or within one quartile by both methods. They were 
categorized as grossly misclassified if they were categorized in opposite quartiles by 
both methods. Consistency in categorizing individuals at the same or extreme 
quartiles was tested by contingency tables.
2.8.10 Reproducibility testing 
Consistency of FFQ 1 and FFQ 2 in estimating mean energy and nutrients intakes was 
evaluated by paired t-test. Intra-class correlation coefficient was defined as the 
proportion of the total variability due to the intra-individual variability. Cronbach’s 
coefficient alpha, a special case of the intra-class correlation coefficients, is an index 
of the reliability of the mean of a series of measures.
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Chapter 3
Dietary copper and zinc 
supplementation in a rabbit model 
of atherosclerosis
3.1 Introduction
It has previously been shown that dietary copper can modulate the extent of 
atherosclerosis in the thoracic aorta of cholesterol-fed rabbits. The metabolism of 
copper and zinc are closely related, and it has been hypothesized that the balance of 
dietary copper to zinc may be important in determining coronary risk.
3.2 Specific aim
We aimed to assess the effects of dietary zinc and copper supplementation 
administered either singly or in combination on atherogenesis in the cholesterol-fed 
rabbit model. Indices of atherosclerosis, which develops only in the presence of 
hypercholesterolemia, were assessed using histological and biochemical techniques.
3.3 Experimental design and methods
Weanling male New Zealand White rabbits (6-10 weeks old, average body weight
2.1 ± 0.4 kg) were obtained from, and housed within the animal house in King Fahad 
Medical Research Center, King Abdul-Aziz University, Jeddah. The experimental 
protocol was approved by the Ethical committee for animal care of the King Fahad 
Medical Research Center. At this age, NZW rabbits are known to show a rapid 
increase in atherosclerotic lesion formation when fed a cholesterol rich diet. They 
were adapted to experimental conditions for a week and randomly allocated to one of 
eight dietary groups with eight animals in each group; chow, or cholesterol-fed with 
either plain water, or water containing 0 .2 % (w/w) of copper as copper sulphate 
(CUSO4), 0.5% (w/w) of zinc as zinc sulphate (ZnS0 4 ), or both (Figure 3.1). Water 
and food were allowed ad libitum. Food intake was calculated on a daily basis and 
weight was recorded at the start of the experiment and at fortnightly intervals.
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Figure 3.1: Flow chart showing the random allocation of 64 NZW rabbits of 8  
animals into 8  groups. Rabbits were fed either a normal diet; or a diet containing 0.25- 
1% (w/w) cholesterol. Drinking water was either unsupplemented or supplemented 
with zinc as its sulfate at 0.5% (w/w) or with copper as its sulfate at 0.2% (w/w) or 
with both in the supplemented groups.
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3.3.1 Animal diet
Rabbits were fed either a normal diet; or a diet containing 0.25-1% (w/w) cholesterol. 
The chow diet was supplied by the Grain Silos and Flourmills Organization, Saudi 
Arabia. Cholesterol was dissolved in ether, mixed with the diet and allowed to dry 
before feeding to the animals. The cholesterol containing diet was prepared in three 
concentrations = 0.25%- 0.5%- 1%. This enabled the modification of the cholesterol 
content of the diets to maintain the serum cholesterol at ~ 20 mmol/1, this level was 
chosen based on previous experiments to produce predictable levels of aortic 
atherosclerosis (Lamb et ah, 1999). The different concentrations were prepared by 
mixing the 1% cholesterol diets with the corresponding chow diet to produce 
individually tailored diets with different cholesterol content. In the cholesterol-fed 
groups, serum cholesterol levels increased to ~ 20mmol/L by on average four weeks 
after commencing the diet containing 1% cholesterol. The serum cholesterol levels 
were measured at the start of the experiment and at fortnightly intervals.
The regular chow diet was analysed for its zinc and copper content in order to 
determine the amount added in drinking water as a supplement (see appendix 4 for the 
normal composition of the diet). It was found to contain 21.05 pg Cu /gm diet and
90.09 pg Zn /gm of diet. Unsupplemented drinking water provided <4 pg of copper 
and <33 pg of zinc per day. This was supplemented with zinc as its sulfate at 0.5% 
(w/w) or with copper as its sulfate at 0.2% (w/w) or with both. The dietary 
supplementation of copper was chosen on the basis of previous work that indicated 
that 0.2% copper supplementation in the drinking water would inhibit lesion 
formation (Lamb et al. 1999). The 0.5% zinc supplementation of drinking water was 
chosen because similar concentrations have been used previously in vivo studies in
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rodents (Tobia et al., 1998), and it was hypothesized that the excess zinc would have a 
substantial effect on copper metabolism (Barone et al., 1998). Total dietary copper and 
zinc in the chow-fed rabbits was approximately 3.7 mg/day of copper and 
approximately 15.8 mg/day of zinc.
3.3.2 Collection of samples
Fasting blood was drawn from the marginal ear vein using a siliconised 24-gauge 
minicath intravenous catheter (Becton-Dickinson and Co. Rutherford, NJ, USA) into 
heparinized tubes. Samples were centrifuged within two hours of collection at 1500 x 
g for 10 minutes. Plasma and serum samples were aliquoted and stored in a Falcon 
polypropylene tubes at -80°C until time of analysis.
3.3.3 Animal euthaniasia and perfusion fixation
After twelve weeks on the formulated diets, the fasting animals were anaesthetised 
with xylazine (3.5 mg/kg i.m.) and ketamine (18 mg/kg i.m.) (Alfasan, Woerden- 
Holland) and heparinized (300 lU/kg intravenously) (Sigma-Aldrich Ltd, ON, 
Canada). An abdominal incision was made to access the abdominal aorta for insertion 
of a cannula connected to a perfusion apparatus. Blood was collected and rabbits were 
then euthanised with an overdose of pentobarbitone (Biochemie GmbH, Vienna- 
Austria) intravenously and the jugular veins transected for perfusion run-off.
Rabbits were perfused with isotonic saline at a rate of 100-120 ml/min/kg body 
weight (Figure 3.2) (see appendix 1 for details on the preparation of perfusion fixation 
solution). When the run off was clear, the saline was replaced with 4% 
paraformaldehyde in phosphate buffered saline (PBS) at the same flow rate in half the 
animals from each group. Perfusion was continued for fifteen minutes. The other half, 
whose tissues were used for tissue enzyme determinations were perfused with isotonic 
saline. Following perfusion, the entire thoracic aortae were isolated and carefully
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cleaned of fascia to avoid stretching and endothelium damage. The aorta was divided 
longitudinally into two halves, pinned, lumen side up and divided into segments 
(Figure 3.3). Professional assistance from a veterinary physician was provided during 
the time of euthaniasia.
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Figure 3.2: Perfusion apparatus of isotonic saline solution and the fixative solution of 
4% paraformaldehyde in phosphate buffered saline. An abdominal incision was made 
to access the abdominal aorta for insertion of a cannula connected to a perfusion 
apparatus. Rabbits were first perfused with isotonic saline at a rate of 100-120 
ml/min/kg body weight until the run off was clear. The saline was then replaced with 
4% paraformaldehyde in phosphate buffered saline at the same flow rate in half the 
animals from each group. Perfusion was continued for fifteen minutes. The other half, 
whose tissues were used for tissue enzyme determinations were perfused with isotonic 
saline until the run off was clear.
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Figure 3.3(a): A schematic diagram of the levels at which aortic samples were taken 
at different intercostal segments of aorta in perfused fixed rabbits for further 
processing. The first intercostals artery branch point were stained with haematoxylin 
and eosin (H&E) stain to assess lesion size and the seventh intercostals artery branch 
point were stained with orcein elastin stain. Segments from the ascending aorta and at 
the second intercostal artery branch point of the thoracic aortae are taken for scanning 
electron microscopy (SEM). Segments taken from the third up to the sixth intercostal 
artery branch point were used to determine the extent of atherosclerosis (i.e., 
quantification of lesional area) by staining with oil red O (ORO).
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Figure 3.3(b): A schematic diagram of the levels at which aortic samples were taken 
at different intercostal segments of aorta in saline pefused unfixed rabbits for further 
processing. The first intercostals artery branch point were stained with haematoxylin 
and eosin (H&E) stain to assess lesion size and the seventh intercostals artery branch 
point were stained with orcein elastin stain. Segments at the second intercostal artery 
branch point of the thoracic aortae are taken for the determination of lipid peroxides 
(LPO) by TEARS method. Segments taken from the third up to the sixth intercostal 
artery branch point were used to determine the extent of atherosclerosis (i.e., 
quantification of lesional area) by staining with oil red O (ORO).
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3.3.4 Tissue dissection and processing
Segments from the ascending aorta and at the second intercostal artery branch point of
the thoracic aortae of perfiision fixed rabbits were placed at room temperature in 2% 
glutraldehyde in 0.15 mol/1 cacodaylate buffer, pH 7.3 (Pelco, CA, USA). Tissue 
segments for scanning electron microscopy (SEM) were post fixed in 2% osmium 
tetroxide followed by washing in cacodylate buffer (Pelco, CA, USA). After that, the 
segments were dehydrated in a graded ethanol series and critical point dried with 
carbon dioxide transition fluid in a critical point drying system (Pelco CPD-2, Ted 
Pella, Inc. Redding, CA, USA). The specimens were mounted on aluminium stubs 
with silver paint and sputter coated with gold plate using a Polaron sputter coater 
(SEM coating E5100, Polaron Equipment limited, Watford, England). They were then 
examined and photographed using a Scanning Electron Microscope (XL20, Philips, 
Holland) at lOkV. See appendix (1) for details of the buffer preparation.
For the histological examination, five-micron sections in thickness of aortic arch from 
two blocks were taken at the first and the seventh intercostals levels, which 
macroscopically showed the most severe lesions in each segment. They were fixed in 
4% paraformaldehyde overnight prior to paraffin embedding. The first intercostals 
artery branch point were stained with haematoxyllin and eosin (H&E) stain to assess 
lesion size (Fluka Chemika-Biochemika, Buchs, Switzerland) and the seventh 
intercostals artery branch point were stained with orcein elastin stain (Fluka Chemika- 
Biochemika, Buchs, Switzerland) (Luna, 1968). See appendix (2) for details of both 
staining methods.
The extent of atherosclerosis was measured by histological determination of the 
intimal-medial ratio (IMR) using a Zeiss axioskop microscope (Carl Zeiss Ltd, 
Welwyn Garden City, Hertfordshire, UK) equipped with a xlO achroplan objective.
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JVC CCD video camera and Qwin 550C image analysis software (Leica 
Microsystems, Cambridge, Cambridgeshire, UK). Intimai area was calculated by 
subtracting lumen area from the area within the internal elastic lamina. Medial area 
was calculated as the area between the internal and external elastic lamina.
Segments taken from the third up to the sixth intercostal artery branch point were 
placed in 4% paraformaldehyde and the extent of atherosclerosis (i.e., quantification 
of lesional area) were determined by staining with oil red O (Sigma-Aldrich Ltd, ON, 
Canada) (Rutherford et al., 1997). See appendix (2) for details of the staining method. 
The sections were pinned out on a corkboard and photographed en face.
Images were acquired using a JVC CCD camera. Surface area of the atherosclerotic 
lesions was determined from photographs of the luminal surface of the aorta. The area 
staining positively with oil red O was quantified using Qwin 550C image analysis 
software (Leica Microsystems, Cambridge, Cambridgeshire, UK) and expressed as a 
percentage of the total area analyzed (Lamb et al., 1999).
Segments at the second intercostal artery branch point of the thoracic aortae are taken 
for the determination of lipid peroxides (LPO) by TEARS method. Segments from the 
descending aorta and at the eighth intercostal artery branch point from all animals 
were frozen at -80 °C for the determination of trace elements content (copper and 
zinc) and at the ascending aorta in the saline perfused animals for the determination of 
enzymes activities (superoxide dismutase and glutathione peroxidase). Other tissues 
were also collected; liver, kidney, and skeletal muscle for the determination of copper 
and zinc content.
The methods used for biochemical measurements in chapter 3 have been described 
elsewhere in this thesis (Chapter 2, section 2.4, page 94).
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3.4 Results
3.4.1 Changes in weight and blood cholesterol
All diets were well tolerated; however, animals receiving the control chow gained 
significantly more weight over the duration of the experiment compared with the one 
receiving the supplemented diets (p<0.05). Weight gain did not differ significantly in 
animals receiving cholesterol with or without trace elements. Integrated blood 
cholesterol values were similar for all the cholesterol-fed animal groups, and were 
also comparable for all the groups of animals receiving normal chow (Figure 3.4). As 
would be expected, integrated serum cholesterol levels were significantly higher in all 
animals receiving the cholesterol-enriched diet compared to all groups of animals on 
normal chow (p<0.001 in all cases). The integrated cholesterol value was derived by 
calculating the mean serum cholesterol value for each animal over the period of the 
measurement.
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Figure 3.4: Integrated serum cholesterol levels in rabbits that were fed with chow or 
cholesterol diets and receiving either copper, zinc, copper and zinc or no additions to 
their drinking water for 12 weeks. Each bar represents the mean ± SEM from 8 
rabbits. *P < 0.001 (all cholesterol vs. all chow diets).
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3.4.2 Blood Chemistry
3.4.2.1 Effects of diets on serum trace element concentrations
The mean serum copper concentration was significantly higher in the copper 
supplemented animals whether cholesterol was added (p=0.001) or not (p<0.05) 
compared to the non-supplemented animals, and the presence of zinc did not have any 
significant effect on serum copper concentration (p>0.05) (Table 3.1). Similarly the 
mean serum zinc concentration increased significantly in supplemented animals in the 
presence or absence of cholesterol (p=0.001), and the presence of copper did not have 
any effect on serum zinc concentration (p>0.05).
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3.4.2.2 Serum caeruloplasmin
Serum caeruloplasmin levels (measured as ferrioxidase activity) were significantly 
higher in animals receiving a cholesterol-enriched diet, irrespective of their trace 
element supplementation (p<0.001). Among the cholesterol-fed animals serum 
ferrioxidase activity was significantly higher in animals receiving copper in the 
presence or absence of zinc compared to those receiving cholesterol alone (p<0.05) 
(Figure 3.5).
3.4.2.3 Serum lipid peroxides
Serum lipid peroxides, estimated by the FOX assay, were significantly higher in the 
animals on the cholesterol diet compared to animals on chow diets with or without 
zinc, or copper supplements (p=0.001) (Figure 3.6a). Levels were significantly lower 
in the cholesterol-fed animals receiving copper or zinc supplements compared to 
those on no supplements (p<0.001) (Figure 3.6a). Similar results were obtained for 
serum TEARS (Figure 3.6b).
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Figure 3.5: Sérum caeruloplasmin (ferroxidase activity) in rabbits that were fed with 
chow or cholesterol diets and receiving either copper, zinc, copper and zinc or no 
additions to their drinking water for 12 weeks. Each bar represents the mean ± SEM 
from 8 rabbits. *P < 0.001 (all cholesterol vs. all chow diets); fP < 0.05 (vs. 
cholesterol alone).
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Figure 3.6(a): Serum levels of lipid peroxides estimated by the FOX assay in rabbits 
that were fed with chow or cholesterol diets and receiving either copper, zinc, copper 
and zinc or no additions to their drinking water for 12 weeks. Each bar represents the 
mean ± SEM from 8 rabbits. *P < 0.001 (vs. cholesterol alone); j  P<0.001 (vs. chow 
alone).
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Figure 3.6(b): Serum levels of lipid peroxides estimated by the TEARS method in 
rabbits that were fed with chow or cholesterol diets and receiving either copper, zinc, 
copper and zinc or no additions to their drinking water for 12 weeks. Each bar 
represents the mean ± SEM from 8 rabbits. *P < 0.001 (vs. cholesterol alone); f  
P<0.001 (vs. chow alone).
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3.4.2.4 Effects of diets on blood antioxidant enzymes 
Erythrocyte superoxide dismutase 
The mean erythrocyte SOD was significantly higher in the cholesterol-fed rabbits 
compared with those on normal chow diet (p<0.01). Supplementation with copper or 
zinc individually or together did not appear to affect erythrocyte SOD in the 
cholesterol-fed animals (Table 3.2).
Erythrocytes glutathione peroxidase  
The mean erythrocyte GPx was significantly lower (p<0.001) in cholesterol-fed 
animals receiving copper or zinc supplements singly compared to those on no 
supplements (Table 3.2). A smaller decrease was also noted due to supplementation 
with copper in chow fed animals (Table 3.2).
3.4.3 Tissue Chemistry
3.4.3.1 Effects of diets on tissue antioxidant enzyme concentrations 
and lipid peroxides
The activity of SOD per mg of protein in aortic tissue was higher in animals receiving 
copper supplements in the presence of cholesterol (p<0.05) but not significantly so in 
its absence. A similar increase was observed with copper plus zinc supplementation in 
chow fed groups (p<0.05). Conversely GPx enzyme activity showed non-significant 
increase with copper supplements in the presence and absence of cholesterol. Aortic 
tissue levels of MDA as estimated by the TEARS method were significantly higher 
(p<0.05) in animals receiving copper with or without zinc when compared with those 
on chow diet alone and with copper supplements only in cholesterol-fed animals 
(Table 3.2). Supplementation with copper with or without zinc caused a significant 
increase in hepatic SOD enzyme activity in the absence of cholesterol (p<0.05). 
However, no such affect was noted in the cholesterol-fed animals. Though
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supplementation with both copper and zinc seemed to increase the level but due to 
small number of animals per group, no significance was found (Table 3.2).
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3.4.3.2 Effects of the diets on tissue copper and zinc concentrations
Supplementation with copper (p<0.001) or zinc (p<0.05) or both (p<0.001) were 
associated with a significant increase in liver copper content in chow fed rabbits 
(Table 3.3). The addition of cholesterol to the diet caused a significant increase in 
hepatic copper as well (p<0.05). Moreover, in these animals supplementation with 
copper alone or with zinc caused a non-significant increase in hepatic copper content. 
The mean copper content of the aorta was significantly higher in cholesterol-fed 
rabbits supplemented with copper alone (p=0.001) or with copper and zinc (p<0.05) 
than those fed cholesterol alone. No significant effects of either copper or zinc were 
observed in the chow-fed rabbits (Table 3.3). Supplementation with copper in the 
presence or absence of zinc was accompanied with significant increase in kidney 
copper content in chow fed groups (p<0.001) when compared to those in non­
supplemented groups. The hepatic zinc content was significantly higher in 
cholesterol-fed rabbits supplemented with zinc alone than in those fed cholesterol 
alone (p<0.05). The mean of hepatic zinc of those fed regular chow and supplemented 
with zinc alone or plus copper were significantly higher than the mean of the non­
supplemented group (p<0.001) (Table 3.3). The mean zinc content of the aorta was 
significantly higher in cholesterol fed rabbits supplemented with zinc alone or with 
both zinc and copper (p<0.05) than in those fed cholesterol alone (Table 3.3). 
Similarly supplementation with zinc alone or zinc with copper caused a significant 
increase in aortic zinc content in the chow fed rabbits (p<0.05 and p<0.001 
respectively). Kidney zinc content showed a significant increase with zinc plus copper 
supplementation among the chow fed groups only (p<0.05). Moreover, muscle 
content of copper and zinc showed no significant changes in response to dietary 
supplementation in all groups (p>0.05).
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3.4.3.S Effects of copper and zinc supplementation on atherosclerosis in the 
thoracic aorta of cholesterol-fed rabbits 
Oil R ed O staining
Longitudinal segments of thoracic aorta were stained with oil red O for quantitation of 
regions of aortae containing macroscopic lesions. Figure (3.7a) shows typical aortae 
from a rabbit fed control chow and from rabbits in the cholesterol-fed groups with or 
without dietary copper and/ or zinc supplements. The percentage of the aortae staining 
positively for lipid using oil red O in all the chow-fed groups was essentially nil. In 
the rabbits receiving cholesterol alone, the area affected was 82.8 ± 4.0% compared to 
58.6 ± 5.1% in animals receiving concomitant copper (p<0.01), 67.7 ± 4.4% in those 
receiving zinc (p<0.05), and 64 ± 6.1% in those receiving both copper and zinc 
(p<0.05) and this did not differ significantly from those animals receiving a single 
supplement (p>0.05) (Figure 3.7b).
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Figure 3.7(a): The percentage en face o f  the aortic area between third and the sixth 
intercostal artery branch point covered by oil red O staining in rabbits that were fed with 
chow  or cholesterol diets and receiving either copper, zinc, copper and zinc or no additions to  
their drinking water for 12 weeks. Chow-fed diet groups did not develop any lipid lesions 
during the study period. Each bar represents the mean ±  SEM  from 8 rabbits. *P < 0.001 (all 
cholesterol vs. all chow diets); fP  < 0.05 (cholesterol + copper; cholesterol +  zinc; cholesterol 
+ copper + zinc vs. cholesterol alone).
Chow Chol-fed Chol+Zn Chol+Cu Chol+both
Figure 3.7(b): Representativ e enface sections o f  aortae between third and the sixth intercostal 
artery branch point, stained with oil red O in rabbits fed chow  or cholesterol diets and 
receiving either copper, zinc, copper and zinc or no additions to their drinking water for 12 
weeks.
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H & E and orcein stainings 
Sections taken at the level of the first intercostal artery branch point were stained by 
H&E stain. Atherosclerotic lesions were evaluated as the intima: media ratio (IMR). 
Intimai area was defined as the region between the lumen and the internal elastic 
lamina. Medial area was defined as the region between the internal and external 
elastic laminas. There was no evidence of microscopic lesions at these areas in the 
chow-fed groups. Chow fed groups did not develop any lipid lesions and thus their 
IMR values were nil. Paradoxically the animals in the high-cholesterol group showed 
lower IMR than the zinc supplemented group (p<0.05) (Figure 3.8a).
Figure 3.8(b) shows representative 8 examples of the 8 groups stained with H&E 
staining and taken at first intercostal level. They reveal thicker intima in the 
cholesterol fed groups (F and G) illustrated by the double-headed arrow.
Figure 3.8(c) shows another section of the first intercostals level of aorta stained with 
Hematoxylin-eosin from a high-cholesterol rabbit showing enlarged intima filled with 
foam cells.
Figure 3.8(d) shows section of the seventh intercostals level of aorta stained with 
orcein from a rabbit on a normal chow diet. Arrowhead indicates internal elastic 
lamina.
Histological examination at the seventh intercostals level revealed that the elastic 
lamina was distorted and that the distance between the lumina of the aorta and the 
elastic lamina was considerably increased (Figure 3.8e) among the cholesterol fed 
animals regardless of their dietary supplements.
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Figure 3.8(a): Intima media ratio (IMR) values in rabbits that were fed with chow or 
cholesterol diets and receiving either copper, zinc, copper and zinc or no additions to 
their drinking water for 12 weeks. Intimai area was calculated by subtracting lumen 
area from the area within the internal elastic lamina. Medial area was calculated as the 
area between the internal and external elastic lamina. Chow-fed diet groups did not 
develop any lipid lesions during the study period. Each bar represents the mean ± 
SEM from 8 rabbits. *P < 0.001 (all cholesterol vs. all chow diets); jP  < 0.05 
(cholesterol + zinc vs. cholesterol alone).
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Figure 3.8(b): Representative sections of the first intercostal level of aorta stained 
with Hematoxylin-eosin from a single rabbit of each group according to the 
following: A, control aorta; B, aorta from a zinc supplemented rabbit; C, aorta from a 
copper supplemented rabbit; D, aorta from a zinc and copper supplemented rabbit. E, 
aorta from a cholesterol-fed rabbit; F, aorta from a cholesterol-fed plus zinc rabbit; G, 
aorta from a cholesterol-fed plus copper rabbit; H, aorta from a cholesterol-fed plus 
both trace elements rabbit. Thicker media in the cholesterol fed groups (F and G) is 
illustrated by the double-headed arrow. (L, lumen). Magnification ~ xl 0.
»
Figure 3.8(c): Section of the first intercostals level of aorta stained with 
Hematoxylin-eosin from a high-cholesterol rabbit showing the presence of fatty 
streaks. Magnification =x250. The double-headed arrow indicates the thickness of the 
intima area in this section (A, atherosclerotic plaque; IE, internal elastic lamina; M, 
media).
16 9
Figure 3.8(d): Section of the seventh intercostals level of aorta stained with orcein 
from a rabbit on a normal chow diet. Arrowhead indicates internal elastic lamina. 
Magnification =x250.
Figure 3.8(e): Section of the seventh intercostals level of aorta stained with orcein 
from a rabbit on a high cholesterol diet. Arrowhead revealed that the elastic lamina 
was distorted and that the distance between the lumina of the aorta and the elastic 
lamina was considerably increased. Magnification = x250.
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3.4.4 Electron microscopy
After 12 weeks on the formulated diet, rabbits fed a cbolesterol-ricb diet developed 
macroscopically apparent lesions within the common carotid artery, although lesions 
were present elsewhere, particularly in the aortic arch. However, isolated patches of 
subendothelial foam cells were seen in some animals related to intercostals artery 
branch points, irrespective of whether or not they received zinc and copper 
supplementation. There were no adherent cells on the luminal surface of the aortas of 
the normally fed plus supplements groups. There was no difference in surface 
morphology between the cholesterol fed rabbits and the cholesterol fed plus 
supplements rabbits. Our results indicate that lipid accumulation on the surface of 
atherosclerotic lesions have not been effected with copper and/or zinc 
supplementations.
Figures (3.9) and (3.10) show typical scanning electron micrographs of the ascending 
aortas from rabbits of each group. The control aorta (Figure 3.9A) showed a fairly 
smooth surface with endothelial cells arranged in an irregular orientation. A typical 
ascending aorta from a cholesterol-fed rabbit (Figure 3.10A) showed the presence of 
extensive fatty streaks and adherent leucocytes and platelets. Micrographs from the 
zinc and/or copper supplemented groups show a regular, smooth, and intact 
endothelial cell layer covering the luminal surface (Figure 3.9B- 3.9C- 3.9D). 
Scanning electron micrographs of the aortae from the groups of rabbits fed cholesterol 
plus zinc, or cholesterol plus copper, or cholesterol plus both trace elements (Figure
3.1 OB- 3.IOC- 3.10D) showed extensive fatty streak development, a pattern similar to 
the cholesterol-fed rabbits (Figure 3.10A). Therefore it appears that there was no 
absolute protective effect of zinc and copper individually or together against 
cholesterol-induced atherogenesis at this particular point.
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Figure 3.9: Scanning electron micrographs of the ascending aorta of rabbits fed 
normal chow diets with or without additional copper and/or zinc for 12 weeks. 
Original magnification was xlOO. A, control aorta; B, aorta from a zinc supplemented 
rabbit; C, aorta from a copper supplemented rabbit; D, aorta from a zinc and copper 
supplemented rabbit. Bar: 200pm.
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Figure 3.10: Scanning electron micrographs of the ascending aorta of rabbits fed 
cholesterol-enriched diets with or without additional copper and/or zinc for 12 weeks. 
Original magnification was xlOO. A, aorta from a cholesterol-fed rabbit; B, aorta from 
a cholesterol-fed plus zinc rabbit; C, aorta from a cholesterol-fed plus copper rabbit; 
D, aorta from a cholesterol-fed plus both trace elements rabbit. Bar: 200pm.
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Figures (3.11) and (3.12) show scanning electron micrographs of the ascending aortae 
from rabbits of each group at higher magnification magnification. In all cholesterol- 
fed groups, fatty streak was apparent. However, only the cholesterol-fed group 
(Figure 3.12A) showed more extensive and developed lesions compared to the other 
supplemented groups (Figure 3.12B- 3.12C- 3.12D). Original magnification was x300 
and xl200 respectively.
Figure (3.13) and (3.14) show a set of scanning electron micrographs of the 
descending aortas from rabbits of each group around the second intercostal artery 
branch point at 2 different magnifications. Chow fed rabbits whether receiving trace 
elements or not had smooth and clear endothelial surfaces. Endothelial cells were 
oriented in the line of blood flows. In cholesterol-fed rabbits leukocytes were 
frequently observed in small clusters adjacent to branches in the thoracic aorta of the 
cholesterol plus zinc, or copper, or both supplements groups (fig. 3.14B- 3.14C- 
3.14D). The original magnification was x50 and xlOO respectively.
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Figure 3.11: Scanning electron micrographs of the ascending aorta at higher 
magnification power of rabbits fed normal chow diets with or without additional 
copper and/or zinc for 12 weeks. Original magnification was x300 and xl200 
respectively. A, control aorta; B, aorta from a zinc supplemented rabbit; C, aorta from 
a copper supplemented rabbit; D, aorta from a zinc and copper supplemented rabbit. 
Bar: 100 and 20pm in the smaller window.
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Figure 3.12; Scanning electron micrographs of the ascending aorta at higher 
magnification power of rabbits fed cholesterol enriched diets with or without 
additional copper and/or zinc for 12 weeks. Original magnification was x300 and 
xl200 respectively. A, aorta from a cholesterol-fed rabbit; B, aorta from a cholesterol- 
fed plus zinc rabbit; C, aorta from a cholesterol-fed plus copper rabbit; D, aorta from 
a cholesterol-fed plus both trace elements rabbit. Bar: 100 and 20pm in the smaller 
window.
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Figure 3.13: Scanning electron micrographs of the thoracic aorta near to the 2"  ^
intercostals branch points at higher magnification power of rabbits fed normal chow 
diets with or without additional copper and/or zinc for 12 weeks. The original 
magnification was x50 and xlOO respectively. A, control aorta; B, aorta from a zinc 
supplemented rabbit; C, aorta from a copper supplemented rabbit; D, aorta from a 
zinc and copper supplemented rabbit. Bar: 500 and 200 pm in the smaller window.
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ndFigure 3.14: Scanning electron micrographs of the thoracic aorta near to the 2 
intercostals branch points at higher magnification power of rabbits fed cholesterol 
enriched diets with or without additional copper and/or zinc for 12 weeks. The 
original magnification was x50 and xlOO respectively. A, aorta from a cholesterol-fed 
rabbit; B, aorta from a cholesterol-fed plus zinc rabbit; C, aorta from a cholesterol-fed 
plus copper rabbit; D, aorta from a cholesterol-fed plus both trace elements rabbit. 
Bar: 500 and 200 pm in the smaller window.
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Figures (3.15) and (3.16) show scanning electron micrographs of the proximal end of 
the descending aortas from rabbits of each group. Most of the endothelial lining of 
rabbits from the zinc and/or copper supplemented groups (Figure 3.15B- 3.15C- 
3.15D) was intact. The endothelial lining of the descending aortae of rabbits from 
cholesterol, cholesterol plus zinc, cholesterol plus copper, or cholesterol plus both 
trace elements (Figure 3.16B- 3.16C- 3.16D) contained small areas of endothelial 
denudation, and areas with extensive erosions. They also showed similar areas of 
adherent leukocytes. Original magnification was xl50.
In the cholesterol-fed rabbits, of all the aortic regions, the proximal thoracic showed 
the greatest amount of fatty streak formation and the largest number of attached cells. 
In general, lesions were most extensive in the area between intercostals artery branch 
points. Figure (3.17) shows aortae from 2 rabbits in the cholesterol-fed groups (Figure 
3.17A- 3.17B) compared to that of 2 rabbits of the control groups (Figure 3.17C- 
3.17D). Original magnification was x40.
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iFigure 3.15 Scanning electron micrographs of the descending aorta of rabbits fed 
normal chow or cholesterol enriched diets with or without additional copper and/or 
zinc for 12 weeks. Original magnification was xl50. A, control aorta; B, aorta from a 
zinc supplemented rabbit; C, aorta from a copper supplemented rabbit; D, aorta from 
a zinc and copper supplemented rabbit. Bar: 200pm.
180
I?
# # # : ' %
^iiS iP
m m m m m
/W   ^ f  . T« .
„ . #ÿ /
‘^^ ti •* ’ - ' ‘/^■ ' 'W W ’'f%:>£k
im m
t
Figure 3.16 Scanning electron micrographs of the descending aorta of rabbits fed 
normal chow or cholesterol enriched diets with or without additional copper and/or 
zinc for 12 weeks. Original magnification was xl50. A, aorta from a cholesterol-fed 
rabbit; B, aorta from a cholesterol-fed plus zinc rabbit; C, aorta from a cholesterol-fed 
plus copper rabbit; D, aorta from a cholesterol-fed plus both trace elements rabbit. 
Bar: 200pm.
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ndFigure 3.17 Scanning electron micrographs of the thoracic aorta near to the 2 
intercostals branch points of rabbits fed normal chow or cholesterol enriched diets for 
12 weeks. Original magnification was x40. A and B, aortae from a cholesterol-fed 
rabbit; C and D, aortae from a chow-fed rabbit. Bar: 500pm.
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Lipid peroxidation products generated during LDL oxidation are chemotactic for both 
monocytes and T cells, and inhibit the motility of macrophages, thus trapping them in 
the intima. Ox-LDL mediated events would then induce monocytes transformation 
into macrophages, and subsequent uptake of ox-LDL by scavenger receptors would 
result in foam cell formation. Figure (3.18) shows the accumulation of numerous 
macrophage-derived foam cells beneath an intact endothelium in cholesterol-fed 
rabbit, suggesting changes in atherosclerosis. These foam cells were generally found 
in the aortic arch and adjacent to major branch points in the thoracic and upper 
abdominal aortas.
One of the early visible changes in the atherosclerosis is the increased adherence of 
monocytes to arterial endothelium, followed by transendothelial migration into 
subendothelial space and differentiation into macrophages. Figure (3.19) shows 3 
micrographs of one of the cholesterol-fed rabbits at 3 different magnification powers. 
Few scattered adherent mononuclear cells appear accumulated on the endothelial 
surface of the proximal end of the thoracic aorta. The original magnification was x80, 
X170 and x440 respectively.
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Figure 3.18 A scanning electron micrograph shows the accumulation of numerous 
macrophage-derived foam cells beneath an intact endothelium in cholesterol-fed 
rabbit. Original magnification was x300. Bar: 50pm.
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Figure 3.19 Scanning electron micrographs of the proximal end of the descending 
aorta from a cholesterol-fed rabbit at 3 different magnification powers. Micrographs 
showing leukocytes adhesion to the endothelial surface. The original magnification 
was x80 in A, x 170 in B and x440 in C. Bar: 200, 100, and 50pm respectively in the 
three windows.
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Progressive accumulation of leukocytes, monocytes, and foam cells occurs on the 
lesion surface, thereby promoting lipid conversion from fatty streak to plaque. Figure 
(3.20) shows clusters of numerous leukocytes and platelets in the aorta of one of the 
cholesterol-fed rabbits. Increased monocytes and T lymphocytes adherence precedes 
their entry into the artery wall. Following adherence to the endothelial surface, 
leukocytes are observed in a variety of shapes as they spread and/or penetrate through 
the endothelium. Original magnification was x300.
Most of the cells are rounded, although a few of them appear to be in the process of 
spreading on the surface of the endothelium. Figure (3.21) shows a penetrating 
leukocyte between the surface endothelial cells indicated by the red arrow. The 
original magnification was x400.
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-Figure 3.20 A scanning electron micrograph of the ascending of aorta of a 
cholesterol-fed rabbit. It shows clusters of numerous leukocytes and platelets attached 
to the aorta surface. Increased monocytes and T lymphocytes adherence precedes their 
entry into the artery wall. Original magnification was x300. Bar: 50pm.
Figure 3.21: A scanning electron micrograph shows a penetrating leukocyte between 
the surface endothelial cells of one of the cholesterol-fed rabbits. The original 
magnification was x400. Bar: 50pm.
18 7
Figure (3.22) shows the endothelial surface of a developing fatty streak. This figure 
demonstrates how lesions principally from distal end of thoracic aorta to branch 
points develop. In this case, the branching of an intercostals artery is from the thoracic 
aorta. The lobular appearance of the surface of the lesion is due to large number of 
underlying lipid-filled macrophages or foam cells. Continual entry of monocytes and 
lymphocytes into artery wall will lead to further lesion expansion. These early fatty 
streaks appeared as groups of large rounded irregularities that deform the surface 
contours of the endothelium.
Endothelial disruption developed at later stages along with increased surface 
aggregates of platelets, monocytes, and foam cells. Large accumulation of those cells 
favors the development of an atheromatous core and the progression of some fatty 
streaks to atheromatous plaques. Figure (3.23) shows platelet thrombus on the surface 
of atheroslcerotic lesion indicated by the red arrow accompanied by the disruption of 
endothelial cells and the attachment of leukocytes and monocytes.
The morphologic criteria for identifying cell types by SEM were based on the 
description of other investigators. Small leukocytes had diameters ranging fi-om 7 to 
11pm, monocytes had diameters of 11-15 pm, and foam cells had diameters >15 pm. 
Figure (3.24) shows both a white blood cell and platelet adhering to morphologically 
abnormal endothelium.
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Figure 3.22: A scanning electron micrograph shows the endothelial surface of a 
developing fatty streak. The original magnification was x900. Bar: 20pm.
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Figure 3.23: A scanning electron micrograph shows platelet thrombus on the surface 
of atheroslcerotic lesion accompanied by the disruption of endothelial cells and the 
attachment of leukocytes and monocytes. Bar: 100pm.
189
•ttV «petMwt / l#W#* WK ".
M M 'i .
Figure 3.24: Scanning electron micrographs of the proximal end of the descending 
aorta from a cholesterol-fed rabbit. It shows both a white blood cell and platelet 
adhering to morphologically abnormal endothelium by 2 arrows. The original 
magnification was xl27. Bar: 200 pm.
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3.5 Discussion
A biphasic relationship between dietary copper intake and atherosclerosis in the 
cholesterol-fed rabbit has previously been described (Lamb et al.,2001). It has also 
been suggested that the balance between dietary copper and zinc modulates serum 
cholesterol concentrations (Klevay 1975). Thus it was proposed as a risk factor for 
coronary disease in man, this being mediated in part by effects on lipoprotein 
metabolism (Klevay 1975, Mielcarz et al., 1997).
There have been previous studies on the individual effects of copper, or zinc status on 
the vasculature in rodents, however most of these have focused on trace element 
deficiency (Shields et al., 1962, Coulson and Carnes, 1965, Hunt and Carlton, 1965, 
Petering et al., 1986, Vlad et al., 1993, Pucheu et al., 1995, DiSilvestro and 
BlosteinFujii, 1997, Hamilton et al.,2000).
Although the original hypothesis of Klevay (1975) suggested that it was the effect of 
the balance of dietary copper and zinc on blood cholesterol levels that contributed to 
atherogenesis, other putative mechanisms for the effects of these trace elements on 
atherogenesis have been proposed (reviewed by Ferns et al., 1997; Hennig et al.,1992; 
Wilkins and Leake, 1994; DiSilvestro and BlosteinFujii, 1997; Wu et al.,1998). 
Because of the possibility of interactions between dietary copper and zinc, we 
investigated the effects of the balance between dietary copper and zinc on 
atherogenesis in dietary sufficiency, or excess, using a well-established model of 
atherogenesis.
3.5.1 Effects of Experimental Diets on Tissue and Serum Trace Elements
Dietary copper or zinc supplementation was associated with increased serum copper 
and zinc levels respectively in both chow and cholesterol-fed rabbits. When both trace 
elements were concomitantly administered no significant reciprocal effects on serum
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levels were observed; similar serum levels of zinc or copper were attained as for 
animals receiving a single supplement. Hence the levels of dietary copper and zinc 
supplementation used in this study were not associated with significant reciprocal 
interference in absorption as previously suggested (Lamb et al, 1997). Hepatic tissue 
copper levels were significantly increased in the chow-fed rabbits receiving copper 
supplements in the presence or absence of zinc. This is expected since the liver is the 
main organ involved in copper and zinc metabolism. Absorption of copper and zinc 
was also confirmed by the increase of copper and zinc levels in kidney and muscle. 
Liver content of copper in the cholesterol-fed groups showed no significant difference 
from those on cholesterol alone. Copper redistribution might be a possibility with 
increased inflammation among cholesterol fed groups as previously indicated by other 
investigators (Iskra et al., 1993), especially in view of a significant increase in aortic 
copper in the cholesterol-fed rabbits, and elevated level of serum caeruloplasmin, 
which might be related to increased inflammatory response in this group. Increased 
endothelial cell permeability reported in inflammation would allow caeruloplasmin- 
associated copper to accumulate in the vascular wall hence the increased aortic 
copper. Caeruloplasmin may contribute to LDL oxidation (Ehrenwald and Fox, 1996), 
and the higher levels of caeruloplasmin in the copper supplemented cholesterol-fed 
rabbits may have been expected to exacerbate the atherosclerotic process. This was 
not found to be so, at the level used in our study, and may be related to the 
counterbalanced effects of the increased aortic superoxide dismutase level as 
discussed further below. Moreover, the contribution of copper supplementation to 
caeruloplasmin values could not be distinguished from the contribution of 
inflammation.
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Levels of hepatic zinc were higher in association with zinc supplementation in chow 
fed as well as cholesterol fed rabbits. However, dietary supplementation with both 
elements was associated with further increase in hepatic zinc in the presence of 
cholesterol. Whether this was due to modified tissue kinetics remains to be clarified, 
however the interaction between dietary copper, zinc and cholesterol in relation to 
both copper and zinc absorption, transport and tissue distribution appears complex. 
Previous reports on the relationship between copper and zinc status with lipid 
parameters, in both animal and human studies, have also been conflicting (Hess et 
al., 1977, Allen and Klevay, 1978, Sandstead et al., 1980, Klevay et al., 1984, Kromhout 
et al., 1985, Jiang et al., 1992).
In aortic tissue, zinc supplementation increased zinc accumulation in the presence or 
absence of cholesterol even though there was no concomitant increase in aortic 
superoxide dismutase activity. This might suggest a different mechanism for the 
inhibitory effect of zinc supplementation on the atherogenesis process since zinc has 
been reported to have a direct antioxidant effect in vitro (Wilkins and Leake, 1994).
3.5.2 Effects of Experimental Diets on Tissue and Serum antioxidant 
enzymes activities and Lipid Peroxides 
Atherogenesis, at least in experimental animal models, is associated with oxidative 
stress. Biochemical markers of LDL oxidation are found in serum and plaque tissue, 
and pro-atherogenic genes are induced in vascular cells by oxidative stress (reviewed 
by Parthasarathy et al., 1992). Our two measures of lipid peroxidation, TBARS and 
the FOX assay showed consistent changes in the different groups of rabbits. These 
assays showed that single supplementation with either copper or zinc was associated 
with a reduction in serum lipid peroxides. It has been previously reported that there is 
a reduction in serum lipid peroxide levels with copper supplementation (Lamb et
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al,, 1999). Zinc deficiency was associated with an increased susceptibility of LDL 
oxidation in the rat (DiSilvestro and BlosteinFujii, 1997). Furthermore zinc deficiency 
is associated with impaired endothelial cell barrier function (Hennig et al., 1992), and 
endothelial cell apoptosis (Szuster-Ciesielska et al., 2000; Meerarini et al., 2000). The 
former would allow entry of serum constituents, including caeruloplasmin, which is 
capable of oxidizing LDL (Ehrenwald and Fox, 1996). In the same context, moderate 
zinc deficiency in rat was found to be associated with high serum caeruloplasmin 
(Parson and DiSilvestro, 1994). Zinc supplementation is expected to maintain 
endothelial cell barrier function, thus reducing the possibility of entry of 
caeruloplasmin and consequently decreasing the risk of oxidizing LDL. Even though 
this was not supported by Gatto and Samman (1995) in man, the possibility of zinc 
antioxidant protection against LDL oxidation cannot be completely ruled out.
Unlike caeruloplasmin, erythrocytes Cu/Zn-SOD activity has been shown to reflect 
copper intake whether or not inflammation was present (DiSilvestro and 
Marten, 1990). Conversely, human erythrocytes SOD activity has been reported to be 
reduced by zinc supplementation (Yadrick et al., 1989). This could be due to the 
antagonizing effect of high zinc intake on copper absorption. Zinc has also shown to 
prevent lipid peroxidation by inhibiting glutathione depletion in man (Gibbs et 
al., 1985). However, the rise in activity level of erythrocytes SOD with copper and 
zinc supplementation in the absence of cholesterol was statistically insignificant and 
the lower activity level of erythrocytes GPx detected with single supplementation of 
copper and zinc among cholesterol fed groups was conversely significant. It has been 
reported that in thé presence of inadequate selenium, an increase in superoxide anion- 
mediated peroxide formation with limited GPx activity for subsequent removal of 
these peroxides may lead to excessive cellular damage (Paynter,1980). It has also
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been previously reported that copper supplementation increases aortic Cu/ Zn SOD 
activity in rabbits (Lamb et ah, 2001) and erythrocytes SOD in man (Reiser et 
ah, 1985). In the present study aortic tissue SOD levels were higher in the copper 
supplemented animals. It has been proposed that an acute phase response may 
increase copper requirements (DiSilvestro and Marten, 1990). It is possible that copper 
supplements, by stimulating the production of free radicals, indirectly cause an 
induction of SOD activity, thereby reducing oxidative stress, inhibiting pro- 
atherogenic gene expression; which is in part associated with increased serum 
caeruloplasmin level (Lamb et al., 1999); and increasing nitric oxide bioavailability 
(Lamb et al.,2005) as illustrated in figure (3.25).
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Figure 3.25: A schematic representation of the proposed role of copper and zinc 
supplementation in an animal model of experimental atherosclerosis.
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Indeed it has been reported that copper supplementation increases endothelium- 
dependent responses in isolated carotid rings from cholesterol-fed rabbits (Lamb et 
al., 1997). Thus, increased aortic SOD activity with copper supplementation in the 
presence of cholesterol may have also resulted in decreased aortic lipid peroxidation. 
Furthermore an increase in hepatic SOD activity in rabbits given copper singly or in 
combination with zinc supplementation, in chow fed rabbits but not in cholesterol fed 
groups, suggests that SOD expression might be induced by a response to both copper 
and zinc supplementation in hepatic tissue in the absence of inflammation, but not in 
its presence. This is supported by the suggestion that increased demands for more 
copper incorporation into caeruloplasmin induced by inflammation have been 
proposed to decrease SOD activity in liver (DiSilvestro and Marten, 1990).
SOD and GPx are known as key enzymes maintaining the pro-oxidants/antioxidant 
balance. Previous reports have indicated depressed GPx activity with dietary copper 
deficiency, although the mechanism for this was unknown (Allen et al., 1988). One 
possible mechanism may involve the secondary effect of copper deficiency on tissue 
levels of hydrogen peroxide, which in turn alters the expression of GPx. Moreover, 
the non-significant increase in aortic GPx activity in the cholesterol fed plus copper 
supplement group was accompanied by a decrease in the aortic lipid peroxides level. 
This may be due to a direct responsive link to the lipid peroxides level.
3.5.3 Dietary supplements of zinc or copper reduced the extent of 
atherosclerosis
In rabbits matched for integrated levels of serum cholesterol, we found that dietary 
supplementation of either zinc or copper was associated with a reduction in extent of 
atherosclerosis. The effects of copper supplementation were consistent with previous 
results (Lamb et al., 1999). The reduction in the extent of atherosclerosis associated
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with zinc supplementation was of a similar magnitude as that seen in the copper 
supplemented rabbits. However no synergy was observed in the group of animals 
receiving both supplements. This may indicate that the protective effects are being 
mediated by similar or related mechanisms.
Copper ions have potentials to play proatherogenic as well as antiatherogenic roles in 
the development of atherosclerosis according to the supplementation dose (reviewed 
by Ferns et al., 1997). Copper supplementation has shown to reduce intima: media 
ratio values in cholesterol-fed rabbits (Lamb et al., 1999). Furthermore, high serum 
copper levels were associated with increased caroteid intima-media thickness in man 
(Salonen et al.,1991b). The observed higher IMR values in the supplemented groups 
are not consistent with their reduced percentage of atherosclerotic lesion area. 
However, the IMR values vary greatly between different sites along a single aorta. 
Thus, enlace staining gives a more reliable measure of overall atherosclerosis.
The cholesterol fed groups of rabbits developed the typical morphological features of 
atherosclerosis, with leukocyte adherence at sites of predilection, and fatty streak 
formation, particularly around and between intercostals branch points as indicated 
from the scanning electron microscopy micrographs. However, there were no gross 
differences in morphology that could have discriminated in between the groups. It is 
possible that other sites along the arterial tree have shown different rates of lesion 
progression with the supplementation, and thus different endothelial surface texture. 
However, this could have been easily niissed as all observations were detected at the 
same position of the arterial tree in each animal.
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3.6 Limitations
Due to the limitations of studying atherosclerosis in humans, animals have become 
particularly important in atherosclerosis research and a large number of animal 
models have been developed. Our model, in particular, has the advantage of rapid 
development of atherosclerosis in response to dietary cholesterol feeding and the 
difference in arterial response among animals can be controlled as a consequence of 
maintaining their plasma cholesterol levels.
Quantitation of atherosclerotic lesion development along the descending aorta has the 
advantage that it is a site of early lesion development, but has a number of 
disadvantages in not being the characteristic site for atherosclerosis development in 
human. Also it does not reflect the pattern of atherosclerosis in other regions of the 
arterial tree. Assessment of the lesion area by staining with oil red O was useful in 
showing lipid accumulation but gave no information on the structure of the lesions. 
With 8 animals in each group, statistical considerations such as the risk of type II 
error, which mainly depends on sample size, could mean that many real differences 
have been underestimated.
3.7 Conclusions
Dietary supplements of copper or zinc inhibit atherogenesis in the cholesterol-fed 
rabbit. Although zinc supplementation did not appear to reduce the efficacy of copper 
supplements, there was no significant additional effect when used in combination. At 
the doses used, both trace elements reduced serum lipid peroxides, indicating that they 
may act by an effect on lipid oxidation.
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Chapter 4
Dietary macronutrient and 
micronutrient intake and 
demographic characteristics of 
healthy Saudi subjects and age- 
matched atherosclerotic patients
4.1 Introduction
The risk of several chronic conditions including coronary heart disease is likely to 
vary markedly by ethnicity and socioeconomic status (Block et ah, 1988, Stram et 
al.,2000). Some of these differences may be explained by differences in dietary 
intake. However, most previous studies have been undertaken in Western Caucasian 
populations (Rimm et al., 1993, de Lorgeril et a., 1999).
4.2 Specific aim
1. To test the validity and reproducibility of the food frequency questionnaire in 
a subset sample of Saudi male subjects.
2. To investigate whether the dietary intake of total energy; macronutrients; 
micronutrients; and fiber differ between age groups, categories of 
socioeconomic class, and racial groups among a sample of male Saudi subjects 
from the Western province of the Kingdom of Saudi Arabia, stratified by age, 
socioeconomic status, and race.
3. To investigate the association between the intake of nutritional factors and 
coronary heart disease prevalence and their correlation with established 
cardiovascular risk factors in Saudi males with established atherosclerosis and 
age-matched controls.
4. To estimate the prevalence of vitamins and trace elements inadequacy in a 
diverse sample of male Saudi controls from the Western province of the 
Kingdom of Saudi Arabia, stratified by age tertiles, socioeconomic status, and 
race as well as in Saudi males with established atherosclerosis and age- 
matched controls.
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4.3 Methods
Data were collected from 303 male subjects, aged 15-80 years. They were selected 
randomly from students and staff members of King Abdulaziz University as well as 
blood donors and patients with minor conditions but with no evidence of CVD (e.g. 
orthopedic patients) from the King Abdulaziz University Hospital in Jeddah, Saudi 
Arabia. They were grouped according to their age tertiles, socioeconomic status, and 
racial groups. The subjeets were asked to complete a questionnaire concerning their 
demographic characteristics, health history, lifestyle, and dietary habits (see appendix 
3). Demographic and dietary intake data of 260 CVD patients and their age-matched 
controls were also assessed.
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4.4 Results
4.4.1 Variation of demographic data within the healthy Saudi subjects
4.4.1.1 Variation of demographic data with age tertiles within 
controls
The demographic characteristics of the study population of 303 subjects, stratified by 
age groups are shown in table (4.1). The distribution of racial characteristics was 
similar for each age group (p>0.05), with approximately 54% of the total population 
being of Arabic descent. The prevalence of hypertension, dyslipidaemia and diabetes 
mellitus increased significantly with age (p<0.0001) as did BMI (p=0.001) but with 
no difference between the middle and old age groups. The prevalence of hypertension 
was particularly high (58%) in the subgroup, which was >50 years old, and 
approximately 37% of this group of subjects was diabetic. The prevalence of these 
latter conditions was considerably higher in our population than reported for Western 
populations. Approximately 38% of the older age groups were classified as obese. 
However the prevalence of obesity and overweight was lower in the youngest group 
(p=0.001), with approximately 27% of this subgroup being obese. A family history of 
heart disease was reported in approximately 23% of the sample, and 47% of the study 
population had a family history of diabetes, both being high compared to a Western 
Caucasian population. Current smoking habit was reported in a higher proportion of 
young subjects (p<0.0001), though more of these subjects engaged in physical 
exercise more than three times weekly compared to the older, but not the middle age, 
group (p<0.05). Socioeconomic status also varied significantly by age tertiles
(p<0.001).
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Table 4 .1 :  V a r ia t io n  in  d e m o g r a p h ic  fa c to r s  w it h  a g e  te r t i le s  in  S a u d i s a m p le
Parameter <33
Age groups (years) 
34-49 >50
P
n 101 99 103
Age (years) 24.8 ± 0.5 41.5 ±0.5 61 ±0.9 <0.0001
Height (cm) 170 ±1.6 168.5 ±0.7 168.3 ± 0.8 NS
Weight (Kg) 76.8 ±2.1 82.6 ± 1.6 § 81.6 ±1.6* <0.05
Body mass index (Kg/m2) 26.5 ± 4.0 29 ±0.5# 28.8 ± 0.5 * <0.0001
Systolic blood pressure 120.3 ± 0.9 123.7 ± 1.5 § 128.1 ±2.1 * <0.05
(mm Hg)
Diastolic blood pressure 79 ± 0.7 80 ± 0.9 80 ±1.0 NS
(mm Hg)
Hypertensive, n(%) 4(4) 20 (20) 60(58) <0.0001
Dyslipidemia, n(%) 3(3) 17(17) 270%) <0.0001
Diabetics, n(%) 1(1) 18(18) 38^7) <0.0001
Bodv mass index, n(%) 
Normal 47 (47) 20 (20) 260%) =0.001
Overweight 27(27) 39(39) 38(37)
Obese 27GU) 40 (40) 39(38)
Familv Historv, n(%) 
Heart disease 25(25) 26(26) 20 (19) NS
Diabetes mellitus 51(51) 51(52) 41 (40)
Race, n(%) 
Arabian tribes 63(62) 52(53) 50 (49)
Africans 6(6) 8(8) 12(12)
Caucasians 9(9) 9(9) 9(9) NS
Indians 9(9) 6(6) 7(7)
Far Easterns 7(7) 8(8) 2(29)
Mediterraneans 7(7) 16(16) 23 (22)
Socioeconomic status, 
n(%) 31(31) 33 (33) 58(56)
Low 68(67) 61(62) 35(34) <0.0001
Middle 2(2) 5(5) 10(10)
High
Smoking status, n(%) 
Never 51(51) 44 (44) 56(54)
Former 9(9) 16(16) 35 (34) <0.0001
Current (<20 cigarette) 25(25) 17(17) 4(4)
Current (>20 cigarette) 16(16) 22(22) 8(8)
Phvsical activity, n(%) 
<3 times/week 46 (46) 37 (37) 58(56) <0.05
>3 times/week 55 (55) 62(63) 45 (44)
On a diet, n(%) 18(18) 29(29) 28(27) NS
Numeric data are presented as mean ± SEM and categorical data as number and percentage.
Categorical data were compared by test, continuous variables were compared by Kruskal-Wallis test. 
NS: not significant. § P<0.05 (first & second groups), # P<0.001 (first & second groups), * P<0.05 
(first & third groups), ¥  P<0.001 (first & third groups), % P<0.05 (second & third groups), f  P<0.001 
(second & third groups)
2 0 3
4.4.1.2 Variation of demographic data with SES within controls
The demographic characteristics of the study population, stratified by socioeconomic 
status are shown in table (4.2). Due to the small number of individuals in the high 
socioeconomic class group (n=17), they were excluded from the following 
comparative analysis. The prevalence of hypertension, dyslipidaemia, and diabetes 
mellitus was higher among low socioeconomic class individuals. Racial background 
and smoking history varied significantly by socioeconomic status (p<0.001 and 
p<0.05 respectively). Higher proportions of overweight subjects and smokers (36% 
and 35% respectively) were found among the middle socioeconomic class when 
compared to the low socioeconomic class (31% and 22% respectively). More Afi'icans 
and Mediterranean descendents were of low socioeconomic class (16% and 19% 
respectively).
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T a b le  4 .2 :  V a r ia t io n  in  d e m o g r a p h ic  f e a tu r e s  w it h  s o c i o e c o n o m ic  s ta tu s  in  a  h e a lt h y
Parameter Low
SES
Middle high
P
n 122 164 17
Age (years) 47.4 ± 1.7 38.2 ±1.1 50.5 ±3.2 <0.0001
Height (cm) 165.5 ± 1.1 170.0 ±0.8 169.0 ±1.6 <0.0001
Weight (Kg) 79.8 ± 1.7 81.8 ±1.3 80.7 ±4.5 NS
Body mass index 30.9 ±2.5 29.5 ±1.6 28.1 ±1.2 NS
(Kg/m2)
Systolic blood pressure 124.6 ± 1.6 123.1 ±1.2 129.6 ±3.9 NS
(mm Hg)
Diastolic blood pressure 79.6 ±0.9 79.4 ± 0.6 82.8±:L8 NS
(mm Hg)
Hypertensive, n(%) 43 (35) 32(20) 9(53) <0.05
Dyslipidemia, n(%) 28(23) 12(7) 7(41) <0.0001
Diabetics, n(%) 34(28) 19(12) 4(23) <0.0001
Bodv mass index, n(%) 
Normal 41 (34) 48(29) 4(24)
Overweight 38(31) 59(36) 7(41) NS
Obese 43 (35) 57(35) 6(35)
Familv Historv. n(%) 
Heart disease 27(22) 39(24) 5(29) NS
Diabetes mellitus 51(42) 79(48) 13 (77) NS
Race, n(%) 
Arabian tribes 66(54) 90(55) 9(53)
Africans 19(16) 7(4) 0(0) <0.0001
Caucasians 3(3) 21(13) 3(1%
Indians 6(5) 14(9) 2(12)
Far Easterns 5(4) 11(7) 1(6)
Mediterraneans 23(19) 21 (13) 2(E%
Smoking status, n(%) 
Never 61 (50) 84(51) 6(35) <0.05
Former 34(28) 23 (14) 3(18)
Current (<20 cigarette) 10(8) 34 (21) 2(12)
Current (>20 cigarette) 17 (14) 23 (14) 6(35)
Phvsical activitv, n(%) 
<3 times/week 59(48) 76 (46) 6(35) NS
>3 times/week 63 (52) 88(54) 11(65)
On a diet, n(%) 30(25) 40 (24) 5(29) NS
Numeric data are presented as mean ±  SEM and categorical data as number and percentage. 
Categorical data were compared by ^  test, continuous variables were compared by Mann Whitney test. 
NS: not significant
2 0 5
4.4.1.3 Variation of demographic data with race within controls
Even though mixed marriages do exist in Saudi Arabian society, the maternal race did 
not differ significantly from the father race among individuals in this sample 
(p>0,05). Therefore, this variable was excluded from the analysis. Subjects were 
initially classified into 6 racial groups. However, individuals of Caucasian Mid- 
Asians, Indian Asians, and Far Eastern Asian descendents were merged in one 
subgroup and collectively labelled as Asians due to small numbers in each subgroup. 
Furthermore, due to the small number of African descent (n=26), they were excluded 
from the following comparative analysis.
There were considerable differences in the distribution of several demographic 
characteristics with ethnicity (Table 4.3). Obesity, diabetes mellitus, hypertension and 
dyslipidaemia were most prevalent among the subjects with a Mediterranean 
background. This may have been due to the higher mean of age of this group. Self- 
reported physical activity was also the lowest in this group. Socioeconomic status and 
BMI classes varied significantly by ethnicity (p<0.05). The majority of low 
socioeconomic class individuals were of Mediterranean descents and Asians 
constitute the majority of middle socioeconomic class individuals. Current smoking 
was most frequently reported among Asians.
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Table 4.3: Variation in demographic features with ethnicity in Saudi sample
population. ___________________________________________________________
Race
Parameter Arabian
tribes
Mediterraneans Asians Africans P
n 165 46 66 26
Age (years) 40.7 ± 1.3 50.1 ± 2.3 #1 40.6 ±1.8 46.5 ± 3.5 <0.001
Height (cm) 166.8 ±0.9 171.8 ±0.9# 169 ±1.6* 168.9 ±2.3 <0.001
Weight (Kg) 77.6 ±1.3 91.5 ± 2.0 § t 83.5 ±2.5 * 76.8 ±3.6 <0.0001
Body mass index 
(Kg/m2)
29.3 ± 1.9 31.1 ± 0.8 § 32.2 ± 4.0 26.9 ± 1.1 <0.0001
Systolic blood 
pressure (mm Hg)
125 ±1.2 124 ±2.7 121.8 ±2.0 124.4 ±3.8 NS
Diastolic blood 
pressure (mm Hg)
79.8 ± 0.7 82.4 ± 1.2 t 78.64 ± 1.1 76.5 ± 2.2 <0.05
Hypertensive, n(%) 31 (19) 21 (46) 17(26) 15(58) <0.001
Dyslipidemia, n(%) 19(12) 13 C%) 12(18) 3(12) <0.05
Diabetics, n(%) 
Bodv mass index. 
n(%)
27 (16) 11(24) 11(17) 8(31) NS
Normal 56(34) 3(7) 21(32) 13 (50) <0.05
Overweight 60(36) 18(39) 20 (30) 6C%)
Obese
Familv Historv, 
n(%)
49 (30) 25(54) 25 (38) 7CU)
Heart disease 37(22) 14 (30) 14(21) 6CM) . NS
Diabetes mellitus 
Socioeconomic 
status, nt%)
75 (46) 21 (46) 38(58) 9(35) NS
Low 66 (40) 23 (50) 14(21) 19(73) <0.05
Middle 90(55) 21 (46) 46 (70) 7CU)
High
Smoking status, 
n(%)
9(6) 2(4) 6(9) 0(0)
Never 81(49) 22 (48) 31 (47) 17(65) NS
Former 34 (21) 9(20) 11(17) 6C%)
Current (<20 cig) 26(16) 7(15) 12(18) 1(4)
Current (>20 cig) 
Phvsical activitv.
n(%)
24(15) 8(17) 12(1% 2(8)
<3 times/week 74 (45) 23 (50) 30 (46) 14(54) NS
>3 times/week 91(55) 23 (50) 36(55) 12 (46)
On a diet, n(%) 40 (24) 11(24) 19(29) 5(1% NS
Numeric data are presented as mean ± SEM and categorical data as number and percentage. 
Categorical data were compared by test, continuous variables were compared by Kruskal-Wallis test. 
NS: not significant. § P<0.05 (first & second groups), # P<0.001 (first & second groups) * P<0.05 (first 
& third groups), ¥  P<0.001 (first & third groups) % P<0.05 (second & third groups), f  P<0.001 (second 
& third groups)
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4.4.2 Variation of dietary intake data within controls
4.4.2.1 Affects of age on Dietary intake among healthy controls
The nutrient intake of the study population stratified by age groups is shown in table 
(4.4). Energy intake fell with age (p<0.05). Intake was low compared to the RNI for 
all age groups. Total fat and protein intake fell with age, but was similar for all groups 
when expressed as a percentage of energy intake. For all groups, the mean value of 
the latter was higher than the RNI. The percentage energy in the form of carbohydrate 
fell with age, with a low mean value for carbohydrate compared to the RNI. Mean 
cholesterol intake was higher than the RNI for all groups, but fell with age group 
(p<0.0001) (Table 4.4). SFA and MUFA intake, expressed as percentage energy 
intake were both high compared to the RNI, whereas PUFA intake was lower than the 
RNI. The youngest group had the highest percentage energy provided by SFA 
(p<0.001), and lowest PUFA:SFA ratio (p<0.001) and percentage energy as PUFA 
(p<0.05) compared to the other groups (Table 4.4). The intake of fibre and 
PUFA:SFA ratio rose with age, and was significantly higher in the older group 
(p<0.05, p<0.001 respectively).
Table (4.5) shows the association between age and macronutrients intake. PUFA:SFA 
ratio and dietary intake of protein, PUFA, and fibre were positively associated with 
age while dietary intake of energy, carbohydrates, cholesterol, and SFA were 
inversely associated with age.
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Table 4.4: E n e r g y  a n d  D ie ta r y  m a c r o n u tr ie n t  in t a k e s  o f  s u b j e c t s  in  d i f f e r e n t  a g e
g r o u p s  in  S a u d i s a m p le  p o p u la t io n .
Nutrient RNI <33
(n=101)
A ge groups (years) 
33-49  
(n=99)
>50
(n=103)
P
Energy (Kcal) 2755(15-18) 2036.6 ± 49.5 ¥: 1936.3 +  46.8 1834.9 +  45.4 <0.05
Unadjusted protein
2550 (19-59) 
2380 (60-74) 
2100 (75+)
7 2 .6 + 1 .8 71.3 + 1.9 6 9 .7 + 1 .8 NS
(gm)
% o f  energy 15% 14.4 +  0.2 14.8 + 0.2 15.2 + 0 .2  ¥ <0.05
Energy-adjusted 67.3 + 0.1 67.5 +  0.1 67.7 + 0 .1  ¥ <0.05
protein (gm) 
Unadjusted 247.1 + 6 .7  ¥ 229.7 + 6.5 If 213.1 +  5.7 =0.001
carbohydrate (gm) 
% o f  energy 55 % 48.6 ±  0.6 47.5 + 0.7 46.6 + 0.6 NS
Energy-adjusted 222.2 +  0.1 222 + 0.1 221.8 +  0.1 NS
carbohydrate (gm) 
Unadjusted total fat 84.2 ± 2.4 81.3 +  2.6 78.2 +  2.4 NS
(gm)
% o f  energy 3 0 % 37 + 0.6 37.8 + 0.7 38.1 +  0 .6 NS
Energy-adjusted fat 77.9 +  0.1 78 + 0.1 78.1 + 0.1 NS
(gm)
Cholesterol (mg) 2 8 0 .9+  10.3 ¥ 2 6 1 .4 + 1 1 .2 2 2 3 .4 +  10.8 <0.0001
Categories o f  
cholesterol intake <200 mg 20(20) 34(34) 50(49) <0.0001
^% ) >200 mg 81(80) 65(66) 53(52)
Unadjusted SFA 30.4 +0.9 # ¥ 2 6 .7 + 1 .0 2 5 .4 + 1 .0 <0.0001
(gm)
% o f  energy 10% 15 + 0.3 §* 13.7 + 0.3 13.6 + 0.3 <0.05
Energy-adjusted 25.9 + 0.1 25.6 +  0.1 25.6 + 0.1 <0.05
SFA (gm) 
Unadjusted MUFA 29.9 ± 0.7 * 28.8 + 0.9 27.7 + 0.9 <0.05
(gm)
% o f  energy 10% 15 + 0.3 15 + 0.3 15 + 0.3 NS
Energy-adjusted 27.5 + 0.1 27.6 + 0.1 27.6 + 0.1 NS
MUFA(gm) 
Unadjusted PUFA 16.9 +  0.6 17.7 +  0.7 17 + 0.6 NS
(gm)
% o f energy 10% 8.4 +  0.2 9.2 + 0 .3  § 9.3 + 0.3 * <0 .05
Energy-adjusted 15.2 + 0.1 15.5 + 0.1 15.5 + 0.1 <0.05
PUFA (gm) 
P:S ratio NA 0.55 ± 0.02 0.68 + 0.02 # 0.68 + 0.02 ¥ <0.0001
Fiber (gm) 18 gm 16.9 +  0.5 17.9 +  0.5 18.5 +  0 .4 * <0.05
Numeric data are presented as mean ± SEM and categorical data as number and percentage. Categorical data were 
compared by test, continuous variables were compared by Kruskal-Wallis test. NS: not significant. P:S ratio: 
polyunsaturated fatty acids: saturated fatty acids ratio RNI: reference nutrient intake, § P<0.05 (first & second 
groups), # P<0.001 (first & second groups), * P<0.05 (first & third groups), ¥ P<0.001 (first & third groups), % 
P<0.05 (second & third groups), t  P<0.001 (second & third groups)
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Table 4.5: Correlation coefficients between age and various feature of macronutrient 
intake in Saudi sample population
Age vs. r P
Energy -0.183 0.001
Protein, unadjusted -0.082 0.153
Protein, as % of energy supplied 0.137 0.017
Protein, energy-adjusted 0.179 0.002
Carbohydrates, unadjusted -0.212 0.0001
Carbohydrates, as % of energy supplied -0.093 0.105
Carbohydrates, energy-adjusted -0.106 0.065
Fat, unadjusted -0.121 0.035
Fat, as % energy supplied 0.052 0.364
Fat, energy-adjusted 0.069 0.232
Cholesterol -0.235 0.0001
Saturated fatty acids, unadjusted -0.229 0.0001
Saturated fatty acids, as % energy -0.188 0.001
supplied
Saturated fatty acids, energy-adjusted -0.137 0.017
Monounsaturated fatty acids, unadjusted -0.132 0.021
Monounsaturated fatty acids, as % energy -0.004 0.940
supplied
Monounsaturated fatty acids, energy- 0.017 0.303
adjusted
Polyunsaturated fatty acids, unadjusted 0.001 0.990
Polyunsaturated fatty acids, as % energy 0.156 0.007
supplied
Polyunsaturated fatty acids, energy- 0.139 0.016
adjusted
P:S ratio 0.228 <0.0001
Fiber 0.126 0.029
P:S ratio: polyunsaturated fatty acids: saturated fatty acids ratio
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The micronutrient intakes are presented in table (4.6). All intakes of micronutrient fell 
with age except for vitamin E and carotenoids. Compared to the old age group, the 
youngest age group had a higher intake of all other micronutrients although all 
differences were not statistically significant, except for copper (p<0.05). The older 
age group had significantly higher intake of carotenoids than the youngest age group 
(p<0.05). A large proportion of subjects in each age tertile had less than adequate 
levels of selenium intake (87%, 82%, and 87% respectively). Almost one half of 
subjects in each tertile of age had less than adequate levels of vitamin A (42%, 43%, 
and 54% respectively) and vitamin E (53%, 41%, and 29% respectively) intake. One 
third of subjects in each age tertile had less than adequate levels of vitamin C intake 
(38%, 33%, and 32% respectively) (Figure 4.1).
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Table 4.6: M ic r o n u tr ie n t  in ta k e s  a n d  a d e q u a c y  o f  th e ir  in t a k e s  in  d if f e r e n t  a g e  g r o u p s
in  S a u d i m a le s  p o p u la t io n  ( n = 3 0 3 ) .
Age groups (years) P
<33 34-49 >50
n 101 99 103
Selenium (pg) 45.5 ± 1.6 45.1 ± 1.7 42.0 ± 1.3 NS
Copper (mg) 1.43 + 0.05 * 1.36 ±0.05 1.25 ±0.04 <0.05
Zinc (mg) 9.26 + 0.3 8.94 ± 0.3 8.75 ± 0.2 NS
Vitamin E (mg) 11.6 + 0.5 12.0 ±0.5 12.5 ±0.4 NS
Vitamin A (pg) 863.2 + 84.8 923.5 ± 103.8 734.5 ± 70.2 NS
Carotenoids (mg) 8.97 + 0.5 10.29 ±0.5 11.05 ±0 .4* <0.05
Vitamin C (mg) 45.6 ±5.1 45.2 ±4.7 41.8 ±3.4 NS
Data are presented as mean ±  SEM. Continuous variables were com pared by Kruskal-W allis test. NS: 
not significant. * P<0.05 (first & third groups)
<UJ
)o
d>
100
80
60
40
20
0
■ Selenium
■ Copper
□ Zinc
□ Vitamin E 
H Vitamin A 
a Vitamin C
<33 34-49 >50
Age tertiles
Figure 4.1: Percentage of Saudi sample population categorized by age tertiles 
consuming micronutrient intakes below the estimated average requirement
2 1 2
4.4.2.2 Dietary intake by socioeconomic status in healthy subjects
Variation in dietary intake according to socioeconomic status is shown in table (4.7). 
Intake of energy and carbohydrates, as percentage of total caloric intake, was low 
compared to the RNI for all classes. People of middle socioeconomic class consumed 
more energy and carbohydrates (p<0.05 and p<0.001 respectively), less total fat, 
PUFA expressed as percentage of total caloric intake and PUFA:SFA ratio (p<0.05) 
than those of low socioeconomic class. No significant differences were observed for 
dietary intake of protein and fiber between all classes, nor were they different from 
RNI values. Mean cholesterol intake was higher than the RNI for all socioeconomic 
classes, with the majority in each class consuming above 200mg (62%, 70%, and 53% 
respectively). Total fat, saturated fat and monounsaturated fat intake, expressed as 
percentage energy intake were high compared to the RNI, whereas PUFA intake was 
lower than the RNI.
Table (4.8) shows the association between socioeconomic classes; classified as low, 
middle, and high, with demographic and dietary characteristics. Socioeconomic 
classes was positively correlated with carbohydrates intake in grams and inversely 
correlated with the percentage of calories provided by PUFA intake and with the 
PUFA: SFA ratio.
Table (4.9) shows that the middle socioeconomic class reported the highest intakes of 
all micronutrient except for vitamin E and carotenoids. Regarding the adequacy of 
micronutrient intakes, the proportion of subjects who had an inadequate intake of 
selenium (83%, 87%, and 88% respectively) and vitamin A, to some extent, (53%, 
35%, and 71% respectively) in the three socioeconomic classes was considerable 
(Figure 4.2).
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T a b le  4 .7 :  E n e r g y  a n d  d ie ta r y  m a c r o n u tr ie n t  in t a k e s  o f  s u b j e c t s  in  d if f e r e n t
s o c i o e c o n o m ic  c la s s e s  in  S a u d i s a m p le  p o p u la t io n .
SES P
Nutrient RNI Low Middle High
(n=122) (n=164) (n=17)
Energy (Kcal) 2755 (15-18) 
2550(19-59) 
2380 (60-74) 
2100 (75+)
1856.6 + 39.5 1999.3 + 39.4 1881.7+118.9 <0.05
Unadjusted 69.6 +1.6 72.7+1.5 68.4 + 4.8 NS
protein (gm)
% of energy 15 % 15.1 + 0.2 14.7 + 0.2 14.5 + 0.4 NS
Energy-adjusted 67.6 + 0.1 67.4 + 0.1 67.4 + 0.2 NS
protein (gm)
Unadjusted 215.4 + 5.3 242.5 + 5.2 212.3 + 16.4 <0.001
carbohydrate
(gm)
% ofenergy 55% 46.5 + 0.6 48.6 + 0.5 44.8+1.3 <0.05
Energy-adjusted 221.8 + 0.1 222.2 + 0.1 221.6 + 0.2 <0.05
carbohydrate
(gm)
Unadjusted total 79.6 + 2.2 82.1+2.0 84.3 + 5.2 NS
fat (gm)
% of energy 30% 38.4 + 0.6 36.7 + 0.5 40.6+1.1 <0.05
Energy-adjusted 78.15 + 0.1 77.8 + 0.1 78.4 + 0.2 <0.05
fat (gm)
Cholesterol (mg) 245.1 + 9.5 263.5 + 8.8 244 + 28.4 NS
Categories of
cholesterol intake <200 mg 46(38) 50(31) 8(47) NS
nC%) >200 mg 76(62) 114(70) 9(53)
Unadjusted SFA 26.3 + 0.9 28.4 + 0.8 27.7 + 2.0 NS
(gm)
% of energy 10% 14 + 0.3 14.2 + 0.3 14.9 + 0.7 NS
Energy-adjusted 25.7 + 0.1 25.7 + 0.1 25.9 + 0.2 NS
SFA (gm)
Unadjusted 28 + 0.8 29.2 + 0.7 30.4+1.8 NS
MUFA (gm)
% of energy 10% 15.1 + 0.3 14.7 + 0.2 16.4 + 0.6 NS
Energy-adjusted 27.7 + 0.1 27.5 + 0.1 28.1 + 0.2 NS
MUFA(gm)
Unadjusted 17.4 + 0.6 17.0 + 0.5 17.7+1.7 NS
PUFA (gm)
% of energy 10% 9.4 + 0.3 8.6 + 0.2 9.3 + 0.6 <0.05
Energy-adjusted 15.6+0.1 15.3 + 0.1 15.6 + 0.2 <0.05
PUFA (gm)
P:S ratio NA 0.73 + 0.03 0.64 + 0.01 0.66 + 0.1 <0.05
Fiber (gm ) 18 gm 18.2 + 0.5 17.6 + 0.4 17.3 + 1.5 NS
Numeric data are presented as mean ± SEM and categorical data as number and percentage. Categorical data were 
compared by test, continuous variables were compared by Mann Whitney test. NS: not significant P:S ratio: 
polyunsaturated fatty acids: saturated fatty acids ratio, RNI: reference nutrient intake
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Table 4.8: Correlation coefficients between socioeconomic class and dietary 
characteristics in Saudi sample population
Socioeconomic class vs. r P
Energy 0.109 0.059
Protein, unadjusted 0.037 0.525
Protein, as % of provided calories -0.111 0.053
Protein, adjusted -0.097 0.092
Carbohydrates, unadjusted 0.105 0.068
Carbohydrates, as % of provided 0.100 0.081
calories
Carbohydrates, adjusted 0.141 0.014
Fat, unadjusted 0.049 0J96
Fat, as % of provided calories -0.066 0.253
Fat, adjusted -0.079 0.169
Cholesterol 0.045 0.437
Saturated fatty acids, unadjusted 0.091 0.114
Saturated fatty acids, as % of 0.056 0.335
provided calories
Saturated fatty acids, adjusted 0.021 0.718
Monounsaturated fatty acids. 0.072 0.210
unadjusted
Monounsaturated fatty acids, as -0.014 0.811
% of provided calories
Monounsaturated fatty acids. -0.017 0.771
adjusted
Polyunsaturated fatty acids. -0.022 0.704
unadjusted
Polyunsaturated fatty acids, as % -0.117 0.043
of provided calories
Polyunsaturated fatty acids. -0.111 0.054
adjusted
P:S ratio -0.122 0.034
Fiber -0.022 0.702
P:S ratio: polyunsaturated fatty acids: saturated fatty acids ratio
2 1 5
Table 4.9: M ic r o n u tr ie n t  in ta k e s  a n d  a d e q u a c y  o f  th e ir  in t a k e s  in  d if fe r e n t
s o c i o e c o n o m ic  c la s s e s  in  S a u d i m a le s  p o p u la t io n  ( n = 3 0 3 ) .
SES P
Low Middle High
n 122 164 17
Selenium (pg) 43.35 ± 1.3 45.07+ 1.23 41.8 + 4.09 NS
Copper (mg) 1.28 + 0.04 1.40 + 0.04 1.29 + 0.1 <fr05
Zinc (mg) 8.68 + 0.2 9.23 + 0.2 8.75 + 0.6 NS
Vitamin E (mg) 12.8 + 0.4 11.5 + 0.4 12.1 ± 1.0 <ao5
Vitamin A (pg) 758.4 + 66.9 930.7 + 76.1 535.8+ 148.4 <0.05
Carotenoids (mg) 11.5 + 0.3 9.2 + 0.4 8.6+ 1.1 <ao5
Vitamin C (mg) 42.4 + 3.6 45.5 + 3.8 44.0 + 8.2 NS
Data are presented as mean ±  SEM. Continuous variables were com pared by M ann W hitney test. NS: 
not significant.
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Figure 4.2: Percentage of Saudi sample population categorized by socioeconomic 
class consuming micronutrient intakes below the estimated average requirement.
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4.4.2.3 Dietary intake by race within controls
Variation in dietary intake according to race is shown in table (4.10). Descendents of 
Arabian tribes had a lower PUFA:SFA ratio (p<0.05) and consumed more cholesterol 
and SFA than those with a Mediterranean background even after adjustment for total 
energy intake (p<0.05). Arabian tribes descendents had also lower PUFA: SFA ratio 
and higher SFA intake adjusted for total caloric intake than those of Asians 
descendents (p<0.05). Similarly, the highest (73%) and lowest (48%) proportions of 
subjects consuming more than 200mg/day of cholesterol were for those of Arabian 
tribes and Mediterranean backgrounds respectively.
Table (4.11) shows the association between age and macronutrient intake within each 
racial group. Age was positively associated with energy-adjusted PUFA intake and 
PUFA: SFA ratio as well as inversely associated with energy intake, carbohydrates, 
total fat, cholesterol, SFA, and MUFA intake within members of the group of Arabian 
descent. Similarly age was inversely correlated with carbohydrates and positively 
correlated with energy-adjusted protein intakes within Africans. Within Asians, age 
was inversely correlated with energy-adjusted SFA intake and positively correlated 
with energy-adjusted PUFA, PUFA: SFA ratio, and fiber. A similar correlation 
between age and dietary fiber existed within the Mediterranean group.
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o Table 4.10: E n e r g y  a n d  d ie ta r y  m a c r o n u tr ie n t  in t a k e s  o f  s u b j e c t s  in  d i f f e r e n t  r a c e s  inS a u d i s a m p le  p o p u la t io n .
Arabian tribes 
(n=I65)
Race
Mediterraneans
(n=46)
Asians
(n=66)
Africans
(n=26)
P
1962.5 +  37.6 1798.9 +  61.8 1987.4 +  61.3 1871.5 +  97.8 NS
7 2 .2 + 1 .5 67.8 +  2.2 71 .2  +  2 .4 70 .9  +  4.1 NS
14.8 +  0.2 15.2 +  0.3 14.4 +  0.2 15.3 +  0.5 NS
67.5 +  0.1 
233.1 +  5.0
67.6  +  0.1 
215 .7  +  8.3
67.3 +  0.1 
239.9  +  8.5
67 .7  +  0.3 
20 9  +  12.7
NS
NS
47.5  + 0.5 48.1 +  1.0 48.3  +  0.8 4 4 .8 + 1 .5 NS
222 +  0.1 
82.3 +  1.9
222.1 +  0.1 
73.9  +  3.4
222.1 +  0.1 
82.5 +  3.1
2 2 1 .6  +  0.2  
83 .6  +  5.3
NS
NS
37 .6  +  0.5 3 6 .7 + 1 .0 37.3 +  0.8 4 0 + 1 .4 NS
78 + 0.1 77.9  +  0.1 77.9  +  0.1 78 .4  +  0.2
NS
263.45 +  7.9 § 222 +  14.4 260.3 +  16.0 245 .7  +  23.5 <0.05
45 (27) 
120 (73)
24  (52)  
22C W )
24  (36) 
42  (64)
1 1 (4 2 )  
15 (58)
<0.05
28 .7  + 0 .8  § 2 4 +  1.3 2 6 .8 + 1 .2 2 7 .9  +  2.1 <0.05
14.6 +  0.3 *§ 13.2 +  0.5 13.4 +  0.4 14.7 +  0.7 <0.05
25.8  +  0.1 *§ 25.5 +  0.1 25.5  +  0.1 2 5 .9  +  0.2 <0.05
29.1 +  0.6 2 6 .7 + 1 .2 2 9 + 1 .1 30 .3  +  1.8 NS
15 +  0.2 14.8 +  0.5 14.7 +  0.3 16.2 +  0.6 NS
27 .6  +  0.1 27 .6  +  0.1 27.5 +  0.1 28  +  0.2 NS
17.1 +  0.5 15.9 +  0.8 18.4 +  0.8 1 7 .2 + 1 .5 NS
8.8 +  0.2 8.9 +  0.4 9.4 +  0.3 9 .1 +  0.5 NS
15.3 +  0.1 15.4 +  0.1 15.6 +  0.1 15.5 +  0 .2 NS
0.64  +  0.02  
17.4 +  0.4
0.71 +  0.03  
18.3 +  0.8
0.74  +  0 .04  * 
18.6 +  0.7
0 .66  +  0.05 § 
16.9 +  0 .9
<0.05
NS
Nutrient RNI
o
Energy (Kcal)
Unadjusted 
protein (gm)
% o f energy
Energy-adjusted 
protein (gm) 
Unadjusted 
carbohydrate (gm) 
% o f energy
Energy-adjusted 
carbohydrate (gm) 
Unadjusted total 
fat (gm)
% o f energy
Energy-adjusted 
fat (gm)
(fholegerol (mg)
Categories o f  
cholesterol intake 
r{%)
Unadjusted SFA 
(^m)
% o f energy
Imergy-adjusted 
SfFA (gm) 
Unadjusted 
Î /TUFA (gm) 
f) o f  energy
I inergy-adjusted 
t /lUFA(gm) 
Jnadjusted PUFA  
• { gm)
)  ^4 o f  energy
I inergy-adjusted 
PUFA (gm)
P:S ratio 
Fiber (gm)
2755 (15-18) 
2550(19-59)  
2380 (60-74) 
2100 (75+)
15%
5 5 %
30%
<200 mg 
>200 mg
10%
10%
10%
NA  
18 gm
Numeric data are presented as mean ±  SEM and categorical data as number and percentage Categorical 
data were compared by ^  test, continuous variables were compared by Kruskal-Wallis test. P:S ratio: 
polyunsaturated fatty acids: saturated fatty acids ratio NS: not significant. RNI: reference nutrient 
intake, § P<0.05 (first & second groups), # P<0.001 (first & second groups),* P<0.05 (first & third 
groups)
o
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Table 4.11: Correlation coefficients between age and macronutrient intake within 
racial groups in Saudi sample population
Age in: M acronutrient r P
Arabian tribes Energy -0.211 0.007
Protein, unadjusted -0.138 0.078
Protein, as % energy 0.06 0.444
Protein, adjusted 0.066 0.398
Carbohydrates, unadjusted -0.213 0.006
Carbohydrates, as % energy -0.064 0.414
Carbohydrates, adjusted -0.064 0.417
Fat, unadjusted -0.154 0.048
Fat, as % energy 0.047 0.548
Fat, adjusted -0.198 0.011
Cholesterol -0.301 <0.0001
Saturated fatty acids, unadjusted -0.262 0.001
Saturated fatty acids, as % energy -0.222 0.004
Saturated fatty acids, adjusted -0.315 <0.0001
Monounsaturated fatty acids, unadjusted -0.170 0.029
Monounsaturated fatty acids, as % energy -0.023 0.769
Monounsaturated fatty acids, adjusted -0.008 0.916
Polyunsaturated fatty acids, unadjusted -0.036 0.649
Polyunsaturated fatty acids, as % energy 0.145 0.064
Polyunsaturated fatty acids, adjusted 0.171 0.028
P:S ratio 0.240 0.002
Fiber 0.068 0.387
Africans Energy -0.333 0.096
Protein, unadjusted 0.028 0.893
Protein, as % energy 0.497 0.010
Protein, adjusted 0.525 0.006
Carbohydrates, unadjusted -0.457 0.019
Carbohydrates, as % energy -0.219 0.283
Carbohydrates, adjusted -0.406 0.039
Fat, unadjusted -0.206 0.313
Fat, as % energy 0.041 0.841
Fat, adjusted 0.134 0.514
Cholesterol -0.193 0.345
Saturated fatty acids, unadjusted -0.173 0.397
Saturated fatty acids, as % energy 0.056 0.787
Saturated fatty acids, adjusted 0.125 0.542
Monounsaturated fatty acids, unadjusted -0.206 0.312
Monounsaturated fatty acids, as % energy 0.049 0.814 ,
Monounsaturated fatty acids, adjusted 0.075 0.716
Polyunsaturated fatty acids, unadjusted -0.138 0.503
Polyunsaturated fatty acids, as % energy 0.047 0.821
Polyunsaturated fatty acids, adjusted 0.052 0.800
P:S ratio -0.043 0.835
Fiber -0.125 0.543
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Asians Energy -0.041 0.745
Protein, unadjusted 0.015 0.905
Protein, as % energy 0.083 0.507
Protein, adjusted 0.095 0.447
Carbohydrates, unadjusted -0.080 0.526
Carbohydrates, as % energy -0.062 0.622
Carbohydrates, adjusted -0.091 0.467
Fat, unadjusted 0.001 0.991
Fat, as % energy 0.040 0.749
Fat, adjusted 0.067 0.593
Cholesterol -0.167 0.181
Saturated fatty acids, unadjusted -0.181 0.145
Saturated fatty acids, as % energy -0.276 0.025
Saturated fatty acids, adjusted -0.232 0.061
Monounsaturated fatty acids, unadjusted -0.005 0.971
Monounsaturated fatty acids, as % energy 0.013 0.916
Monounsaturated fatty acids, adjusted 0.044 0.726
Polyunsaturated fatty acids, unadjusted 0.274 0.026
Polyunsaturated fatty acids, as % energy 0.357 0.003
Polyunsaturated fatty acids, adjusted 0.369 0.002
P:S ratio 0.439 0.0001
Fiber 0.355 0.003
Mediterraneans Energy -0.019 0.901
Protein, unadjusted 0.046 0.764
Protein, as % energy 0.079 0.601
Protein, adjusted 0.046 0.764
Carbohydrates, unadjusted -0.084 0.580
Carbohydrates, as % energy -0.136 0.366
Carbohydrates, adjusted -0.133 0.380
Fat, unadjusted 0.040 0.793
Fat, as % energy 0.113 0.457
Fat, adjusted 0.102 0.499
Cholesterol 0.043 0.778
Saturated fatty acids, unadjusted -0.031 0.838
Saturated fatty acids, as % energy -0.021 0.887
Saturated fatty acids, adjusted -0.025 0.868
Monounsaturated fatty acids, unadjusted -0.029 0.849
Monounsaturated fatty acids, as % energy -0.047 0.757
Monounsaturated fatty acids, adjusted -0.024 0.874
Polyunsaturated fatty acids, unadjusted -0.019 0.900
Polyunsaturated fatty acids, as % energy 0.005 0.974
Polyunsaturated fatty acids, adjusted -0.009 0.951
P:S ratio 0.002 0.998
Fiber 0J86 0.008
P:S ratio: polyunsaturated fatty acids: saturated fatty acids ratio
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There was an inconsistent pattern for micronutrient intake between different races 
(Table 4.12). Individuals of Asian descent had the highest intake of most of the 
micronutrient (p>0.05), however, no significant differences were detected between 
racial groups. A high proportion of subjects reported consuming inadequate selenium 
(85%, 81%, 89%, and 85% respectively) and vitamin A, to a lesser extent, (43%, 
50%, 56%, and 39% respectively) in the different races in similar patterns to previous 
ones of micronutrients inadequacy when subjects were stratified by age tertiles or 
socioeconomic classes (Figure 4.3).
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Table 4.12: Micronutrient intakes and adequacy of their intakes in different races in 
Saudi males population (n=303).
Race P
Arabian tribes Mediterraneans Asians Africans
n 165 46 66 26
Selenium (pg) 43.8 ± 1.1 43.09 ±2.1 45.76 ±2.2 44.6 ± 3.5 NS
Copper (mg) 1.38 ±0.04 1.27 ± 0. 1 1.40 ±0.1 1.19± 0.1 NS
Zinc (mg) 9.13 ±0.2 8.48± OJ 9.01 ±0.3 8.88± 0.5 NS
Vitamin E (mg) 11.7 ±0.3 12.0 ± 0.7 12.5 ±0.5 13.1 ± 1.0 NS
Vitamin A (pg) 879.8 ± 70.8 797.0 ± 98.5 800.4 ± 120.1 754.2 ± 138.7 NS
Carotenoids (mg) 9.7 ±0.4 10.5 ±0.7 9.8 ±0.6 12.5 ± 1.0 NS
Vitamin C (mg) 43.5 ± 3.4 43.6 ±6.2 46.1 ±6.0 44.6 ± 8.9 NS
Data are presented as mean ± SEM. Continuous variables were compared by Kruskal-Wallis test. NS: 
not significant.
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Figure 4.3: Percentage of Saudi sample population categorized by race consuming 
micronutrient intakes below the estimated average requirement. AT: Arabian tribes, 
AF: Africans, AS: Asians, M: Mediterraneans.
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4.4.3 Comparison between cases and age-matched controls
4.4.3.1 Demographic characteristics
Table (4.13) shows the distribution of demographic and predisposing coronary risk 
factors in the study population. Overall, there was an increased prevalence of diabetes 
mellitus, metabolic syndrome (p<0.0001) and hypertension (p<0.05) in the CVD 
patients. A higher proportion of the controls had never smoked and higher proportion 
of former smokers among CVD patients (p<0.001), and the controls were slightly 
taller (p<0.05).
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T a b l e  4 .1 3 :  D e m o g r a p h ic  c h a r a c te r is t ic s  o f  p a t ie n ts  w it h  C V D  a n d  c o n tr o ls .
Parameter Controls 
(n= 130)
Cases
(n=130)
P
Age (years) 55.6 ± 1.1 55.0 ± 1.0 NS
Weight (Kg) 80.8 ± 1.3 81.1 ±1.4 NS
Height (cm) 168.6 ±0.7 166.0 ± 0.6 <0.05
Body mass index (Kg/m2) 28.4 ±0.4 29.4 ± 0.4 NS
Systolic blood pressure 128.0 ± 1.7 127.5 ± 2.0 NS
(mm Hg)
Diastolic blood pressure 79.9 ± 0.9 77.6 ±1.0 NS
(mmHg)
Dyslipidemia n (%) 122 (94) 124(95) NS
Diabetes mellitus n (%) 47 (36) 78#W) <0.0001
Hypertension n (%) 68(52) 85 6%) <0.05
Metabolic syndrome n(%) 29C%) 61 (47) <0.0001
Body mass index n {%)
Normal 33 C#) 20(15)
Overweight 51 (39) 64 (49) NS
Obese 46(35) 46(35)
Family history n (%)
Diabetes 61 (47) 70 (54) NS
Heart diseases 32C%) 34 (26)
Race. n(%)
Arabian tribes 57 (44) 67(52)
Africans 14(11) 16(12) NS
Caucasians 11(9) 9(7)
Indians 10(8) 11(9)
Far Easterns 7(5) 3 (2)
Mediterraneans 31 (24) 24 (19)
Socioeconomic status, n(%)
Low 72 0%) 67 (52) NS
Middle 48 (37) 55 (42)
High 10 (8) 8 (6)
Smoking status n (%)
Never 66 (51) 43 (33) <0.001
Former 33 C%) 61 (47)
Current (<20 cigarette) 11(9) 14(11)
Current (>20 cigarette) 20(15) 12(9)
Physical activity status n f%)
<3 times/week 38^:9) 34(26) NS
>3 times/week 92 (71) 96 (74)
On a diet, n(%) 38CW) 51 (39) NS
Statins,n (%) 29 (19) 65 (50) <0.0001
Aspirin,n (%) 50 (39) 102 (79) <0.0001
Oral hypoglycemic drugs, n(%) 19(1% 29 (22) NS
Numeric data are presented as mean ± SEM and categorical data as number and percentage. 
Categorical data were compared by test, continuous data were compared by unpaired t tests or 
Mann-Whitney tests for non-normally distributed data. NS = not significant
2 2 4
4.4.3.2 Dietary intake
Table (4.14) compares the average intake of energy and macronutrients intake 
between patients and controls. CVD patients had a higher total energy intake 
(p<0.05), probably arising from higher intake of fat (p<0.05). However, this 
difference was eliminated when results were expressed as percentage of total caloric 
intake and after adjusting for total caloric intake. Cholesterol intake was also higher 
among CVD patients (p<0.05), represented by the higher percentage of cases 
consuming more than 200mg of cholesterol per day (67% vs. 53% respectively).
Table (4.15) shows correlation coefficients of age with macronutrient intakes in CVD 
patients and their respective controls. Energy intake seems to be decreasing with 
advancing age in controls only whereas crude intake of PUFA and energy adjusted 
intake of SFA is increasing with age in CVD patients.
CVD patients reported higher intakes of all micronutrient (Table 4.16). A large 
proportion of controls and CVD patients had less than adequate levels of selenium 
(87% and 84% respectively) and approximately one half of both groups had less than 
adequate vitamin A (59% and 44% respectively) intakes (Table 4.16). Almost one 
third of controls and CVD patients had less than adequate levels of vitamin C (32% in 
each case) (Figure 4.4).
225
T a b l e  4 .1 4 :  D ie t a r y  n u tr ie n t  in ta k e s  o f  a g e d - m a t c h e d  a t h e r o s c le r o t ic  S a u d i m a le s
Nutrient RNI
Controls 
(n= 130)
Cases
(n=130) P
E nergy (K cal) 2755 (15-18) 
2550 (19-59) 
2380 (60-74) 
2100 (75+)
1848.4 ±37.3 1974.4 ±38.2* <0.05
U nadjusted protein  
(gm)
15 94
69.3 ± 1.5 74.2 ± 1.5 NS
% o f  energy 15.0 ±0.2 15.1 ±0.2 NS
Energy-adjusted  
protein (gm )
68.9 ±0.1 68.9 ±0.1 NS
U nadjusted  
carbohydrate (gm )
213.7 ±4.9 219.6 ±4.4 NS
% o f  energy 55% 46.4 ± 0.6 44.8 ± 0.5 NS
Energy-adjusted  
carbohydrate (gm )
211.6±0.1 211.4 ± LO NS
U nadjusted total fat 
(gm )
79.59 ±2.1 88.79 ± 2.3 * <0.05
% o f  energy 30% 38.6 ± 0.5 40.07 ± 0.5 NS
Energy-adjusted fat 
(gm )
79.59 ±0.1 79.81 ±0.1 NS
C holesterol (m g) 223.81 ± 8.5 264.05 ± 10.6* <0.05
C ategories o f <200 mg 61 (47) 43 (33) <0.05
ch olesterol intake 
n(%)
>200 mg 69(53) 87(67)
U nadjusted S F A  (gm ) 25.5 ± 0.8 28.5 ± 0.9 NS
% o f  energy 10% 13.7 ±0.3 14.2 ± 0.3 NS
Energy-adjusted SFA  
(gm )
24.7 ±0.1 24.7 ±0.1 NS
U nadjusted M U F A  
(gm )
28.2 ±0.8 31.4 ±0.8 NS
% o f  energy 10% 15.2 ±0.2 15.8 ±0.2 NS
Energy-adjusted
M U F A (gm )
27.7 ±0.1 27.9 ±0.1 NS
U nadjusted P U F A  
(gm )
17.3 ±0.5 20.1 ±0.6 NS
% o f  energy 10% 9.6 ± 0.2 10.1 ±0.2 NS
E nergy-adjusted  
P U F A  (gm )
17.3 ±0.1 17.5 ±0.1 NS
P:S ratio NA 0.74 ± 0.03 0.76 ± 0.02 NS
Fiber (gm ) 18 gm 18.9 ±0.4 20.4 ± 0.4 NS
Numeric data are presented as mean ± SEM and categorical data as number and percentage. 
Categorical data were compared by test, continuous data were compared by unpaired t tests or 
Mann-Whitney tests for non-normally distributed data. NS = not significant, P:S ratio: polyunsaturated 
fatty acids: saturated fatty acids ratio, RNI: reference nutrient intake
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Table 4.15: Correlation coefficients between age and macronutrient 
intake in CVD patients and their respective controls
M acronutrient Controls Cases
(n= 130) (n=130)
r P r P
Energy -0.189 0.031 0.073 0.409
Protein, unadjusted 0.050 0.569 -0.024 0.790
Protein, as % of energy 0.146 0.097 0.045 0.615
Protein, adjusted 0.136 0.124 0.082 0.356
Carbohydrates, unadjusted 0.069 0.436 0.048 0.590
Carbohydrates, as % of energy -0.046 0.601 -0.130 0.141
Carbohydrates, adjusted -0.100 0.259 -0.149 0.091
Fat, unadjusted -0.014 0.875 0.056 0.529
Fat, as % of energy 0.007 0.941 0.114 0.196
Fat, adjusted 0.069 0.436 0.124 0.159
Cholesterol -0.051 0.561 0.011 0.901
Saturated fatty acids, adjusted 0.083 0.349 0.268 0.002
Saturated fatty acids, unadjusted 0.003 0.977 -0.020 0.819
Saturated fatty acids, as % of energy 0.008 0.930 -0.076 0.391
Monounsaturated fatty acids, unadjusted -0.012 (1889 0.061 0.493
Monounsaturated fatty acids, as % of 0.002 0.978 0.104 0.237
energy
Monounsaturated fatty acids, adjusted 0.055 0.534 0.130 0.140
Polyunsaturated fatty acids, unadjusted -0.031 0.722 0.192 0.029
Polyunsaturated fatty acids, as % of -0.009 0.919 -0.137 0.121
energy
Polyunsaturated fatty acids, adjusted -0.002 0.979 -0.168 0.056
P:S ratio -0.039 0.663 0.011 0.905
Fiber -0.091 0.302 -0.029 0.745
P:S ratio: polyunsaturated fatty acids: saturated fatty acids ratio
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Table 4.16: Micronutrient intakes and adequacy of their intakes in age-matched 
atherosclerotic Saudi sample population (n=260).
RNI EAR Controls(n=130)
Cases
(n=130)
P
Selenium (pg) 75 pg 57.7 pg 42.07 ± 1.2 47.38 ± 1.6 0.002
Copper (mg) 1.2 mg 0.92 mg 1.26 ±0.03 1.44 ±0.04 0.001
Zinc (mg) 9.5 mg 7.31 mg 8.67 ± 0.2 9.44 ± 0.2 0.003
Vitamin E (mg) 15 mg 11.5 mg 13.2 ±0.3 14.4 ±0.4 0.043
Vitamin A (pg) 700 pg 538.5 pg 656.0 ± 60.5 1084.7 ± 120.6 0.001
Carotenoids (mg) NA NA 12.0 ±0.2 12.4 ±0.2 NS
Vitamin C (mg) 40 mg 30.8 mg 41.3 ± 1.4 41.2 ± 1.6 NS
Data are presented as mean ± SEM. Continuous variables were compared by Mann Whitney test. EAR: 
estimated average requirements, NA: not available, NS: not significant, RNI: reference nutrient intake
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Figure 4.4: Percentage of subjects consuming micronutrient intakes below the 
estimated average requirement in Saudi patients with CVD and controls
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4.4.4 Validation study
Table (4.17) shows the mean daily intake of energy and macronutrients estimated by 
the FFQ and the 24hr dietary recalls. Slightly higher mean levels of intake were 
obtained from the FFQ for the majority of nutrients with the exception of protein, 
total fat, PUFA, cholesterol, zinc, and vitamin A, whose mean estimates were higher 
in the 24hr dietary recall. Significant correlation coefficients varied from 0.110 for 
total fat to 0.295 for carbohydrates. Dietary methods agreement and/or disagreement 
in classifying individuals in the same, adjacent, or extreme (top and bottom) quartiles 
of the distribution of energy and nutrient intakes are shown in table (4.18). The 
proportion of subjects in the same and/or adjacent quartile (i.e. exact agreement) and 
the extreme opposite quartile (i.e. disagreement) was on average 67% and 11% 
respectively. The lowest exact agreement corresponded to intake of 57% of 
cholesterol and the highest proportions of subjects classified into the extreme opposite 
quartiles was 13% and observed for cholesterol, vitamin A, vitamin E and zinc. The 
nutrients with highest exact agreement and lowest proportion of misclassification 
were 92% of PUFA and 8% of carbohydrates respectively. After dividing subjects 
into quartiles according to energy and nutrients intake by both methods, the expected 
misclassifications of individuals were evaluated by contingency table analysis (Table 
4.18). The observed proportions of misclassifications were not significantly different 
from that expected for energy and the nutrients tested. It also showed consistent 
classification of subjects by both methods (p>0.05). Pearson correlation coefficients 
between serum biomarkers and vitamins intake as assessed by the FFQ are given in 
table (4.19). Serum vitamin A concentrations correlated with dietary vitamin A in the 
group of subjects as a whole (r = 0.129, p<0.05) and in the patients with CVD (r = 
0.222, p<0.05).
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Table 4.17: Dietary nutrients intakes assessed by the food frequency questionnaire 
and by 24hr recall in Saudi sample population and their correlation coefficients 
(n=263).
Nutrient FFQ 24hr recall
Correlation coefficients
Mean SEM Mean SEM Spearman Pearson ICC
Energy (Kcal) 2184.94 3T5 2012.41 35.29 123* 0.129* 0.219 *
Carbohydrates 281.09 5.03 213.27 4.39 175 * 0.204 # 0.295 *
(gm)
Protein (gm) 72.53 1.19 84J2 1.61 -0.008 -0.017 -0.015
Total fat (gm) 98.66 3.07 102.44 Z73 0.119* 0.110 § 0.212 *
Saturated fatty 34.99 0.94 17.79 0.87 0.097 0.134* 0.235*
acids (gm)
Monounsaturated 37.90 0.96 31.07 1.02 0.070 0.020 0.131
fatty acids (gm)
Polyunsaturated 30.61 &89 34.44 1.21 0.014 -0.002 0.026
fatty acids (gm)
Fiber (gm) 39.68 0.84 16.68 0.65 0.080 0.064 0.144
Cholesterol (mg) 241.99 &96 323.21 13.67 0.005 -0.042 0.008
Selenium (pg) 59.22 1.81 46.74 2.18 0.099 0.091 0.177
Copper (mg) L98 0.06 1.24 0.04 0.003 0.119 § 0.005
Zinc (mg) 10.23 0.18 10.434 0.24 0.023 0.007 0.043
Vitamin E (mg) 19.14 0.59 6.66 0.29 0.012 0.017 0.019
Vitamin A (pg) 797.09 69.37 896.51 37.16 0.006 -0.025 0.010
Vitamin C (mg) 155.85 4.68 83.75 4.69 0.224 * 0.138 * 0.167
FFQ: food frequency questionnaire, ICC: intra-class correlation coefficient, SEM: standard error o f  
mean, * p<0.05, # p<0.001, § p=0.05
2 3 0
Table 4.18: The percentage of agreement between the food frequency questionnaire 
and 24hr recall in Saudi sample population based on cross-classification of quartiles 
(n=263) and the p values of joint classification between quartiles of nutrient intakes
Nutrient Same
category
Adjacent
category
Opposite
category
P
Energy (Kcal) 29 37 11 0.178
Carbohydrates 29 41 8 0.176
(gm)
Protein (gm) 24 38 11 &856
Total fat (gm) 23 45 8 0J82
Saturated fatty 25 39 10 0.913
acids (gm)
Monounsaturated 24 38 8 0.685
fatty acids (gm)
Polyunsaturated 54 38 10 0.646
fatty acids (gm)
Fiber (gm) 22 44 11 0.336
Cholesterol (mg) 22 35 13 0.213
Selenium (pg) 26 40 10 0.645
Copper (mg) 30 35 11 0.058
Zinc (mg) 29 36 13 0.153
Vitamin E (mg) 30 37 13 0.058
Vitamin A (pg) 22 43 13 0.21
Vitamin C (mg) 27 41 11 0.377
Mean 28 39 11
Table 4.19: Correlation coefficients of dietary vitamins A and E intake estimated 
from the food frequency questionnaire compared with serum biomarkers and adjusted 
for age and plasma lipids in Saudi sample population (n=260)
All
(n=260)
Controls
(n=130)
Cases
(n=130)
Serum vitamin A (pmol/L) vs. 
dietary vitamin A (pg)
0.129 * 0.056 0.222 *
Serum vitamin E (pmol/L) vs. 
dietary vitamin E (mg)
-0.064 -0.041 -0.084
Serum vitamin A (pmol/L) vs. 
serum vitamin E (pmol/L)
0.279 # 0.315# 0.229 #
*p<0.05,#p<0.001
2 3 1
4.4.5 Reproducibility study
The mean intakes of energy and nutrients from FFQl and FFQ2 were shown in table 
(4.20). In general, estimated intake of most nutrients was lower for FFQl than for 
FFQ2, although most differences were not statistically significant (p>0.05). 
Reproducibility was assessed by calculating the intra-class correlation coefficient 
between the paired values of repeated measurements of energy as well as macro- and 
micronutrients. Cronbach’s coefficient alpha, a special case of the intra-class 
correlation coefficients, for the mean of energy and nutrients intakes ranged from 
0.334 (p<0.05) for fiber to 0.931 (p<0.0001) for energy (Table 4.21).
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Table 4.20: Energy and nutrient intakes in Saudi sample population (n=50) as 
estimated from FFQl and FFQ2, along with paired differences between both FFQs
FFQ (1) FFQ (%
Nutrient Mean SEM Mean SEM Paired
differences
Energy (Kcal) 1939.9 58.25 1932.6 62.84 0.809
Carbohydrates 226.9 8 J4 223.7 9.64 0.626
(gm)
Protein (gm) 72.3 2J3 72.7 2.17 0.559
Total fat (gm) 82.6 3.3() 83.0 3.17 &836
Saturated fatty 29.9 1.55 26.7 1.39 0.085
acids (gm)
Monounsaturated 28.6 1.21 29J 1.10 0.49
fatty acids (gm)
Polyunsaturated 14.9 0.95 18.2 0.86 0.003
fatty acids (gm)
Fiber (gm) 15.7 0.73 18.5 0.63 0.003
Cholesterol (mg) 288.8 15.80 283.9 18.72 0.654
Selenium (pg) 46.31 2.15 4&88 2.28 0.761
Copper (mg) 1.66 0.09 1.60 0.10 0.34
Zinc (mg) 9.45 0.37 9.22 0.29 0.923
Vitamin E (mg) 9.91 0.65 13.18 0.59 <0.001
Vitamin A (pg) 1151.9 174.14 1047.9 204.26 0.308
Vitamin C (mg) 85T3 11.03 75.04 11.11 0.039
Carotenoids (mg) 4.93 0.64 11.17 0.50 <0.001
FFQ: food frequency questionnaire, SEM: standard error o f  mean
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Table 4.21: Correlation of energy and nutrient intakes in Saudi sample population 
(n=50) estimated by intra-class correlation coefficients and Cronbach’s alpha 
correlation coefficients between FFQl and FFQ2
Nutrient Cronbach’s alpha ICC P
Energy (Kcal) 0.931 0.930 <0.0001
Carbohydrates 0.770 0.773 <0.0001
(gm)
Protein (gm) 0.721 0.725 <0.0001
Total fat (gm) 0.730 0.734 <0.0001
Saturated fatty 0.583 0.57 0.001
acids (gm)
Monounsaturat 0.632 0.635 <0.0001
ed fatty acids
(gm)
Polyunsaturate &387 0352 0.045
d fatty acids
(gm)
Fiber (gm) 0.376 0.334 0.05
Cholesterol 0.257 0.261 0.15
(mg)
Selenium (pg) 0.135 0.137 0.31
Copper (mg) 0.782 0.783 <0.0001
Zinc (mg) 0.777 0.779 <0.0001
Vitamin E (mg) 0.181 0147 0.24
Vitamin A (pg) 0.579 0382 0.001
Vitamin C 0683 0.684 <0.0001
(mg)
Carotenoids -0.820 -0.311 0.98
(mg)
FFQ: food frequency questionnaire, ICC: intra-class correlation eoefficient
2 3 4
4.5 Discussion
Elements of a Western diet are becoming more accessible to urban dwellers in the 
Middle East and elsewhere. At the same time it is noted that the prevalence of chronic 
conditions, such as diabetes, dyslipidaemia, obesity and coronary heart disease, once 
associated with a Western lifestyle, is increasing globally, and specifically in the 
Arabian peninsula (Alwan,1993, Alobaid et ah, 1994).
Many epidemiological studies have observed that nutritional habits are involved in the 
aetiology of coronary artery diseases (Rimm et al., 1993, de Lorgeril et a., 1999). 
Dietary intake was assessed using a food frequency questionnaire, and macronutrient 
intake estimated using food tables. This approach for estimating nutrient intake has 
been used in several previous studies (Willett et al., 1985; Bloek et al., 1986, 
Bohlscheid-Thomas et al., 1997, Klipstein-Grobusch et al., 1999) in the West.
We hypothesized that these habits may be influenced by age, ethnicity and 
socioeconomic status, and these potentially confounding characteristics were 
evaluated by questionnaire.
4.5.1 The demographic characteristics of the study population 
Jeddah is an ethnically diverse city and the sample population reflected this. There 
was no reason to suspect that the sample population was unrepresentative of the male 
population from which it was drawn. A good sample from each category of 
socioeconomic class, age and race was obtained. Even though they were not equally 
presented (e.g.) descendants of Arabian tribes were over presented and subjects with 
high socioeconomic class were veiy few, however, their distribution was similar to 
that of general population as a whole.
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4.5.2 Coronary risk factors in the Saudi population
Overall the risk of cardiovascular disease for the population as a whole was high. A 
high proportion of the total study population was either overweight (34%) or obese 
(35%), and although lower in the youngest age group (27% in each class) it was still 
substantial. A large proportion of the oldest group was hypertensive (58%), although 
many of these subjects were on medication for this. The prevalence of diabetes 
mellitus also rose dramatically with age, with 37% of the oldest group having this 
condition. It is likely that the majority of these were type II diabetics, and that obesity 
was a contributory factor. Dyslipidaemia was also found to be high (26%) in the older 
group of subjects. A high reported prevalence of a family history of heart diseases and 
diabetes mellitus in the population as a whole (23% and 47% respectively) is 
consistent with these findings. Our findings compare favorably with those reported in 
several studies in Saudi Arabia (El-Hazmi et al., 1996, Al-Nozha et al., 1997, Al- 
Nuaim, 1997b) and in the neighboring Arab states (Al-Mahroos et al.,2000, Jackson 
et al.,2001). Of particular concern was the high frequency of smokers among the 
youngest group of subjects (41%). This was in part due to greater awareness of the old 
age group of subjects to discontinue smoking as they advance in age indicated by their 
highest proportion of former smokers (34%). The extent of self reported exercise is 
also a matter of concern, as a high proportion of the youngest subjects undertook less 
than three episodes per week (46%), and in combination with the high energy intake 
may account for the high prevalence of obesity in the youngest group of subjects as 
reported similarly in other studies on young populations (Yagalla et al., 1996). 
However, self reported data, like physical activity level, are a potential source of bias 
in epidemiological studies.
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4.5.3 Macronutrient intake varies with age
Macronutrient intake may be influenced by several factors including accessibility, 
socioeconomic status, ethnicity, cultural background and food preference. It is also 
possible that physical activity, smoking habit and other demographic characteristics 
affect preference (Raj et al., 1999; Gillman et al.,2001).
We found that total energy intake was highest in the young age group of subjects. 
Limited number of studies have been conducted in the Middle East (Abahusain et 
al., 1999; Shahar et al.,2003; Sibai et al.,2003). These studies as well as other 
international studies (Deurenberg-Yap et al.,2000, Oh and Hong,2002) have also 
reported low total calorie intakes in the populations under investigation compared to 
the recommendation. This may be partially related to a systematic under-estimation of 
dietary intake by the participants, the fact that a proportion of the subjects reported 
being on a diet, the high proportion of sedentary participants in the study, and the 
possibility that the RNI is designed for a Caucasian population. It has also been 
reported that older, overweight subjects are more likely to underreport their actual 
dietary intake (Briefel et al., 1997). As in other studies among elderly subjects (Sibai 
et al.,2003), the reported low energy intake did not seem to adversely affeet the 
protein intake across all age groups.
The intake of total fats was also a matter of concern in this study. Dietary cholesterol 
and percentage energy derived from saturated fat, were both higher than the RNI for 
all three age groups. This may relate to the availability and consumption of high 
levels of food products of animal origin as reported in the food balance sheets for the 
kingdom of Saudi Arabia for the period of (1974-1976) to (1996-1998) and as found 
by other studies (Cid-Ruzafa et al., 1999) or due to increased reliance on foods 
prepared outside the home, which tend to be higher in fat and calories. In agreement
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with studies on young people (Xie et al.,2003), a less favorable dietary pattern for 
cardiovascular health was noted in the young age group with a significantly lower 
PUFA: SFA ratio (p<0.0001). On the other hand percentage energy fi-om 
carbohydrate and polyunsaturated fat was low in all groups, as was dietary fibre 
intake. This macronutrient profile has previously been associated with increased risk 
of coronary disease (Keys, 1957). The low dietary fibre is possibly due to an 
inadequate intake of fruit, vegetables and pulses. Low fibre consumption is reported 
to be associated with hyperinsulinaemia and insulin resistance (Marshall et al., 1993), 
and previous studies of Saudi populations have reported low levels of dietary fibre 
(Al-Shagrawi et al., 1995) which might contribute to the high prevalence of diabetes 
mellitus in this population.
Despite the possibility of underestimation of actual intake, the reported differences 
with age are likely to reflect real differences, assuming that biases in self-reported 
dietary intakes are similar among all age groups.
4.5.4 M acronutrient intake varies with SES 
It has been previously reported, as observed in our study, that members of different 
ethnic and socioeconomic groups and individuals from different geographic regions 
differ significantly in the foods they consume, the method of food preparation, and in 
the usual amounts consumed (Stram et al.,2000). Social desirability could influence 
how participants record or recall food intake across all types of dietary assessment 
instruments. However, specific demographic characteristics of study subjects did not 
readily explain the differences in nutrient intakes as discussed below.
Compared to individuals of low socioeconomie class, the middle class individuals had 
significantly higher intakes of total energy and carbohydrates as well as non­
significant higher intakes of protein, SFA, MUFA, and cholesterol. This can be
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partially explained by the observed significant decrease of energy intake with age 
since they had the lowest mean age among the three socioeconomic groups. It could 
in part be related to other reasons like: foods affluency or different food preferences in 
between socioeconomic classes. Even though the middle class individuals comprise a 
smaller proportion of smokers and overweight individuals than those of high 
socioeconomic class, this may not be truly the case taking into account the small 
number of high socioeconomic class subjects (17 vs. 164).
Underestimation or over-reporting of food intake may also be due to the tendency of 
subjects to conceal their true dietary intake consciously or unconsciously. In this 
context, individuals of low socioeconomic class reported the highest consumption of 
protein while those of high socioeconomic class, despite their small number, reported 
the highest intake of total fat, MUFA, and PUFA. In addition, not all reporting errors 
are necessarily proportional to energy intake since most of these differences remained 
even after calculating their respective energy-adjusted values (Willett and 
Stampfer,1986).
4.5.5 M acronutrient intake varies with race 
Diet is thought to be an important potential determinant explaining differences in 
CVD ineidence between racial groups (Block et al., 1988). This is truly the case in our 
region, in which a fairly extensive intermingling of all races resulted in diets 
comprising food originating from different ethnic backgrounds. The ethnic differences 
in nutrient intake and food consumption which are possibly affected by culturally 
derived dietary norms and eating habits may be associated with different risk factors 
and susceptibility in the development and occurrence of chronic diseases in different 
ethnic populations.
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Individuals of Mediterranean descent reported the lowest intake of energy, protein, 
total fat, cholesterol, SFA, and MUFA. Conversely, Arabians reported the highest 
intake of crude protein, SFA, and cholesterol whereas Asians reported the highest 
intake of crude carbohydrates and PUFA.
Energy-adjusted intakes of all macronutrients were more favourable than crude ones 
with respect to disease causation since the total caloric intake is a combined function 
of body size, physical activity, and intrinsic individual metabolic efficiency (Willett 
and Stampfer,1986). To further guard against the problem of energy intake 
misreporting, energy-adjusted values were compared. Significant differences in SFA 
intake for Mediterraneans remained after adjustment. The association between 
increased consumption of co-S PUFA and CVD was originally established following 
observation in Greenland Eskimo Inuit (Kromann and Green, 1980). More than half of 
the Asians and Arabian tribes descendents were of middle socioeconomic class 
whereas low socioeconomic class was common among the majority of Africans and 
Mediterraneans. Overweight and obesity, and low employment grade have been 
shown to be associated with probability of underreporting dietary intake (Stallone et 
al., 1997). Therefore, differences in BMI, socioeconomic status and physical activity 
might have influenced estimates of nutrient intake in the different racial groups. The 
Mediterranean group contained the highest proportion of overweight and obese 
subjects as well as the highest mean age, which might explain the lower energy intake 
and high BMI. Different trend was observed in another study, in which high BMI was 
associated with Western dietary patterns (i.e. high fat intake) (Maskarinec et al.,2000). 
Thus, BMI values may in part be genetically predetermined rather than due to 
increased caloric intake since it were mostly contributed by those of Mediterranean
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descent, who are well known for their cardio-protective dietary habits (de Lorgeril et 
ah, 1999).
4.5.6 Dietary macronutrient imbalance may contribute to coronary risk
Dietary patterns in the Gulf region have been influenced by nationwide changes in 
food supply such as increased consumption of restaurant and/or fast food and frozen 
convenience foods (Musaiger and O’Sullivan, 1998). Estimates of recent dietary 
intake of older people are unlikely to reflect the diet consumed over most of their 
adult life. Similarly, people diagnosed with CVD may be prone to change their diet. 
This may suggest that their estimates of recent diet may also be less likely to reflect 
past diet. Moreover a substantial proportion of CVD patients followed prescribed 
diets (39% vs. 29% in controls). However, CVD patients have reported higher daily 
intakes of energy, total fat, and cholesterol (p<0.05). This might indicate higher 
intakes before following the diet.
4.5.7 Adequacy of micronutrient intakes in the Saudi population
Our data are consistent with the findings of other studies, though they neither 
considered the same age group nor did they use the same methods (Deurenberg-Yap 
et al.,2000. Oh and Hong 2002). When the groups were stratified by race, SES, and 
age tertiles, the average intake of selenium and vitamin E were below recommended 
levels, thus reflecting probable inadequacy in the diet of Saudis. Consistent with other 
results (Monge and Beita, 2000), deficient vitamin E intake is alarming among the 
young age group, particularly considering that their diet also presents the highest 
content of SFA (15%) and the lowest content of PUFA (8%). This implies that the 
ratio of vitamin E to PUFA in the tissues does not protect against lipid peroxidation, a 
process intimately involved in the development of atherosclerosis (Halliwell, et al 
1995). Selenium deficiency has been reported to be associated with higher incidence
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of cancer and cardiovascular disease (reviewed by Rayman,2000). Inadequate 
selenium intake could be attributed to variability in dietary habits and preferences of 
this population. Even though the mean intake of vitamin A was fairly adequate, the 
wide range of vitamin A levels leads to the interpretation that approximately one half 
of population could be consuming below recommended levels. Similar proportions of 
subjects consuming less than the EAR of selenium, and vitamin A were also attained 
when atherosclerotic patients were compared with their age-matched controls.
This may suggest that there is a high prevalence of suboptimal micronutrient intake in 
our sample. However, the use of two dietary assessment methods could explain 
whether this is merely an underestimation of micronutrient intakes. Indeed we must 
take into account that we are only evaluating intake but not the effects of absorption, 
energy expenditure, or other metabolic factors.
4.5.8 Validation study 
Different dietary assessment methods have been designed to assess energy and 
nutrients intake in epidemiological studies (Friedenreich et al., 1992). Each of these 
methods has its own strengths and weaknesses. FFQ is considered to be one of the 
most practical dietary assessment methods to assess long-term diet (Sampson, 1985). 
Although dietary intakes estimated by FFQ are correlated with true intake, such 
estimates are often beset by systematic errors such as underreporting or over-reporting 
at the level of the individual. Therefore, more detailed methods are required to 
validate FFQ results. There is no “gold standard” for food intake, however, an 
acceptable proxy is using 24hr recalls, which are thought to provide superior food 
intake data within the period covered by FFQ (Rimm et al., 1992). Lower estimates of 
most of micronutrient intakes in the 24hr recall suggests an underestimation of less 
frequently reported foods (i.e. seasonal foods such as vegetables), which are usually
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accounted for by the FFQ and this may explain the lack of correlations for vitamins 
except for vitamin C. Previous comparisons of FFQ and 24hr recalls have either 
shown similar (Bohlscheid-Thomas et ah, 1997), the opposite (Patterson et ah, 1999), 
or no real differences between methods (Pisani et ah, 1997). One reason for this may 
be the variation of forms and length of the FFQ. Correlation coefficients for 
estimation of nutrient intake derived from FFQ with estimates from a criterion 
measure of multiple days of dietary records or recalls typically ranged from 0.40 to 
0.70 (Willett, 1998). These values have been generally accepted as indicative of the 
ability to the FFQ to rank individuals appropriately according to their nutrient intake. 
The observed correlation coefficients between FFQ and 24hr recalls in this study, 
ranging from 0.10 to 0.30, is similar to those reported in other studies (Margetts et 
al.,1989; Gnardellis et al., 1995). Such low, albeit significant, correlation coefficients 
are expected because correlation coefficient is usually sensitive to the intra-individual 
variability in the reference method and a single 24hr dietary recall did not provide a 
stable estimate of the usual dietary intake.
Other measures of concordance also include cross-classification by quartile categories 
of nutrients distribution by both dietary methods. Ranking or classifying subjects by 
relative nutrient intakes is usually more realistic in epidemiological studies rather than 
by absolute nutrient intakes. Garrow (1995) has advocated the use of simple cross­
classification of methods in dietary validation studies, arguing that this approach will 
make the different methods more readily comparable. Random errors in FFQ usually 
result in ranking errors and misclassification. Differences in frequency and method of 
assessment of the reference dietary information and possible differences in the 
underlying diet of the study populations may be contributing factors. However the 
proportion of subjects correctly classified in the same or adjacent quartiles by both
2 4 3
dietary methods for different nutrients was fairly good ranging between 22%-54% (in 
the same quartile) and 35%-45% (in the adjacent quartile), with a minimum of gross 
misclassification (11%). The favourable correlations and quartile classifications that 
were obtained suggest that this instrument is suitable for ranking individuals correctly 
according to their macronutrient intakes. The ability of the FFQ to categorize the 
majority of individuals (-70%) correctly into the same or adjacent quartiles of 
micronutrients intake with the 24hr recalls was consistent with other reports (Bolton- 
Smith et al., 1991, Brunner et al.,2001).
However, both methods can be affected by underreporting. Thus, the use of additional 
biochemical markers of dietary intake as unbiased ascertainment of nutrient intake is 
increasingly used in validation studies (Willett et al., 1983(a); Roidt et al., 1988; 
Aschierio et al., 1992). It has the advantage in that the potential sources of random 
error occurring with serum antioxidant vitamins are different from those of the FFQ 
and 24hr recalls measurements. The modest positive correlation between serum 
vitamin A levels and dietary vitamin A (r = 0.222, p<0.05) is similar to those reported 
in previous reports (Willett et al., 1983(a); Roidt et al., 1988; Mayer-Davis et al., 1999), 
and provides an objective validation of our FFQ. Serum levels of vitamin A have been 
shown to remain constant over a wide range of intake in well fed populations due to 
homeostatic control (Willett, 1998). Also, biochemical marker levels are subjected to 
laboratory error and are not influenced by diet alone (Bolton-Smith et al., 1991). 
Serum vitamin E has been found to be responsive to experimental supplementation 
with vitamin E (Willett et al., 1983(b)). Higher correlation coefficients between diet 
and blood measurements of these two vitamins have been reported in studies using 
vitamin supplements (Willett et al.,1983(b), Kardinaal et al., 1993). However, in our 
study vitamin intakes were restricted to vitamins contained in foods and, unlike other
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validation studies, did not include vitamin supplements. This information was further 
collected in the questionnaire to eliminate possibilities of taking any supplement 
without reporting it. Our findings for vitamin E are consistent with observations of 
poor correlations to blood concentrations in studies with no supplement users 
included (Willett et ah, 1983(a), Coates et ah, 1991, Block et ah, 1994) or no 
association at all (Stryker et ah, 1988, Ascherio et ah, 1992, Sinha et ah, 1993). Lack of 
association between serum and dietary vitamin B levels in this study might also be in 
part due to under-reporting of vitamin E intake from food since major food sources of 
this nutrient tend to be high in oil and these foods may be systematically under­
reported.
4.5.9 Reproducibility study 
Dietary reproducibility test reflects both errors in reporting and true dietary change. 
Both of which are relevant in epidemiological studies in which the goal is to assess 
the impact of long-term dietary habits on chronic diseases. Intra-subject variation 
between the 2 FFQ measurements was essentially nil for most of the nutrients.
In other reproducibility studies, the correlation coefficients have generally varied 
from 0.5 to 0.8 for nutrient intakes (Willett, 1998) and our results are comparable with 
such results. Mean estimates of internal consistency reliability, Cronbach’s alpha, and 
intra-class correlation coefficients, ranging from 0.6 to 0.9, obtained in this study 
compared favourably with those reported by other reproducibility studies (Bittoni and 
Wikins,1994; Gnardellis et al., 1995). Thus, it is highly unlikely that the used FFQ has 
nutrient omissions and there is a little chance that the FFQ fails to represent an 
accurate measure of the usual nutrient intakes.
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4.6 Limitations
Some methodological aspects of the dietary assessment methods need to be discussed. 
The main reason for including 2 alternative methods in the study was to compare their 
results independently on correlated errors between both dietary assessment methods. 
Ideally multiple 24hr dietary recalls should have been collected but this was not 
feasible due to the lack of access to subjects after their initial meeting given the pre­
defined timeframe of the study. Furthermore, the apparent differences among 
validation studies in overestimating or underestimating nutrient intakes and degree of 
bias may also be explained partly by variations in the number and specificity of items 
on the questionnaire (Wameke et al.,2001).
The validity of this study is not expected to be absolute, as no dietary survey method 
has been shown to be free of systematic errors in free living subjects (Van Staveren 
and Burema,1990). Thus, we cannot exclude the possibility of an overrepresentation 
of persons with a dietary pattern similar to a healthier population, specifically, in the 
older age groups. If this is true, the observed decreased intake of most nutrients with 
age is probably underestimated as compared with the general population of this age. 
The presence of over- and underreporting in dietary assessment has been extensively 
documented for various methods and for diverse populations and age groups (Black et 
al.,1991).
The use of biochemical markers in this study makes it more likely that the criteria of 
independent error are met. However, it should be emphasized that validation studies 
differ in terms of demographic characteristics of their study populations, types of 
reference data used, sample size, length of questionnaire, and study designs (Subar et 
al.,2001).
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Nutrient intakes were compared with UK adults’ requirements, as there are no 
specific nutrient recommendations for Saudi adults. The comparison mainly serves to 
highlight the various nutritional recommendations for Saudi population. The UK 
RNI’s will not give a true indication of Saudis nutritional status but for the sake of 
comparison and uniformity this was the reference choice for the present study.
The calculation of P-carotene intake alone was not possible because no 
comprehensive food composition database for individual carotenoids has been 
available in the UK food composition tables. Alternatively, carotenoids content in 
food items, the sum of p-carotene and half the amounts of a-carotene, a- and P- 
cryptoxanthins, was calculated (Holland et al.,1991).
The association of diet and disease is of particular interest in a multiethnic 
populations living in the same environment like ours, in which dietary intake would 
be highly variable. However, small numbers in some racial groups is a limitation to 
the present study.
Despite these limitations, the reported results of validation and reproducibility tests 
suggested that the used FFQ adequately measured habitual energy and nutrient 
intakes.
4.7 Conclusion
In conclusion, the increasing availability of Western-type diets to urban dwellers in 
the Kingdom of Saudi Arabia appears to have resulted in an imbalance of 
macronutrient intake among all sectors of the population. Young men appear to be 
particularly prone to this, and appear to have a high intake of cholesterol and energy 
as saturated fat, and a low PUFA/ SFA ratio. Despite various limitations, these data 
provide an insight into different dietary patterns within the Saudi population and their 
impact on macronutrient intake. It is apparent that dietary recommendations are not
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being followed. While the reasons for this are complex, knowledge about diet does 
influence food choice and dietary behavior. This is further compounded by a high 
prevalence of other coronary risk factors, including diabetes mellitus, a sedentary 
lifestyle, positive smoking habit and obesity. This is likely to lead to an escalation in 
the incidence of cardiovascular disease over the next decade. This problem can only 
be averted by raising public awareness and the development of appropriate 
population-specific nutritional guidelines.
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Chapter 5
Trace element parameters in Saudi 
males with and without 
atherosclerosis
5.1 Introduction
Traditional coronary risk factors do not fully explain variations in cardiovascular 
disease (CVD) incidence. Epidemiological studies have implicated perturbations in 
selenium, copper, and zinc metabolism in the aetiology of CVD. However, these 
studies have been undertaken principally in Caucasian populations, in which trace 
element intake is generally insufficient (Salonen et ah, 1982, Reunanen et ah, 1996).
5.2 Specific aim
The hypothesis of this study was that a suboptimal trace elements status may 
predisposed Saudi males to increased coronary risk. The aim of this present study was 
to investigate indices of copper, zinc and selenium status in Saudi males with 
established coronary atherosclerosis, comparing them with an age-matched population 
of subjects without CVD. Taking into account the effect of age, chronic diseases, and 
the extent of coronary disease severity.
5.3 Methods
Selenium, copper, and zinc status were determined in 130 Saudi male subjects with 
established CVD and 130 age-matched controls. Serum and urine levels were 
measured by AAS (Chapter 2, section 2.4.6, page 113) and dietary intakes were 
calculated from FFQ as previously described (appendix 3). Other measures included: 
antioxidant enzymes; SOD and GPx in erythrocytes, lipid peroxides; TEARS and 
FOX in serum, inflammatory markers; sICAM-1, hs-CRP, and caeruloplasmin in 
serum as previously described (Chapter 2, section 2.4.3, 2.4.4, 2.4.5, pages 101, 106, 
110). Serum lipid profiles (total cholesterol, triglycerides, HDL-C, LDL-C) and 
glucose were also measured using methods described in Chapter 2, section 2.4, page 
94.
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5.4 Results
5.4.1 Comparison of trace element related parameters and biochemical data 
between groups
Table (4,13) summarizes the demographic data for 130 subjects with established CVD 
and 130 controls. Compared with controls, patients had significantly higher serum 
triglycerides and glucose levels (p<0.001), a finding consistent with the higher 
proportion of diabetics within this group (60% vs. 36%).
Table (5.1) shows a summary of the trace element measurements in controls and 
cases. There was no significant difference in serum copper, nor zinc between the 
groups. However, urinary zinc and copper, corrected for creatinine, were both higher 
among controls (p<0.05 and p<0.001 respectively). The mean serum selenium level 
for the control group was significantly higher than for the cases (p<0.001). 
Furthermore, 52% of patients with CVD had a serum selenium concentration 
<lpmol/L, compared to 22% of the controls (p<0.0001); 65% of CVD patients had a 
serum selenium concentration <1.27pmol/L versus 30% of the controls (p<0.0001). 
However, urinary selenium levels were not significantly different between the groups. 
We found that erythrocyte SOD and GPx enzyme activities were higher in controls 
than patients with CVD, though this failed to reach statistical significance (Table 5.1). 
Erythrocyte GPx and SOD were highly correlated with each other among controls 
(r=0.607, p<0.0001) and cases (r=0.509, p<0.0001). SOD activity was also positively 
correlated with serum copper (r=0.28, p<0.001) in the controls and with serum zinc 
(r=0.25, p<0.05) in the cases (Table 5.2a and 5.2b). Moreover, serum copper was 
correlated with GPx among controls (r=0.226, p<0.05), though not among cases 
(Table 5.2a). Erythrocytes GPx activity level was also inversely correlated with serum
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selenium in controls (r= -0.280, p<0.001) but positively so in the population as a 
whole (r=0.222, p<0.05) when serum selenium level was dichotomized using 
1 pmol/L as a cut off value.
5.4.2 Differences in trace element-related parameters with age 
Table (5.3) shows mean values for trace element related parameters in controls and 
cases categorized according to their tertiles for age. None of the parameters measured 
varied significantly with age in either group, except for higher erythrocytes GPx 
activity among controls of the middle age tertile than controls in the old tertile of age 
(p<0.05). Moreover, age was negatively correlated with urinary zinc (r= -0.206, 
p<0.05) and selenium (r= - 0.207, p<0.05) levels among controls only (Table 5.2b and 
52cX
The reported average intake of trace elements was above the EAR value except for 
selenium. However, there was no significant difference for dietary intake of the 3 
trace elements between groups (p>0.05).
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Table 5 .1 :  B io c h e m i c a l  p a r a m e te r s  in  p a t ie n ts  w it h  C V D  a n d  c o n tr o ls
Param eter Controls (n=130) Cases (n=130)
Mean SEM Mean SEM
Total cholesterol 5.41 0.13 5J2 0.12
[mmol/L]
Triglycerides 1.65 0.08 1.92** 0.07
[mmol/L]
HDL-C [mmol/L] 1.31 0.05 1.36 0.05
LDL-C [mmol/L] 3.78 0.13 3.57 0.12
Atherogenic index 4.62 0.16 4.55 0.18
(TC/HDL) 
Glucose [mmol/L] 7.15 0.26 8.55 ** 0.32
TEARS (pM) 2.29 0.08 2.42 0.08
FOX (pM) 2.01 0.08 2.15 0.07
Caeruloplasmin [U/L] 51.17 3.10 49.96 :L83
Glutathione peroxidase 88^9 6.82 70.74 5.02
[U/gmHb]
Superoxide dismutase 195.34 12.28 167.20 11.06
[U/gmHb]
Hs-C reactive protein 2.21 0.10 2.14 0.10
(mg/L)
SICAM-1 (ng/ml) 264.4 10.83 295.4 11.5
Serum copper 14.56 0.79 12.95 0.52
(pmol/L)
Serum zinc (pmol/L) 19.85 L38 20.16 1.0
Serum copper/zinc 1.59 0.18 1.03 0.1
ratio
Serum selenium L86** 0.09 1.12 0.06
(pmol/L) 
Urine copper 0.52 ** 0.03 0.44 0.04
(pmol/mmol 
Creatinine) 
Urine zinc Z72* 0.23 2.48 0.24
(pmol/mmol
Creatinine)
Urine copper/zinc 0.32 0.03 0.29 0.02
ratio
Urine selenium 1.13 0.09 1.50 0.14
(pmol/mmol
Creatinine)___________________________________________________________
Data were compared by unpaired t tests or Mann-Whitney tests for non-normally distributed data. 
HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, SEM: 
standard error o f  mean, sICAM-1: soluble adhesion m olecule-1, * P  <0.05, ** P  <0.001.
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Table 5.2(a): Correlations between serum and urine copper levels with demographic, biochemical, and 
dietary parameters in patients with CVD and controls. Pearson's or Spearman's correlation coefficients 
were calculated for each group separately.
Controls Cases
(n=130) (n=130)
Serum copuer vs. Demosranhic features
r P r P
Age -0.137 0.121 -0.139 0.114
SB? [mm-Hg] 0.095 0.281 -0.051 0.561
DBF [mm-Hg] -0.012 0.895 0.111 0.209
Body mass index -0.017 0.845 -0.008 0.924
Smoking (Yes/ No)
Serum copper vs. Biochemical features
0.246 0.005 -0.173 0.051
Total cholesterol (mmol/L) 0.042 0.631 0.025 0.781
Triglycerides (mmol/L) 0.060 0.495 -0.163 0.063
LDL (mmol/L) -0.047 0.598 0.031 0.729
HDL (mmol/L) 0.079 0.372 0.03 0.736
Caeruloplasmin (U/L) -0.145 0.099 -0.131 0.138
Superoxide dismutase (U/g Hb) 0.460 0.001 0.050 0.580
Glutathione peroxidase (U/g Hb) 0.226 0.010 -0.078 0.377
Hs-C reactive protein (mg/L) -0.028 0.749 0.041 0.643
SICAM-1 (ng/ml)
Serum Conner vs. Dietary features
0.233 0.008 -0.056 0.527
Copper (mg) 0.225 0.010 -0.159 0.070
Zinc (mg) 0.080 0.364 -0.065 0.466
Selenium (pg)
Urine Conner vs. Demoeranhic features
0.038 0.666 -0.047 0.592
Age -0.085 0.337 -0.058 0.512
SB? [mm-Hg] -0.041 0.640 0.242 0.005
DBF [mm-Hg] 0.039 0.660 0.213 0.015
Body mass index -0.037 0.672 -0.053 0.547
Smoking (Yes/ No)
Urine Conner vs. Biochemical features
0.060 0.496 -0.058 0.510
Total cholesterol (mmol/L) 0.022 0.806 -0.049 0.576
Triglycerides (mmol/L) -0.028 0.754 0.019 0.831
LDL (mmol/L) 0.013 0.888 -0.030 0.737
HDL (mmol/L) 0.078 0.378 0.019 &828
Caeruloplasmin (U/L) -0.083 0.349 -0.031 0.727
Superoxide dismutase (U/g Hb) -0.139 0.115 -0.054 0.544
Glutathione peroxidase (U/g Hb) -0.082 0.354 -0.001 0.988
Hs-C reactive protein (mg/L) 0.222 0.011 -0.182 0.038
SICAM-1 (ng/ml)
Urine copner vs. Dietary features
0.009 0.920 0.009 0.917
Copper (mg) 0.162 0.065 0.087 0.327
Zinc (mg) 0.159 0.070 0.045 0.613
Selenium (pg) 0.056 0.528 -0.006 0.948
HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, sICAM-1:
soluble adhesion m olecule-1
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Table 5.2(b): Correlations between serum and urine zinc levels with démographie, biochemical, and
dietary parameters in patients with CVD and controls. Pearson's or Spearman's correlation coefficients
Controls (n=130) Cases (n=130)
Serum zinc vs. Demoeranhic features
r P r P
Age -0.078 0.379 -0.042 0.636
SBP [mm-Hg] 0.024 0.785 0.002 0.984
DBF [mm-Hg] 0.017 0.850 0.045 0.608
Body mass index -0.108 0.219 0.070 0.428
Smoking (Yes/ No)
Serum zinc vs. Biochemical features
0.043 0.628 -0.036 0.682
Total cholesterol (mmol/L) -0.060 0.497 0.009 0.923
Triglycerides (mmol/L) -0.153 0.083 0.119 0.176
LDL (mmol/L) -0.009 0.918 0.037 0.674
HDL (mmol/L) -0.092 0.297 -0.099 0.265
Caeruloplasmin (U/L) -0.118 0.183 -0.050 0.573
Superoxide dismutase (U/g Hb) 0.130 0.130 0.250 0.004
Glutathione peroxidase (U/g Hb) 0.171 0.052 0.051 0.567
Hs-C reactive protein (mg/L) -0.078 0.377 0.062 0.486
SICAM-1 (ng/ml)
Serum zinc vs. Dietarv features
0.049 0.580 0.143 0.105
Copper (mg) -0.025 0.779 -0.029 0.740
Zinc (mg) 0.057 0.520 -0.006 0.942
Selenium (pg)
Urine zinc vs. Demoeranhic features
-0.059 0.504 0.040 0.650
Age -0.206 0.019 -0.003 0.97
SBF [mm-Hg] -0.030 0.731 0.32 0.717
DBF [mm-Hg] 0.034 0.701 0.148 0.094
Body mass index 0.046 0.604 -0.029 0.747
Smoking (Yes/ No)
Urine zinc vs. Biochemical features
0.155 0.078 -0.013 0.884
Total cholesterol (mmol/L) 0.039 0.660 0.133 0.132
Triglycerides (mmol/L) 0.031 0.723 -0.051 0.567
LDL (mmol/L) -0.031 0.730 0.152 0.084
HDL (mmol/L) 0.086 0.328 -0.035 0.689
Caeruloplasmin (U/L) -0.134 0.127 0.114 0.196
Superoxide dismutase (U/g Hb) -0.087 0.326 -0.018 0.836
Glutathione peroxidase (U/g Hb) -0.084 0.340 0.047 0.597
Hs-C reactive protein (mg/L) 0.119 0.177 -0.027 0.760
SICAM-1 (ng/ml)
Urine zinc vs. Dietarv features
0.097 0.272 0.084 0.343
Copper (mg) 0.137 0.120 0.022 0.804
Zinc (mg) 0.138 0.118 0.15 0.089
Selenium (pg) 0.030 0.736 0.005 0.951
HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, sICAM-1:
soluble adhesion m olecule-1
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Table 5.2(c): Correlations between serum and urine selenium levels with demographic, biochemical,
and dietary parameters in patients with CVD and controls. Pearson's or Spearman's correlation
Controls Cases
(n=130) (n=130)
Serum selenium vs. Demographic features
r P r P
Age 0.034 0.699 0.014 0.876
SBP [mm-Hg] -0.089 0.312 -0.217 0.013
DBP [mm-Hg] 0.002 0.982 -0.063 0.475
Body mass index -0.078 0.376 0.085 0.338
Smoking (Yes/ No)
Serum selenium vs. Biochemical features
0.282 0.001 0.178 0.043
Total cholesterol (mmol/L) 0.105 0.233 -0.028 0.751
Triglycerides (mmol/L) 0.195 0.026 0.088 0.321
LDL (mmol/L) 0.032 0.717 -0.042 0.638
HDL (mmol/L) 0.142 0.108 0.008 0.927
Caeruloplasmin (U/L) 0.057 0.517 0.057 0.516
Superoxide dismutase (U/g Hb) 0.112 0.204 0.021 0.810
Glutathione peroxidase (U/g Hb) -0.280 0.001 0.020 0.780
Hs-C reactive protein (mg/L) -0.038 0.669 0.039 0.657
SICAM-1 (ng/ml)
Serum selenium vs. Dietarv features
-0.122 0.165 -0.049 0.581
Copper (mg) -0.041 0.640 0.165 0.061
Zinc (mg) -0.194 0.027 0.097 0.271
Selenium (pg)
Urine selenium vs. Demoeranhic features
-0.104 0.239 -0.009 0.915
Age -0.207 0.018 -0.12 0.175
SBP [mm-Hg] 0.001 0.987 0.262 0.003
DBP [mm-Hg] -0.010 0.907 0.179 0.042
Body mass index -0.016 0.853 0.012 0.888
Smoking (Yes/ No)
Urine selenium vs. Biochemical features
0.143 0.105 -0.037 0.673
Total cholesterol (mmol/L) 0.145 0.100 0.018 0.838
Triglycerides (mmol/L) 0.037 0.679 -0.056 0.529
LDL (mmol/L) 0.067 0.449 0.053 0.546
HDL (mmol/L) 0.078 0.379 -0.066 0.453
Caeruloplasmin (U/L) -0.125 0.157 0.019 0.831
Superoxide dismutase (U/g Hb) -0.155 0.078 -0.087 0.327
Glutathione peroxidase (U/g Hb) -0.131 0.138 0.047 0.592
Hs-C reactive protein (mg/L) 0.140 0.112 -0.175 0.047
SICAM-1 (ng/ml)
Urine selenium vs. Dietarv features
0.151 0.086 0.093 0.294
Copper (mg) 0.288 0.040 -0.008 0.925
Zinc (mg) 0.180 0.040 -0.006 0.946
Selenium (pg) 0.136 0.124 0.039 0.660
HDL-C: high density lipoprotein cholesterol, LDL-C: low  density lipoprotein cholesterol, sICAM-1:
soluble adhesion m olecule-1
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5.4.3 Comparison of dietary trace element intake between groups and 
relationship to serum and urine levels
Table (5.4) compares the average intake of fiber and trace elements. In general, CVD 
patients had a higher intake of trace elements (p<0.05 in selenium and zinc, p<0.001 
in copper) and fiber (p>0.05). Of the three trace elements, selenium intake was well 
below the EAR value (57.7 pg) in both groups.
Levels of dietary copper intake were positively associated with their serum levels in 
controls (r = 0.225, p<0.05) whereas the levels of dietary zinc intake were negatively 
correlated with urinary copper/zinc ratio in patients (r = -0.201, p<0.05). In addition, 
as shown in figures (5.1) and (5.2) there were strong associations between dietary 
intake of copper and zinc in CVD patients (r = 0.763, p<0.0001) and in their 
respective controls (r = 0.697, p<0.0001).
Dietary copper intake was positively associated with urinary copper and urinary 
selenium levels in controls (Table 5.2a). Similarly, dietary zinc intake was positively 
associated with zinc and selenium in urine among controls (Table 5.2b).
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T a b l e  5 .4 :  M ic r o n u t r ie n t  in ta k e s  in  p a t ie n t s  w it h  C V D  a n d  c o n tr o ls
Parameter RNI EAR Controls(n=130)
Cases
(n=130)
Selenium (pg) 75 pg 57.7 pg 42.07 ± 1.22 47.38 ±1.60*
Copper (mg) 1.2 mg 0.92 mg 1.26 ±0.03 1.44 ±0.04**
Zinc (mg) 9.5 mg 7.31 mg 8.67 ± 0.20 9.44 ± 0.20 *
Copper/Zinc NA NA 0.15 ±0.002 0.15 ±0.002
Fiber (gm) 18 gm 13.85 gm 18.9 ±0.40 20.4 ± 0.40
Data were compared by unpaired t tests or Mann-Whitney tests for non-normally distributed 
data. * P  <0.05, ** P <0.001 EAR: estimated average requirements, RNI: reference nutrient 
intake, SEM: standard error of mean, NA:not available
2 5 8
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Figure 5.1: Scatter plot showing the correlation between dietary intake of copper and 
zinc in CVD patients (r= 0.763, p<0.0001).
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Figure 5.2: Scatter plot showing the correlation between dietary intake of copper and 
zinc in controls (r= 0.697, p<0.0001).
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5.4.4 Differences in trace elements status-related parameters with chronic 
diseases
Diabetes mellitus
Non-diabetic controls had higher serum selenium, urine copper, and urine zinc than 
non-diabetic patients with CVD (p<0.001 in all). Additionally, non-diabetic controls 
had higher serum selenium and urine copper than CVD patients with diabetes 
(p<0.001 for both). Diabetic controls had higher serum selenium (p<0.001) than 
atherosclerotic patients with diabetes. When compared to non-diabetics patients with 
CVD, diabetic controls had higher serum selenium (p<0.001) and urine zinc (p<0.05). 
Mean intakes of the 3 trace elements were above EAR values except for selenium in 
all groups. CVD patients with diabetes reported the highest intake of zinc compared to 
all other groups (p<0.05 with diabetic controls and non-diabetic CVD patients, 
p<0.001 with non-diabetic controls) and higher intake of copper and selenium than 
the controls, whether diabetics (p<0.001) or non-diabetics (p<0.05) (Table 5.5a).
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Table 5.5(a): Comparison of trace elements status in patients with CVD and their 
controls according to the presence of diabetes mellitus
Controls (n=130) Cases (n=130) P
Serum copper
Nondiabetics
(n=82)
15.13 ±1.09
Diabetics
(n=48)
13.58 ± 1.05
Nondiabetics
(n=52)
13.30 ±0.85
Diabetics
(n=78)
12.72 ± 0.67 NS
(pmol/L) 
Serum zinc 21.66 ± 1.87 16.77 ± 1.88 22.31 ±1.45 18.72 ± 1.31 NS
(pmol/L)
Serum 1.47 ±0.20 1.80 ±0.31 0.91 ±0.15 1.11±0.12 NS
copper/zinc
ratio
Serum 1.79 ± 0.11 ¥£ 1.97 ±0.14 fa 1.16 ±0.09 1.09 ±0.07 <0.0001
selenium 
(pmol/L) 
Urine copper 0.54 ± 0.04 ¥£ 0.48 ± 0.04 0.39 ± 0.05 0.48 ± 0.05 <0.0001
(pmol/mmol 
(Creatinine) 
Urine zinc 2.87 ± 0.33 ¥ 2.46 ± 0.25 H 1.76 ±0.22 2.96 ± 0.35 ^ <0.05
(pmol/mmol
(Creatinine)
Urine 0.30 ±0.03 0.36 ± 0.06 0.33 ± 0.04 0.25 ± 0.03 NS
copper/zinc
ratio
Urine 1.28 ±0.13 0.88 ±0.10 1.58 ±0.22 1.45 ±0.18 NS
selenium
(pmol/mmol
(Creatinine)
Caeruloplasm 49.7 ±3.36 53.63 ± 6.16 47.03 ±4.31 51.92 ±3.74 NS
in [U/L] 
Glutathione 84.10 ±8.45 95.17 ±11.58 69.71 ±7.89 71.43 ±6.56 NS
peroxidase
[U/gmHb]
Superoxide 190.55 ± 14.78 203.54 ±21.81 174.51 ±16.93 162.33 ± 14.64 NS
dismutase 
[U/gmHb] 
Copper intake 1.27 ±0.04 1.25 ±0.05 1.37 ±0.05 1.48 ± 0.06 <0.05
(mg)
Zinc intake 8.67 ± 0.26 8.66 ± 0.30 8.84 ± 0.25 9.84± 0.27 £€0 <0.05
(mg)
Dietary 0.15 ±0.001 0.15 ±0.001 0.15 ±0.001 0.15 ±0.003 NS
copper/zinc
Selenium 41.79 ±1.42 42.53 ± 2.26 45.54 ±2.06 48.60 ± 2.28 t  € <0.05
intake (pg)
Data are shown as mean ± SEM, Continuous variables were compared by Kruskal-Wallis test. NS: not 
significant, SEM: standard error o f  mean, § P<0.05 (first & second groups), # P<0.001 (first & second 
groups) * P<0.05 (first & third groups), ¥  P<0.001 (first & third groups) ^ P<0.05 (second & third 
groups), t  P<0.001 (second & third groups) $ P<0.05 (first & forth group), £ P<0.001 (first & forth 
group) €  P<0.05 (second & forth group), ^ P<0.001 (second & forth group) 0 P<0.05 (third & forth 
group), $ P<0.001 (third & forth group)
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M etabolic syndrome
Controls with metabolic syndrome had higher serum copper than CVD patients with 
or without metabolic syndrome (p<0.001 in both) and higher urine copper than CVD 
patients with no metabolic syndrome (p<0.05). Compared to CVD patients with or 
without metabolic syndrome, controls without metabolic syndrome had higher copper 
in serum and urine (p<0.001). Also, controls without metabolic syndrome had higher 
urine selenium than controls with metabolic syndrome (p<0.05). CVD patients with 
metabolic syndrome had higher urine selenium than controls with metabolic 
syndrome (p<0.05).
Levels of trace elements intake were above EAR values except for selenium. CVD 
patients with or without metabolic syndrome had a higher intake of copper and 
selenium than controls without metabolic syndrome (p<0.05). CVD patients with 
metabolic syndrome had higher zinc intake than controls with or without metabolic 
syndrome (p<0.05) (Table 5.5b).
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Table 5.5(b): Comparison of trace elements status in patients with CVD and their 
controls according to the presence of metabolic syndrome(MS)
Controls (n=130) Cases (n=130)
Non MS (n=101) MS (n=29) Non MS (n=69) MS (n=61)
Semm copper 
(pmol/L)
14.7 ±0.91 14.02 ± 1.58 13.42 ±0.72 12.42 ±0.76 NS
Semm zinc 
(pmol/L)
20.20 ± 1.60 18.63 ±2.75 20.58 ± 0.25 19.68 ± 1.56 NS
Semm
copper/zinc
ratio
1.49 ±0.18 1.95 ±0.44 1.01 ±0.14 1.05 ±0.13 NS
Semm
selenium
(pmol/L)
1.87 ± 0.10 ¥£ 1.82 ±0.17 f a 1.13 ±0.07 1.11 ±0.09 <0.00
Urine copper 
(pmol/mmol 
(ireatinine)
0.55 ± 0.04 ¥£ 0.42 ±0.03 If 0.41 ±0.04 0.48 ± 0.06 <0.00
Urine zinc
(pmol/mmol
(Zreatinine)
2.76 ± 0.28 2.60 ± 0.29 2.23 ±0.31 2.76 ± 0.36 NS
Urine
copper/zinc
ratio
0.35 ± 0.03 0.24 ± 0.04 0.31 ±0.03 0.26 ± 0.03 NS
Urine
selenium
(pmol/mmol
Creatinine)
1.24 ±0.11 § 0.73 ±0.10 1.40 ±0.18 1.62 ±0.22 <0.05
Caemloplasm 
in [U/L]
50.32 ±3.18. 54.12 ±8.52 52.68 ± 4.52 46.89 ±3.19 NS
Glutathione 
peroxidase 
[U/gm Hb]
86.29 ± 6.96 94.82 ± 18.89 71.88 ±6.44 69.45 ± 7.90 NS
Superoxide
dismutase
[U/gmHb]
185.55 ± 13.21 229.46 ± 29.84 186.75 ±16.32 145.09 ± 14.27 NS
Copper intake 
(mg)
1.26 ±0.04 1.26 ±0.07 1.41 ±0.05* 1.46 ±0.06$ <0.05
Zinc intake 
(mg)
8.67 ± 0.23 8.67 ± 0.41 9.21 ±0.24 9.70 ± 0.31 $€ <0.05
Dietary
copper/zinc
0.15 ±0.003 0.15 ±0.005 0.15 ±0.004 0.15 ±0.004 NS
Selenium 
intake (pg)
41.75 ±1.43 43.17 ±2.23 46.68 ±1.79* 48.17 ±2.75$ <0.05
Data are shown as mean ±  SEM, Continuous variables were compared by Kruskal-Wallis test. NS: not 
significant, SEM: standard error o f  mean,- § P<0.05 (first & second groups), # P<0.001 (first & second 
groups) * P<0.05 (first & third groups), ¥  P<0.001 (first & third groups) ^ P<0.05 (second & third 
groups), t  P<0.001 (second & third groups) f  P<0.05 (first & forth group), £ P<0.001 (first & forth 
group) €  P<0.05 (second & forth group),  ^P<0.001 (second & forth group) 0 P<0.05 (third & forth 
group), $ P<0.001 (third & forth group)
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Hypertension
Hypertensive controls had higher semm selenium and urine copper than CVD patients 
with or without hypertension (p<0.001 in all). Similarly, non-hypertensive controls 
had higher semm selenium and urine copper than both of non-hypertensive CVD 
patients (p<0.001) and CVD patients with hypertension (p<0.001 in semm selenium, 
p<0.05 in urine copper).
The reported mean intakes of trace elements were above the EAR values for copper 
and zinc and below EAR for selenium. Non-hypertensive CVD patients had the 
highest intake of copper (p<0.05 with hypertensive CVD patients, p<0.001 with 
controls with or without hypertension) and selenium (p<0.05) than all other groups. 
Furthermore, non-hypertensive CVD patients also reported higher zinc intake than 
hypertensive and non-hypertensive controls (p<0.05) (Table 5.5c).
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Table 5.5(c): Comparison of trace elements status in patients with CVD and their 
controls according to the presence of hypertension
Controls (n=130) Cases (n=130)
Non hypertensives 
(n=62)
Hypertensives
(n=68) Non hypertensives (n=45)
Hypertensives
(n=85)
Semm copper 15.09± 1.13 14.07 ±1.10 12.95 ± 0.83 12.95 ± 0.67 NS
(pmol/L)
Semm zinc 19.79 ±1.89 19.91 ±2.01 21.68 ± 1.38 19.36 ±0.31 NS
(pmol/L)
Semm 1.63 ±0.25 1.56 ±0.23 0.76 ± 0.08 1.17±0.14 NS
copper/zinc
ratio
Semm 1.82 ± 0.12 ¥£ 1.89 ± 0.12 fd 1.20 ±0.10 1.08 ±0.07 <0.0001
selenium
(pmol/L)
Urine copper 0.56 ± 0.05 ¥ t 0.48 ± 0.03 t  d 0.33 ± 0.03 0.50 ± 0.06 <0.0001
(pmol/mmol
Creatinine)
Urine zinc 3.37 ±0.43 2.13 ±0.16 2.23 ± 0.37 2.61 ±0.30 NS
(pmol/mmol
Creatinine)
Urine 0.29 ± 0.04 0.36 ± 0.04 0.23 ± 0.02 0.31 ±0.03 NS
copper/zinc
ratio
Urine 1.34 ±0.17 0.94 ± 0.08 1.37 ±0.19 1.57 ±0.19 NS
selenium
(pmol/mmol
Creatinine)
Caemloplasm 48.53 ±4.50 53.58 ±4.29 53.71 ±6.22 47.98 ± 2.82 NS
in [U/L]
Glutathione 92.15 ±9.15 84.58 ± 10.07 82.04 ± 8.57 64.76 ± 6.14 NS
peroxidase
[U/gmHb]
Superoxide 191.83 ± 17.28 198.55 ± 17.52 175.41 ± 17.93 162.86 ± 14.06 NS
dismutase
[U/gm Hb]
Copper intake 1.25 ±0.04 1.27 ±0.05 1.54±0.06¥t 0 1.39 ±0.05 <0.001
(mg)
Zinc intake 8.66 ± 0.28 8.68 ±0.28 9.70 ± 0.28 * 1 9.30 ± 0.26 <0.05
(mg)
Dietary 0.15 ±0.004 0.15 ±0.004 0.16 ±0.004 0.15 ±0.004 NS
copper/zinc
Selenium 41.82 ±1.94 42.29 ± 1.52 51.22 ± 2.73 ¥ 1 ^ 45.34 ± 1.95 <0.05
intake (pg)
Data are shown as mean ±  SEM, Continuous variables were compared by Kruskal-Wallis test. NS: not 
significant, SEM: standard error o f  mean, § P<0.05 (first & second groups), # P<0.001 (first & second 
groups) * P<0.05 (first & third groups), ¥  P<0.001 (first & third groups) % P<0.05 (second & third 
groups), t  P<0.001 (second & third groups) $ P<0.05 (first & forth group), £ P<0.001 (first & forth 
group) €  P<0.05 (second & forth group),  ^ P<0.001 (second & forth group) 0 P<0.05 (third & forth 
group), $ P<0.001 (third & forth group
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Differences in trace elements status-related param eters with coronary 
disease severity
A total of 180 patients were admitted to undergo angiography. Due to the small 
number of those who were categorized as having single vessel disease (n=4), they 
were merged with those who were categorized with zero vessel disease (n=27). Table 
(5.6) shows that CVD patients with ZVD/SVD had significantly higher serum copper 
(p<0.001), serum copper/zinc ratio (p<0.001), urine copper (p<0.05), and serum 
selenium (p<0.001) compared to CVD patients with MVD. Similarly, CVD patients 
with ZVD/SVD had significantly higher serum copper, serum copper/zinc ratio, and 
serum selenium than CVD patients with DVD (p<0.001 in all). Additionally, CVD 
patients with ZVD/SVD had significantly higher erythrocytes GPx activity than CVD 
patients with DVD and MVD (p<0.05 in both). Serum selenium and serum 
copper/zinc ratio was significantly higher in CVD patients with DVD than those with 
MVD (p<0.05 in both).
In terms of trace elements intake, the reported intake levels were above EAR except 
for selenium with no significant difference between the groups (p>0.05).
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Table 5.6: Trace elements in CVD patients divided by the number of coronary vessels 
occluded
ZVD/SVD DVD MVD P
n
Serum copper
31
21.51±1.7#¥
67
13.30 ±0.72
82
12.26 ±0.66 <0.0001
(pmol/L) 
Serum zinc 18.63 ±1.8 19.01 ±1.29 22.38 ±1.39 NS
(pmol/L)
Serum 1.72 ± 0.30 §¥ 1.11±0.15T| 0.76 ± 0.08 <0.0001
copper/zinc 
Semm selenium 0.50 ± 0.04 § ¥ 0.46 ± 0.04 % 0.41 ± 0.05 <0.0001
(pmol/L) 
Urine copper 0.28 ± 0.05 0.27 ± 0.04 0.73 ± 0.28 * <0.05
(pmol/mmol 
Creatinine) 
Urine zinc 2.98 ± 0.40 * 2.82 ± 0.34 2.38 ± 0.26 NS
(pmol/mmol
Creatinine)
Urine copper/zinc 0.37 ±0.17 0.37 ±0.11 1.7 ±0.89 NS
Urine selenium 1.23 ±0.17 1.57 ±0.18 1.39 ±0.17 NS
(pmol/mmol
Creatinine)
Caemloplasmin 32.81 ±4.73 35.85 ±2.81 36.87 ±2.76 NS
[U/L]
Glutathione 107.21 ±9.71 §* 81.49 ±9.03 93.56 ±8.32 <0.05
peroxidase
[U/gmHb]
Superoxide 187.51 ±17.93 192.54 ±20.06 164.13 ± 14.36 NS
dismutase 
[U/gm Hb] 
Copper intake 1.34 ±0.08 1.54 ±0.06 1.48 ±0.06 NS
(mg)
Zinc intake (mg) 9.13 ±0.47 10.01 ±0.25 10.05 ±0.29 NS
Dietary 0.15 ±0.01 0.15 ±0.01 0.15 ±0.01 NS
copper/zinc 
Selenium intake 46.85 ±2.51 52.09 ± 2.87 50.03 ± 1.71 NS
(pg)
Data are shown as mean ±  SEM, continuous variables were compared by Kruskal-Wallis test. DVD: 
double vessel disease, MVD: multi- vessel disease, NS: not significant, SEM: standard error o f  mean, 
SVD: single vessel disease, ZVD: zero vessel disease, * P<0.05 (first & third groups), ¥  P<0.001 (first 
& third groups), § P<0.05 (first & second groups), # P<0.001 (first & second groups), ^ P<0.05 (second 
& third groups), f  P<0.001 (second & third groups)
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5.4.5 Correlations between trace elements status with demographic and 
biochemical parameters
Among controls, smoking habit (categorized as yes/no) was associated with serum 
copper (r=0.246, p<0.01) and selenium (r=0.282, p<0.001) whereas in CVD patients 
smoking habit was associated with serum selenium only (r=0.178, p<0.05) (Table 
5.2a and Table 5.2c).
Within the patient group, there was a positive relationship between the intake of both 
copper and zinc with TEARS (p<0.05 for both). Serum selenium was positively 
associated with serum triglycerides (r=0.195, p<0.05) among controls only (Table 
5.2c).
Of the inflammatory markers, CRP was positively correlated with urine copper 
(r=0.222, p<0.05) in controls, negatively so with urine copper (r= -0.182, p<0.05) and 
urine selenium in CVD patients (r= -0.175, p<0.05). Serum copper in controls was 
correlated with serum sICAM-1 (r=0.233, p<0.01).
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5.4.6 Multivariate analysis
Conditional logistic regression analysis was performed to determine the association of 
trace elements status with atherosclerosis. Potentially confounding and effect- 
modifying factors with p value up to 0.1 were included in the model. Diabetes 
mellitus (Odds ratio: 13.64, 95% Cl: 1.53-121.41, p<0.05), hypertension (Odds ratio: 
9.15, 95% Cl: 1.63-61.39, p<0.05), serum zinc (Odds ratio: 0.92, 95% Cl: 0.85-0.99, 
p<0.05), serum copper/zinc ratio (Odds ratio: 0.31, 95% Cl: 0.10-0.96, p<0.05), 
serum selenium (Odds ratio: 0.07, 95% Cl: 0.02-0.31, p<0.01 ) and urine selenium 
(Odds ratio: 3.34, 95% Cl: 1.40-1.99, p<0.01) were shown to be independently 
associated with atherosclerosis based on this model (table 5.7). Trace elements were 
modeled as continuous variables in the model. Diabetes mellitus and hypertension 
were entered as categoric variables with 0 value: no disease and 1 value: presence of 
disease. The strongest association, even after adjustment for confounders, was shown 
by serum selenium with a Wald statistic of 11.97.
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Table 5.7: Adjusted odds ratio of CVD calculated from conditional logistic regression 
model
OR 95% Cl P Wald
Param eter Lower Upper
bound bound
Serum zinc 0.92 0.85 0.99 0.021 5^5
Serum 0.31 0.10 0.96 0.043 4.10
copper/zinc ratio
Serum selenium 0.07 0.02 0.31 0.001 11.97
Urine selenium 3.34 1.40 7.99 0.007 7.35
Diabetes mellitus 13.64 1.53 121.41 0.019 5.49
Hypertension 9.15 1.63 61.39 0.023 5.19
OR: odds ratio, 95% Cl: 95% confidence interval
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5.5 Discussion
Considerable efforts have been made to control the classical coronary risk factors and 
to detect new factors that could promote the progression of CVD in different 
countries. Saudi Arabia is no exception. There have been previous reports of the high 
prevalence of coronary risk factors in Saudi Arabia (Al-Nuaim et al., 1996; Al- 
Nuaim, 1997(b); Alsaif et al.,2002). In our sample of Saudi males, there was a high 
prevalence of classical coronary risk factors, including dyslipidaemia, diabetes 
mellitus, hypertension, obesity and a positive smoking habit, even among those with 
no overt CVD.
Although there have been several studies investigating the putative role of trace 
elements in Caucasian populations, there are few published data on copper and zinc 
status in non-Western populations (Abiaka et al.,2003a). As far as we are aware there 
are no data on reference values for serum selenium and other trace element-related 
parameters among Saudi populations, and little information relating trace element 
status to CVD risk factors (El-Yazigi et al., 1991 ; El-Yazigi et al.,1993 ; El-Yazigi 
and Legayada,1996).
Although there are strong hypothetical reasons why trace element status may be 
involved in the etiology of CVD, epidemiological studies have been inconsistent. In 
animal experiments a diet low in copper and high in zinc leads to 
hypercholesterolemia and cardiovascular complications (Klevay,1980). In 
epidemiological studies, serum copper has been shown to be raised in patients with a 
history of acute myocardial infarction (Kok et al., 1988; Iskra et al., 1993; Reunanen et 
al., 1996), whereas serum zinc was found to be normal or decreased (Oster et al., 1989, 
Jain and Mohan, 1991). Similarly, though several prospective studies have shown that 
selenium deficiency is associated with an increased risk of MI (Salonen et al., 1982,
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Virtamo et al., 1985); this has not been confirmed by others (Kok et al., 1987, Ringstad 
et al., 1987). These apparent inconsistencies may be partly attributable to 
methodological problems, or the level of dietary sufficiency for the particular trace 
element in the population under investigation.
5.5.1 Associations of trace elements status with demographic 
characteristics
Age
Ours is the first study on Saudi males examining the effects of age on several indices 
of trace element status. However our sample size was limited, particularly for the 
younger age groups. We did not observe any significant differences in serum copper, 
zinc or selenium when age categories were used, however in the controls there was an 
inverse relationship between age, as a continuous variable, and urinary zinc and 
selenium that was not observed in the cases. Other studies have reported either similar 
results (Bratakos et al., 1990, Wright et al., 1995) or no association with age 
(Alexander et al., 1983). This might be attributed to low dietary intake in elderly 
subjects or the effect of advancing age on reducing the efficiency of intestinal 
absorption of trace elements. Yet, a decrease in trace elements intake with age was not 
shown in our sample.
Smoking
Smoking is one of the major sources of free radicals formation and is responsible for 
enhancing oxidative stress in vivo (Preston, 1991). Some investigators have observed 
low serum copper and zinc levels with smoking (Faruque et al., 1995, Kim et al.,2003) 
while others have reported higher copper levels in smokers (Durak et al., 1999). 
Similarly, lower (Bukkens et al., 1990) or normal (Olivieri et al., 1994) serum selenium 
levels were found in smokers than in non-smokers.
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Among controls, serum copper and selenium concentrations were positively 
associated with smoking habits when categorized into 2 categories (yes and no). 
Similar correlations were attained by CVD patients, though a negative correlation was 
indicated with serum copper but of borderline significance (p=0.051). This could be 
attributed to an indirect effect of smoking on trace elements metabolism while 
inducing antioxidant enzymes activities. The induction in antioxidant enzymes 
activities was interpreted by some investigators as a self defense mechanism (Sohn et 
al., 1993). However, this dichotomy may be insufficient to adequately describe 
smoking behavior.
5.5.2 M arkers of inflammation and lipid peroxidation 
Coronary disease has many features of a chronic inflammatory disease (Ross, 1999) 
and hence changes in trace element status may be a secondary manifestation of 
inflammation. However we did not find significant differences in the inflammatory 
markers, CRP and sICAM-1 between CVD patients and their respective controls. 
Neither did caeruloplasmin, an acute phase reactant and an inflammatory marker, 
show any difference between the groups. This may be due, at least in part, to overlap 
in distribution of CRP values between CVD patients and controls. This is in contrast 
to some other reports in other populations (Liuzzo et al., 1994, Reunanen et al., 1992, 
Rohde et al., 1998). Such a finding might be expected with the use of anti­
inflammatory drugs by 39% of controls and 79% of CVD patients. Also, cigarette 
smoking has been reported to be associated with elevated serum copper concentration 
in epidemiological studies (Kok et al., 1988). A positive smoking habit (i.e. current 
smokers) was found in 24% of controls and 20% of CVD patients. The combined 
effects of increased anti-inflammatory drug use, a higher percentage of diabetics 
among CVD patients, as well as the higher percentage of smokers among controls
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could explain the lack of significant difference in caeruloplasmin and lipid peroxides 
levels between the groups. However, urinary copper was positively associated with 
CRP levels among controls and inversely so in CVD patients. The former correlation 
could be a consistent finding with CRP role as a marker for low-grade inflammation 
(Danesh et al.,2000a) in controls and the latter relationship can be a conservation 
mechanism of copper in cases. The same can be true for the inverse correlation 
between urinary selenium levels and serum CRP levels in CVD patients, knowing that 
kidney is the major organ of selenium homeostasis.
Lipid peroxidation is thought to be an early event during atherogenesis, being 
associated with the production of modified LDL and affecting antioxidant status. 
Although copper and zinc supplementation have been shown to reduce plasma lipid 
peroxides in cholesterol-fed rabbits, indicating that they may inhibit atherogenesis by 
an effect on lipid oxidation (Alissa et al.,2004), this was only observed using high 
levels of dietary supplementation in an experimental study. Neither marker of lipid 
peroxidation state differed significantly between the study groups. This could be 
explained by the exclusion of supplementation users from this study, and therefore it 
is unlikely that copper and zinc intake from dietary sources only could have had an 
influence on lipid peroxides levels.
We found a very strong association between serum SOD activity and serum GPx in 
both cases and control subjects suggesting that they are acting in a sequential manner. 
However, this could either be a contributory cause of the disease, a result of the 
disease, or an effect of drug treatment. In addition, oxidative stress has been shown to 
cause downregulation in the expression of the protective antioxidant enzymes via NF- 
kB (Brand et al., 1997) and activated NF-kB is present within lesions of 
atherosclerosis (Brand et al., 1996). Therefore, it is possible that levels of enzymes
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activities are being controlled in a coordinated manner by changes in redox potential 
within cells. However, increased antioxidant enzyme activities may not be sufficient 
to prevent continuous lipid peroxidation associated with increased coronary risk 
among controls.
5.5.3 Serum copper and zinc concentrations do not differ between Saudi
males with and without cardiovascular disease
Despite the lack of published normative data for serum trace element levels for Saudi 
subjects, the distribution of serum concentrations of copper and zinc were similar to 
previously reported reference ranges in apparently healthy subjects (Rukgauer et 
ah, 1997).
Our results show that Saudi subjects with established CVD do not have significantly 
different serum levels of copper, zinc, or copper/ zinc ratio. These data are consistent 
with some previous studies in Caucasian subjects (Mikkelsen et al., 1992, Mielcarz et 
al.,2001), but in contrast to other reports (Kok et al.,1988; Salonen et al., 1991(a); 
Reunanen et al., 1996). The lack of difference in between CVD patients and controls 
can be ascribed to the highly adaptive capacity of human body to various dietary 
intake levels of trace elements and their biological indicators such as serum levels. 
This can be attributed to tight control of trace elements homeostasis, which is the 
ability of the human body to maintain a constant internal state of trace elements with 
varying external conditions in case of extremely low or high intakes because of their 
essential nature, in addition to trace elements redistribution to repair damaged tissue 
in response to inflammatory response among CVD patients. However, such a 
difference in trace element levels might be more pronounced in larger scale studies.
It is known that increased lipid peroxidation and reduced antioxidant status may 
contribute to the development of CVD (Buczynski et al., 1993). Although the lower
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serum copper levels and reduced erythrocytes SOD activity among CVD patients as 
well as the higher lipid peroxides levels did not reach statistical significance, it may 
be an indication of increased production of lipid peroxides usually accompanying 
degenerative diseases. Most of tissue copper is specifically bound to protein such as 
SOD and a marginal copper status enhances peroxidative damage due to a reduction 
of the SOD activity (Paynter,1980). Furthermore, it has been reported that 
glycosylation of the active site of Cu/Zn-SOD results in decreased activity of the 
enzyme in the erythrocytes of diabetic patients (Kawamura et al., 1992). A consistent 
finding with higher proportion of diabetics among the CVD patients.
A strong correlation between serum copper and erythrocyte SOD activity in controls 
may be indicative of an induction of SOD synthesis or stimulation of SOD activity in 
the presence of sufficient copper. Thus, it is conceivable that increased SOD activity 
may provide increased protection against oxidative stress, yet enzyme activities in 
erythrocytes do not necessarily reflect the antioxidant defense of the whole body. 
Decreased GPx activity in copper-deficient animals suggested that copper might play 
a role in GPx metabolism independent of selenium status (Prohaska et al., 1992). Thus 
explaining the positive correlation between serum copper and erythrocytes GPx 
activity among controls.
A moderate correlation between serum zinc and erythrocyte SOD activity in CVD 
patients is hard to explain since it is well known that zinc plays a structural role in 
SOD unless it is suggestive of its antioxidant and membrane stabilizing properties 
(Hennig et al., 1996). Extracellular SOD activity found to be more vulnerable to mild 
zinc deficiency in man than in rats (Davies et al., 1998). However, this isozyme was 
not measured in our study.
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5.5.4 Low urinary copper and zinc levels in Saudi males with 
cardiovascular disease
It is unlikely that the changes in urinary copper and zinc in CVD patients were caused 
solely by dietary imbalance. However, because selenium intake was largely below 
EAR (87% and 84% in controls and cases respectively), urinary output of selenium 
probably reflects body stores and recent intake more than blood levels (Alaejos and 
Romero, 1993) as discussed further below.
Diabetes mellitus, a common predisposing factor for CVD, can disturb zinc 
metabolism leading to increased excretion. The hyperzincuria appears to be caused by 
renal inadequacy related to elevated blood glucose (McNair et al., 1981). More than 
half of the CVD patients were diabetics and within CVD patients, diabetic ones had 
significantly higher urinary zinc levels than non-diabetic CVD patients (p<0.05). Yet 
in the population as whole urinary zinc levels were higher among the controls 
(p<0.05) that had lower percentage of diabetes than CVD patients. This might either 
indicate a higher body content of zinc in controls, thus allowing more zinc to be 
excreted, or that more zinc is taken up by cells in CVD patients because of a 
preexisting deficient body stores of zinc, thus decreasing the output. One reason for 
increased requirement of zinc is depleted body reserves of antioxidants due to a state 
of oxidative stress usually accompanying diabetes mellitus (Halliwell,1989). The 
same could also be true for increased urinary copper outputs among CVD patients 
with diabetes. As copper is an enhancer of lipid peroxidation, the increase in urinary 
output of copper in CVD patients with diabetes may contribute to diabetic 
nephropathy (Mooradian and Morley,1987).
Interestingly levels of dietary zinc intake were negatively correlated with urinary 
copper/zinc ratio in patients (r=-0.201, p<0.05). Increased urinary zinc excretion is a
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consistent finding in diabetes mellitus and may indicate a decrease in the total body 
zinc content as discussed above. With higher prevalence of diabetes among CVD 
patients, such a finding is most likely to occur. However, those diabetic patients were 
not zinc deficient, therefore, an altered tissue zinc levels is also a possibility.
5.5.5 Saudi males with cardiovascular disease have low serum selenium and 
high urinary selenium levels 
Serum selenium is often used as an index of selenium status in epidemiological 
studies (Suadicani et al., 1992, Salvini et al., 1995) since serum levels respond more 
rapidly to changes in selenium balance than whole blood levels. However, the 
interpretation of such changes is complicated by the fact that the chemical 
composition of many selenium compounds, such as selenoportein P, in serum and 
blood is only partly characterized. For patients and controls, interpretation of serum 
levels should be based on locally derived references ranges. However, such data are 
not available for Saudis. A reference interval of 40-200 pg/L (0.51-2.53 pmol/L) of 
serum selenium suggested by Alfthan and Neve (1996) was used instead, within 
which, measured levels in this study lie.
In an epidemiological study in Eastern Finland, a serum selenium concentration 
<0.57pmol/L (<45 pg/L) was associated with an increased risk of coronary heart 
disease, cerebrovascular disease, and myocardial infarction (Salonen et al., 1982). 
However, low selenium levels may be expected in a region such as Eastern Finland, 
that is known to have a low selenium content in soil and water as well as high copper 
concentration in drinking water. It was suggested that when copper concentration is 
high a decrease in plasma selenium might result from a decrease in selenium 
availability (Salonen et al., 199lb). Such levels are uncommon in Middle Eastern
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populations, that cultivate and obtain food from soils with a relatively higher content 
of selenium (Al-Saleh,2000).
A cut-off value of Ipmol/L of serum selenium was applied in a study in Denmark; 
this marked a threshold value below which, an increased risk of ischemic heart 
disease was observed (Suadicani et ah, 1992). In our study we observed a positive 
correlation between serum selenium values below Ipmol/L and erythrocytes GPx in 
the population as a whole (r=0.222, p<0.05) and that more than half of CVD patients 
but less than one third of controls had a serum selenium concentration <lpmol/L. This 
suggests that a low selenium status may be a contributory factor for coronary heart 
disease in the Saudi population.
Furthermore, serum selenium concentrations were significantly lower in CVD patients 
in spite of their higher dietary intake, whereas urinary levels did not differ between 
the groups. Urinary output is supposed to reflect recent intake (Alaejos and 
Romero, 1993). Similar to other studies (Navarro-Alarcon et al., 1999), it seems that 
even with improved dietary habits of CVD patients, selenium intake may have been 
used to replenish depleted stores thus resulting in low serum levels. Such an 
impairment of urinary elimination is also suspected in controls because of their 
relatively lower intake of selenium, subsequently leading to no significant difference 
between controls and CVD patients in terms of urinary selenium levels. There have 
been reports of low serum selenium concentration during the acute phase following a 
myocardial infarction and it has been suggested that serum selenium is a negative 
acute phase reactant (Sattar et al., 1997). Our study was limited to individuals whose 
myocardial infarction occurred around 6 months previously, and therefore this is 
unlikely to have had an influence on our findings. Our results are consistent with 
previous prospective epidemiological studies in European populations (Salonen et
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al., 1982; Virtamo et al., 1985; Suadicani et al., 1992). Thus suggesting that the 
significant decrease of serum selenium levels observed in CVD patients may be 
because they 'were originally severely deficient and are trying to retain more selenium 
intracellularly. By taking into account selenium protective role against CVD, this 
reaction would contribute to regulate selenium homeostasis in order to maintain body 
content near adequate levels.
Serum selenoproteins, such as glutathione peroxidase and selenoprotein P may be 
important in coronary prevention due to their antioxidant properties (reviewed by 
Alissa et al.,2003). There was no significant difference in antioxidant enzyme 
activities between CVD patients and their respective controls. However, it is difficult 
to compare their results with published values in other studies. Besides constitutional 
individual differences in gene expression, antioxidative enzyme activities depend on 
variations in life-style and environmental factors. Analytical variations are usually 
caused by methodological differences and the absence of standardized methods for 
the determination of enzymes activities.
An inverse association between serum selenium and erythrocyte GPx among controls 
might be due to increased GPx synthesis in the presence of adequate selenium inside 
the cells thus leading to a decrease in extracellular level. It also indicates that higher 
GPx activity level is required in CVD patients to overcome the increased production 
of hydrogen peroxide molecules, thus more serum selenium is trapped intracellularly 
whereas in controls the antioxidative role of serum selenium might be less needed or 
that decreased GPx activity, mediated by low selenium status, might be compensated 
by other cellular antioxidants, such as vitamin E. Moreover, sub-clinical state of 
selenium deficiency might be expected to be associated with reduced levels of GPx. 
Some studies have suggested that a serum selenium concentration of < 1.27 pmol/L is
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associated with suboptimal GPx activity (Thomson et ah, 1982). One third of controls 
and more than half of CVD patients were below that level suggesting a high 
possibility of low GPx activity.
5.5.6 High trace elements intake in Saudi males with cardiovascular 
disease
The relation between dietary intake levels of trace elements and their circulating 
concentrations is more complex. Generally circulating concentrations of copper were 
shown to be relatively stable in short-term studies (Milne, 1994) since strong 
homeostatic mechanisms keep circulating levels within a fairly tight range 
(Tumlund,1998). Thus, short-term changes in copper intake between 0.8mg/day and 
7.5mg/day are unlikely to result in substantial changes in circulating concentrations, 
albeit, association between circulating serum copper and dietary copper intake levels 
among controls suggests that both variables are useful for estimating copper status. 
Increased dietary copper may affect intestinal absorption and urinary excretion of 
selenium in rat (Yu and Beynen,2000). Thus the positive correlation between dietary 
copper and urinary selenium levels in controls could be explained by the enhancement 
of urinary selenium excretion.
The impact of dietary zinc on selenium status should be evaluated with respect to the 
total body content of selenium. Dietary zinc could affect selenium bioavailability 
through the action of intestinal metallothionein, thus explaining the inverse 
correlation between zinc intake and serum selenium in controls. However the positive 
correlation between zinc intake and urinary selenium in controls is hard to explain but 
it may reflect an inhibitory effect of adequate intake of zinc on low intake of 
selenium, as suggested by our findings, or it may indicate a shared mechanism of 
renal tubular transport.
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Levels of copper and zinc intake in controls and patients were approximately at the 
recommended intakes (Dietary Reference Values for food energy and nutrients for the 
UK,2003). It is noteworthy that people tend to improve their dietary habits upon 
manifestation of CVD symptoms. This is clearly demonstrated by higher intakes of 
micronutrient and fiber among the patients. However, the role of phytate, mainly 
found in plant seeds and grains and in lesser amounts in fruits and vegetables, in 
forming insoluble complexes with cations rendering them unavailable to animals and 
humans is very important in determining copper, zinc, and selenium bioavailability 
(Juliano et al., 1991). In spite of their wide distribution among foodstuffs (Table 1.4), 
insufficiency may result from the dietary presence of other nutrients in large 
quantities thus affecting their bioavaliability, such as, the effect of high intake of zinc, 
iron and carbohydrates on copper bioavailability (Tumlund,1988).
Wheat is a major source of selenium in many diets (discussed in Alissa et al.,2003), 
and much of the wheat used in Saudi Arabia is grown in desert irrigation projects (Al- 
Saleh and Al-Doush,1997). It is possible that this is not supplemented with sufficient 
selenium, a problem that may be easily remedied. Altogether with the large scale 
trade in food in Saudi Arabia may mask a possible relationship between local soil, 
foodstuff level and selenium status in our region. Previous observations of low 
selenium content in soil were reported by Al-Saleh (2000) in Kingdom of Saudi 
Arabia. Supplementation of fertilizers with selenium proved to be safe and effective 
means of increasing intake of both animals and humans in countries with low 
selenium in the soil.
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5.5.7 Changes in trace elements status according to the presence of 
chronic diseases
Diabetes mellitus
Trace elements status is highly affected in the presence of diabetes mellitus 
(Strain, 1991). Numerous studies have reported normal zinc (Zargar et al., 1998) or 
decreased zinc levels in diabetes probably due to zinc malabsorption and 
hyperzincuria (Isbir et al., 1994, Abou-Seif and Youssef,2004). In contrast, copper has 
been shown to be normal (Rohn et al., 1993) or elevated in diabetic patients (Isbir et 
al., 1994; Zargar et al., 1998; Abou-Seif and Youssef,2004), which may exacerbate the 
oxidative stress state and the increased renal copper content may contribute to diabetic 
nephropathy. Malabsorption is also recognized as being responsible for selenium 
deficiency in diabetics (Ruiz et al., 1998). Conversely, other investigators have shown 
an increase in selenium status (Cser et al., 1993) or similar serum selenium levels to 
their matched controls (Wang et al., 1995).
The significant increase in urinary zinc levels in diabetic CVD patients against non­
diabetic CVD patients is a typical complication of diabetes. Lower serum selenium 
levels were significantly evident with the coexistence of diabetes in CVD patients 
when either compared to controls with or without diabetes. Lower urinary copper 
levels among CVD patients with diabetes than non-diabetic controls could be due to a 
combined effect of both conditions.
Although poor nutrient intake among individuals with diabetes has been reported in 
other Caucasian populations (Virtanen et al.,2000), our results showed higher intake 
of all 3 trace elements among diabetic CVD patients than their diabetic and non­
diabetic controls. However, micronutrient bioavailability is compromised due to the 
presence of other nutrients that might interfere with the absorption of ingested trace
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elements. Furthermore, except for selenium (Diplock,1993), the increase in intake is 
not expected to be reflected on their circulatory levels except in case of severely 
depleted stores (Hambidge and Krebs, 1995, Milne, 1994).
M etabolic syndrome
Metabolic syndrome is widely recognized as a cluster of metabolic risk factors, such 
as, dyslipidemia, hypertension, hyperglycemia, and central obesity (Reaven et 
al., 1994). Since we do not have waist: hip ratio measurements for all subjects, the 
definition of metabolic syndrome by the WHO was used (Alberti and Zimmet,1998). 
Several studies have shown high serum caeruloplasmin in diabetes and it was 
hypothesized that it might be due to increased metabolic stress because of its 
independent association with intra-abdominal fat thickness, in addition to total 
cholesterol and triglycerides (Cignarelli et al., 1996). Careuloplasmin is also the major 
copper-containing protein in plasma and is usually elevated in chronic inflammation 
because of its action as an acute-phase protein. In line with this, we found an increase 
in urine copper concentrations in controls with metabolic syndrome when compared 
to CVD patients without metabolic syndrome. Controls with metabolic syndrome had 
more selenium in serum than CVD patients with or without metabolic syndrome and 
excreted less selenium in urine than controls without metabolic syndrome or CVD 
patients with metabolic syndrome, thus illustrating that selenium levels may be 
retained more within the body by renal adjustment of their excretory rate. Selenium 
levels were found to be unchanged in metabolic syndrome patients in the NHANES 
III and it was attributed to similar rates of intake and consumption of the nutrient 
(Ford et al.,2003). However, due to small number of control subjects with metabolic 
syndrome (n=29) verses CVD patient subjects with metabolic syndrome (n=61) or
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without metabolic syndrome (n=69) as well as lack of information on central obesity 
values, the prevalence of metabolic syndrome might have been underestimated.
Even with the reported increased intake of all 3 trace elements by CVD patients with 
metabolic syndrome than their controls, the influence of other food components, such 
as fiber or carbohydrates, in hindering trace elements bioavailability could not be 
completely ruled out.
Hypertension
Hypertension is a well-established coronary risk factor. The risk of hypertension is 
also related to antioxidant status. It has been hypothesized that an imbalance between 
copper and zinc might be a risk factor in hypertension (Klevay,1975, Klevay,1980). 
This has also been proposed in other studies (Vivoli et al., 1995). Hypertensive CVD 
patients had lower serum selenium and lower urine copper than their respective 
controls with or without hypertension. In the same context, blood pressure was 
inversely correlated with serum selenium and positively correlated with urine copper 
and urine selenium among CVD patients as a whole. This could be an attempt by 
body to preserve the whole body selenium content by shifting in tissue selenium 
concentrations. Salonen et al., (1991b) have suggested a synergistic effect of high 
serum copper, as a pro-oxidant, with low serum selenium and increased LDL-C in 
atherogenesis.
Dietary intake of trace elements is highly unlikely involved because there was no 
significant difference between hypertensive CVD patients and their respective 
controls.
Dyslipidemia
One of the implications of copper and zinc in the etiology of CVD is through their 
effects on serum lipids (Hess et al., 1977, Sandstead et al., 1980, Kromhout et al., 1985,
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Jiang et al., 1992). Klevay (1975) suggested that the increase in zinc to copper ratio in 
diet caused hypercholesterolemia, and leads to atherosclerosis. Experimental and 
epidemiological data on copper and zinc relation to serum lipids are rather conflicting 
(Black et al.,1988, Gatto and Samman,1995, Hess et al., 1977, Sandstead et al., 1980). 
Low selenium level could also contribute to atherosclerosis, as a cofactor of GPx, 
through an increase in lipid peroxides (Hussein et al., 1997).
It was hard to do any comparisons with 95% of the CVD patients and 94% of their 
matched controls being dyslipidémies. Furthermore, copper and zinc showed no 
correlation with serum lipids parameters in our sample as previously indicated in 
other studies (Neggers et al.,2001). As in other studies (Navarro-Alarcon et al.,1999), 
serum selenium was associated with serum triglycerides in controls as a whole and it 
was attributed to its protective role against increased lipid peroxides since 
triglycerides are the target substances for oxidation.
Coronary disease severity 
Overall, the profile of trace elements status was similar to that when CVD patients 
were compared to their matched controls. Moreover, there was a trend of decreased 
serum copper, urine copper, urine zinc, and serum selenium when coronary disease 
severity increases. The opposite was true for serum zinc. However, among patients 
evaluated by coronary angiography, those with ZVD/SVD had significantly higher 
serum copper, serum copper/zinc ratio, and serum selenium than both of those with 
DVD and MVD. Similarly, those with DVD had significantly higher serum selenium 
and serum copper/zinc ratio than those of MVD. This was in accordance with 
previous reports (Moore et al., 1984) but not with others (Oster et al., 1986). Using 
different criteria of disease severity (i.e. >75% of luminal occlusion) could be one 
reason for this discrepancy. Data available on the activity of GPx in atherosclerotic
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patients with different degrees of disease severity are limited. We found higher 
erythrocyte GPx activity in CVD patients with ZVD/SVD than those of DVD and 
MVD. Thus indicating an incremental increase in free radical production with the 
increase in disease severity. Other observations in French acute myocardial infarction 
patients found no significant difference in GPx activity regarding the number of 
affected vessels (Lafont et al., 1996).
5.5.8 Multivariate analysis 
For optimal comparison, we attempted to match cases and controls for age. The 
confounding effects of non-independent factors were eliminated by a multivariate 
analysis. There was a trend toward a decreased coronary risk at higher levels of serum 
selenium, serum copper/zinc ratio, and to a lesser extent serum zinc. Urine selenium 
as well as the traditional risk factors, hypertension and diabetes mellitus also emerged 
as independent risk factors from our analysis. Depending on the definition of these 
risk factors the risk estimates increased by an Odds ratio of 9.15 (95% Cl: 1.63-61.39) 
with the presence of hypertension and by an Odds ratio of 13.64 (95% Cl: 1.53- 
121.41) with the presence of diabetes mellitus. Clear association has been previously 
established by other studies linking altered trace elements status with diabetes 
mellitus and hypertension, in which trace elements profile was found to be different in 
hypertensive and diabetic patients from those with CVD (Bhanot et al., 1994, Lopez et 
al.,1991).
In terms of trace elements status, elevated risk of CVD among individuals with high 
urine selenium or low serum zinc or serum copper/zinc ratio or serum selenium was 
indicated by this model. A protective effect of high zinc status has also been 
suggested by other prospective studies (Kok et al.,1988, Singh et al, 1998) but not in 
the case of selenium (Kardinaal et al, 1997, Salvini et al., 1995). Significant predictive
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power of high serum copper/zinc ratio to cardiovascular mortality was also observed 
in other studies (Reunanen et al., 1996). It should be noted that only low explanatory 
power was observed with serum zinc concentration (Odds ratio 0.92, Cl 0.85-0.99, 
p<0.05). Furthermore, the association of serum zinc and serum copper/zinc ratio with 
low risk of atherosclerosis may be suggestive of a certain threshold effect of zinc in 
the protection against CVD. Increased risk of developing CVD was observed with 
high urinary selenium levels. Moreover, low serum selenium concentrations were 
found to be highly associated with atherosclerosis after adjusting for other risk 
factors, including erythrocyte GPx. This suggests that the benefits of selenium may be 
conferred by a mechanism unrelated to the antioxidant effects of GPx.
5.6 Limitations
There is no single universally accepted measure suitable to accurately assess trace 
elements status. The most often used approach to assessment of trace element status is 
the measurement of serum levels. Although relatively convenient, serum levels alone 
may not reflect their actual status. Further they are affected by various factors, such 
as, infections, stress, and hormones (King, 1990). Thus the assessment of trace 
elements levels is rather difficult. Therefore, in our study, the measurement of trace 
elements in other body fluids as well as the assessment of potential surrogate markers 
was an attempt to determine their true body status.
The retrospective nature of the study design may have some drawbacks. For example, 
people tend to improve their dietary habits upon manifestation of CVD symptoms. 
Because symptomatic CVD may influence the dietary habits of persons, this 
difference is a potential source of bias. For this reason one must be very cautious in 
excluding the possibility of an association between dietary intakes of trace elements 
alone and CVD risk.
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Although confounding was minimized by multivariate analysis, the possibility that 
other factors associated with trace element status might be responsible for the 
observed effects cannot be fully ruled out. Furthermore it can be assumed that many 
possible associations between trace elements and CVD outcomes may have been 
diluted. Similarly the lacks of associations do not necessarily mean that the element is 
not relevant either as a risk determinant or a prognostic factor.
Additional sources of error might be the use of the UK food composition tables to 
calculate micronutrient content of dietary intake as well as the recommended 
nutritional intake values for UK adults as there are no published data for food present 
in the Saudi market or for Saudi population.
5.7 Conclusions
Measures of selenium status in serum and urine, serum zinc as well as serum 
copper/zinc ratio appear to be associated with the risk of atherosclerosis in a Saudi 
male population. Even though some potential confounders were adjusted for, the 
possibility still remains that other factors associated with these trace elements might 
be responsible for the observed effects. The results do not reflect direct causal effects. 
We have yet to determine whether the differences in trace element status are simply 
the consequence of the disease or if they contribute directly to its etiology. Therefore, 
larger prospective cohort studies are needed to confirm our observations, and 
experimental data may further elucidate the biological mechanisms of the 
associations.
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Chapter 6
Dietary and biochemical 
characteristics related to 
antioxidant vitamins in Saudi males 
with and without atherosclerosis
6.1 Introduction
Considerable evidence has been gathered in support of the hypothesis that free 
radical-mediated oxidative processes play a key role in atherogenesis. 
Epidemiological studies have not been entirely consistent with regard to the 
relationship between antioxidant vitamin intake and CVD and there appears to be 
little data on this relationship in non-Caucasian populations (Blot et al., 1993, Omenn 
et al., 1996, Stephens et al., 1996).
6.2 Specific aim
The hypothesis of this study was that a suboptimal intake of antioxidant vitamins may 
lead Saudi males to have a predisposition to develop CVD . The aim of this study was 
to investigate the relationship between self-reported dietary intake of the antioxidant 
vitamins A, C, vitamin E, and the carotenoids, serum vitamin E and A concentrations, 
and indices of lipid peroxidation in Saudi males with established CVD and a 
population of age-matched subjects without CVD. Taking into account the effect of 
age, chronic diseases, and the extent of coronary disease severity.
6.3 Methods
We assessed the dietary intake of vitamin A, C, and E and carotenoids, by a food 
frequency questionnaire; and measured serum vitamin A and E concentrations by 
HPLC, in 130 Saudi male subjects with established CVD, and 130 age-matched 
controls using methods previously described in Chapter 2, section 2.4.7, page 126. 
We also determined serum inflammatory markers (hs-CRP, sICAM-1), glucose, lipid 
profiles (total cholesterol, triglycerides, HDL-C, LDL-C), lipoprotein (a), oxidized 
LDL, and serum lipid peroxide concentrations (Chapter 2, section 2.4, 2.4.3, 2.4.5, 
pages 94, 101, 110).
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6.4 Results
6.4.1 Comparison of biochemical and demographic data between groups
The distribution of demographic and predisposing coronary risk factors in the study 
population of 130 CVD patients and their age-matched 130 controls has been 
discussed previously in chapter 4 (Table 4.13).
Table (6.1) summarizes the biochemical measurements among controls and cases. 
Lipid profiles were similar for the groups, although serum triglycerides were 
significantly higher among the patients (p<0.001) a finding consistent with the higher 
proportion of diabetics within this group (60% vs. 36%).
Ox-LDL showed to be positively correlated with total cholesterol (r=0.227, p<0.01) 
among controls and inversely so with HDL (r =-0.254, p<0.01) among CVD patients. 
Importantly, 86% and 98% of controls and CVD patients respectively had lipoprotein 
(a) levels >30mg/dl.
6.4.2 Serum antioxidant vitamins levels
Vitamin A and E serum levels in CVD patients showed no significant difference to 
from age-matched controls (Table 6.1).
A substantial proportion, 64% and 66% of controls and patients respectively, had 
serum vitamin E levels below 30 pmol/L, and 49% and 56% of controls and patients 
respectively had serum vitamin A levels below 2.8 pmol/L.
6.4.3 Differences in serum and dietary intake vitamin levels with age
Table (6.2) shows the means of serum levels and dietary intake of antioxidant vitamin 
A and E in controls and cases categorized according to their tertiles for age. Both 
vitamins intake was above the EAR value. However, none of the parameters measured 
varied significantly with age in either group (p>0.05).
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T a b l e  6 .1 :  B io c h e m i c a l  p a r a m e te r s  in  p a t ie n t s  w i t h  C V D  a n d  c o n tr o ls .
Controls (n=130) Cases (n=130)
Mean SEM Mean SEM
Total cholesterol [mmol/L] 5.41 0.13 5.32 0.12
Triglycerides [mmol/L] 1.65 0.08 1.92# 0.07
HDL-C [mmol/L] 1.31 0.05 1.36 0.05
LDL-C [mmol/L] 3.78 0.13 3.58 0.12
Atherogenic index (TC/HDL) 4.62 0.16 4.55 0.18
LDL/HDL ratio 3.33 0.16 3.20 0.16
Oxidized-LDL [U/L] 66.13 2.98 60.94 3.19
Oxidized -LDL/ LDL-C ratio 20.16 1.25 20.35 1.44
Oxidized-LDL/TC ratio 12.71 0.58 12.32 0.76
Lipoprotein (a) [mg/dl] 77.99 5.67 73.86 5.07
Glucose [mmol/L] 7.15 0.26 8.55# 0.32
TBARS [pM] 2.29 0.08 2.42 0.08
FOX [pM] 2.01 0.08 2.14 0.07
Hs-C reactive protein (mg/L) 2.21 0.10 2.14 0.10
SICAM-1 (ng/ml) 264.4 10.83 295.4 11.5
Vitamin A (pmol/L) 2.95 0.09 2.76 0.08
Vitamin E (pmol/L) 29.21 0.78 28.7 0.67
Vitamin A/TC ratio 0.58 0.02 0.55 0.02
Vitamin A/TC+TG ratio 0.44 0.02 0.40 0.02
Vitamin E/TC ratio 5.61 0.15 5.56 0.12
Vitamin E/TC+TG ratio 4.26 0.11 4.06 0.08
Data were compared by unpaired t tests or Mann-Whitney tests for non-normally distributed data. 
HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, SEM: 
standard error o f  mean, sICAM-1: soluble adhesion m olecule-1, * P  <0.05 # P  <0.001
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6.4.4 Dietary antioxidant vitamins intake
Table (6.3) compares the average intake of energy, total fat, and antioxidant vitamins. 
CVD patients had a higher total energy intake (p<0.05). Although both serum vitamin 
A and E were similar between the groups (Table 6.1), the absolute dietary intake of 
vitamin A and E were higher among cases (p<0.001 and p<0.05 respectively). The 
difference remained significant for vitamin A intake (p<0.05) after correction for total 
fat intake. The mean daily intake of vitamin C and carotenoids did not differ 
significantly between the groups.
The percentage of subjects in our study who reported consuming less than the EAR of 
vitamin A were 55% and 31% of controls and CVD patients respectively. The 
percentage of subjects reporting consuming less than the EAR of vitamin E were 14% 
and 12% of controls and CVD patients respectively. None of our subjects reported 
dietary vitamin C consumption less than the EAR.
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T a b l e  6 .3 :  T o ta l  d a i ly  c a lo r ie ,  fa t  a n d  a n t io x id a n t  v i t a m in  in ta k e  in  p a t ie n t s  w i t h  C V D
a n d  c o n tr o ls .
RNI Controls (n= 130) Cases (n=130)
Mean SEM Mean SEM
Energy (Kcal) 2755(15-18) 1848.36 37.34 1974.40* 38.15
2550 (19-59) 
2380 (60-74) 
2100 (75+)
Total fat (gm) 79.59 2.07 88.79 * 2.34
Adjusted fat (gm) 79.59 0.09 79.81 0.08
% Energy supplied 30% 3&60 0.54 40.07 0.51
by fat
Polyunsaturated 17.65 0.54 20.09 0.63
fatty acids (gm)
Adjusted 17.29 0.08 17.51 0.09
Polyunsaturated
fatty acids (gm)
% Energy supplied 10% 9.5724 0.24 10.12 0.23
by Polyunsaturated
fatty acids
Cholesterol (mg) <200 pg 223.81 8.48 264.05 * 10.62
Fiber (gm) 18 gm 18.93 0.40 20.41 0.44
Vitamin C (mg) 40 mg 41.32 1.41 41.24 1.58
Vitamin A (pg) 700 pg 655.98 60.49 1084.70# 120.61
Carotenoids (mg) NA 12.03 0.22 12.41 0.17
Vitamin E (mg) 15 mg 13.17 0.32 14.41* 0.40
Vitamin A/total fat NA 9.11 0.93 13.17* 1.47
(Hg/gm)
Vitamin E/total fat NA 0.18 0.01 0.18 0.01
(mg/gm)
Vitamin E/ NA 0.83 0.03 0.82 0.03
Polyunsaturated
fatty acids (mg/gm)
Data were compared by unpaired t tests or Mann-Whitney tests for non-normally distributed data. NA: 
not available, RNI; reference nutrient intake,SEM: standard error o f  mean, * P  <0.05 # P  <0.001
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6.4.5 Differences in serum and dietary vitamin levels with chronic conditions
Table (6.4) shows that were no significant differences in serum vitamin levels when 
they were compared with regard to the presence of diabetes mellitus, metabolic 
syndrome, and hypertension. The reported mean intake of vitamins was above the 
EAR values when CVD patients and their age-matched controls were categorized 
according to the presence or absence of all 3 chronic conditions.
However, diabetic CVD patients had a higher vitamin A intake than non-diabetic 
controls (p<0.05) and non-diabetic CVD patients had higher vitamin A intake than 
controls with or without diabetes (p<0.05). A similar pattern was observed in 
metabolic syndrome with higher vitamin A intake among CVD patients whether they 
had metabolic syndrome or not compared to controls with or without diabetes 
metabolic syndrome (p<0.05). With hypertension, the difference between 
hypertensive and non-hypertensive CVD patients verses their controls with or without 
hypertension persisted even after standardization for total fat intake (p<0.05).
6.4.6 Differences in serum vitamin levels with coronary disease severity
A total of 180 patients were admitted to undergo angiography. Due to the small 
number of those who were categorized as having a single vessel disease (n=4), they 
were merged with those who were categorized with zero vessel disease (n=27). Table 
(6.5) shows that CVD patients with ZVD/SVD had significantly higher serum vitamin 
A (p<0.05) compared to CVD patients with DVD and with MVD. In terms of 
vitamins intake, they all report higher daily intake than the EAR values but no 
significant difference existed between groups (p>0.05).
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Table 6.4 (a): Comparison of serum vitamins in patients with CVD and their controls 
according to the presence of diabetes mellitus
Controls (n=130) Cases (n=130)
Vitamin A
Non-diabetics
(n=82)
3.01 ±0.12
Diabetics
(n=48)
2.85 ±0.12
Non-diabetics
(n=52)
2.86 ±0.14
Diabetics
(n=78)
2.69 ±0.10 NS
(pmol/L) 
Vitamin E 28.35 ± 0.82 30.67 ± 1.58 27.76 ±098 29.33 ± 0.90 NS
(pmol/L)
Vitamin 0.59 ± 0.03 0.57 ± 0.04 0.58 ± 0.04 0.53 ± 0.02 NS
A/TC ratio 
Vitamin 5.49 ±0.17 5.79 ±0.30 5.40 ± 0.20 5.66 ± 0.15 NS
E/TC ratio 
Vitamin A 625.7 ± 72.2 707.8 ± 108.4 1135.9 ±194.7*1 1050.6 ±154.4$ <0.05
intake (pg) 
Vitamin E 13.43 ± 0.39 12.73 ± 0.57 14.16 ±0.056 14.59 ±0.56 NS
intake (mg) 
Vitamin 8.30 ± 1.05 10.49 ± 1.77 12.57 ±2.25 13.57 ± 1.94 NS
A/total fat
(pg/gm)
Vitamin 0.17 ±0.01 0.18 ±0.01 0.16 ±0.01 0.19 ±0.01 NS
E/total fat 
(mg/gm)
Data are shown as mean ±  SEM, Continuous variables were compared by Kruskal-Wallis test. NS: not 
significant, SEM: standard error o f  mean § P<0.05 (first & second groups), # P<0.001 (first & second 
groups) * P<0.05 (first & third groups), ¥  P<0.001 (first & third groups) H P<0.05 (second & third 
groups), t  P<0.001 (second & third groups) f  P<0.05 (first & forth group), £ P<0.001 (first & forth 
group) €  P<0.05 (second & forth group),  ^ P<0.001 (second & forth group) 0 P<0.05 (third & forth 
group), $ P<0.001 (third & forth group)
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Table 6.4 (b): Comparison of serum vitamins in patients with CVD and their controls 
according to the presence of metabolic syndrome (MS)
Controls (n=130) Cases (n=130)
V itam in  A
Non- M S (n=101) 
3 .0 0  ± 0 .1 0
M S (n=29) 
2 .7 8  ± 0 .1 5
Non-M S (n=69) 
2 .73  ± 0 .1 2
M S (n=61) 
2 .7 8  ± 0 .1 1 NS
(pm ol/L ) 
V itam in  E 2 8 .5 9  ± 0 .7 9 3 1 .3 6 ± 2 .1 4 2 7 .3 6  ± 0 .7 9 3 0 .2 2  ±  1.09 NS
(pm ol/L )
V itam in 0 .5 9  ±  0 .02 0.55  ±  0 .04 0 .57  ±  0.03 0 .53  ±  0.03 NS
A /T C  ratio 
V itam in  E/TC 5 .46  ± 0 .1 5 6 .12  ± 0 .4 6 5 .5 4  ± 0 .1 7 5 .57  ± 0 .1 8 NS
ratio
V itam in  A 6 6 2 .45  ±  68 .7 6 3 3 .4 4  ± 1 2 9 .6 9 6 7 .9 7  ± 1 3 3 . 6 * 1 1216 .74  ±  2 0 7 .9  $ € <0.05
intake (pg) 
V itam in  E 12.95 ± 0 .3 8 13.93 ± 0 .5 8 14.57 ± 0 .5 3 14 .24  ± 0 .6 2 NS
intake (m g) 
V itam in 9 .0 9  ±  1.02 9 .15  ± 2 .2 0 11.53 ± 1 .7 1 15.02 ± 2 .4 5 NS
A /total fat
(p g /gm )
V itam in 0 .1 7  ± 0 .0 1 0 .19  ± 0 .0 1 0 .1 8  ± 0 .0 1 0 .1 8  ± 0 .0 1 NS
E/total fat 
(m g/gm )
Data are shown as mean ±  SEM, Continuous variables were compared by Kruskal-Wallis test. NS: not 
significant, SEM: standard error o f  mean § P<0.05 (first & second groups), # P<0.001 (first & second 
groups) * P<0.05 (first & third groups), ¥  P<0.001 (first & third groups) 1 P<0.05 (second & third 
groups), t  P<0.001 (second & third groups) $ P<0.05 (first & forth group), £ P<0.001 (first & forth 
group) €  P<0.05 (second & forth group),  ^ P<0.001 (second & forth group) 0 P<0.05 (third & forth 
group), $ P<0.001 (third & forth group)
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Table 6.4 (c): Comparison of serum vitamins in patients with CVD and their controls 
according to the presence of hypertension
Controls (n=130) Cases (n=130)
Non hypertensives 
(n=62)
Hypertensives
(n=68)
Non hypertensives 
(n=45)
Hypertensives
(n=85)
Vitamin A 2.99 ±0.15 2.92 ±0.10 2.64 ±0.14 2.81 ±0.10 NS
(pmol/L) 
Vitamin E 29.87 ±1.27 28.60 ± 0.95 29.33 ± 1.05 28.37 ±0.86 NS
(pmol/L)
Vitamin 0.59 ± 0.04 0.58 ± 0.03 0.54 ± 0.03 0.56 ± 0.03 NS
A/TC ratio
Vitamin E/TC 5.59 ±0.24 5.62 ± 0.20 5.76 ± 0.20 5.44 ±0.15 NS
ratio
Vitamin A 764.17 ±97.02 557.33 ±73.15 1213.9 ± 221.0 * t 1016.3 ± 143.1 € <0.001
intake (pg) 
Vitamin E 12.59 ± 0.46 13.70 ±0.45 14.49 ± 0.75 14.38 ±0.48 NS
intake (mg) 
Vitamin 10.34 ±0.39 7.99 ± 0.24 15.25 ±3.051 12.06 ± 0.56 € <0.05
A/total fat
(pg/gm)
Vitamin 0.17 ±0.01 0.18 ±0.01 0.18 ±0.01 0.18 ±0.01 NS
E/total fat
(mg/gm)
Data are shown as mean ±  SEM, Continuous variables were compared by Kruskal-Wallis test. NS: not 
significant, SEM: standard error o f  mean § P<0.05 (first & second groups), # P<0.001 (first & second 
groups) * P<0.05 (first & third groups), ¥  P<0.001 (first & third groups) % P<0.05 (second & third 
groups), t  P<0.001 (second & third groups) $ P<0.05 (first & forth group), £ P<0.001 (first & forth 
group) €  P<0.05 (second & forth group), à P<0.001 (second & forth group) 0 P<0.05 (third & forth 
group), $ P<0.001 (third & forth group)
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Table 6.5: Levels of serum and dietary intake of vitamins in CVD patients divided by 
the number of coronary vessels occluded
ZVD/SVD DVD MVD P
n 31 67 82
Vitamin A (pmol/L) 3.3 ± 0.25 § * 2.6 ±0.11 2.6 ± 0.98 <0.05
Vitamin E (pmol/L) 24.3 ± 1.03 27.0 ±0.91 28.1 ±0.89 NS
Vitamin A/TC ratio 0.67 ± 0.06 § * 0.52 ± 0.03 0.52 ± 0.02 <0.05
Vitamin E/TC ratio 4.9 ± 0.25 5.4 ±0.20 5.4 ±0.14 NS
Vitamin A intake 1092.9 ±213.6 1373.4 ±217.3 1013.2± 118.6 NS
w
Vitamin E intake 14.33 ± 0.76 14.82 ±0.56 15.21 ±0.51 NS
(mg)
Vitamin A/total fat 0.17 ±0.01 0.16 ±0.01 0.18 ±0.01 NS
(pg/gm)
Vitamin E/total fat 11.77 ±2.27 13.96 ±2.18 11.02 ± 1.24 NS
(mg/gm)
Data were compared Kruskal-Wallis test for non-normally distributed data. DVD: double vessel 
disease, MVD: multi- vessel disease, NS: not significant, SEM: standard error o f  mean, SVD: single 
vessel disease, ZVD: zero vessel disease, * P<0.05 (first & third groups), ¥  P<0.001 (first & third 
groups), § P<0.05 (first & second groups), # P<0.001 (first & second groups), 1 P<0.05 (second & third 
groups), t  P<0.001 (second & third groups)
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6.4.7 Univariate analysis
The univariate association between serum and dietary levels of antioxidant vitamins A 
and E, lipoproteins and measures of lipid peroxidation are shown in table (6.6). Serum 
vitamin A concentrations correlated with dietary vitamin A in the group of subjects as 
a whole (r = 0.129, p<0.05) and in the patients with CVD (r = 0.222, p<0.05) 
suggesting that the FFQ provided a good estimate of intake as mentioned earlier in 
chapter 4. Simple linear regression indicated that this association accounted for 2% 
and 5% of the variability in serum vitamin A levels in the group of subjects as a 
whole and in CVD patients respectively.
The dietary intake of vitamin E and A were correlated in the group as a whole (r = 
0.146, p <0.05) and among controls only (r = 0.174, p<0.05). Serum concentrations of 
vitamin A and E corrected for total cholesterol were strongly positively associated in 
both groups of subjects (controls r = 0.480, p<0.0001; cases r = 0.377, p<0.0001). 
There was a negative correlation between serum vitamin E level and the ox-LDL/LDL 
ratio among the combined group (r =-0.197, p<0.001) and cases (r = -0.287, p<0.001) 
but not in the controls (p>0.05) (Figure 6.1). However, there was a positive 
association between serum vitamin A level and the ox-LDL/LDL ratio among the 
combined group (r =0.124, p<0.05) and controls (r = 0.194, p<0.05) but not cases 
(p>0.05) (Figure 6.2).
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Table 6.6: Correlation coefficient between serum vitamin A and biochemical and 
demographic parameters in patients with CVD and controls. Pearson’s or Spearman's 
correlation coefficients were calculated for each group separately.
Controls
(n=130)
Cases
(n=130)
Serum vitamin A vs. biochemical 
parameters
r P r P
LDL-C (mmol/L) -0.032 0.717 -0.028 0.749
Triglycerides (mmol/L) 0.078 0.377 0.024 0.786
Oxidized-LDL (U/L) 0.16 0.07 0.091 0.302
Oxidized-LDL/LDL-C ratio 0.194 0.025 0.07 0.428
TC/HDL-C ratio -0.08 0.366 0.09 0.306
Lipoprotein (a) (mg/dl) -0.016 0.856 -0.052 0.554
Hs-C reactive protein (mg/L) 0.054 0.541 0.039 0.662
sic AM-1 (ng/ml) -0.041 0.644 -0.165 0.06
Serum vitamin E (pmol/L)
Serum vitamin A vs. dietarv parameters
0.315 <0.0001 0.229 0.009
Dietary vitamin A (pg) 0.056 0.527 0.222 0.011
Dietary vitamin E (mg) -0.058 0.511 -0.005 0.951
Dietary vitamin C (mg) 0.115 0.191 -0.029 0.743
Serum vitamin A vs. demographic 
parameters
Age -0.122 0.166 -0.021 0.816
BMI -0.078 0.378 0.007 0.941
SBP(mmHg) 0.132 0.135 0.049 0.579
DBP (mm Hg) 0.058 0.514 0.060 0.495
Smoking 0.202 0.021 0.112 0.204
Serum vitamin A/TC ratio vs.
Vitamin E/TC 0.480 <0.0001 0.377 <0.0001
SBP (mm Hg) 0.197 0.025 0.023 0.795
Hs-C reactive protein (mg/L) 0.065 0.461 0.031 0.730
sICAM-1 -0.113 0.199 -0.192 0.029
Dietarv vitamin A vs.
Oxidized-LDL (U/L) 0.074 0.404 0.180 0.041
Dietary vitamin E (mg) 0.174 0.048 0.086 0.329
Smoking 0.181 0.039 0.208 0.018
BMI; body mass index, DBF: Diastolic blood pressure, LDL-C: low density lipoprotein cholesterol, 
SBP: systolic blood pressure, sICAM-1: soluble adhesion m olecule-1
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Table 6.7: Correlation coefficient between serum vitamin E and biochemical and 
demographic parameters in patients with CVD and controls. Pearson's or Spearman's 
correlation coefficients were calculated for each group separately.
Controls Cases
Serum vitamin E vs. biochemical 
parameters
r P r P
LDL-C (mmol/L) 0.331 <0.0001 0.453 <0.0001
Triglycerides (mmol/L) 0.306 <0.0001 0.29 0.001
Oxidized-LDL (U/L) 0.084 0.344 -0.085 0.377
Oxidized-LDL/LDL-C ratio -0.115 0.195 -0.287 0.001
TC/HDL-C ratio 0.188 0.032 0.322 <0.0001
Lipoprotein (a) (mg/dl) -0.102 0.250 0.039 0.658
Hs-C reactive protein (mg/L) 0.007 0.936 0.137 0.121
sICAM-1 (ng/ml)
Serum vitamin E vs. dietarv parameters
-0.177 0.044 -0.019 0.830
Dietary vitamin E (mg) -0.041 0.642 -0.084 0.340
Dietary vitamin A (pg) 0.098 0.266 -0.031 0.724
Dietary vitamin C (mg)
Semm vitamin E vs. demographic
0.177 0.044 -0.099 0.261
parameters
Age
-0.023 0.166 -0.013 0.885
BMI -0.108 0.221 0.07 0.941
Smoking 0.086 0.331 -0.086 0.332
SBP (mm Hg) -0.104 0.237 0.097 0.270
DBP (mm Hg)
Serum vitamin E/TC vs.
-0.095 0.282 0.221 0.011
sICAM-1 0.037 0.678 -0.044 0.617
Hs-C reactive protein (mg/L) 
Dietarv vitamin E vs.
0.067 0.448 0.109 0.218
Oxidized-LDL (U/L) -0.129 0.142 0.020 0.818
Smoking -0.021 0.817 0.120 0.172
BM I: body mass index, DBP: Diastolic blood pressure, LDL-C: low density lipoprotein cholesterol, 
SBP: systolic blood pressure, sICAM -1: soluble adhesion m olecule-1
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Figure 6.1(a): Scatter plot show ing correlation betw een serum vitamin E level and 
ox-LDL/LDL-C ratio in the whole population (r=-0.197, p<0.001).
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Figure 6.1(b): Scatter plot show ing correlation betw een serum v itamin E le\ el and 
ox-LDL/LDL-C ratio in cases (r=-0.287, p<0.001 ).
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6.4.8 Correlations between serum vitamin levels with demographic and
inflammatory markers
Among controls, standardised serum vitamin A level was shown to be correlated with 
smoking habits (r=0.202, p<0.05) and with SBP (r=0.197, p<0.05) . Serum vitamin E 
level was correlated with DBF (r=0.221, p<0.05) among CVD patients only.
Of the inflammatory markers, only sICAM-1 was inversely correlated with serum 
vitamin A/TC ratio (r= -0.192, p<0.05) among CVD patients and with serum vitamin 
E level (r= -0.177, p<0.05) among controls.
6.4.9 Multivariate analysis
Conditional logistic regression analysis was performed to determine the association of 
antioxidant vitamins status with atherosclerosis. Potentially confounding and effect- 
modifying factors with p value up to 0.1 were included in the model. Vitamin levels 
were entered as continuous variables in the model. Diabetes mellitus was categorized 
into 0 and 1 with 0 value: no disease and 1 value: presence of disease. Diabetes 
mellitus, total fat intake, serum vitamin A and vitamin A intake corrected for total fat 
intake were shown to be significantly associated with atherosclerosis based on this 
model (table 6.8). Serum vitamin A with an odds ratio of 0.72 implies around a 30% 
reduction in coronary events in CVD patients compared with the controls. Whereas 
diabetes mellitus, total fat intake, and adjusted vitamin A intake were considered to be 
coronary risk factors that are responsible for increasing the risk of coronary events by 
approximately 2.5 fold in case of diabetes mellitus and 1 fold in case of increased 
intake of total fat and vitamin A adjusted for total fat intake.
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Table 6.8: Adjusted odds ratio of CVD calculated from conditional logistic regression 
model.
OR 95% Cl Wald
Lower
bound
Upper
bound
Serum vitamin A 0.72 0.53 0.99 4.05 0.044
Diabetes mellitus 2.49 1.42 4.37 10.14 0.001
Total fat intake 1.02 1.01 1.03 9.62 0.002
Vitamin A/total 
fat ratio
1.04 1.01 1.06 7.89 0.005
OR: odds ratio, 95% Cl: 95% confidence interval
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6.5 Discussion
Our current understanding of the pathogenesis of atherosclerotic process and role of 
free radicals has led to the proposition that dietary antioxidants may alter coronary 
risk. Though it is attractive, the antioxidant hypothesis has not been supported by data 
from clinical trials. Whilst previous results of observational cohort studies are 
compatible with a benefit of vitamin E supplements in CVD prevention (Rimm et 
al., 1993, Stampfer et al., 1993), this was not the case for vitamin A or C. Randomized 
placebo-controlled trials have generally not confirmed the benefit of antioxidant 
intervention (the ATBC study group, 1994; GISSI prevention group, 1999; the HOPE 
study group,2000; the HPS study group,2002) apart from a single study on patients 
who were post-angioplasty (Stephens et al., 1996). Findings from observational cohort 
studies may not be extrapolatable to intervention studies in high-risk patients. It is 
possible that antioxidant status exerts its effects early in the disease process, rendering 
late intervention ineffective. Most studies of the association between antioxidants and 
CVD have been undertaken in Western Caucasian populations. These findings may 
not be applicable to other populations.
Despite the high prevalence of cardiovascular mortality and morbidity in the Middle 
East (Alwan,1993, Alobaid et al., 1994, Al-Balla et al., 1993), there is only one 
published study on normative serum antioxidant vitamins concentrations in the Arab 
Gulf countries (Abiaka et al.,2002) and two studies of Saudis (Abahusain et al., 1999, 
Al-Senaidy,2000). However, there are no data on the relationship between antioxidant 
status and CHD risk in this population.
6.5.1 Markers of inflammation and lipid peroxidation 
Lipoprotein (a) and ox-LDL are considered to be independent lipid coronary risk 
factors (Rosengren et al., 1990, Holvoet et al.,2001). They have both been shown to be
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elevated in CVD patients in a number of epidemiological studies (Fredrikson et 
al.,2003, Cremer et al., 1994). Each may play an important role in the development of 
atherosclerosis through effects on inflammation and thrombolysis, yet the exact 
mechanisms by which they exert their pathological effects have not been clearly 
defined. However, a non-significant increase in lipoprotein (a) and ox-LDL levels was 
found among controls in this population. This could be attributed to the high risk 
among controls and/or due to the fact that none of the patients had suffered a heart 
attack within 6 months of recruitment into the study and the concomitant post- 
myocardial infarction increase in lipoprotein (a) is believed to be only transient and 
return to normal levels within 1 month (Jauhiainen et al., 1991).
Lipoprotein (a) is found to be particularly important in men in whom LDL-C is 
elevated (Maher and Brown, 1995). A consistent finding with this is the concomitant 
increase in both of lipoprotein (a) and LDL among controls. However, more CVD 
patients had elevated lipoprotein (a) levels when a cut-off value of >30mg/dl was used 
(86% and 98% of controls and CVD patients respectively). This value was defined as 
a cut point above which CVD risk is increased in a number of epidemiological studies 
(Jauhiainen et al., 1991). Furthermore, it is not possible to determine if the difference 
in lipoprotein (a) and ox-LDL levels contributes to the risk of developing 
atherosclerosis in controls or if they only serve as markers of a pre-existing CVD in 
cases. Moreover, even though basal lipoprotein (a) levels are primarily genetically 
determined, which is readily indicated by the diverse ethnic composition of CVD 
patients and controls, lipoprotein (a) also appears to act as an acute-phase reactant 
(Hobbs and White, 1999).
Relatively higher atherogenic ratios (i.e. total cholesterol/HDL, LDL/HDL, and ox- 
LDL/total cholesterol) in control subjects than in CVD patients point to increased risk
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for development of atherosclerosis. In accordance, positive correlation between ox- 
LDL and total cholesterol in the controls as well as the inverse correlation of ox-LDL 
with HDL in the CVD patients may imply that the risk of atherosclerosis is associated 
with the relative degree of LDL oxidation rather than with the total level of serum ox- 
LDL.
Lipid peroxidation is thought to be an early event during atherogenesis, causing the 
production of modified LDL and perturbing antioxidant status. However, neither 
marker of lipid peroxidation differed significantly between the study groups. A 
combination of an increased use of anti-inflammatory drugs and higher percentage of 
diabetics among CVD patients as well as slightly higher percentage of smokers 
among controls could explain the lack of significant difference in lipid peroxides 
levels between them.
Significant inverse relationships between the magnitude of the inflammatory response 
and circulating concentrations of vitamin A and E have been documented (Talwar et 
al., 1997). Neither vitamin showed a significant association with CRP in this study. 
Therefore, the relative extent to which these antioxidant vitamins are consumed as 
part of the inflammatory response or whether they are redistributed into extravascular 
tissues remains to be established. The inverse correlation between serum vitamin E 
and sic AM-1 found in controls might be suggestive of an inhibitory effect of vitamin 
E on sICAM-1 induction as previously demonstrated in an in vitro study (Martin et 
al., 1997). Similarly the inverse correlation between the lipid-normalized serum 
vitamin A and sICAM-1 levels among CVD patients could be due to a possible 
similar role.
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6.5.2 Associations of antioxidant vitamins status with demographic 
characteristics 
A ge
An inverse relationship between age and both of vitamin E and retinol have been 
shown by several investigators (Tebi et al.,2000). Conversely, other studies have 
found no association between plasma vitamin levels and age (Vogel et al., 1997). 
Overall, there was no change in dietary intake or serum levels of both vitamins in 
between age tertiles.
Smoking
It has been demonstrated that smoking may cause an increase in oxidative stress and 
an imbalance in antioxidants intake and status (Faruque et al., 1995). Several studies 
reported that smokers have lower vitamin A concentrations than nonsmokers 
(Nierenberg et al., 1989). This could be due to depletion of antioxidant nutrients in the 
body by oxidative substances in cigarette smoke as well as poorer dietary habits and 
less healthy lifestyles of smokers (Emmons et al., 1995). This is particularly true for 
the consumption of fruits and vegetables which are important sources of several 
antioxidants. However, other bioactive substances in fruits and vegetables may 
contribute to their protective effect (Johnson et al., 1994). With slightly higher 
prevalence of smoking in controls (24%), a correlation between serum vitamin A 
level and smoking habits was only observed among controls. Even though serum 
levels of vitamin A showed no significant difference between the groups, the dietary 
intake of vitamin A was much higher in CVD patients. Thus, potentially providing 
more protection against the increased free radicals generation, albeit, this might have 
been due to dietary modification after the coronary event.
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Obesity
Associations between BMI and both of semm vitamin A and E levels have been 
inconsistent in previous studies (Stryker et al.,1988, Ascherio et al., 1992, Vogel et 
al., 1997, Strauss, 1999, Neuhouser et al.,2001). No significant association with BMI 
was observed with either vitamin in this study. It has been suggested that dietary 
differences and variability in body compartment size are likely explainations for such 
discrepancies (Strauss, 1999).
6.5.3 Serum antioxidant vitamins and indices of lipid peroxidation 
Semm vitamin A and E concentrations and their levels of dietary intake are frequently 
utilized in evaluating vitamins status because of their inverse relationship with the 
development of CVD (Willett, 1998). The estimates of semm levels of vitamins in our 
study are in agreement with those reported by other local (Abahusain et al., 1999, 
Abiaka et al.,2002) and international studies (Ito et al., 1990, Olmedilla et al., 1997). 
Gey (1993) has proposed reference values for semm vitamin A (2.2-2.8 pmol/L) and 
vitamin E (28-30 pmol/L) based on the results of the Basel prospective study (Gey et 
al., 1993) and the Edinburgh angina control study (Riemersma et al., 1991). They have 
found an inverse relationship between mortality from ischaemic heart disease and 
semm vitamin levels. Thus these values were considered optimal for the prevention of 
ischaemic heart disease and cancer. Approximately half of our study population had 
semm concentrations of semm vitamin E and A below the lower reference limit. This 
could be of either dietary or metabolic origin. Because both vitamins have an 
exclusive dietary origin, a possible explanation for their decrease might be that diet is 
extremely poor. Other behavioral factors, such as positive smoking habits, might have 
depleted both vitamins semm levels.
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Tocopherols are preferentially bound by the hepatic tocopherol binding protein, thus 
they are preferentially incorporated into LDL and HDL (Traber and Kayden,1989). A 
significant proportion of tocopherol is transported in cholesterol-rich lipoproteins, 
LDL, HDL and VLDL. This may explain the observed association between serum 
vitamin E both of LDL and total cholesterol/HDL ratio. Serum vitamin E 
concentrations were also positively correlated with serum triglycerides. Similar 
findings have been reported in previous studies (Ascherio et al., 1992). Serum vitamin 
A and E levels variability depends on concurrent serum lipids. Thus, the sum of 
cholesterol, triglycerides, and phospholipids has been suggested to be used for more 
definitive standardization of vitamin A and E. However, our data indicate that lipid 
normalization for total cholesterol alone did not differ from the sum of total 
cholesterol and triglycerides (Table 6.1). Hence highly atherogenic lipoproteins 
correlated well to total cholesterol, it has been solely used frequently to standardize 
vitamin A and E but the ideal method of integrating the major lipid fractions still 
remains to be ascertained.
A high vitamin E/ total cholesterol ratio should theoretically be indicative of LDL 
particles that are more resistant to peroxidation. However this ratio was ineffective in 
discriminating between the subject groups in our study as well as in other studies 
(Cleary et al., 1997). This could be due to the finding that tocopherols are slowly 
affected by oxidation in vitro and may therefore not be indicative of early oxidative 
damage to serum lipoproteins (Hennekens and Gaziano,1993). However, within the 
patient group, there was a strong inverse relationship between serum vitamin E and 
ox-LDL/LDL ratio (Table 6.7 and Figure 6.1b).
In contrast, there was a significant positive association between serum vitamin A and 
ox-LDL/LDL ratio suggesting that vitamin A content may not protect LDL from
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oxidation (Table 6.6 and Figure 6.2b). It could be that under mild oxidative conditions 
or in the absence of other antioxidants, vitamin A is able to function as a pro-oxidant 
towards lipoprotein oxidation.
The strong positive correlation between serum concentrations of vitamin A and E may 
be related to the common mode of transportation in serum, which parallels that 
obtained by others (Jordan et al., 1995). Although the liver secretes retinol-binding 
protein into blood stream, serum vitamin A correlates with serum lipids almost as 
strongly as vitamin E does (Gey and Puska,1989). However, the stronger correlation 
obtained after lipid standardization between both vitamins suggests a possible 
biological antioxidant cooperation or interdependence. Thus, indicating that lipid 
standardization can strengthen differences or similarities in lipophilic vitamins that 
are hardly detectable using their absolute concentrations.
6.5.4 Dietary antioxidant vitamins levels 
In our population sample there was a relatively low intake of antioxidant vitamins, 
compared with the recommended dietary intake among both patients and control 
subjects (Table 6.3). Inadequate intake of vitamins in diet is an imperceptible 
possibility to explain lower values of serum levels occasionally measured in 
atherosclerosis (Hennekens and Gaziano,1993). Although the dietary intakes of 
vitamin A and E were significantly higher in the CVD patients, this was not reflected 
in the concentrations of serum a-tocopherol and vitamin A concentrations, which 
were similar for the two groups. This may, in part, be related to the higher prevalence 
of a smoking history (i.e. former and current smokers) and diabetes (p<0.0001 for 
both) in the patient group, both conditions being associated with increased oxidative 
stress, and hence antioxidant consumption. Increased dietary vitamins consumption as 
a part of the antioxidative reactions may also explain the decrease in their serum
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levels. Furthermore, this may be related to the higher total fat intake among these 
patients as pointed out in chapter 4 regarding unhealthy dietary habits adapted by 
young Saudi males. The higher total caloric intake reported by the CVD patients 
despite that higher proportion of them being on a diet (39%) suggests that these 
patients have not been fully compliant with dietary advice. It is also possible that their 
original caloric intake was even higher prior to their coronary event.
Fat-soluble vitamins, particularly, vitamin A and E are widely abundant in fats (Table 
1.4). Their absorption is influenced by the amount of fat in the diet; thus, their intake 
levels were adjusted for total fat intake. However, food sources of tocopherols are 
also major contributors to PUFA but this is not always the case (Lehmann et 
al., 1986). Requirement of vitamin E may increase as intakes of PUFA increase 
because of the preventative role of vitamin E against the formation of oxidative 
products of unsaturated fatty acids. Therefore, vitamin E levels were also expressed as 
vitamin E/PUFA ratio, albeit it did not change the interpretation of the current finding 
of no significant difference between CVD patients and their respective controls (Table 
6.3).
Vitamin C and carotenoids are mainly found in fruits and vegetables and their 
consumption pattern largely dependes on population lifestyle, culture, and food 
distribution system. CVD patients and their control counterparts had approximately 
similar levels of intake of both vitamins. One third of the study participants had 
vitamin C intake below the estimated average requirements. However, vitamin C is 
heat labile and may be substantially lost from dietary sources due to different methods 
of food preparation or in a country with an extremely hot climate like ours. It has been 
clarified that combined vitamin C and E had better defensive ability against oxidative 
damage compared with single vitamins (McCay,1985). The positive association
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between vitamin C intake and serum vitamin E in controls may be an indication of the 
role of vitamin C in regenerating the active form of vitamin E. However, the 
relevance of this relation in vivo is still unclear. On a similar line to our findings, total 
vitamin C intake was also a significant predictor of serum vitamin E level in 
Framinghan heart study (Vogel et al, 1997).
Recommendations on adequate intake of carotenoids are not yet available and 
seasonal changes in diet, temperature, and sunlight exposure make it difficult to 
compare carotenoids levels in between studies. However the estimated levels in this 
study are similar to those published by other studies (Rimm et al., 1992). Besides 
being vitamin A precursor compounds, carotenoids can act synergistically with 
vitamin E. They can also interact with each other, and the ability to use one may be 
affected by another (Micozzi et al., 1992).
The modest positive correlations between serum vitamin A levels and dietary vitamin 
A in the group as a whole and among CVD patients are similar to previous reports 
(Roidt et al., 1988), and provides an objective validation of our FFQ. Correlation 
coefficient values of 0.222 in CVD patients and 0.129 in the group as a whole 
accounted for 5% and 2% of the variability in serum vitamin A levels respectively. 
Potential disadvantages of dietary assessment methods in case-control studies may 
have limited these associations including exposure misclassification or recall bias. 
Another factor that might have decreased the dietary-serum association is the large 
proportion of positive smoking habits (current and former) in the study sample (58%). 
It has been reported that differences in study population with respect to age, sex, 
smoking status, general health, fasting state may account for further variation in 
vitamin levels and predetermine the strength of the association of vitamin level in 
serum and diet (Asherio et al., 1992). Moreover higher correlation coefficients
316
between these two parameters have been reported in studies using vitamin 
supplements (Mayer-Davis et al., 1999).
In addition, total caloric intake calculation from FFQ data may represents consistent 
over- or underreporting of dietary intake and it may represent biological factors 
including body size, physical activity, and metabolic rate (Willett and Stampfer, 1986). 
Thus it is important to account for caloric intake when considering dietary-serum 
relations. However, inclusion of caloric intake did not improve the fit of the 
constructed model.
The lack of association between serum vitamin E levels and dietary vitamin E might 
be due to under-reporting of vitamin E intake from food since major food sources of 
this nutrient tend to be high in oil and these foods may be systematically under­
reported. Vitamin E bioavailability is also an important determinant of dietary-serum 
correlations because vitamin E from ingested food is not uniformly absorbed 
(Cohn, 1997). Bioavailability may also be influenced by concurrent dietary factors, 
particularly, higher intake of total fat that may include butter, which is an extremely 
poor source of tocopherols. Other factors could have accounted for differences 
between our findings and those reported by others like the use of different FFQ and/or 
different nutrient databases to analyse them. The poor association between dietary 
vitamin E and serum vitamin E may also be due to the fact that tocopherols in foods 
are primarily y-tocopherol (Rimm et al., 1992).
Furthermore, only few studies have reported an association between serum a- 
tocopherol and vitamin E intake from diet alone, and those that did generally found 
small positive associations (Willett et al., 1983(a), Coates et al.,1991) or no association 
(Stryker et al., 1988, Ascherio et al., 1992, Sinha et al., 1993, Block et al., 1994). These 
studies were based on nutrient databases that give lU of vitamin E activity, which is a
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sum of different tocopherols in which each is weighed for its biological activity. 
Nevertheless, strong associations were only shown when users of vitamin 
supplements were included in the analysis (Willett et ah, 1983(b), Kardinaal et 
ah, 1993).
6.5.5 Differences in vitamin status in chronic diseases
Antioxidant defense system in diabetics may be damaged by oxidative stress after 
glycosylation (Kardinaal et ah, 1993). Vitamin E levels have been found to be 
decreased in diabetic patients, suggesting its utilization in the process of scavenging 
free radicals (Anjali et al.,2000). Metabolic syndrome is characterized by a 
constellation of 5 metabolic abnormalities; obesity, hyperglycemia, hyperinsulinemia, 
hypertension, and hypertriglyceridemia (Reaven,1994). Lower antioxidant 
concentrations among those with metabolic syndrome may result from lower intakes 
of antioxidants, increased use of antioxidants, or both. Suboptimal concentrations of 
several antioxidants including vitamin A, as retinyl esters, and E was found in 
metabolic syndrome patients (Ford et al.,2003). Vitamin E has also been reported to 
diminish high blood pressure through its antioxidant properties (Newaz and 
Nawal,1998). Decreased serum levels of both vitamins were reported in 
hyperlipidemia, a metabolic situation which has been shown to be associated with 
high oxidative stress that resulted in low levels of lipid normalized antioxidants in 
plasma and lipoproteins (Araujo et ah, 1995). However, a comparison was not possible 
in this study with 95% of the CVD patients and 94% of their matched controls being 
dyslipidémie.
Our data did not show any significant difference in serum vitamin levels in the 
presence or absence of diabetes mellitus, metabolic syndrome, and hypertension. 
However, there was an association between serum vitamin A and systolic blood
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pressure in controls as well as between serum vitamin E and diastolic blood pressure 
in CVD patients. The increase in free radical production in hypertension contributes 
to oxidative stress and exhausts the antioxidant system. Thus, the observed positive 
correlations might be in response to the extra demands created by consumed body 
store.
Unlike our findings, other investigators have reported lower consumption rates of 
vitamins among diabetic patients (Riemersma et ah, 1991, Singh et ah, 1995). The 
reported increased intake of vitamin A in CVD patients with diabetes, metabolic 
syndrome, and hypertension is in accordance with improving dietary habits that 
presumably took place after acquiring the disease. However, other factors might have 
influenced absorption efficiency and wide inter-individual variability in the degree of 
responsiveness is also involved. Furthermore, various ways of cooking and storing of 
fruit and vegetables might have affected vitamins content and bioavailability.
6.3.6 Differences in sernm vitamin levels according to disease severity 
There was a graded decrease in serum vitamin A level with the increase in coronary 
disease severity. Our finding of a higher serum vitamin A levels among CVD patients 
diagnosed with a SVD than those with DVD or MVD is a further indication of its 
antioxidant properties. It could also indicate further depleted body stores of vitamins 
in DVD and MVD patients that may generate greater demands for antioxidants than 
SVD patients. Alternatively, redistribution of vitamin A into extracellular spaces may 
also be occurring to allow high bioavailability to depleted tissues. However, many 
factors may influence circulating vitamin concentrations such as bioavailability, 
absorption, and non-dietary factors such as BMI, smoking status, and serum lipids.
6.5.7 M ultivariate analysis
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For optimal comparison, we attempted to match cases and controls for age. The 
confounding effects of non-independent factors were eliminated by a multivariate 
analysis. Conditional logistic regression analysis identified 4 parameters that were 
significantly and independently correlated with atherosclerosis. According to the 
model, the increase in serum vitamin A levels seemed to be associated with low risk 
of atherosclerosis. Conversely, intakes of total fat and vitamin A levels were 
associated with high risk of atherosclerosis. The traditional risk factor, diabetes 
mellitus also revealed a significant contribution from our analysis. Individuals with 
diabetes mellitus are known to be exposed to higher levels of oxidative stress that 
résultés in decreased levels of antioxidant vitamins (Kardinaal et al., 1993). Serum 
vitamin A levels have shown to be of a protective value with an odds ratio of 0.72 
(p<0.05, 95% Cl: 0.53-0.99). Perhaps unexpectedly dietary vitamin A also emerged 
as a significant determinant of CVD with an odds ratio of 1.04 (p<0.01, 95% Cl: 1.01- 
1.06). The importance of this finding is difficult to assess especially when 
intervention trials using vitamin A supplements have not shown any significant 
cardiovascular benefit (Redlich et ah, 1999), and in our study there was a positive 
association between dietary vitamin A and indices of LDL oxidation (Table 6.6). Such 
an effect may relate to other dietary nutrients interaction that impact on vitamin A 
activity in vivo including the potential for vitamin A to act as a pro-oxidant rather 
than an antioxidant especially in diabetics. However, reasons for such an effect cannot 
be easily deduced from the available literature.
6.6 Limitations
Owing to the design of this study, serum measures only reflect concentrations at a 
single point in time. Thus, measurement errors may occur due to short-term month-to- 
month biological variation and therefore result in attenuation of any potential
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association of vitamins levels in serum and diet. In addition, many of the other factors 
relied on self-report. Differential recall between cases and controls may have biased 
the results when the dietary questionnaire were used retrospectively to assess intake. 
Thus, the use of a second dietary recall method as well as the use of serum biomarker 
levels was thought to be a suitable solution. Low correlations between vitamin serum 
levels and dietary intake as measured by the FFQ could occur if important 
contributors of vitamins are missing from the FFQ. This is unlikely since the FFQ 
used in this study has been constructed to include food items grouped into categories 
with similar nutrient contents. However there might be some degree of unavoidable 
measurement error including estimation of foods consumed over a 1-year period and 
accuracy of database information since nutrient contents of foods can vary over time. 
Variability in serum vitamin levels across different ethnic groups could have also 
been due to differences in dietary intake that the FFQ cannot measure with precision. 
Additionally, wide variation in absorption, metabolism, and excretion of vitamins 
could have contributed to the observed moderate correlations (Cohn, 1997).
6.7 Conclusions
Multivariate analysis showed that dietary total fat and vitamin A were independent 
coronary risk factors. This is the first report of a potentially deleterious role in CVD 
of dietary vitamin A in a non-Caucasian population. Unidentified, residual 
confounding factors, however may account for this finding. It is possible that the 
differences in antioxidant vitamin status are a consequence of the disease rather than 
contributory determinants. Our observations along with the strong biological rationale 
and epidemiological data relating antioxidants to lower coronary risk justify the need 
for further prospective cohort studies in non-Caucasian populations in order to 
confirm it.
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Chapter 7
The relationship between serum 
inflammatory markers and 
coronary risk in healthy Saudi male
subjects
7.1 Introduction
The relationship between coronary risk score estimated by the Framingham and 
PROCAM risk charts; individual coronary risk factors, and serum inflammatory 
markers, including CRP, caeruloplasmin, and sICAM-1 was studied in 140 Saudi 
males without clinically evident CVD.
Several serum inflammatory markers were used in this study because they have 
different sources, release kinetics, and involvement in atherogenesis. CRP is an acute- 
phase protein, that is produced by the liver in response to IL-6 and provides sensitive 
information on the baseline of inflammation/ infection. ICAM-1 is expressed on 
leukocytes, fibroblasts, smooth muscle cells, and endothelial cells and important in 
indicating the activation stage of macrophages. It is released as a soluble molecule by 
the action of specific proteases and can then be measured as sICAM-1. 
Caeruloplasmin as a copper-containing protein as well as an acute-phase reactant that 
is produced by liver and can also be indicative of systemic inflammation including 
atherosclerosis.
7.2 Specific aim
To examine the relationship between some of the known inflammatory markers to 
coronary risk score in healthy Saudi male subjects without established coronary heart 
disease, to relate these markers to individual classical risk factors, and self-reported 
dietary fat and micronutrients intake.
7.3 Methods
Demographic data together with an estimate of coronary risk score were obtained, and 
serum lipid profile, glucose, hsCRP, sICAM-1, and caeruloplasmin were measured in 
all subjects as previously detailed in Chapter 2, section 2.4, 2.4.3, pages 94, 101. Total
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fat and micronutrient intake was assessed by FFQ as previously described (see 
appendix 3). The relationship between coronary risk score, biochemical markers and 
diet were assessed by univariate and multivariate analysis.
7.4 Results
7.4.1 Demographic data
The demographic and anthropometric data of 140 subjects without CVD are shown in 
Table (7.1). The frequency of coronary risk factors; hypertension, diabetes mellitus, 
metabolic syndrome, dyslipidaemia, and obesity increased with age tertiles. There 
was no clear distinction between age groups for smoking habit and physical activity. 
However a significant proportion of the young and middle-aged group were current 
smokers compared to the older group of subjects. A large proportion of all age groups 
had dyslipidaemia (89%). A large proportion (approximately 30%) of the combined 
group of middle and older individuals had a history of diabetes mellitus.
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T a b l e  7 .1 :  D e m o g r a p h ic  a n d  a n th r o p o m e tr ic  c h a r a c te r is t ic s  o f  1 4 0  S a u d i c o n tr o ls
d iv id e d  in to  t e r t i le s  b y  a g e .
Parameter <30
Age groups (years)
31-48 >49
P
n 46 47 47
Age (years) 23.4 ±0.6 38.3 ±0.7# 61.5 ±1.6 ¥t <0.0001
Height (cm) 169.9 ±0.9 167.9 ± 1.2 168.2 ± 1.2 NS
Weight (Kg) 75.8 ±2.5 79.6 ± 2.3 81.3 ±2.2 NS
Body mass index (Kg/m2) 26.3 ± 0.8 28.1 ± 0.7 § 28.8 ± 0.8 * <0.05
Systolic blood pressure (mm 122.4 ± 1.5 127.9 ±2.0 125.3 ±3.2 NS
Hg)
Diastolic blood pressure (mm 78.8 ±1.1 83.1 ±1.3 §1 79.4 ±1.6 <0.05
Hg)
Hypertensive, n(%) 10(22) 15(32) 24(51) <0.05
Dyslipidemia, n(%) 37 (80) 44 (94) 44 (94) NS
Diabetics, n(%) 0(0) 14 (30) 17(36) <0.0001
Metabolic syndrome, n(%) 0(0) 7(1% 11 (23) <0.05
Body mass index. n(%) 
Normal 23 (50) 11(23) 14 (30)
Overweight 13 (28) 22 (47) 12 (25) <0.05
Obese 10 (22) 14 (30) 21 (45)
Family History. n(%) 
Heart disease 11(24) 12 (26) 10(21) NS
Diabetes mellitus 25 (54) 25(53) 17(36) NS
Race. n(%) 
Arabian tribes 26(57) 29(62) 24(51)
Africans 3 (7) 2(4) 6(13) <0.05
Caucasians 6(13) 4(9) 1(2)
Indians 6(13) 3 (6) 0(0)
Far Easterns 4 (9) 3 (6) 2(4)
Mediterraneans 1(2) 6(13) 14 (30)
Socioeconomic status. n(%) 
Low 18(39) 19 (40) 33 (70)
Middle 27(59) 26(55) 11(23) <0.05
High 1(2) 2(4) 3(6)
Smoking status. n(%) 
Never 30(65) 19(40) 27 (57)
Former 4(9) 6 (13) 15(32) <0.001
Current (<20 cigarette) 4(9) 7(15) 1(2)
Current (>20 cigarette) 8 (17) 15(32) 4(9)
Physical activity. n(%) 
<3 times/week 13 (28) 14 (30) 12 (25) NS
>3 times/week 33 (72) 33 (70) 35(75)
On a diet, n(%) 4(9) 11(23) 10(21) NS
Numeric data are presented as mean ±  SEM for normally distributed data and as median (interquartile 
range) for non-normally distributed data and categorical data as number and percentage. Categorical 
data were compared by test, continuous variables were compared by Kruskal-Wallis test. NS: not 
significant, * P<0.05 (first & third groups), ¥  P<0.001 (first & third groups), § P<0.05 (first & second  
groups), # P<0.001 (first & second groups), % P<0.05 (second & third groups), f  P<0.001 (second & 
third groups
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7.4.2 Biochemical data
The biochemical data for the groups segmented by age are shown in Table (7.2). A 
large proportion of all age groups had a fasting serum total, LDL-cholesterol, HDL- 
cholesterol, and triglycerides levels above the guidelines of the National Cholesterol 
Education Program Expert Panel on Detection, Evaluation, and Treatment of High 
Blood Cholesterol in Adults /Adult Treatment Panel III (NCEP/ATP III). The middle 
age group appeared to have the higher mean of triglycerides. Fasting glucose levels 
rose with age, consistent with the high frequency of diabetes in the oldest group. 
There was no significant difference in median hsCRP, sICAM-1 or caeruloplasmin 
between the age groups (Table 7.2). However, median serum inflammatory markers 
were lowest in the youngest group of subjects. Figure (7.1) shows error bars 
representing the median values of the 3 inflammatory markers in the 3 age tertiles. 
Tables (7.3) and (7.4) show different inflammatory markers levels according to 
variation in Framingham risk score, PROCAM score, BMI classes, race, 
socioeconomic status, diabetes mellitus, metabolic syndrome, hypertension, and 
dyslipidaemia among the participants.
Serum sICAM-1 levels were significantly higher among those of Arab descendents 
verse non-Arabs (p<0.05). When smoking habits were dichotomized into yes/no, 
serum CRP levels were significantly higher among smokers (p<0.05). Hypertensives 
had significantly higher serum caeruloplasmin levels than non-hypertensives 
(p<0.05).
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T a b l e  7 .2 :  B io c h e m i c a l  c h a r a c te r is t ic s  o f  1 4 0  S a u d i c o n tr o ls  d iv id e d  in to  t e r t i le s  b y
a g e .
Parameter <30
Age groups (years) 
31-48 >49
P
n 46 47 47
Total cholesterol 5.38 ±0.19 6.01 ± 0.20 5.69 ±0.23 NS
[mmol/L]
Triglycerides [mmol/L] 1.14(0.86-1.5) 1.55 (0.95-2.5) § 1.34 (0.77-2.1) <0.05
HDL-C [mmol/L] 1.45 ±0.09 1.49 ±0.09 1.29 ±0.07 NS
LDL-C [mmol/L] 3.67 ±0.21 4.2 ±0.19 4.1 ±0.22 NS
Atherogenic index 4.40 ± 0.32 4.6 ± 0.29 4.9 ± 0.29 NS
(TC/HDL)
Glucose [mmol/L] 5.37 (4.9-5.8) 5.80 (5 2 - 1 2 )  # 6.10(5.4-9.3)¥ <0.0001
Hs-C reactive protein 1.83 (1.1-3.7) 2.21 (1.0-3.0) 2.12(1.4-3.2) NS
(mg/L)
SICAM-1 (ng/ml) 211.6(158.3-329.8) 219.1 (161.1-328.7) 219.5 (160.9-288.6) NS
Caeruloplasmin (U/L) 33.1 (23.0-42.8) 35.6 (18.8-60.6) 36.9 (23.8-70.0) NS
Total cholesterol 25 (54) 31 (66) 27 (57) NS
>5.2 mmol/L, n(%)
Triglycerides 9(20) 21 (45) 16 (34) <0.05
>1.7 mmol/L, n(%)
HDL-C 14 (30) 12 (26) 12 (26) NS
<1.04 mmol/L, n(%)
LDL-C 26 (57) 33 (70) 31 (66) NS
>3.36 mmol/L, n(%)
Numeric data are presented as mean ±  SEM for normally distributed data and as median (interquartile 
range) for non-normally distributed data and categorical data as number and percentage. Categorical 
data were compared by test, continuous variables were compared by Kruskal-Wallis test. HDL-C: 
high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol, NS: not significant, 
sICAM-1: soluble adhesion molecule-1,* P<0.05 (first & third groups), ¥  P<0.001 (first & third 
groups), § P<0.05 (first & second groups), # P<0.001 (first & second groups), % P<0.05 (second & third 
groups), t  P <0.001 (second & third groups)
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Figure 7.1(a): Error bars representing mean and 95% Cl of serum caeruloplasmin 
concentration by age tertiles.
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Figure 7.1(b): Error bars representing mean and 95% Cl of serum soluble adhesion 
molecule-1 concentration by age tertiles
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Figure 7.1(c): Error bars representing mean and 95% Cl of serum high sensitivity C- 
reactive protein concentration by age tertiles
328
Table 7.3: Inflammatory markers of 140 Saudi controls divided into tertiles by 
Framingham coronary risk score and by body mass index.
Parameter Median (IQR) Median (IQR) Median (IQR) P
FRS Low Moderate High
n 104 31 5
Hs-C réactive protein 
(mg/L)
2.1 (1.3-3.1) 2 .5(1 .5-3 .4) 1.0 (0.5-1.5) NS
SICAM-1 (ng/ml) 226.1 (160.9-328.8) 218.3 (156.9-269.8) 297.9(198.5-400) NS
Caeruloplasmin (U/L) 33.1 (20.9-49.7) 44.4 (24.4-69.4) 72.8 (23.3-118.1) NS
PROCAM Low Moderate High
n 110 18 12
Hs-C reactive protein 
(mg/L) 2.1 (1.2-3.1)
2.31 (1.3-4.1) 1 .5(1.2-2.3)
NS
SICAM-1 (ng/ml)
223.5 (162.7-328.8) 226.3 (135.6-295.0) 210.1 (160.9-229.0)
NS
Caeruloplasmin (U/L)
34.4 (21.3-52.0) 34.1 (22.5-61.4) 35.3 (19.1-67.2)
NS
BMI Normal Overweight Obese
n 48 47 45
Hs-C reactive protein 
(mg/L)
1.8(1.1-3.2) 2.2 (1.4-3.2) 2.1 (1.5-3.0) NS
SICAM-1 (ng/ml) 208.5 (159.3-280.4) 215.8 (160.9-278) 251.2(166.1-349.1) NS
Caeruloplasmin (U/L) 29.1 (20.0-43.9) 36 .9(21.9-51.3) 40 .6(24 .1-65 .6) NS
Data are presented as median (interquartile range). Continuous variables were compared by Kruskal- 
Wallis test. BMI: body mass index, FRS: Framingham risk score, NS: not significant, sICAM-1: 
soluble adhesion m olecule-1
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T a b le  7 .4 :  In fla m m a to ry  m arkers o f  140  Sau d i co n tro ls  d iv id e d  a cco rd in g  to  race,
socioeconomic status 
hypertension.
, diabetes mellitus. metabolic syndrome, dyslipidaemia, ai
Parameter Median (IQR) Median (IQR) P
Race Arabs (n=79) Others (n=61)
Hs-C reactive 2.2(1.5-3.2) 1.7 (1.0-3.0) NS
protein (mg/L)
SICAM-1 (ng/ml) 204.2 (156.0-299.7) 233.1 (194.8-320.3) <0.05
Caeruloplasmin 35.6(23.1-53.1) 33.1 (20.3-55.6) NS
(U/L)
SES Low (n=70) Middle (n=64)
Hs-C reactive 2.3 (1.3-3.1) 2.1 (1.3-3.2) NS
protein (mg/L)
SICAM-1 (ng/ml) 216.4 (161.0-293.6) 229.1 (157.3-328.9) NS
Caeruloplasmin 35.9 (23.6-62.5) 33.1 (20.2-49.8) NS
(U/L)
Smoking Yes (n=64) No (n=76)
Hs-C reactive 2.3 (1.5-3.3) 1.7(1.1-3.0) <0.05
protein (mg/L)
SICAM-1 (ng/ml) 213.0 (157.0-324.4) 228.9 (166.3-297.5) NS
Caeruloplasmin 33.1 (21.7-53.0) 35.6(20.9-54.1) NS
(U/L)
Diabetes Mellitus Nondiabetics Diabetics
(n=105) (n=29)
Hs-C reactive 2.13(1.3-3.25) 2.23(1.5-3.0) NS
protein (mg/L)
SICAM-1 (ng/ml) 226.5(160.9-324.7) 210.1 (159.2-296.3) NS
Caeruloplasmin 33.1 (20.9-51.3) 44.4 (23.1-64.7) NS
(U/L)
Metabolic Non MS MS
Syndrome (n=117) (n=17)
Hs-C reactive 2.2 (1.3-3.4) 1.8 (1.2-2.7) NS
protein (mg/L)
SICAM-1 (ng/ml) 219.5 (158.1-303.7) 231.6(181.8-365.9) NS
Caeruloplasmin 35 (21.6-51.9) 40.6 (18.1-95.9) NS
(U/L)
Hypertension Non hypertensives Hypertensives
(n=88) (n=46)
Hs-C reactive 2.1 (1.4-3.1) 2.4(1.0-3.2) NS
protein (mg/L)
SICAM-1 (ng/ml) 223.5 (157.7-331.5) 218.9(162.7-272.6) NS
Caeruloplasmin 31.9 (20.0-49.8) 40.6 (25.0-62.7) <0.05
(U/L)
Dyslipidaemia Non dyslipidémies Dyslipidaemlcs
(n=15) (n=125)
Hs-C reactive 1.9(1.1-2.4) 2.1 (1.2-3.1) NS
protein (mg/L)
SICAM-I (ng/ml) 269.2 (176.0-311.7) 215.8 (159.8-303.4) NS
Caeruloplasmin 41.3(21.9-51.9) 33.1 (21.3-55.0) NS
(U/L)
Data are presented as median (interquartile range). Continuous variables were compared by Mann 
Whitney test. NS: not significant, SES: soc ioecon om ic status, sICAM-1: soluble adhesion m olecule- 
1.
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7.4.3 Coronary Risk Score
The proportion of subjects with a high or moderate risk score rose with age group, as 
might be expected as both algorithms are dependent on age and other age-related 
conditions (Table 7.5). The two scoring schemes were highly correlated for the groups 
combined (p<0.0001) (Figure 7.2). Both coronary risk scores varied with age
(p<0.0001).
Serum caeruloplasmin showed a gradual, non-significant rise with increasing 
Framingham risk score (Figure 7.3).
7.4.4 Dietary data
Dietary total fat, saturated fat and cholesterol were all highest in the youngest age 
group (Table 7.6). Total calorie intake decreased with age group; the proportion of 
subjects consuming adequate dietary calories or above the RNI was highest in the 
youngest group of subjects. This may be explained in part by lower proportion of 
young individuals on a diet (9%). The intake of total fat and cholesterol was above 
recommended values for all age groups. Subjects in the young age tertile had the least 
PUFA: SFA ratio of all age groups (p<0.05).
In terms of micronutrients intake, the old age group had the least copper intake of all 
age subgroups (p<0.05) and less dietary selenium than the youngest age group 
(p<0.05).
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T a b l e  7 .5 :  R is k  fa c t o r  s c o r e s  o f  1 4 0  S a u d i c o n tr o ls  d iv id e d  in t o  t e r t i le s  b y  a g e
Parameter
<30
Age groups (years) 
31-48 >49
Framingham score
Low n(%) 46 (100) 39 (83) 19 (40)
Moderate n(%) 0(0) 8(17) 23 (49)
Highn(%) 0(0) 0(0) 5(11)
Total 46 (100) 47 (100) 47 (100)
PROCAM
Low n(%) 45(98) 45 (96) 20 (43)
Moderate n(%) 1(2) 2(4) 15 (32)
Highn(%) 0(0) 0(0) 12 (26)
Total 46 (100) 47 (100) 47 (100)
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Figure 7.2: Association between Framingham and PROCAM coronary risk scores for 
140 Saudi males without coronary disease. The Spearman's correlation coefficient 
was r = 0.790 (p<0.0001 ).
ICp[U/L]
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Figure 7.3: Serum caeruloplasmin concentration in 140 Saudi controls stratified 
according to Framingham risk score. Each bar represents the median ± interquartile 
range.
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T a b l e  7 .6 :  D ie t a r y  c h a r a c te r is t ic s  o f  1 4 0  S a u d i c o n tr o ls  d iv id e d  in to  t e r t i l e s  b y  a g e .
Nutrient RNI <30
Age groups (years) 
31-48 >49
P
n 46 46 47
Energy (Real) 2755 (15-18) 
2550 (19-59) 
2380 (60-74) 
2100 (75+)
2188.7 + 66.2 ¥ 2010.6 + 64.7 1840.0 +  62.8 <0.001
Unadjusted total fat 
(gm)
92.6 + 3.01 * 85.0 +  3.69 79.5 +  3.59 <0.05
% o f  energy 30% 38.3 + 0.72 38.1 +  1.02 38.5 +  0.88 NS
Energy-adjusted fat 
(gm)
82.9 + 0.13 83.0 + 0.18 83.1 +  0.13 NS
Cholesterol (mg) 
Categories o f
313.2+15.5 ¥ 272.1 +  18.6 238.1 +  14.9 <0.05
cholesterol intake <200 mg 2(4) 15(32) 21 (45) <0.0001
n(%) >200 mg 44 (96) 32 (68) 26 (55)
Unadjusted SFA  
(gm)
3 2 .7 + 1 .3  §¥ 2 7 .8 + 1 .6 4 2 6 .0 + 1 .4 2 <0.05
% o f  energy 10% 15.0 + 0.40 13.7 +  0.55 13.9 +  0.51 NS
Energy-adjusted 
SFA (gm)
27.8 + 0.13 27.6 +  0.18 27.7 +  0.13 NS
Unadjusted MUFA  
(gm)
3 1 .8 + 1 .0 30.1 +  1.37 2 8 .0 + 1 .2 9 NS
% o f  energy 10% 14.7 +  0.34 15.1 +  0.48 15.1 +  0.38 NS
Energy-adjusted
MUFA(gm)
29.4 +  0.12 29.5 +  0.18 29.6 +  0.12 NS
Unadjusted PUFA  
(gm)
18.4 +  0.85 18.2 +  0.83 17.2 +  0.96 NS
% o f  energy 10% 8.4 + 0.32 9.1 + 0.32 9.3 +  0.40 NS
Energy-adjusted
PUFA(gm )
16.8 + 0.14 17.1 +  0.14 17.1 +  0.15 NS
P:S ratio N A 0.58 + 0.03 0.71 + 0 .0 4  § 0.72 +  0.05 * <0.05
Fiber (gm) 18 gm 18.34 + 0.68 18.53 + 0.81 18.92 + 0.72 NS
Selenium (pg) 75 pg 47.92 + 2.2 * 46.07 + 2.73 41.67 + 0.80 <0.05
Copper (mg) 1.2 mg 1.56 + 0.07 * 1.42 + 0 .0 7  H 1.23 +  0.05 <0.05
Zinc (mg) 9.5 mg 9.77 +  0.33 9.34 + 0.42 8.66 + 0.35 NS
Vitamin E (mg) 15 mg 13.01 + 0.54 13.80 + 0.78 12.68 + 0.56 NS
Carotenoids (mg) N A 11.13 + 0.53 11.92 +  0.51 12.22 +  0.28 NS
Vitamin C (mg) 40 mg 52.28 + 3.95 44.15 + 3.18 45.23 +  2.50 NS
Vitamin A  (pg) 700 pg 948.39+ 103.4 688.08 + 97.95 851 .78+  106.9 NS
Numeric data are presented as mean ±  SEM and categorical data as number and percentage. 
Categorical data were compared by test, continuous variables were compared by Kruskal-Wallis test. 
MUFA: monounsaturated fatty acids, NS: not significant, P:S ratio: polyunsaturated fatty acids, PUFA: 
polyunsaturated fatty aeids, RNI: reference nutrient intake, SFA: saturated fatty acids, * P<0.05 (first & 
third groups), ¥  P<0.001 (first & third groups), § P<0.05 (first & second groups), # P<0.001 (first & 
second groups), ^ P<0.05 (second & third groups), f  P<0.001 (second & third groups)
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7.4.5 Relationship between inflammatory markers and coronary risk
In the group as a whole, serum caeruloplasmin concentrations were positively 
correlated with Framingham risk score, age, hypertension, intake of SFA and MUFA, 
both adjusted for total caloric intake. SICAM-1 was positively associated with HDL 
cholesterol and crude intake of SFA, and negatively correlated with PROCAM risk 
score, total cholesterol/HDL-C ratio, and LDL cholesterol (Table 7.7).
Among those of middle socioeconomic class, serum caeruloplasmin concentrations 
were positively correlated with the followings: Framingham risk score (r=0.304, 
p<0.05), among those of all races other than Arabian tribe descents (r =0.257, 
p<0.05), among dyslipidaemic subjects (r = 0.187, p<0.05), and among smokers (r = 
0.338, p<0.01). Similarly serum caeruloplasmin concentrations were positively 
correlated with PROCAM risk score among those of middle socioeconomic class (r = 
0.333, p<0.01) and among smokers (r = 0.266, p<0.05).
Serum sICAM-1 concentrations were inversely correlated with the PROCAM risk 
score among those of Arabian tribes descent (r = -0.249, p<0.05). Serum HDL-C was 
inversely correlated with serum sICAM-1 levels among diabetics (r=-0.397, p<0.05) 
and positively so among non-diabetics (r=0.360, p<0.001).
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Table 7.7: Correlation coefficients between Classical CVD risk factors and serum 
inflammatory markers in 140 Saudi controls
Serum
inflammatory
m arker
Risk factor r P
Hs-C reactive 
protein (mg/L)
Demoeranhic features 
Age 0.046 0.591
BMI 0.078 0.360
Smoking 0.128 0.131
SES -0.073 0.392
Hypertension 0.002 0.984
Diabetes mellitus -0.008 0.924
Metabolic syndrome -0.087 0.309
Dyslipidemia 0.036 0.675
Framingham -0.117 0.170
PROCAM score 0.030 0.721
Biochemical features 
HDL-C (mmol/L) 0.039 0.646
LDL-C (mmol/L) -0.017 0.841
TC/HDL-C -0.041 0.630
TG (mmol/L) 0.029 0.734
Glucose (mmol/L) -0.055 0.519
Dietarv features 
SFA, unadjusted 0.107 0.208
SFA, % energy 0.032 0.703
SFA, adjusted -0.058 0.494
MUFA, unadjusted 0.094 0.269
MUFA, % energy -0.006 0.942
MUFA, adjusted -0.038 0.658
PUFA, unadjusted 0.079 0.353
PUFA, % energy -0.012 0.886
PUFA, adjusted 0.006 0.945
sic  AM-1 
(ng/ml)
Demoeranhic features 
Age -0.064 0.453
BMI 0.044 0.608
Smoking -0.024 0.775
SES 0.053 0.537
Hypertension -0.084 0.322
Diabetes mellitus -0.050 0.561
Metabolic syndrome 0.029 0.731
Dyslipidemia -0.116 0.172
Framingham -0.114 0.180
PROCAM score -0.183 0.030
Biochemical features 
HDL-C (mmol/L) 0.046 0.593
LDL-C (mmol/L) -0.106 0.211
TC/HDL-C -0.268 0.001
TG (mmol/L) -0.106 0.211
Glucose (mmol/L) -0.012 0.884
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Caeruloplasmin
(U/L)
Dietarv features
SFA, unadjusted -0.168 0.047
SFA, % energy -0.090 0.291
SFA, adjusted -0.026 0.761
MUFA, unadjusted -0.070 0.410
MUFA, % energy -0.072 0.398
MUFA, adjusted -0.080 0.348
PUFA, unadjusted -0.088 0.300
PUFA, % energy -0.047 0.585
PUFA, adjusted -0.072 0.399
Demoeranhic features
Age 0.224 0.008
BMI 0.116 0.174
Smoking -0.054 0.523
SES -0.135 0.112
Hypertension 0.190 0.024
Diabetes mellitus 0.109 0.200
Metabolic syndrome 0.057 0.503
Dyslipidemia -0.041 0.634
Framingham 0.174 0.039
PROCAM score -0.014 0.865
Biochemical features
HDL-C (mmol/L) 0.062 0.465
LDL-C (mmol/L) -0.113 0.185
TC/HDL-C -0.059 0.489
TG (mmol/L) 0.000 0.997
Glucose (mmol/L) 0.116 0.174
Dietarv features
SFA, unadjusted 0.098 0.250
SFA, % energy 0.175 0.039
SFA, adjusted 0.190 0.025
MUFA, unadjusted 0.093 0.272
MUFA, % energy 0.167 0.049
MUFA, adjusted 0.195 0.021
PUFA, unadjusted -0.093 0.275
PUFA, % energy -0.085 0.318
PUFA, adjusted -0.087 0.310
HDL-C: high density lipoprotein cholesterol, LDL: low density lipoprotein cholesterol, MUFA: 
monounsaturated fatty acids, PUFA: polyunsaturated fatty acids, TG: triglycerides, SES: 
socioeconom ic status, SFA: saturated fatty acids sICAM-1: soluble adhesion m olecule-1
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7.4.6 Multivariate analysis
The best fitting stepwise multiple regression model with serum caeruloplasmin level 
as a dependent variable, and including all variables that showed association with a p 
value up to <0.01 as independent variables to demonstrate their relationship to serum 
caeruloplasmin, adjusting for confounding factors. The regression coefficients and 
95% confidence intervals obtained from the model are illustrated in table (7.8).
Age and SFA intake together explained 7.9% of the variation (R^) in serum 
caeruloplasmin level when introduced in a multiple regression model, in which age 
alone explained 4.3% of the variation. When SFA intake was included in the 
regression model, R  ^ increased substantially. However, the correlations between 
serum caeruloplasmin and Framingham risk score and MUFA intake found at 
univariate level became insignificant.
Similarly stepwise multiple regression model was fitted for serum sICAM-1 level as a 
dependent variable, including all variables that showed association with a p value up 
to <0.01 as independent variables to demonstrate their relationship to serum sICAM- 
1, adjusting for confounding factors. The regression coefficients and 95% confidence 
intervals obtained fi*om the model are illustrated in table (7.9).
In this model that explained 6.5 % of the variation (R^) in serum sICAM-1 level, only 
total cholesterol/HDL-C ratio was found to be significantly inversely related to serum 
sic AM-1 level.
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Table 7.8: Stepwise multiple regression analysis in 140 Saudi controls with serum 
caeruloplasmin as dependent variable and age, Framingham risk score, saturated fatty 
acids intake, and monosaturated fatty acids intake as independent variables that have 
shown to be correlated with serum caeruloplasmin at a univariate level.
Independent P Adjusted P 95% C l
variables (%)
Age 0.237 4.3 0.004 0.13 : 0.68
SFA intake 0.204 7.9
c c  . , n /  . ______
0.013 1.28 : 10.88
Table 7.9: Stepwise multiple regression analysis in 140 Saudi controls with serum 
sic AM-1 as dependent variable and total cholesterol/HDL-C ratio, PROCAM risk 
score, and saturated fatty acids intake as independent variables that have shown to be 
correlated with serum sICAM-1 at a univariate level.
Independent p Adjusted R^ p 95% Cl
variables (%)
TC/HDL-C ratio -0.268 6.5
^ n/ •___
0.001 -24.02 : -5.89
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7.5 Discussion
The inflammatory nature of the atherosclerotic plaque has been well described and its 
potential importance in determining plaque rupture and the consequential vascular 
complications has received considerable attention over recent years (Ross, 1999, 
reviewed by Fuster et al.,2003). It has been proposed that serum markers of 
inflammation, such as CRP may partially reflect inflammatory events within the 
plaque, and hence may be predictive of outcome (Pasceri et al.,2000). This is 
supported by epidemiological studies, which have consistently reported increased 
coronary risk among subjects with high serum levels of inflammatory markers 
(Caterina et al., 1997, Rohde et al., 1998, Koenig et al., 1999, Strandberg and 
Tilvis,2000). Although the increased risk of inflammation has been reported to be 
independent of other risk factors in women (Ridker et al.,2000), other studies have 
reported a positive relationship between coronary risk score and CRP concentrations 
(Ridker et al., 1998a). Most previous studies have been undertaken in industrialized 
Caucasian populations, and it is difficult to be certain that these data are applicable to 
non-Caucasian subjects living in other geographical locations. The predictive power 
of serum inflammatory markers is likely to be altered by prevalent low-grade 
infection in these populations. It is also possible that diet and other lifestyle factors 
will also have an impact on the strength of any association between serum 
inflammatory marker concentrations and coronary risk. Dietary fatty acids have been 
reported to affect both coronary risk (Lemaitre et al.,2003) and immune responses 
(Yaqoob et al., 1998, Tsimikas et al., 1999).
In this present study we have investigated the relationship between classical coronary 
risk factors, dietary fats and micronutrients, and serum inflammatory markers in a 
Saudi male population sample. It is clear that in this population, as elsewhere in the
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Middle East, there has been a rapid increase in coronary risk factors, including 
obesity, diabetes mellitus, hypertension and dyslipidaemia (Alwan,1993). A worrying 
feature within our population sample from the Middle East is the very high prevalence 
of obesity, positive smoking history and physical inactivity. Compounding this cluster 
of high-risk lifestyle characteristics is a poor diet, with a high intake of total fat, 
saturated fatty acids, and cholesterol. These dietary features were worst for the 
younger age groups, and may be related to the adoption of Westem-style dietary 
habits (Alissa et al.,2005).
7.5.1 Serum inflammatory markers and coronary risk score 
Equations based on the Framingham heart study have been widely used in Caucasian 
populations to calculate individual’s absolute risk of CHD or CVD (Wilson et 
al,, 1998). These equations use 6 risk factors; age, gender, total cholesterol, HDL-C, 
systolic blood pressure (treated or untreated), and smoking habits. An alternative risk 
prediction equation has been derived from the PROCAM study, that other than total 
cholesterol, uses the same risk factors as the Framingham equation and additionally 
includes triglycerides, LDL-C, and the presence or absence of diabetes mellitus and a 
family history of CHD (Assman,1993). Coronary risk scores, calculated using the 
Framingham or PROCAM algorithm categorized subjects in a similar way as each 
other in a male urban Saudi population. However, small differences in risk calculated 
by both methods may be affected by hypertriglyceridemia commonly seen in diabetes 
mellitus, a condition highly prevalent in this population (22%).
Of the serum inflammatory markers, only serum caeruloplasmin showed a gradual, 
non-signiflcant rise in its median value with increasing Framingham risk scores 
(Figure 7.3). Moreover, caeruloplasmin levels were also correlated with the 
Framingham risk score (r = 0.174, p<0.05). Several prospective studies have indicated
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that serum caeruloplasmin level could be an independent risk factor for CVD 
(Reunanen et al., 1992, Mantarri et al., 1994). Caeruloplasmin has been shown to 
oxidatively modify LDL in vitro (Lamb and Leake, 1994). Therefore, caeruloplasmin 
can either function as a pro-oxidant and/or act synergistically with other acute-phase 
reactant proteins in vivo (Mori et al., 1995). Hence endothelial injury may result in 
response to diabetes mellitus and hypertension, caeruloplasmin role as an acute-phase 
reactant may provide another possible explanation of a low-grade inflammation as a 
marker for these conditions. Additionally, it has been suggested that serum copper 
bound to caeruloplasmin may contribute to lipid peroxidation (Craig et al., 1995). 
Thus, caeruloplasmin might act as a scavenger of the resulting superoxide radicals 
generated by copper.
In line with this, higher serum caeruloplasmin levels in hypertensives (p<0.05), 
diabetics and those with metabolic syndrome (p>0.05 in both) were found when 
compared to their respective norms. An increase in serum caeruloplasmin levels has 
also been reported before in patients with diabetes mellitus (Memisogullari and 
Bakan,2004) and metabolic syndrome (Kim et al.,2002).
Inasmuch as there was a little increase in serum sICAM-1 levels with increasing 
Framingham risk score, serum sICAM-1 levels were negatively correlated with 
PROCAM score (r = -0.183, p<0.05). This could be due to the fact that 75% of our 
study population were below 50 years old whereas other studies showing elevated 
sic AM-1 levels with increased risk for future coronary events were performed on 
elderly people (Calabresi et al.,2002). Another possibility is that PROCAM risk charts 
take diabetes mellitus into account when Framingham risk charts do not. A 
particularly strong negative correlation was observed between sICAM-1 and HDL-C 
(r=-0.397, p<0.05) among diabetic subjects in this population. Similar observations
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were made by other studies on adhesion molecules in diabetic patients (Abe et 
a l, 1998).
Some studies in Western, Caucasian populations have shown that serum hsCRP 
concentrations are consistently associated with coronary risk score (Ridker et 
al., 1998a). Although some investigators have doubted such a role (Folsom et al.,2001, 
Levinson,2004). We were unable to show this in our population sample probably 
because subjects in the group of highest risk score were improperly classified.
7.5.2 Serum inflammatory markers and individual classical risk factors
Age
Caeruloplasmin was positively correlated with age. Such a relationship was also 
found in a study on metabolic syndrome patients (Kim et al.,2002). Furthermore, there 
was a gradual non-significant rise in mean caeruloplasmin (Figure 7.1(a)) and a 
similar fall in mean sICAM-1 with age tertiles (Figure 7.1(b)). Previous studies have 
reported modest, yet significant, positive correlation of serum sICAM-1 levels with 
age (Rohde et al., 1999). CRP fails to show a uniform pattern because of small 
differences in mean values as well as wide and overlapping 95% CIs across age 
tertiles (Figure 7.1(c)). Intraindividual variations have been reported for CRP (de 
Maat et al., 1996), which if present, could result in an underestimation of the true 
relationship. Other studies have shown that the predictive value of CRP for ischemic 
heart disease was attenuated with age (Tracy et al., 1997, Strandberg and Tilvis,2000).
Smoking
Smoking has been linked to abnormal endothelial dysfunction and increased 
leukocytes adhesion (Howard et al., 1998). Previous studies have reported a positive 
relationship between smoking habit and serum inflammatory markers (Mendall et 
al., 1996, Rohde et al., 1998). Smokers had significantly higher CRP levels than non­
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smokers in the population as a whole. The effect of smoking on serum caeruloplasmin 
and sic AM-1 levels has been less consistent. However, the association between 
serum caeruloplasmin and coronary risk score was more evident among smokers, (r = 
0.338, p<0.01) with Framingham risk score and (r = 0.266, p<0.05) with PROCAM 
risk score. Again, this could merely be an indication of inflammation, given its 
antioxidant property.
Obesity
BMI increased significantly with age tertile (p<0.05). Serum sICAM-1 and 
caeruloplasmin levels showed non-significant increment when BMI values were 
categorized into 3 subclasses; normal, overweight, and obese. The positive 
relationship between inflammatory markers and obesity has been reported previously 
(Cignarelli et al., 1996, Mendall et al., 1996, Keaney et al.,2004). It could be explained 
by the fact that adipose tissue is a source of inflammatory cytokines, such as IL-6 and 
TNFa, which induce the production of acute phase reactants by the liver (Yudkin et 
al.,2000). A similar mechanism could explain the relation between obesity and 
sic AM-1 because human endothelial cells in culture release sICAM-1 in response to 
TNF-a and IL-1 (Leewenberg et al., 1992).
Lipid profile
Experimental studies suggest that modified lipoproteins or their constituents modulate 
expression of adhesion molecules (Caterina et al., 1994). Yet a report from the 
Atherosclerosis Risk in Communities (ARIC) study failed to demonstrate any 
significant association between sICAM-1 and triglycerides, total cholesterol, LDL-C, 
or HDL-C levels (Hwang et al., 1997). In addition, it has been reported that HDL 
inhibits cytokine-induced expression of cellular adhesion molecules in cultured cells 
(Cokerill et al., 1995). Our findings do not support this since we found a negative
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association between serum sICAM-1 and total cholesterol / HDL-C ratio (r = -0.268, 
p<0.001). This could be due to the fact that 75% of our study population was below 
50 years old whereas the other studies were performed on elderly people (Calabresi et 
al.,2002). Table (7.9) shows that total cholesterol/ HDL-C ratio is the only predictor 
with a standardized regression coefficient value of -0.268, explaining nearly -7%  of 
the variance observed in serum sICAM-1 level. This could be due the expected 
intercorrelations between HDL-C and LDL-C. Serum sICAM-1 levels were shown to 
be inversely correlated with HDL-C in individuals with low HDL- 
C but not in those with normal or high HDL-C (Calabresi et al.,2002). This was not 
the case in our study in which less than one third of the whole population had HDL-C 
levels below 1.04mmol/L. A possibility made more likely to be the case by our 
findings of a negative association between sICAM-1 and HDL cholesterol among 
diabetic subjects (r = -0.397, p<0.05) and a positive one with nondiabetics (r=0.360, 
p<0.001) in this population. This is a consistent finding with other studies on adhesion 
molecules in diabetic patients in which increased levels of triglycerides and low HDL 
are frequently seen (Abe et al., 1998, Rohde et al., 1999).
Serum inflammatory markers in chronic conditions 
None of the 3 inflammatory markers was associated with diabetes mellitus, 
dyslipidaemia, or metabolic syndrome. Similar results were obtained in other studies 
(Strandberg and Tilvis,2000) but not all (Hackman et al., 1996, Yudkin et al., 1999, 
Frohlich et al.,2000). Failure to find relationships between inflammatory markers and 
each risk factor in isolation could imply that the coexistence of multiple risk factors 
may also fail to significantly influence these markers. Furthermore, most of these 
studies have been limited by small sample size and different population 
characteristics.
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However, caeruloplasmin was positively associated with hypertension (r = 0.190, 
p<0.05). Moreover, hypertensive subjects had significantly higher serum 
caeruloplasmin levels than normotensive subjects (p<0.05). It has been suggested that 
the atherogenic mechanism of hypertension may involve activation of redox sensitive 
genes, a proposed common final pathway by which risk factors may act on the arterial 
wall (Kume and Gimbrone,1994).
Serum inflammatory markers in different socioeconomic classes and racial
groups
Racial effects on the prevalence of chronic conditions, such as hypertension among 
African Americans and diabetes mellitus in Indians, are well recognized. Therefore, 
the increased cardiovascular risk cannot only be explained by conventional risk 
factors. The possibility of ethnic differences in CRP as a coronary risk factor has been 
recently studied (Forouhi et al.,2001). SICAM-1 has also been shown to be of a 
significant heritability (Keaney et al.,2004). Due to small numbers of subjects in races 
other than Arabian tribes, they were collectively called others. Serum sICAM-1 levels 
were significantly higher among the others (p<0.05). Serum caeruloplasmin levels 
were correlated with Framingham risk score among the others (r = 0.257, p<0.05) and 
serum sICAM-1 levels were correlated with Framingham risk score among Arabs (r = 
-0.249, p<0.05). It is also possible that ethnic differences could be explained by 
variations in other confounding factors that were not adjusted for. Alternatively the 
heterogeneity within different culturally diverse ethnic groups could account for such 
relations.
Similarly only low and middle socioeconomic class individuals were included in the 
comparison due to the small number of the high socioeconomic class individuals in 
the whole sample (4%). Serum caeruloplasmin levels were correlated with coronary 
risk score among the middle socioeconomic class individuals, (r = 0.304, p<0.05)
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with Framingham score and (r = 0.333, p<0.01) with PROCAM score. High 
caeruloplasmin levels, as a marker of inflammation, may be involved in the 
pathogenesis of atherosclerosis by reflecting response to injury (Mori et al., 1995).
7.5.3 Serum inflammatory markers and dietary fat 
There has been great interest in the effects of dietary fatty acids on lipoprotein 
metabolism (Kris-Etherton et al., 1999). Fatty acid composition of the diet plays a 
critical role in determining the tissue fatty acid composition, thus the ratio between 
PUFA/SFA rather than the absolute amounts are more important in determining their 
effects on tissue fatty acid composition (Gibney and Hunter, 1993). It is well known 
that PUFA are prone to peroxidation and that generated free radicals and ox-LDL may 
both be cytotoxic (Steinberg et al., 1989). H-3 and co-6 PUFA are essential fatty acids. 
The Western diet is abundant in co-6 PUFA mainly from vegetable oils. The role of 
long chain co-3 PUFA found in fish and fish oil in the prevention and management of 
CVD is well documented (Hu et al.,2002). However, deleterious effects of PUFA 
supplementation are suggested to be due to their increased susceptibility to oxidation 
(Frankel et al., 1994), although contradictory results have been reported (Brude et 
al., 1997). MUFA, abundant in olive oil are thought to be partly responsible for the 
antiatherogenic effects attributed to the Mediterranean diet (Carluccio et al., 1999). 
However, studies using MUFA-rich diets have reported conflicting results (Chang and 
Huang, 1990, Wahrburg et al., 1992).
Dietary total fat, saturated fat, and cholesterol were significantly higher in the 
youngest age group, and there was a gradual decrease in their intake with advancing 
age. Dietary PUFA intake was equally high in the middle and old tertiles for age. 
Serum CRP concentrations were the highest in the middle age subgroup. This is 
consistent with the possibility that dietary PUFA may enhance the inflammatory
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response, having a potentially deleterious effect in inflammatory conditions including 
atherosclerosis. Thus, elevated levels of acute-phase proteins may reflect response to 
infection or inflammation. However, it should be pointed out that high fatty acids 
preparations are far more likely to induce oxidation than fatty acids supplemented in 
diet (Johansen et al., 1999).
Serum sICAM-1 levels were inversely correlated with dietary intake of SFA 
unadjusted for total caloric intake (r = -0.168, p<0.05), which turned out to be of 
insignificant value when assessed by multivariate analysis. Serum caeruloplasmin 
levels were positively correlated with dietary intake of SFA (r = 0.19, p<0.05) and 
MUFA (r = 0.195, p<0.05), both adjusted for total caloric intake. This is in 
accordance with the findings of increased expression of receptors for IL-2 and 
transferrin with diet enrichment with olive oil in animal experiments (Yaqoob et 
al., 1994). The effect of high content of SFA in diet on increasing concentrations of 
plasma total cholesterol and LDL has been well documented (Keys et al., 1965). Table 
(7.8) shows that age and SFA intake are the significant predictors affecting serum 
caeruloplasmin levels, with more influence on caeruloplasmin levels attributed to age 
(Beta = 0.237) than SFA intake (Beta = 0.204). However, it should be noted that the 
magnitude of variability explained by changes in age is only modest (-4%).
7.5.4 Serum inflammatory markers and dietary micronutrients 
Selenium and zinc are known to be negative acute-phase reactants whereas copper is 
usually increasing as a part of acute-phase response (Shenkin,1995). Such changes are 
a direct result of increased hepatic synthesis of caeruloplasmin, the major copper 
containing protein, and decreased circulating levels of albumin, the zinc and selenium 
binding protein, in inflammatory conditions. The mediation of such changes is 
controlled by the cytokines, IL-1 and IL-6 which promote the change in trace element
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tissue concentrations at sites of inflammation (Cousins and Leinart,1988, 
Shenkin,1995).
There was a trend of decreased intake of trace elements with advancing age. Intake 
levels of selenium and copper were lower among the old age group. This might 
suggests a contribution of low levels of intake of both trace elements on increased 
inflammation with age, as suggested by the association of caeruloplasmin serum level 
with age. Several experimental and epidemiological studies have shown that copper 
and selenium deficiency are associated with an increased risk of CHD (Klevay, 1975, 
Klevay,1980, Hassel et al., 1982, Salonen et al., 1982, Suadicani et al., 1992).
Some evidence suggests that vitamin A and vitamin C are a negative inflammatory 
reactants (Labadarios et al., 1987). The fall in their circulating levels is suggestive of 
redistribution to the injured tissue rather than a true deficiency. Even though it has 
been shown that reduced levels of carotenoids, with unchanged vitamin E levels, are 
associated with low-grade inflammation (Boosalis et al., 1996), evidence relating 
vitamin E and carotenoids to inflammatory response is insufficient.
Dietary PUFA increase the content in PUFA of LDL particles, which makes them 
prone to oxidation. The role of dietary micronutrients, specifically antioxidant 
vitamins, in the prevention of coronary events has been the target of many cohort 
studies (Enstrom et al., 1992, Kardinaal et al.,1993, Rimm et al.,1993, Stampfer et 
al.,1993, Knekt et al.,1994, Kritchevsky et al.,1998). Even with the increased intake 
of PUFA across age tertiles, none of the estimated vitamin intakes showed a 
significant difference.
7.6 Limitations
One of the major limitations of our study was the use of this model risk algorithm to 
predict the 10-year risk of developing CVD rather than using a prospective study
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design. Even though multicultural studies have shown that Framingham model is a 
reasonable tool for predicting absolute risk of CVD (Ramachandran et al.,2000), its 
applicability to other ethnic groups is still questionable. This is because Framingham 
residents are largely whites of European origin; therefore it is uncertain whether 
baseline absolute risk is similar to that of non-Caucasian populations. Framingham 
risk equations can only be applied to those aged 30-74 years and age ranged between 
16 and 87 years in our sample. Also, the equations exclude triglycerides and relatively 
few diabetic patients were included in the Framingham cohort. Thus the use of 
PROCAM equation to account for diabetes mellitus was attempted; however the 
equation’s use is limited to men aged 40-65 years. Similarly the prognostic value of 
CRP seems to vanish in individuals aged 75-80 years. Another common limitation in 
recruiting controls in any observational study is that it is often assumed that they are 
free of CVD, as they have no clinical manifestation of the disease. But this might not 
be totally true in our study, especially that they have coronary risk factors.
Calculation of dietary intake of fatty acids could only be estimated in total from food 
composition tables. Thus, it was not possible to discriminate between co-3 or co-6 
PUFA content in food items.
Finally, our study design limits our ability to infer a causal relationship between 
inflammatory markers and CVD, as there may be unrecognised confounding factors 
that affect out interpretation.
7.7 Conclusions
The relationship between coronary risk score and serum CRP and sICAM-1 was not 
significant in our population, as has been shown in Caucasian populations, although a 
positive association was seen with caeruloplasmin concentrations. Clearly 
inflammation augments future coronary risk in addition to traditional risk factors.
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However, owning to the current study design it is hard to specify whether the 
elevation in serum caeruloplasmin levels is to overcome the increased oxidative stress 
or merely reflecting systemic inflammation.
Within the young population of Saudi males there was a high frequency of poor 
lifestyle habits, including positive smoking habit, obesity and high dietary fat. These 
are likely to result in an even greater prevalence of vascular disease in future decades. 
However large-scale prospective studies and intervention trials are needed to establish 
a firm conclusion.
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Chapter 8
Conclusion
8.1 Introduction
Over the last thirty years the Kingdom of Saudi Arabia has witnessed major socio­
economic development leading to significant changes in the standard of living and 
lifestyle of its inhabitants. Changes in dietary habits and related social practices have 
contributed to the high prevalence of conditions such as obesity, 
hypercholesterolemia, and diabetes mellitus (Al-Nuaim et al., 1996; Al- 
Nuaim, 1997(b); Alsaif et al.,2002) that contribute to atherosclerosis.
Atherosclerosis has a multifactorial etiology. Considerable efforts have been made 
worldwide to control the classical coronary risk factors and to detect other factors that 
may promote the progression of CVD. Dietary factors that may be implicated include 
sub-optimal antioxidant vitamins and trace elements (Rock et al., 1996). The essential 
micronutrients, copper, zinc, selenium, vitamin E, vitamin A, vitamin C, and p- 
carotene, may play a protective role in the prevention of disease initiated or promoted 
by harmful free radicals (Diplock,1991).
Although there are strong hypothetical reasons why trace element status may be 
involved in the etiology of CVD (Klevay, 1975), results from epidemiological studies 
have been inconsistent (Manthey et al., 1981, Niskanen et al., 1986) and there are few 
published data on trace element status in non-Westem populations (Abiaka et 
al.,2003b). Furthermore, little information relating trace element status to CVD risk 
factors among Saudis is available (El-Yazigi et al., 1991 ; El-Yazigi et al.,1993 ; El- 
Yazigi and Legayada,1996).
The present understanding of the pathogenesis of atherosclerosis has raised the 
possibility that dietary antioxidants may affect coronary risk. Though attractive, the 
antioxidant hypothesis has not been supported by data from clinical intervention trials 
(Hennekens et al., 1996a, Omenn et al., 1996, Stephens et al., 1996, GISSI prevenzione
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investigators, 1999, PPP study group,2001). Most studies of the association between 
antioxidants and CVD have been undertaken in Western Caucasian populations 
(Rimm et a l, 1993, Stampfer et a l, 1993) and there are no data on this relationship in 
Middle Eastern populations; despite the high prevalence of cardiovascular mortality 
and morbidity in the Middle East (Alwan,1993), there is only one published study on 
normative serum antioxidant vitamin concentrations in the Arab Gulf countries 
(Abiaka et al,2002) and two studies of Saudis (Abahusain et a l, 1999, Al- 
Senaidy,2000). However, none of the aforementioned studies have addressed the 
relationship between diet and cardiovascular disease, especially micronutrients, nor 
did they investigate the possibility of combined suboptimal levels of antioxidant 
vitamins and trace elements in relation to atherosclerosis in a Saudi male population. 
We have examined, for the first time in Saudi Arabia, the relationship between 
antioxidant vitamins and trace elements status and prevalence of atherosclerosis in a 
Saudi male population.
Our study in man was a case-control study of aged-matched Saudi males with and 
without atherosclerosis. The participants were randomly recruited from 2 hospitals in 
the Western province of the Kingdom of Saudi Arabia.
8.2 Differences in demographic characteristics according to age, 
socioeconomic class and race
Our findings are of importance because of the previous lack of data on the prevalence 
of coronary risk factors in Saudi Arabia. A subgroup of particular interest in our 
population is young adults (<33 years of age) in whom smoking habit and physical 
inactivity were reported at a high prevalence when compared to comparable 
Caucasian populations (Gillman et al.,2001). Cardiovascular risk associated with this
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would be expected to be compounded by suboptimal dietary habits as detailed further 
below.
The individuals of middle socio-economic class reported that they had slightly worse 
lifestyle habits than those of low socio-economic class. Unlike the situation in 
developed countries, in which higher education levels were reported to be associated 
with a decreased prevalence of obesity and cigarette smoking, increased level of 
physical activity and appropriate dietary habits (Jacobsen and Thelle,1988).
Another group in which lifestyle was a particular concern is individuals of 
Mediterranean descent in whom the prevalence of chronic diseases, obesity and 
smoking habits were very high. A similar distribution of demographic, clinical, and 
behavioural characteristics has been reported in a dietary study in Greek adults 
(Panagiotakos et al.,2004). Although the putative cardio-protective effects of a 
Mediterranean diet have been well described (de Lorgeril et al., 1999), it is possible 
that many of these individuals no longer maintain their traditional eating habits.
It is noteworthy that definitions of many of these risk factors, such as physical activity 
level, rely on self-reporting and is hard to validate. However, under- or over-reporting 
of cardiovascular risk factors is one of the most common source of systematic bias in 
epidemiological studies (Trelti et al., 1982). This could be due to the tendency of many 
individuals to choose socially desirable responses rather than more objectively 
accurate ones in an effort to present themselves in a positive light to avoid criticism. 
Other potential reasons could be related to cognitive problems in elderly subjects in 
reporting their responses accurately.
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8.3 Demographic, physiologic, and behavioral characteristics of CVD 
patients and their respective controls
In the case-control study, classical coronary risk factors; diabetes, hypertension, 
metabolic syndrome, and dyslipidaemia were found to be a matter of concern in CVD 
patients and their respective controls but they were more common among Saudi 
patients with established CVD. Multivariate analysis further emphasized that 
traditional risk factors, particularly diabetes mellitus and hypertension, were strongly 
correlated with high risk of CVD in our analysis. Both of which are highly prevalent 
in Saudi Arabia according to our results and the results of other local studies (Al- 
Nozha et al., 1997, El-Hazmi et al., 1996). Differences were also evident in some 
reported lifestyle risk factors such as physical activity level and smoking habits with 
the CVD patients being more health conscious as indicated by better lifestyle habits.
8.4 Generational changes in dietary habits
The relationship between diet and the presence of cardiovascular disease risk factors 
was evaluated among a subset of apparently healthy Saudi male controls. The study 
sample comprised a wide range of Saudi males with varying distribution of different 
racial groups and socio-economic classes. The increasing availability of Western-type 
diets to urban dwellers in the Kingdom of Saudi Arabia appears to have resulted in an 
imbalance of macronutrient intake among different socio-economic classes and racial 
groups. In agreement with other studies on Caucasian adolescents (Xie et al.,2003), 
young men in our sample appear to be particularly prone to highly consume Western- 
type diets, and appear to have a high intake of cholesterol and energy as saturated fat, 
and a low PUFA:SFA ratio. The role of the media and increased food supply 
compared to the past also counts. As age increased, healthy food choices may have 
also been affected as reflected on increased carotenoids intake in fruits and
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vegetables. Such an approach was also detected in other international studies among 
non-institutionalized elderly people and attributed to a more varied diet (Drewnowski 
et al., 1997). However, the joint occurrence of a high prevalence of other lifestyle 
coronary risk factors, including sedentary lifestyle and positive smoking habit, would 
further augment the situation.
8.5 Effects of multiracial and diverse socioeconomic makeup of the society 
Differences in nutrient intake and food consumptions with ethnicity, may possibly be 
confounded by social class, but may nevertheless be associated with increased 
susceptibility to the development and occurrence of CVD in our population. Food 
selection and nutrient intake have been shown to have strong social impacts on health 
in other populations (Gex-Fabry et al., 1998). Education levels and family income 
have previously been used as indices of socio-economic status (Liberates et al., 1988). 
It would be expected that subjects with higher education levels would be more health 
conscious and those with higher income can afford diverse diet. However, it was 
thought that occupation plus material possessions might give better indication in an 
aggregate score in the evaluation of socio-economic status in our population. 
Occupation can be a measure of job control in demonstrating someone’s ability in 
work decision authority and skill discretion (Bosma et al., 1997). Material possessions 
could also be an indirect measure of someone’s household socio-economic status 
especially when the subject is unemployed but lives with his rich parents or when a 
subject does not want to reveal his true income. A cluster of suboptimal intake of 
energy and carbohydrate, excessive intake of total fat, SFA, PUFA, and high 
PUFA: SFA ratio were associated with sedentary lifestyle, positive smoking history, 
and higher prevalence of hypertension, diabetes mellitus, and dyslipidaemia in the 
subjects of low social class. Food preference, cost and availability may have
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predisposed to difference in micronutrient intakes between the 3 social class 
categories. Such factors may be additive or even have synergistic effects on the 
deleterious dietary behaviour.
It has been previously reported in other populations that immigrants are at higher risk 
of morbidity and mortality compared with natives of the host countries (Anand et 
al.,2000). Subjects of Arabian tribes descent, who had considerable within-group 
diversity in socioeconomic status, BMI classes, and smoking habits, had a higher 
intake of cholesterol and energy-adjusted SFA and consequently lower PUFA: SFA 
ratio than those of Mediterraneans and Asians background. Albeit they have shown 
the lowest prevalence rates of hypertension, diabetes mellitus, and dyslipidemia 
against the other racial groups, these results suggest that their current dietary patterns 
may predispose to increased adverse health conditions. Thus, it is unclear whether 
increased coronary risk in other racial groups is genetically predetermined or if it is a 
consequence of migration.
8.6 Dietary micronutrients association with cardiovascular risk 
Dietary advice is routinely given to CVD patients after developing the disease; 
however, in our study they reported higher dietary intakes of energy, cholesterol, trace 
elements, vitamin A and E. Thus, it could be speculated that their former diet was 
even higher in fat thereby contributing to their higher proportion of overweight 
subjects. Moreover, a substantial proportion of the whole population is at increased 
risk of developing micronutrients deficiency if the United Kingdom dietary 
recommended values were used as a standard, in the absence of Saudi dietary 
recommendations.
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Our data are consistent with the findings of other studies, though these previous 
studies have neither considered the same age group nor the same target population 
(Deurenberg-Yap et al,2000. Oh and Hong 2002, Shahar et al,2003).
Observational studies provided clear evidence that diets rich in antioxidants reduce 
the relative risk of premature death fi*om CVD (Riemersma et a l, 1991). Accordingly, 
suboptimal levels of several antioxidants may increase the risk independently 
(Gey, 1993). Our data show that the average intake of selenium was below 100% of 
EAR in almost 80% of the population in individuals of the case-control study and 
among participants of the dietary study. Inadequate intake of vitamin E was reported 
by -60% of young Saudi adults and vitamin A inadequacy was also reported in -70% 
of the controls in the case control study, among elderly individuals, those of high 
socioeconomic status, and those of Asian descent. Thus reflecting probable 
inadequacy in the micronutrient content of the normal Saudi diet. Even though the 
mean intake of vitamin A appears adequate, the wide range of vitamin A levels 
indicates that approximately more than half of population maybe consuming below 
100% of the EAR.
8.7 The use of serum biomarkers as an indication of antioxidant status
Serum antioxidant vitamin concentrations have been reported to reflect the 
antioxidant body status (Gey, 1993). They can also serve as an indirect measure of 
antioxidant intake as well as a marker of consumption of healthy food (Rock et 
al., 1996). Although FFQ provide only an approximate measure of usual dietary 
intake, there was a reasonable correlation between serum vitamin A levels and dietary 
intakes, which was comparable to correlations found in previous studies (Willett et 
al., 1983(a), Roidt et al., 1988, Mayer-Davis et al., 1999) but this was not so for vitamin 
E. Low correlations are to be expected since serum biomarkers are not influenced by
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diet alone and previous studies reporting associations between a-tocopherol intake 
and serum levels were undertaken in populations where vitamin E supplement use is 
highly prevalent (Rimm et a l, 1992).
The development of biomarkers to measure oxidative stress means that more reliable 
and precise estimates of oxidative stress may be made (Halliwell,1999). Hence the 
need to measure these biomarkers in micronutrient deficiencies and correlate them to 
micronutrient status may be important. The determination of serum levels of trace 
elements often remains as the sole available method for assessing their effect. 
However, it has not been confirmed that serum levels are reliable indicators of 
nutritional adequacy of trace elements except in extreme situations, albeit, assessing 
the relation between intake levels and biomarkers of their status can be very helpful.
8.8 Influence of interaction between different micronutrients on the 
antioxidant defenses
Interactions are thought to occur between different elements of micronutrient 
metabolism, suggesting that dietary constituents should be studied as profiles rather 
than single factors. Interactions between different antioxidants and their possible 
additive and synergistic effects have been investigated extensively in recent years 
(Blot et al.,1993. Tardif et al., 1997, Hercberg et al., 1998, Salonen et al.,2000). The 
biochemical functions of selenium and vitamin E are interrelated in that both are 
essential components of the antioxidant defence system and they appear to have 
synergistic and compensatory effects in induced deficiency states of one on the other 
(Bartfay et al., 1998). Combined deficiency of vitamin E and selenium leads to 
cardiovascular abnormalities in experimental animals (Ringstad et al., 1988). Vitamin 
C seems to have a sparing effect on vitamin E by recycling the a-tocopheroxyl 
radicals back to the active reduced form of vitamin E (Chan, 1993). Thus, the
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availability of both vitamins would have better defensive ability against oxidative 
damage compared with single vitamins (Wefers and Sies,1998). Zinc and vitamin A 
have also been shown to be interdependent. It is postulated that zinc has a regulatory 
role on vitamin A transport, mediated through retinol-binding protein (RBP) synthesis 
in the liver and participates in the oxidative conversion of retinol into retinal, a critical 
step in the metabolic pathway of vitamin A (Smith et al., 1976). The fluctuation in the 
status of one or both micronutrients is expected to alter the metabolism of the other, 
with functional consequences on the health of the individual (Christian and 
West, 1998).
Micronutrients interaction was clearly demonstrated by our findings of a simultaneous 
inadequate intake of vitamin E and selenium in the young Saudi adults, the protective 
role of high serum zinc and vitamin A levels as indicated by multivariate analysis in 
the case-control study of CVD patients and their age-matched controls. The 
importance of the copper/zinc ratio in serum was also another important finding in 
determining coronaiy risk in the case-control study.
8.9 Findings from the animal study are backing up the human study 
observations on trace elements association with atherosclerosis 
The cholesterol-fed rabbit is the classical model for the study of the role of 
lipoproteins in experimental atherosclerosis (Fox, 1984). The rabbit is extraordinarily 
sensitive to high levels of dietary cholesterol, which induce severe 
hypercholesterolemia associated with rapid development of atherosclerosis. 
Morphologic and immunocytochemical studies were performed to determine the 
sequence of cellular interactions that occur during the initiation of the fatty streak in 
the aorta of hypercholesterolemic fat-fed rabbits but little work has been done in order
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to investigate the effect of trace element supplementation on the progression of 
atherosclerotic lesions.
Copper deficiency has been reported to cause hypertension, hypercholesterolemia, 
and increase in LDL in animal models (Klevay, 1975, Hassel et al., 1982). Our study 
on the effects of the balance between dietary supplementation of copper and zinc on 
atherogenesis in NZW rabbits showed that both individually inhibit atherogenesis. 
This was previously demonstrated by copper supplementation alone using the same 
level (Lamb et al., 1999). Although zinc supplementation did not appear to reduce the 
efficacy of copper supplements, there was no significant additional effect when used 
in combination. At the doses used, both trace elements reduced serum lipid peroxides, 
indicating that they may probably act by an induction of SOD expression. In vitro 
studies have shown that zinc inhibits LDL oxidation by cells or transition metals 
(Wilkins and Leake, 1994, Disilvestro and Blosteinfliji,1997). Thus, suggesting that 
zinc may exert a protective effect against atherosclerosis.
In parallel with this, our data from the human study have shown a possible association 
of serum zinc and serum copper/zinc ratio with low cardiovascular risk. Prospective 
studies have also suggested an association between low serum levels of zinc with an 
increased risk of CVD (Kok et al., 1988, Reunanen et al , 1996). Hence the ratio of 
dietary zinc to copper may be an important determinant of coronary risk, a hypothesis 
first proposed by Klevay (1975). The role of increase in serum copper with unchanged 
zinc and consequently decreased zinc/copper ratio in determining increased risk of 
CVD has been demonstrated in human before (Iskra et al.,1993).
Multivariate analysis also showed that measures of selenium status in serum and urine 
appear to be associated with the risk of atherosclerosis in a Saudi male population. 
Our data were in agreement with other studies (Salonen et al., 1982), which have
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found an increased risk of myocardial infarction in patients with low selenium levels. 
Relating effects of dietary deficiencies to biochemical activity is a major goal in 
understanding the pathophysiology of diseases. Our human data showed that a low 
dietary selenium intake was fairly common in the Saudi population, hence a low 
selenium status may be a contributory factor for CVD in Saudi Arabia. Selenium 
deficiency is often associated with reduced activity of GPx (Salonen et al., 1988). 
However, remarkably, low serum selenium concentrations were found to be of 
significant association with atherosclerosis after adjusting for other risk factors, 
including erythrocyte GPx. This suggests that the benefits of selenium may be 
conferred by a mechanism unrelated to the antioxidant effects of GPx.
Of the various trace elements, only selenium in serum may be considered to fulfil the 
criteria as a reliable biomarker (Diplock,1993). It should be noted that copper and 
zinc levels in serum only reflect trace element status in severe deficiency or excess 
(King, 1990, Milne, 1994). That is because of the homeostatic regulation where the 
release of trace elements from tissues is only impaired in cases of severe overload or 
exhaustion. Thus, we aimed to assess trace elements status by measuring their serum 
levels in addition to several surrogate markers of their intracellular levels (Reiser et 
al., 1985, Milne, 1994, Diplock,1993).
8.10 The role of dietary antioxidant vitamins
In addition to genetic predisposition, dietary factors play an important role in the 
determination of an individual’s health since health is a function of preventable risk 
factors and their determinants. Our data have shown that serum vitamin A, dietary 
total fat and vitamin A intakes were independent coronary risk factors using 
multivariate analysis. Even though some potential confounders were adjusted for, the 
possibility still remains that other factors associated with antioxidant vitamins and
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trace elements might be responsible for the observed effects. This is the first report of 
a potentially deleterious role in CVD of excessive dietary vitamin A in a non- 
Caucasian population. Increased cardiovascular mortality with retinol 
supplementation has been shown previously in a randomized controlled trial (Redlich 
et al., 1999). However, these results do not reflect direct causal effects due to our study 
design. Therefore, it is possible that the differences in antioxidant vitamins and trace 
elements status are a consequence of the disease rather than contributory 
determinants. Moreover, even with the absence of a known recommended value for 
carotenoids in general and specifically dietary p-carotene, the reported high intake of 
carotenoids in this population is highly unlikely to give rise to vitamin A toxicity. The 
carotene cleavage enzyme, carotene dioxygenase, in the intestinal lining is inefficient 
in the conversion of p-carotene to retinal. Recent evidence suggests that antioxidants 
could be prooxidants under certain conditions (Santanam and Parthasarathy, 1995). In 
the same context, vitamin E has been reported to exert pro-oxidant activity in the 
oxidation of LDL, particularly in the presence of peroxides, which have not yet been 
fully characterized in vivo (Upston et al., 1999).
8.11 Inflammatory markers of predictive value in Saudi apparently 
healthy subjects
The importance of elevation of coronary risk and the synergistic effect of multiple 
factors is a serious health issue. Hence, the measurement of more than one 
inflammatory marker with different reactivities in conjunction with traditional 
coronary risk factor may be expected to provide better information about whether 
cardiovascular risk in individuals with heightened concentrations of the inflammatory 
markers is also high.
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Of the serum inflammatory markers measured, only serum caeruloplasmin showed a 
gradual (though non-significant) rise in its median value with increasing Framingham 
risk score. Moreover, caeruloplasmin levels were also correlated with the 
Framingham risk score. This may indicate that serum caeruloplasmin levels may be of 
value in predicting coronary heart disease, which appears to be associated with a state 
of chronic low-grade inflammation, in apparently healthy Saudi subjects. Previous 
studies have also indicated significant associations between serum caeruloplasmin 
levels and traditional risk factors (Cignarelli et al., 1996, Craig et al., 1995). However, 
it is not possible to confirm from our study design whether caeruloplasmin is an 
independent risk factor and has additional predictive value to that of traditional risk 
factors. Moreover, acute-phase proteins are considered to be extremely sensitive to 
infections and inflammation but they are non-specific and can be produced in 
response to most forms of tissue injuries. Subclinical infections might be common and 
undetected in our population from Jeddah, where Muslim pilgrims from different 
parts of the world are visiting for some time after performing the Islamic rituals, Hajj 
and Umraa. However, in recruiting controls it is often assumed that they are free of 
infections, as they have no clinical manifestation.
8.12 Key findings of this study
• In the rabbit model of atherogenesis, dietary copper and zinc supplementation 
have been shown to reduce the development of atherosclerotic lesions and plasma 
lipid peroxides probably by an induction of SOD expression.
• Our results suggest that low serum vitamin A, serum selenium, serum zinc, serum 
copper/zinc ratio, and high urine selenium levels may be associated with increased 
cardiovascular risk. Increased dietary fat and vitamin A intakes were independent 
coronary risk factors as well.
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• Surprisingly, CVD patients have reported higher daily intakes of energy, total fat, 
cholesterol, trace elements and vitamins. This should reflect their improved 
dietary habits after becoming cases; hence, they might have had worse dietary 
intakes in the past. A substantial proportion of both groups, CVD patients and 
their matched controls, had selenium intake below recommended levels
• Inflammation has the potential to augment future coronary risk in addition to 
traditional risk factors indicated by a positive association between serum 
caeruloplasmin concentrations and Framingham coronaiy risk score.
8.13 General limitations of the study design 
Most epidemiological data obtained on the relationship between antioxidants status 
and pathologies are based on an observational approach, comparing several 
populations consuming different levels of vitamins and trace elements or with their 
variable biological status. Thus, it is not possible to simply attribute the differences in 
frequencies of CVD to antioxidants status. A multitude of other potential risk factors, 
such as other dietary and lifestyle characteristics, must be considered. Demonstration 
of a relationship at the cluster level may indicate the reality of this relationship at an 
individual level by the use of case-control studies. However, the main difficulty in 
interpreting these studies lies in the impossibility of determining whether the assessed 
dietary intake or blood concentration of nutrients existed before the onset of the 
disease or were the consequence of the disease process.
Our study shares the limitations of observational studies such as unsuspected selection 
bias and confounding factors. Sources of potential bias in collecting dietary data, such 
as exposure misclassification or recall bias, were minimized by the use of 2 different 
validated methods in which measurement errors by each are independent of the other. 
A related problem in self-reported dietary data is underreporting of dietary energy
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intake, which is most common in obese and dieting adults. Yet the possibility of an 
unexpected finding being due to chance, subtle biases, or residual confounding can 
never be fully excluded in any observational study.
One of the major limitations of this study is the lack of established reference interval 
ranges of trace elements and vitamins serum levels in Saudis as well as the use of 
definitions and/or cut-off values withdrawn from studies undergone in Caucasian 
populations to determine the prevalence of dyslipideima, diabetes mellitus, and 
hypertension. The same is true for using the United Kingdom and US food 
composition tables to analyse macro- and micronutrient intakes as well as the United 
Kingdom dietary recommended values as a measure of nutritional requirements. To 
minimize this problem, we have complimented nutritive values when needed with 
published food composition tables specific for the use in the Middle East region. 
However, this study is the first step in the development of an integrated food 
composition database for Saudi food that could be used in other epidemiological 
studies. Another example is the possibility of misclassification or underestimation of 
the CVD severity by the use of number of coronary vessels with >50% obstruction as 
an indicator. This means that any case with obstruction <50% or the existence of 
obstruction else where along the arteries might be undetected. Furthermore, the use of 
Framingham and PROCAM coronary risk scores to evaluate coronary risk has been 
shown to over-estimate risk in non-Caucasian populations, rendering independent 
validation difficult (Laurier et al., 1994, Wilson et al., 1998).
Other limitations specified to case-control studies are restricted time limit, sample 
size, differential misclassification, and quality of exposure information. For example, 
the lack of information on other co-existing diseases, such as cancer, that might 
substantially affect antioxidant status. Another example is the attainment of single
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measurement of blood levels some time after the index event, thus not distinguishing 
between short-term and long-term exposures to usual blood levels.
8.14 Recommendations
Our observations along with the strong biological rationale and epidemiological data 
relating antioxidants to lower coronary risk justify the need for further prospective 
cohort studies in non-Caucasian populations in order to confirm it.
These data provide insights into the different dietary patterns within the Saudi 
population and their impact on macronutrient intake. It is apparent that healthy dietary 
habits are not being followed. While the reasons for this are complex, knowledge 
about diet does influence food choice and dietary behaviour. This is likely to lead to 
an escalation in the incidence of cardiovascular disease over the next decade. This 
problem can only be averted by raising public awareness and the development of 
appropriate population-specific nutritional guidelines.
In view of the increasing fat consumption and its high contribution to dietary energy 
in a sizable portion of the population, efforts must be made to reverse the trend. It is 
important to strengthen nutritional education in the general population in particular 
among low social class groups with high incidence of chronic diseases.
Dietary intervention strategies could contribute to micronutrient adequacy and chronic 
disease prevention among young individuals.
8.15 Future work
• Several epidemiological studies have shown that increased intake and higher 
plasma levels of antioxidant vitamins are associated with a reduced risk of CVD 
(Knekt et al., 1994, Riemersma et al.,1991). Suboptimal levels of each vitamin 
increase cardiovascular risk singly, whereas combined deficits of antioxidants 
would have multiple effect on increasing cardiovascular risk (Gey, 1995). Other
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carotenoids, such as, lycopene have been shown to have antioxidant properties 
without provitamin A activity and is more potent than a- or p-carotene (DiMascio 
et ah, 1989). Low levels of lycopene were reported to be associated with 
cardiovascular risk (Rissanen et al.,2003). We have reported mean intakes of 
carotenoids and vitamin C but we were not able to measure their serum levels. 
However, their reduced plasma levels of antioxidant vitamins were previously 
documented due in part to smoking habits or unsuitable storage conditions of 
imported fruits and vegetables. Thus, a possibility of reduced serum levels even 
with the reported adequate intakes could not be totally eliminated. The assessment 
of association between dietary intakes of other antioxidant vitamins, such as 
lycopene, vitamin C and P-carotene, to their serum levels might be of importance 
in evaluating cardiovascular risk.
We have demonstrated that dietary supplementations of copper and zinc at the 
doses used both inhibited aortic atherogenesis in the cholesterol fed rabbits, 
although there was no significant additional effect when given in combination 
(Alissa et al.,2004). A biphasic relationship between dietary copper intake and 
atherosclerosis has been described previously in which either copper deficiency or 
excess were associated with increased susceptibility to aortic atherosclerosis 
(Lamb et al.,2001). Furthermore, the ratio of dietary zinc to copper suggested to 
be an important determinant of coronary risk (Klevay,1975). Thus, it would be 
interesting to investigate the antiatherogenic effects of other concentrations of zinc 
supplementation as well as the additive effect of copper and zinc interaction at 
different levels in further experimental studies.
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Appendices
Appendix-1: Buffer solutions
I. Estimation of caeruloplasmin
Acetate buffer, pH5.0, ionic strength 0. IM.
In a IL volumetric flask, 13.608g of sodium acetate‘3H20 and 2.6ml of glacial acetic 
acid were mixed with 800ml deionized distilled water. The pH was measured by a pH 
meter (Coming pH meter-320) and was adjusted to 5.0 by addition of O.IM sodium 
hydroxide or glacial acetic acid. The volume was completed to IL with deionized 
distilled water, mixed well, and stored at 4°C.
II. Electron microscopy
Cacodaylate buffer, pH  7.3, ionic strength 0.15 mol/l.
In a IL volumetric flask, 42.8g of sodium cacodylate was dissolved in 800ml 
deionized distilled water. The pH was measured by a pH meter (Coming pH meter- 
320) and was adjusted to 7.2 by dropwise addition of O.IM sodium hydroxide or IM 
hydrochloric acid. The volume was completed to IL with deionized distilled water, 
mixed well, and stored at 4°C.
III. Perfusion fixation
4% paraformaldehyde in phosphate buffered saline (PBS).
8% paraformaldehyde was prepared by dissolving 8g of paraformaldehyde in -80ml 
of boiling distilled water in a measuring flask. The flask was placed on a heated stirrer 
inside the fume hood until dissolved. Drops of 5M sodium hydroxide were added to 
remove any cloudiness. The mixture was allowed to cool before completing the 
volume to 100ml with deionized distilled water, mixed well, and stored at 4°C. Just 
before use, 1 volume of 8% paraformaldehyde was mixed with 1 volume of PBS.
IV. Tissue SOD
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Phosphate buffer saline (PBS), pH  7.4, ionic strength 50mM, containing 0.3M 
potassium bromide and 3% (v/v) proteases cocktail inhibitor.
20mM PBS was prepared in a IL volumetric flask by dissolving 8.66g of disodium 
hydrogen phosphate, 5.38g of sodium dihydrogen phosphate, and 8.77g of sodium 
chloride in ~800ml deionized distilled water. The solution pH was adjusted to 7.0 by 
dropwise adding of sodium hydroxide (50% w/w solution). Then the volume was 
completed to IL with deionized distilled water, mixed well, and stored at 4°C. The 
homogenizing buffer was prepared by adding: 10ml of PBS, 400mg of potassium 
bromide (0.3M), and 300pl of antiproteolytic agent (protease inhibitor cocktail ® 
Sigma).
Tris-HCL, pH  7.5, ionic strength 50mM, containing 5mM Ethylene Diamine Tetra 
Acetic acid (EDTA) and ImM2-mercaptoethanol.
In a IL volumetric flask, 50mM of Tris base was prepared by dissolving 6.1 g of Tris 
in ~800ml deionized distilled water. 1.46g of EDTA disodium salt was added to 
prepare 4mM of EDTA. 85.69jal of 2-mercaptoethanol was also added in the fume 
hood. Concentrated hydrochloric acid (12M ± 0.5M) was added dropwise to reach the 
pH value of 7.5. Then the volume was completed to IL with deionized distilled water, 
mixed well, and stored at 4°C.
V. Tissue GPx
Tris-HCL, pH 7.5, ionic strength 50mM, containing 5mM EDTA, and ImM Di Thio 
Threitol (DTT).
In a IL volumetric flask, 50mM of Tris base was prepared by dissolving 6.1 g of Tris 
in ~800ml deionized distilled water. 1.46g of EDTA di sodium salt was added to 
prepare 4mM of EDTA. 85.69pl of DTT was also added. Concentrated hydrochloric 
acid (12M ± 0.5M) was added dropwise to reach the pH value of 7.5. Then the
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volume was completed to IL with deionized distilled water, mixed well, and stored at 
4°C.
VI. Tissue TEARS
1 OOmMphosphate buffer saline.
In a IL volumetric flask 23g of disodium hydrogen phosphate, 4.6g of sodium 
dihydrogen phosphate, and 190g of sodium chloride were mixed with -800ml 
deionized distilled water. The solution pH was adjusted to 7.0 by dropwise adding of 
sodium hydroxide (50% w/w solution). Then the volume was completed to IL with 
deionized distilled water, mixed well, and stored at 4°C.
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Appendix-2: Histological staining methods
I. H&E staining
Aortic segments cut in cross section at 3 to 4mm intervals were fixed in neutral 
phosphate buffered formalin 4% overnight. Tissue processing was undertaken in 3 
steps; dehydration in 6 alcohol solutions of different concentrations and purities (70% 
alcohol, 85% alcohol, 95% alcohol, 100% alcohol I, 100% alcohol II, 100% alcohol 
III) for 2hr in each solution, clearing twice in toluene for 2hr in each, and 
impregnation in paraffin wax twice for 2hr in each. Serial 5pc sections in thickness 
were taken from each aortic segment taken at the first intercostals level (Microtome 
from Leica RM2135, LEICA instruments GmbH, Nussloch, Germany). Tissue 
staining was performed according to the following procedure: placing the slides rack 
in xylene I for 10 minutes, in xyelen II for 10 minutes, in ethyl alcohol absolute I for 2 
minutes, in ethyl alcohol absolute II for 2 minutes, in ethyl alcohol 90% for 2 minutes, 
and finally in ethyl alcohol 70% for 2 minutes. Slides were then rinsed in distilled 
water until they are clear. Staining begun by placing the slides rack in haematoxylin 
solution for 3 minutes, then under running tab water for 5 minutes, dipping in ethyl 
alcohol 70% for 10 dips, in eosin/ phloxin mixture for 1 minute, in ethyl alcohol 
95% for 10 dips, in ethyl alcohol absolute I for 10 dips, in ethyl alcohol absolute II 
for 10 dips, in xylene I for 20 dips, in xylene II for 20 dips, and finally in xylene III 
for 20 dips. Mounting the coverslip with DPX resin (which is a mounting media, a 
mixture of distyrene (a polystyrene), a plasticizer (tricresyl phosphate), and xylene).
II. Orcein Elastin stain 
Aortic segments cut in cross section at 3 to 4mm intervals were fixed in neutral 
phosphate buffered formalin 4% overnight. Tissue processing was undertaken as 
stated above. Serial 5pc sections in thickness were taken from each aortic segment
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taken at the seventh intercostals level (Microtome from Leica RM2135, LEICA 
instruments GmbH, Nussloch, Germany). Then the staining procedure was as follows: 
placing the slides rack in 1% potassium permanganate for 5 minutes and in 1% oxalic 
acid for 1 minute. Slides were then rinsed in distilled water. Staining begun by placing 
the slides rack in acid orcein solution (prepared from Igm orcein, 100ml 70% ethanol, 
and 1ml conc. hydrochloric acid) for overnight. The same steps of washing and 
differentiation in absolute alcohol, dehydration in alcohol solutions, clearing in 
xylene solutions and mounting with DPX resin were undertaken as stated before.
III. Oil red O staining
Segments taken from the third up to the sixth intercostals artery branch point were 
fixed in 4% paraformaldehyde overnight. Then the staining procedure was performed 
as followed: dipping the aorta sections in 80% propan-2-ol, adding 2ml oil red O 
solution and stain for 90 seconds. Rinsing in 80% propan-2-ol, in phosphate buffered 
saline and then returning to oil red O and stain again for 90 seconds and rinsing in 
80% propan-2-ol, in phosphate buffered saline. Aortic sections were then returned to 
the fixative. The sections were pinned out fiat with the endothelial surface uppermost 
on a corkboard and photographed en face.
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Appendix-3: Questionnaires
I. General questionnaire 
Medical history
1. Do you have diabetes? O Yes O No
2. Do you take insulin? O Yes O No
3. Do you take any hypoglycaemic drug? O Yes O No
4. Has anyone in your family been diagnosed with diabetes? O Yes O  No
5. Do you have high blood pressure? O Yes □  No
6. If yes, are you now taking medicine for high blood pressure? O Yes O No
7. Do you have high cholesterol? O Yes O No
8. If you have high cholesterol, do you take cholesterol-lowering medication?
□  Yes n  No
9. Has one or more of your parents, grandparents had heart diseases before the 
age of 55? O Yes O No
10. Do you frequently have chest pain? □  Yes O No
11. Have you ever had a heart attack? O Yes O No
12. Have you been diagnosed with coronary heart disease (CAD)? O Yes O  No
13. If yes, have you ever had a cardiac catheterization or angioplasty procedure?
□  Yes O No
14. Have you changed your diet after the heart attack? □  Yes O No
15. Do you have any other serious medical conditions? O Yes O  No
16. Have you been hospitalized in the last 6 months? O Yes O No
17. Have you ever had any operations? O Yes O No
18. Do you have a family history of peripheral vascular diseases (PVD)?
O Yes O No
19. Do you have lower limb discomfort while walking? O Yes O No
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20. Have you had more than 4 colds, sore throat? Flu within last year?
n  Yes n  No
21. How often do you have diarrhea? (diarrhea is more than 4 times a day)
n  Yes D No
22. Do you usually take nutritional, herbal or other natural therapies?
n  Yes n  No
23. If yes, what kind of therapies are you currently on?
24. Do you use any kind of supplementation to protect your health in general?
n  Yes O No
25. If yes, what kind of supplementation do you use?
n  Vitamins O Minerals
n  Vitamins & minerals O Yeast
n  Others, specify................................
26. Do you take your weight regularly? O Yes O No
27. Does your weight fluctuate? □  Yes O No
28. Have you started a diet more than 2 times within the past year? n  Yes O No
29. List your current medications:
30. What kind of water do you use for drinking?
n  Zamzam water O Tab water 
O Imported mineral water (Evian, Volvic)
O Local mineral water (Najran, Alqassem) 
n  Locally bottled water
31. What kind of water do you use for cooking?
n  Tab water
O Local mineral water (Najran, Alqassem)
O Locally bottled water
32. If using a mineral water, what kind?
33. Do you eat salty food or cook with salt? O Yes O No
34. Do you usually use table salt with your meals? O  Yes O  No
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35. Do you use canned food? O Never O Occasionally O Frequently
36. What is your favorite kind?
37. Do you like nuts? n  Yes O No
38. What is your favorite kind?
Socioeconomic status
39. What is the highest grade you completed in school?
n  Primary school or less O Intermediatery school 
n  High school graduate O Community college or polytechnic 
n  College graduate O Postgraduate or professional degree
40. What kind of a job?
n  Retired/ unemployed O Manual worker 
d  Office worker d  Skilled professional
d  Managerial post
41. What kind of residence do you live in?
d  Rented flat d  Owned flat d  Rented villa 
d  Owned villa d  Compound d  Traditional housing
42. What is your annual income?
d  Less than 50,000 riyals d  50,000-100,000 riyals
d  100,000-250,000 riyals d  More than 250,000 riyals
43. How many cars have you got? d  None d  l d  2 d  More than 2
44. How many drivers have you got? d  None d  l d  2 d  More than 2
45. How many maids and other workers have you got?
d  None d  1 d  2 d  More than 2 
Physical activity
46. How do you usually travel on a typical day?
d  Walk d  Bicycle d  Motorcycle
d  Car d  Bus d  Mostly at home
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47. In an average week, how many times do you engage in physical activity 
(which last at least 20 minutes without stopping and which is hard enough to 
make you sweat, breath heavier and your heart beat faster)?
d  Less than 1 time d  1-2 times d  At least 3 times
48. Which best describes how much you exercise?
d  I spend most of the day sitting and rarely get to exercise
d  I spend most of the day sitting but I exercise for at least half an hour at 
least 3 days a week
d  I participate in regular workout exercise in a health club
d  I have a very physical job (construction worker, waitress) and/ or 
exercise at least 1 hour every day
49. Do you experience any shortness of breath during walking?
d  Never d  Only after 15 minutes
d  Only if climbing stairs d  Always
Smoking
50. How would you describe your smoking habits?
d  Never smoked, go to question 57 d  Still smoking
d  Used to smoke, go to question 54
51. How many cigarettes do you usually smoke per a day? Number:
52. How long have you been smoking for? Duration in months:
53. How many Shisha/ argella do you usually smoke?
d  Once a week d  2-4 per week 
d  Once a day d  More than once a day
54. If a former smoker, how many years ago did you stop smoking?
Duration in months:
55. How many cigarettes did you used to smoke per a day? Number:
56. How long did you smoke for? Duration in months:
57. Are you a passive smoker? d  Yes d  No
58. If yes, how long for? Duration in months:
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II. Food Frequency Ouestionairre
Food item Quantity
Average
2-4 
times a 
day
Once
daily
1-3 
times a 
week
1-3 
times a 
month
Almost
never
Code
1
1-1
Grains
Com 1 cone
1-2 Pasta 8 table spoon
1-3 White rice 8 table spoon
1-4 White rice 
with milk 
(Saleeg)
8 table spoon
1-5 Tomato rice 
(Kabsa)
8 table spoon
2
2-1
Bread
White Arabic 
bread
Medium size
2-2 Brown Arabic 
bread
Medium size
2-3 White toast 1 slice medium 
size
2-4 French loaf Medium size
2-5 Afghani bread Medium size
3
3-1
Fmits
Apple Medium size
3-2 Banana Medium size
3-3 Dates 5
3-4 Grapes 10
3-5 Grape fruit Medium size
3-6 Guaya Medium size
3-7 Lemon Medium size
3-8 Mandarin Medium size
3-9 Melon Thin slice
3-10 Orange Medium size
3-11 Watermelon Thin slice
4
4-1
Vegetables
1 cupCauliflower
4-2 Carrots Medium size
4-3 Cucumber 1 cup
4-4 Tomato Medium size
4-5 Aubergine 1 cup
4-6 Marrow Medium size
4-7 Lettuce 1 big leaf or 2 
medium leaves
4-8 Okra 10 pieces
4-9 Olives 10 medium
4-10 Green onion Medium size
4-11 Onions Medium size
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4-12 Green peas Plate
4-13 Hot green 
peppers
Medium size
4-14 Sweet green 
peppers
Plate
4-15 Boiled/ cooked 
potatoes
Medium size
4-16 Fried potatoes 10 sticks
4-17 Molokhiah Vi cup
4-18 Spanish Plate
4-19 Garlic 1 medium clove
5
5-1
Legumes 
Baked beans Plate
5-2 Chick peas Plate
5-3 Lentil Plate
5-4 Fava beans Plate
6
6-1
Nuts
Peanuts 20
6-2 Melon seeds A hand full
6-3 Pistachio V2 cup (peeled)
6-4 Mixed nuts A hand full
7
7-1
Meat, ooultrv 
& fish
Beef & meat 
burgers
1 piece the size 
of a medium 
sized burger
7-2 Chicken Leg or breast
7-3 Brain Vz cup
7-4 Kidney Vz cup
7-5 Lamb 1 piece the size 
of a medium 
sized burger
7-6 Goat meat 1 piece the size 
of a medium 
sized burger
7-8 Liver 1 piece the size 
of a medium 
sized burger
7-9 Tongue 1 piece the size 
of a medium 
sized burger
7-10 Eggs 1 egg
7-11 Spanish
omllette
Plate
7-12 Fish 1 piece the size 
of a medium 
sized burger
7-13 Shrimps 6 pieces
7-14 Chicken
shawerma
1 medium 
sandwich
379
7-15 Meat
shawerma
1 medium 
sandwich
8
8-1
Dairy products
1 table spoonButter
8-2 White/ cream 
cheese
1 slice
8-3 Soft cheese 1 table spoon
8-4 Low fat cheese 1 piece the size 
of kiri
8-5 Milk 1 cup
8-6 Low fat milk 1 cup
8-7 Fat free milk 1 cup
8-8 Yogurt 1 cup
8-9 Low fat yogurt 1 cup
8-10 Free fat yogurt 1 cup
9
9-1
Fat & oil 
Ghee 1 table spoon
9-2 Vegetable oil 1 table spoon
9-3 Olive oil 1 table spoon
10
10-1
Soft drinks
1 glassCanned juices
10-2 Soda 1 glass
10-3 Milk chocolate 1 glass
10-4 Turkish/ 
Arabic coffee
1 cup
10-5 Tea 1 cup
10-6 Fresh juices 1 glass
11
11-1
Miscellaneous
1 cup
& iunk food
Ice cream
11-2 Sesame butter 1 tea spoon
11-3 Honey 1 table spoon
11-4 Ketchup 1 table spoon
11-5 Pizza 1 slice
11-6 Meat pie 
(motabak)
Medium size
11-7 Banana pie 
(motabak)
Medium size
11-8 Meat pie 
(mantoo)
3 pieces
11-9 Spring rolls 3 pieces
11-10 Jam 1 table spoon
11-11 Cream caramel % cup
11-12 Custard Vz cup
11-13 Chocolate Medium size
11-14 Toffee Medium size
11-15 Chips 1 small bag
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III. 24hr dietary recall
When did you wake up yesterday?
Is this your usual time?
What did you have for breakfast?
Did you take anything between breakfast and lunch? If yes, then what? 
What did you have for lunch?
Did you take anything between lunch and dinner? If yes, then what? 
What did you have for dinner?
Did you take anything before going to sleep? If yes, then what?
What time did you go to sleep?
Is this your usual time?
Is this your usual intake of food? If not, how different?
Does your intake differ during the weekend? If so, how?
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Appendix-4: Rabbit chow diet composition
Diet composition Percent
Crude protein 18.50
Crude fat 3.00
Crude fiber 11.50
Ash 7.50
Salt 0.50
Calcium 0.9
Phosphorus 0.60
Vitamin A, lU/Kg 12.00
Vitamin E, lU/Kg 50.00
Vitamin D, lU/Kg 2.20
Energy, ME Kcal/Kg 2000.0
Trace minerals added include: Cobalt, Copper, Zinc,
Selenium, Iron, Iodine, and Manganese._______________
Manufactured by: Grain silos and flour mills organization, Saudi Arabia.
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